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1 - Abbreviations 
 
2D      two-dimensional 
3D      three-dimensional 
A!      Amyloid-! 
ACE      Angiotensine-converting enzyme 
AD      Alzheimer's Disease 
APP      Amyloid Precursor Protein 
AWLN    Advanced Wiswesser Line-Formula Notation 
BEDROC    Boltzmann-enhanced Receiver Operating Characteristic 
BLOSUM    Block Substitution Matrix 
CANGEN    Canonization and Generation 
CbC      Comparison by Compression 
COBRA    Collection Of Bioactive Reference Analogues 
COX      Cyclooxygenase 
CROSSBOW   Computer Retrieval of Organic SubStructures by means of Wiswesser 
CSI      Chemical Substructure Index 
CUDA     Compute Unified Device Architecture 
DDP      Double Dynamic Programming 
DHFR     Dihydrofolatreductase 
dMTP     Deoxythymidine Monophosphate 
EF      Enrichment Factor 
ELISA     Enzyme-linked immunosorbent assay 
FAST      Fragment Alignment Search Tool 
FDA      Food and Drug Administration 
FPGA     Field Programmable Gate Array 
FSM      Finite State Machine 
FXA      Factor Xa 
GPU      Graphics Processing Unit 
GS      "-Secretase 
GSI      " -Secretase Inhibitor 
GSM      " -Secretase Modulator   7!
HTS      High Throughput Screening 
IC50      Inhibitory Concentration 50% 
InChi    International  Union  of  Pure  and  Applied  Chemistry  International 
Chemical Identifier 
InChiKey    International  Union  of  Pure  and  Applied  Chemistry  International 
Chemical Identifier Key 
IUPAC    International Union of Pure and Applied Chemistry 
LBVS     Ligand-based Virtual Screening 
MCMC    Marcov Chain Monte Carlo 
MCMCMC    Metropolis-coupled Marcov Chain Monte Carlo 
MCS      Maximal Common Subgraph 
MIC      Minimal Inhibitory Concentration 
MOE      Molecular Operating Environment 
MOS      Maximum Overlapping Set 
MQL      Molecular Query Language 
NID      Normalized Information Distance 
NIST      National Institute of Standard and Technology 
NP      Non-deterministic Polynomial Time 
NSAID    Non-Steroidal Anti-Inflammatory Drug 
OpenGL    Open Graphics Library 
PAM      Point Accepted Mutations 
PhAST      Pharmacophore Alignment Search Tool 
PID      Percent Sequence Identity 
PPAR     Peroxisome-Proliferator Activated Receptor 
PPP      Potential Pharmacophoric Point 
PSI-BLAST    Position-Specific Iterated Basic Local Alignment Search Tool 
RMSE     Root Mean Squared Error 
ROC      Receiver Operating Characteristic 
ROCAUC    Receiver Operating Characteristic Area Under Curve 
ROSDAL    Representation of Organic Structures Description Arranged Linearly 
SBVS     Structure-based Virtual Screening 
SHA      Secure Hash Algorithm 
SMILES    Simplified Molecular Input Line Entry System 
SPP      Similar Property Principle   8!
SSE2      Streaming Single Instruction Multiple Data Streams Extensions 2 
SXT      combination of Trimethoprim and Sulfamethoxazole 
THR      Thrombine 
VEGFR    Vascular Endothelial Growth-Factor Receptor 
VS      Virtual Screening 
WLN      Wiswesser Line-Formula Notation 
   9!
2 - Zusammenfassung 
 
Die Entwicklung neuer Wirkstoffe ist ein langiweriger und kostenintensiver Prozess, der bis 
zu 15 Jahre dauern und 2 Millarden Dollar kosten kann. Das ‚High Throughput Screening’ 
(HTS)  hat  sich  in  diesem  Prozess  als  Technik  für  die  Identifizierung  vielversprechender 
Startstrukturen, so genannter ‚Hits’, etabliert. Während eines HTS werden 50.000 bis 100.000 
Substanzen automatisiert in einem Assay auf ihre biologische Aktivität getestet. Setzt man 
diese Anzahl evaluierter Substanzen in Relation zu vorsichtigen Schätzungen der Gesamtzahl 
möglicher wirkstoffartiger Verbindungen (10
60), wird klar, dass mit HTS allein ein großer 
Teil dieses ‚Chemischen Raums’ unerforscht bleibt. 
Eine schnellere Alternative bieten computerbasierte Methoden. Ist eine Struktur mit 
einer gewünschten biologischen Wirkung bekannt, ist es mit diesen Methoden möglich, die 
Einträge  in  Molekülsammlungen  nach  ihrer  berechneten  Ähnlichkeit  zu  dieser 
Referenzstruktur zu sortieren. Diese Technik wird als virtuelles Screening bezeichnet. Die 
Annahme  hierbei  ist,  dass  Substanzen,  die  als  ähnlich  zur  verwendeten  Referenzstruktur 
bewertet werden auch in ihren biologischen Wirkeigenschaften ähnlich zu dieser sind. 
In dieser Arbeit wurde eine neue Methode entwickelt und evaluiert, mit der sich die 
Ähnlichkeit  zweier  Moleküle  berechnen  lässt.  Die  Bezichnung  dieser  Methode  ist 
‚Pharmacophore  Alignment  Search  Tool’  (PhAST).  In  dieser  Methode  werden  Moleküle 
verglichen durch paarweises globales Sequenzalignment, einer Technik für den Vergleich von 
Zeichenketten.  Sie  wurde  bisher  nur  auf  Sequenzen  aus  Aminosäuren  oder  Nukleotiden 
angewendet,  um  Homologe  zu  identifizieren.  In  einem  Sequenzalignment  werden  die 
Symbole  zweier  Sequenzen  einander  zugeordnet,  wobei  die  Reihenfolge  der  Symbole 
innerhalb jeder Sequenz erhalten bleibt. Das Einfügen von Lücken (‚Gaps’) in Sequenzen ist 
erlaubt,  wenn  es  die  Gesamtzuordnung  verbessert.  Werden  gleiche  Symbole  einander 
zugeordnet,  wird  dies  als  ‚Match’  bezeichnet,  bei  ungleichen  Symbolen  wird  dies  als 
‚Mismatch’ bezeichnet. Jedes dieser Ereignisse wird bewertet. Der Score eines Alignments 
wird  berechnet  als  die  Summe  der  Einzelbewertungen.  Die  in  dieser  Arbeit  verwendeten 
Algorithmen berechnen stets das ‚optimale’ Alignment, also das, das den höchstmöglichen 
Alignment Score hat. 
Bedingt  durch  die  Unterschiede  zwischen  Biopolymeren  und  wirkstoffartigen 
Molekülen  wurde  Sequenzalignment  auf  die  Problemstellung  des  Molekülvergleichs 
angepasst  und  neue  parametrisiert.  Mit  allen  Parametrisierungen  wurde  PhAST  in   10!
retrospektiven  Screenings  auf  seine  Fähigkeit  getestet,  mit  einer  aktiven  Substanz  als 
Referenz  andere  aktive  Substanzen  zu  erkennen  und  für  diese  höhere  Ähnlichkeiten  zu 
berechnen als für inaktive Substanzen. Werden die Einträge einer Molekülsammlung nach 
den  berechneten  Ähnlichkeiten  absteigend  sortiert,  konzentrieren  sich  so  die  aktiven 
Moleküle  am  Beginn  der  Rangliste,  verglichen  mit  einer  uniformen  Verteilung  über  die 
gesamte  Molekülsammlung  (Anreicherung).  Die  Grundlage  dieser  retrospektiven 
Experimente  war  die  Wirkstoffsammlung  COBRA,  die  in  der  verwendeten  Version  6.1 
insgesamt 8,311 wirkstoffartige Moleküle enthält. Dabei wurden die aktiven Liganden von 
insgesamt sechs verschiedenen Zielproteinen jeweils einmal als Referenz verwendet. 
PhAST berechnet nicht die strukturelle sondern die funktionelle Ähnlichkeit zwischen 
Molekülen. Um dies zu erreichen, wurde eine Abstraktion jedes Moleküls erstellt, die aus 
potentiellen  Interaktionspunkten  besteht.  Die  Zuweisung  dieser  Interaktionsmöglichkeiten 
geschah basierend auf einer Sammlung von Fragmenten, in der jedem nicht Wasserstoff Atom 
eines  Fragments  bereits  eine  Interaktionsmöglichkeit  zugewiesen  war.  Immer,  wenn  ein 
Molekül ein Fragment als Substruktur aufwies, wurden die Zuweisungen aus dem Fragment 
auf die korrespondierenden Atome des Moleküls übertragen. Insgesamt wurde zwischen den 
folgenden  neun  Interaktionstypen  unterschieden:  positive  Ladung,  negative  Ladung, 
aromatisch, lipophil, Wasserstoffbrücken Akzeptor, Wasserstoffbrücken Akzeptor kombiniert 
mit  Wasserstoffbrücken  Donor,  Wasserstoffbrücken  Akzeptor  kombiniert  mit  Polarität, 
Wasserstoffbrücken Akzeptor kombiniert mit Wasserstoffbrücken Donor und Polarität sowie 
keiner  möglichen  Interaktion.  Jeder  dieser  neun  Typen  wurde  durch  ein  einziges  Symbol 
repräsentiert. 
Sequenzen  aus  Aminosäuren  oder  Nukleotiden  sind  unverzweigt,  azyklisch  und 
gerichtet. Wirkstoffartige Moleküle hingegen sind verzweigt, enthalten Ringschlüsse und sind 
ungerichtet. Um paarweises globales Sequenzalignment zum Vergleich von wirkstoffartigen 
Molekülen nutzen zu können, mussten diese folglich zunächst in einer linearisierten Form 
gespeichert werden. Die Notwendigkeit dieses Schritts wurde in dieser Arbeit bewiesen. Die 
Umwandlung von Molekülen in Zeichenketten muss eindeutig sein in dem Sinn, dass für ein 
Molekül  nur  eine  einzige  Zeichenkette  generiert  werden  kann.  Dies  ist  notwendig,  damit 
identische  Moleküle  durch  die  Identität  ihrer  linearen  Repräsentationen  erkannt  werden 
können.  Um  dies  sicherzustellen,  wurden  verschiedene  Algorithmen  implementiert  und 
evaluiert, die den Atomen in einem Molekül einen eindeutigen Satz von Indizes zuweisen. 
Die  Zuweisung  der  Indizes  zu  den  Atomen  ist  eindeutig,  es  wird  also  jedem  Atom  stets 
derselbe  Index  zugewisen,  unabhängig  davon,  in  welcher  Form  das  Molekül  an  den   11!
Algorithmus übergeben wird. Die zugewiesen Indizes bestimmten die Reihenfolge, in der die 
mit  den  Eigenschaften  der  Atome  korrespondierenden  Symbole  zu  einer  Zeichenkette 
zusammengesetzt  wurden,  beginnend  beim  niedrigsten  Index.  Die  evaluierten  Methoden 
lassen sich in zwei Klassen einteilen: Algorithmen die für die kanonische Indizierung von 
Molekülgraphen und Methoden zur Dimensionsreduktion. Die Methode, mit der PhAST in 
den retrospektiven Studien am besten abschnitt, war ‚Minimum Volume Embedding’. Dies ist 
eine Methode zur nichtlinearen Dimensionsreduktion, die in dieser Arbeit mit topologischen 
Distanzen gemessen über einen Diffusionskernel kombiniert wurde. 
Für die Berechnung von Sequenzalignments ist ein Bewertungssystem nötig, das das 
wechselseitige  Zuweisen  gleicher  oder  ungleicher  Symbole  bewertet.  Solche 
Bewertungssysteme  existierten  bisher  nur  für  Aminosäuren  und  Nukleotide.  Im  Rahmen 
dieser Arbeit wurden eine stochastische sowie zwei systematische Methoden entwickelt, mit 
denen  solche  Bewertungsschemata  berechnet  werden  können.  In  den  systematischen 
Varianten wurden die Ereignisse bewertet in Abhängigkeit ihrer Häufigkeit in paarweisen 
Alignments beziehungsweise durch eine Kernelfunktion berechneter Atomzuweisungen, die 
in  einem  Referenzdatensatz  berechnet  und  zu  den  Gesamthäufigkeiten  der  beteiligten 
Symbole  in  Relation  gesetzt  wurden.  Die  resultierenden  Bewertungssysteme  wurden 
untereinander verglichen sowie mit zwei weiteren Bewertungsmöglichkeiten. In einer wurden 
alle Matches sowie alle Mismatches gleich bewertet. Im letzten Bewertungssystem wurden 
die  verschiedenen  Ereignisse  bewertet  basierend  auf  den  relativen  Häufigkeiten  der 
beteiligten Symbole und dem Grad, zu dem sich die durch sie repräsentierten Funktionalitäten 
entsprechen.  Mit  dem  zuletzt  vorgestellten  Bewertungsschema  erzielte  PhAST  in 
retrospektiven  Experimenten  die  höchste  Anreicherung.  Der  beobachtete  Unterschied  war 
signifikant. Das einheitliche Bewertungsschema erzielte signifikant schlechtere Anreichung 
verglichen mit den übrigen Schemata. 
Sequenzalignment als Methode für den Vergleich von Zeichenketten ist umfassend 
parametrisierbar. Dadurch konnte das Bewertungsschema weitergehend modifiziert werden. 
So  war  es  möglich,  Symbole  in  einer  Zeichenkette  stärker  zu  gewichten,  die 
Interaktionsmöglichkeiten  entsprachen,  von  denen  bekannt  war,  dass  sie  essentiell  für  die 
Rezeptor-Ligand-Interaktion  sind.  Am  Beispiel  des  Peroxisom-Proliferator-aktivierten 
Rezeptors  wurde  demonstriert,  dass  mit  einer  sinnvoll  gewählten  Gewichtung  signifikant 
erhöhte  Anreicherung  erzielt  werden  kann.  Es  wurde  gezeigt,  dass  die  systematische 
Anwendung von Gewichten auf alle Positionen in retrospektiven Experimenten dazu geeignet 
ist, essentielle Interaktionspunkte zu identifizieren. Dafür ist es allerdings notwendig, dass ein   12!
entsprechender Datensatz mit einer ausreichenden Anzahl von Strukturen vorhanden ist. Es 
konnte  gezeigt  werden,  dass  Sequenzalignment  auch  für  die  Berechnung  struktureller 
Ähnlichkeiten benutzt werden kann. 
Es  wurden  verschiedene  Algorithmen  für  die  Berechnung  von  globalen 
Sequenzalignment veröffentlicht. Die Standardlösung dieses Problems ist der Algorithmus 
von Needleman und Wunsch, der in seiner generalisierten Form eine Laufzeit von O(n
3) hat. 
In dieser Arbeit wurde zunächst eine angepasste Version dieses Algorithmus verwendet mit 
einer Laufzeit von O(n
2). Ein weiterer Algorithmus wurde implementiert und evaluiert, der 
zwar die gleiche asymptotische Laufzeit hat, in der Praxis jedoch nur 40% der Zeit benötigt, 
um  die  gleiche  Menge  von  Sequenzen  zu  alignieren.  Dies  wird  durch  die  Vereinfachung 
erreicht, dass im Alignment ein Gap in einer Sequenz nicht auf einen Gap in der anderen 
Sequenz folgen darf. Dies reduziert die Anzahl der Rechenoperationen, die zur Berechnung 
eines  Alignment  nötig  sind.  In  einigen  Fällen  wurden  so  jedoch  Sequenzalignments 
berechnet, die von denen des Needleman Wunsch Algorithmus abwichen. Es konnte aber 
gezeigt werden, dass diese Abweichungen auf die von PhAST berechneten Sortierungen von 
Molekülen nur geringen Einfluss hatten. Die entstehenden Ranglisten waren nahezu identisch, 
was  sich  in  einer  hohen  und  als  signifikant  berechneten  Rangkorrelation  widerspiegelte. 
Daher wurde für PhAST der schnellere Algorithmus verwendet. 
Um die Ähnlichkeit von Zeichenketten aus deren Alignment zu berechnen, müssen die 
Alignments bewertet werden. Für die Alignments von Aminosäuresequenzen wurden bereits 
verschiedene Maße entwickelt: die Sequenzidentität, der Alignment Score und die Signifikanz 
des Alignment Scores. Alle drei Ansätze wurden in verschiedenen Varianten implementiert 
und evaluiert. Es konnte gezeigt werden, dass wie auch für Aminosäuresequenzen, der Score 
eines Alignments besser geeignet ist um Ähnlichkeiten zu identifizieren. Mit dem Alignment 
Score als Bewertungskriterium erzielte PhAST signifikant höhere Anreicherung verglichen 
mit der Sequenzidentität. Zur Bewertung der Signifikanz des Scores eines Alignments wurden 
p-Werte brechnet. Die mit ihnen erzielte Anreicherung war vergleichbar mit der, die mit dem 
Alignment Score erzielt wurde. Über die Rangkorrelation der zugehörigen Ranglisten konnte 
dennoch gezeigt werden, dass die berechneten Molekülsortierungen nicht identisch sind. Zur 
Berechnung  von  p-Werten  war  es  zwingend  erforderlich,  die  Verteilung  von  Alignment 
Scores  zu  kennen  für  die  jeweiligen  Paare  von  Sequenzlängen.  Auch  für 
Aminosäuresequenzen  ist  die  Verteilung  der  Scores  globaler  Alignments  nicht  bekannt. 
Folglich  mussten  für  die  Berechnung  von  p-Werten  in  PhAST  die  Verteilungen  von 
Alignment Scores simuliert werden. Dies geschah mit einer Kombination aus Marcov Chain   13!
Monte Carlo Simulationen und Importance Sampling. Nachdem die Verteilungen bestimmt 
waren, wurde für jeden Alignment Score das Integral der zugehörigen Verteilung oberhalb 
dieses  Wertes  als  p-Wert  berechnet.  Für  die  Berechnung  von  E-Werten  wurden  die 
berechneten p-Werte einer Bonferroni Korrektur unterzogen, so dass sie die Gesamtzahl der 
Einträge in der Molekülsammlung berücksichtigen. Als Ergebnis dieser Arbeit wurde für die 
Signifikanz mit PhAST berechneter Ähnlicheiten ein Grenzwert von 1*10
-5 vorgeschlagen: 
Alignments mit einem E-Wert unterhalb dieses Grenzwerts werden als signifikant angesehen. 
PhAST wurde in retrospektiven Experimenten mit anderen Methodem zum virtuellen 
Screening verglichen, die bereits in der Wirkftoffentwicklung eingesetzt werden. Es konnte 
gezeigt  werden,  dass  die  mit  PhAST  erzielte  Anreicherung  vergleichbar  oder  höher  war. 
Allerdings waren die von PhAST berechneten Ranglisten sehr unänhlich zu denen anderer 
Methoden. Folglich ist es mit PhAST möglich, in einem Screening auf den frühen Rängen der 
berechneten Ranglisten eine ähnliche Anzahl von aktiven Substanzen anzureichern, die sich 
jedoch von den mit anderen Methoden identifizierten Hits unterscheiden. Das macht PhAST 
zu einem wertvollen neuen Bestandteil der frühsten Phase der Wirkstoffentwicklung, da mit 
dieser  neuen  Methode  Hits  identifiziert  werden  können,  die  mit  anderen  Methoden  nicht 
gefunden werden. Die Anwendung von PhAST auf dreidimensionale statt zweidimensionale 
Molekülrepräsentationen erzeugte nur leichte Änderungen in der beobachteten Anreicherung, 
wenn auch die erzeugten Ranglisten von einander abwichen. 
PhAST  wurde  erfolgreich  in  zwei  prospektiven  Anwendungen  eingesetzt.  Bei  der 
Suche nach nicht von Nukleosiden abgeleiteten Inhibitoren der bakteriellen Thymidinkinase 
wurde  ein  Hit  identifiziert.  Er  zeigte  eine  deutliche  strukturelle  Abweichung  von  der 
verwendeten Referenzstruktur, war jedoch nur schwach aktiv. In einem Screening nach neuen 
Modulatoren  der  "-Sekretase  wurde  ein  potentes  Molekül  identifiziert.  Es  zeigt  deutliche 
Unterschiede  zur  verwendeten  Referenzstruktur.  Eine  im  selben  Screening  identifizierte 
inaktive  Substanz  ermöglichte  einen  ersten  Eindruck  der  zugehörigen  Struktur-Aktivitäts-
Beziehung, da es sich lediglich durch den Austausch eines einzigen Atoms von der aktiven 
Struktur unterschied, jedoch komplett inaktiv war. 
PhAST unterscheidet sich von anderen Methoden für das virtuelle Screening durch die 
Möglichkeit die Signifikanz der berechneten chemischen Ähnlichkeit zu bestimmen, bekannte 
essentielle  Interaktionspunkte  höher  zu  gewichten,  solche  essentiellen 
Interaktionsmöglichkeiten  zu  identifizieren  und  durch  die  berechneten  Ranglisten  von 
Molekülen. Die gezeigten Beispiele für eine erfolgreiche prospektive Anwendungen haben 
deutlich  gemacht,  dass  PhAST  eine  Bereicherung  für  die  Wirkstoffentwicklung i s t .  14!
3 - Abstract 
 
This  work  investigated  the  applicability  of  global  pairwise  sequence  alignment  to  the 
detection of functional analogues in virtual screening. This variant of sequence comparison 
was developed for the identification of homologue proteins based on amino acid or nucleotide 
sequences. Because of the significant differences between biopolymers and small molecules 
several aspects of this approach for sequence comparison had to be adapted. All proposed 
concepts were implemented as the ‘Pharmacophore Alignment Search Tool’ (PhAST) and 
evaluated in retrospective experiments on the COBRA dataset in version 6.1. 
  The aim to identify functional analogues raised the necessity for identification and 
classification of functional properties in molecular structures. This was realized by fragment-
based atom-typing, where one out of nine functional properties was assigned to each non-
hydrogen atom in a structure. These properties were pre-assigned to atoms in the fragments. 
Whenever a fragment matched a substructure in a molecule, the assigned properties were 
transferred from fragment atoms to structure atoms. Each functional property was represented 
by exactly one symbol. 
Unlike  amino  acid  or  nucleotide  sequences,  small  drug-like  molecules  contain 
branches and cycles. This was a major obstacle in the application of sequence alignment to 
virtual screening, since this technique can only be applied to linear sequences of symbols. As 
a consequence, molecules and their properties had to be encoded as linear representations. To 
ensure the detection of identical molecules and close analogues, these representations had to 
be unambiguous, meaning that one molecule can only be encoded to exactly one sequence. 
This problem was solved by canonical vertex labeling, where an index is assigned to each 
vertex in a molecular graph, and the assignment of indices to vertices is identical each time 
the  same  molecular  graph  is  handled.  This  canonical  set  of  indices  defines  the  order  of 
vertices in the linear representation of molecules. Several algorithms for canonical vertex 
labeling were investigated. They belonged to two classes: Algorithms developed for canonical 
atom labeling and techniques for dimensionality reduction. To the best of knowledge, this 
work represents the first application of dimensionality reduction to graph linearization. 
  Sequence  alignment  relies  on  a  scoring  system  that  rates  symbol  equivalences 
(matches)  and  differences  (mismatches)  based  on  functional  properties  that  correspond  to 
rated symbols. Existing scoring schemes are applicable only to amino acids and nucleotides. 
In this work, scoring schemes for functional properties in drug-like molecules were developed   15!
based on property frequencies and isofunctionality judged from chemical experience, pairwise 
sequence  alignments,  pairwise  kernel-based  assignments  and  stochastic  optimization.  The 
scoring system based on property frequencies and isofunctionality proved to be the most 
powerful  (measured  in  enrichment  capability).  All  developed  scoring  systems  performed 
superior compared to simple scoring approaches that rate matches and mismatches uniformly. 
The frameworks proposed for score calculations can be used to guide modifications to the 
atom-typing in promising directions. 
The scoring system was further modified to allow for emphasis on particular symbols 
in a sequence. It was proven that the application of weights to symbols that correspond to key 
interaction points important to receptor-ligand-interaction significantly improves screening 
capabilities of PhAST. It was demonstrated that the systematic application of weights to all 
sequence positions in retrospective experiments can be used for pharmacophore elucidation. 
A scoring system based on structural instead of functional similarity was investigated and 
found to be suitable for similarity searches in shape-constrained datasets. 
  Three  methods  for  similarity  assessment  based  on  alignments  were  evaluated: 
Sequence identity, alignment score and significance. PhAST achieved significantly higher 
enrichment with alignment scores compared to sequence identity. p-values as significance 
estimates were calculated in a combination of Marcov Chain Monte Carlo Simulation and 
Importance  Sampling.  p-values  were  adapted  to  library  size  in  a  Bonferroni  correction, 
yielding E-values. A significance threshold of an E-value of 1*10
-5 was proposed for the 
application in prospective screenings. 
PhAST  was  compared  to  state-of-the-art  methods  for  virtual  screening.  The 
unweighted version was shown to exhibit comparable enrichment capabilities. Compound 
rankings obtained with PhAST were proven to be complementary to those of other methods. 
The application to three-dimensional instead of two-dimensional molecular representations 
resulted in altered compound rankings without increased enrichment. 
  PhAST was employed in two prospective applications. A screening for non-nucleoside 
analogue  inhibitors  of  bacterial  thymidin  kinase  yielded  a  hit  with  a  distinct  structural 
framework but only weak activity. The search for drugs not member of the NSAID (non-
steroidal  anti-inflammatory  drug)  class  as  modulators  of  "-secretase  resulted  in  a  potent 
modulator with clear structural distiction from the reference compound. 
The  calculation  of  significance  estimates,  emphasizing  on  key  interactions,  the 
pharmacophore elucidation capabilities and the unique compound rannkings set PhAST apart 
from other screening techniques.   16!
4 - Introduction 
 
4.1 - The Drug Development Process 
 
Discovery and development of new drugs is a lengthy and cost-intensive process: Analysis of 
drug  design  campaigns  leading  to  approved  drugs  between  1989  and  2002  resulted  in 
estimated costs (measured in time and money) of 15 years and up to 2 billion dollar per 
successful campaign depending on therapy and developing firm.
1,-3 The first step in target-
based drug discovery (Figure 1) is the identification and validation of a drug target and the 
ascertainment of its role in the disease process. After assays, which are capable of measuring 
activity  modulating  effects  of  proposed  small  organic  molecules,  are  developed,  the  next 
challenge is the identification of ‘hits’: non-promiscuous binding compounds with known 
structure that exhibit reproducible activity above a certain threshold value.
4,5 If their activity 
and  selectivity  is  confirmed  and  they  exhibit  novel  pharmacological  features,  they  are 
optimized to ‘leads’ with respect to pharmacodynamics and pharmacokinetics. At this stage, 
compounds with unwanted groups responsible for fast metabolization or toxicity are weeded 
out. Each remaining lead is subject to further development into a lead series:  compounds 
exhibiting the same molecular frame (‘scaffold’) coupled with variations in one or several 
positions.  These  are  further  optimized  regarding  their  activity,  bioavailability,  toxicity, 
metabolization and off-target activity. Pre-clinical development involves in vitro and in vivo 
tests. The conducted studies test for effectiveness and especially safety for further testing in 
humans. The following clinical trials are separated into three steps: Phase 1 is an initial testing 
 
 
Figure 1. The drug development process. Development time and number of compounds according to 
diMasi et al. 2003,
1 Rankovic & Morphy 2010,
2 and Adams & Brantner 2006.
3   17!
on up to 100 healthy volunteers. The main goal of this clinical study is a first assessment of 
safety in humans and determination of safe dosing ranges. Phase 2 trials involve up to 500 
patients and investigate the candidate drug’s effectiveness. They as well examine short-term 
side effects. In phase 3 drug candidates are studied in a larger number of patients (up to 
5,000). These trials generate statistically significant data regarding efficacy and safety. If a 
drug  candidate  completes  all  clinical  trials,  the  developing  company  files  a  new  drug 
application  with  the  Food  and  Drug  Administration  (FDA).  There,  the  complete  data 
generated during the drug development process is reviewed. If the FDA concludes the drug is 
safe and effective enough, it is approved. After approval, the production process has to be up-
scaled for large-scale manufacturing before the drug can be marketed. 
The identification of hits and leads is a major milestone in drug development, since by 
lack of active compounds every drug discovery campaign is on hold. The identification of a 
large number of diverse hits and leads is essential. According to the Pharmaceutical Research 
and Manufacturers of America, 10,000 hits are necessary on average to get one drug to the 
market"# 
 
4.2 - From High-Throughput Screening to Virtual Screening 
 
Since the early 1990s ‘High Throughput Screening’ (HTS) has dominated hit generation by 
systematically testing compound libraries containing between 50,000 and 100,000 molecules 
in  automated  systems.  Combinatorial  chemistry  helped  maximizing  library  size  by  taking 
advantage of miniaturization and parallel synthesis.
7 The systematic combination of building 
blocks allows the generation of more than 100,000 compounds within several months.
8 So far, 
10
7 small organic compounds have been synthesized by man or were encountered in nature.
9 
But even cautious estimates of the total number of synthesizable organic molecules (also 
known  as  ‘chemical  space’)  exceed  values  of  10
60.
10  These  estimations  are  heavily 
constrained, only considering molecules 
$  with up to 30 non-hydrogen atoms  
$  built solely from the elements carbon, nitrogen, oxygen and sulfur 
$  containing a maximum of four rings 
$  containing up to 10 branch points 
 
Collections of known bioactive compounds contain structures with more than 30 non-
hydrogen  atoms:  Figure  2  displays  the  distribution  of  non-hydrogen  atom  counts  in  the   18!
COBRA
11 collection of bioactive reference compounds. As a consequence, the true size of 
chemical space has to be even higher. Implied by these numbers, it remains unexplored to a 
vast majority. 
 
HTS  is  a  suitable  method  for  evaluating  existing  compounds  that  have  been 
synthesized and stored. But it is limited to this repository due to the fact that it relies on the 
availability of the actual compound. That way, explorations in chemical space by HTS have to 
be preceded by costly and time-consuming syntheses. Speed and cost could be optimized, if 
non-promising  candidates  were  identified  and  excluded  (‘negative  design’)  from  a  set  of 
possible structures, or if efforts could be focused on the most promising candidates (‘positive 
design’). Advances in computer sciences lead to the emerging field of chemoinformatics: 
“The application of informatics methods to solve chemical problems”.
12 It combines aspects 
of computer sciences, chemistry, biology, medicine and pharmacology. These methods allow 
for the computer-based evaluation of chemical compounds with regard to various properties. 
They are based on virtual libraries with the advantages of being independent of synthesized 
compounds and trendmendously faster evaluation compared to HTS, leading to methods for 
compound  prioritization  known  as  ‘Virtual  Screening’  (VS).  VS  has  been  described  in 
literature as “the computational equivalent of high-throughput screening, wherein a large 
number  of  samples  are  quickly  assayed  to  discriminate  active  samples  from  inactive 
samples”.
13 In the beginning, computational methods were used for negative design.
14 This, 
 
 
Figure 2. Distribution of the number of non-hydrogen atoms per structure in the COBRA collection of 
bioactive  reference  compounds  (version  6.1,  8,311  compounds).  Logarithmic  Y-axis  for  better 
visualization of low absolute frequencies. 
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for example, was done by eliminating molecules that judged by their properties appeared non 
‘drug-like’. An example for such a set of criteria is Lipinski’s ‘rule of five’,
15 deduced from 
statistics of known drugs. It describes constraints for molecules with high probability for 
sufficient oral bioavailability. Properties are listed in Table 1. These guidelines have been 
updated ever since their original proposition resulting in a larger number of constraints.
16 As 
the rule of five was compiled based on analysis of properties observed in drugs, it might not 
be ideally suited for the filtering of promising candidates at the beginning of the drug design 
process.
17 As a result, a set of criteria for ‘lead-likeness’ was proposed.
18 The corresponding 
compound properties are also listed in Table 1. Virtual screening methods have evolved and 
are now also used for the selection of promising candidates (positive design). Based on the 
origin of the starting point, virtual screening methods can be distinguished in two concepts: 
structure-based and ligand-based methods. 
Structure-based  (also:  receptor-based
19)  virtual  screening  (SBVS)  relies  on  an 
available  model  of  the  target  obtained  by  X-ray  crystallography  or  nuclear  magnetic 
resonance spectroscopy. The most prominent technique in SBVS is ‘docking’ that aims at 
predicting  the  most  likely  binding  pose  and  the  corresponding  binding  energy.  But  the 
available model might display low resolution or there might actually be no model due to 
induced-fit effects or protein size. In these cases, a homology model for a protein can be built 
with  a  close  homolog  as  template,  and  this  model  will  be  treated  as  the  actual  receptor 
structure. In the absence of an actual structure or appropriate template as well as in parallel to 
structure-based approaches, ligand-based virtual screening (LBVS) is a promising alternative. 
This screening concept relies on the availability of a known active compound as reference 
(‘query’). Screening compounds are ranked according to their calculated similarity to the 
query  based  on  the  expectation  that  compounds  with  activity  against  the  same  target  are 
Table 1. Properties of drug-like
14 and lead-like
18 molecules. Hydrogen-bond donors: nitrogen or oxygen 
atoms with one or more hydrogen atoms, Hydrogen-bond acceptors: nitrogen or oxygen atoms. The 
original desription of the rule of 5 for drug-like compounds does not restrain the number of rotatable 
bonds. 
!
Property  Drug-Like Compounds  Lead-Like Compounds 
Molecular Mass [Dalton]  < 500  < 300 
No. Hydrogen-Bond Donors  < 5  < 3 
No. Hydrogen-Bond Acceptors  < 10  < 3 
Octanol-Water Partition 
Coefficient (logP)  < 5  < 3 
No. Rotatable Bonds  -  < 3 
!
!  20!
enriched on early ranks. These methods are based on the ‘similar property principle’ (SPP), 
which  assumes  a  close  relationship  between  structure  and  activity.  It  states  that  similar 
compounds  exhibit  similar  properties.
20  The  SPP  describes  the  ideal  case,  where  small 
modifications to molecules lead to slight alterations in biological activity. It does not account 
for  so  called  ‘activity  cliffs’,
21  where  small  modifications  cause  drastic  activity  changes 
(examples  in  Figure  3).  Such  effects  may  occur  as  a  consequence  of  small  modification 
eliminating essential interactions or other constraints such as the necessity to coordinate metal 
ions.
23 Methods have been proposed for the characterization of structure-activity relationships 
in order to assess the validity of the SPP for a particular target.
23,24 Ligand-based methods can 
even be applied in the absence of active compounds. In this case, actives for close homologs 
of the target can be used as queries. This strategy started under the term ‘ligand transfer‘ and 
is  now  fully  exploited  as  ‘chemogenomics‘.
25  The  idea  behind  these  approaches  is  that 
proteins of the same family most likely exhibit similarities in the overall structure, especially 
concerning  the  binding  pocket.  Therefore  corresponding  ligands  should  likewise  display 
structural  and  functional  similarities.  Successful  applications  to  protein  kinases  and  G-
protein-coupled receptors have been reported.
26 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure  3. A c t i v i t y  c l i f f s .  S h o w n  a r e  f o u r  v a s c u l a r  e n d o t h e l i a l  g r o w t h -factor  receptor  (VEGFR-2) 
tyrosine kinase inhibitors with different structures and potencies.The two inhibitors at the top are potent 
and bind with IC50 values of 6 nM. Slight structural modifications result in a decrease in activity by two 
to three orders of magnitude. Example adepted from Eckert et al. 2007.
22 
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Even for computational methods, the prediction of activity values for each molecule in 
chemical space or their classification into sets of active and inactives for a particular target is 
not feasible. But these techniques can help to navigate in chemical space, i.e. guiding drug 
design  campaigns  to  interesting  regions  and  limiting  the  number  of  compound  tested  in 
biological assays only to the most promising candidates. This way these techniques help to 
reduce development costs for new drugs and speed up the drug design process: It was shown 
that the combination of VS and HTS reduced the number of compounds that had to be tested 
to find an active to 100 – 1000 instead of 10
4 – 10
6 with HTS alone.
27 
 
4.3 - Chemical Similarity 
 
The key element of ligand-based virtual screening is the assessment of chemical similarity 
that  is  more  an  abstract  concept  than  a  calculable  property.
25  Methods  for  similarity 
assessment are based on calculations performed on the ‘molecular graph‘ that is defined as a 
“connected  undirected  graph  one-to-one  corresponded  to  the  structural  formula  of  a 
chemical compound so that vertices of the graph correspond to atoms of the molecule and 
edges of the graph correspond to chemical bonds between them”.
28 In this definition, vertices 
are labeled with an element symbol derived from the periodic table, edges are labeled with an 
integer indicating their bond order. The molecular graph can be used for direct similarity 
assessment through substructure searching. Given a set of active molecules, their maximal 
common subgraph (MCS) can be calculated and used as query in substructure searches.
29 
Methods for the identification of a disconnected MCS (maximum overlapping set, MOS) 
identify  a  set  of  substructures  common  to  all  known  actives.  The  similarity  of  structures 
matching the MCS or MOS usually also depends on parts of the screening compound not 
matching the query and is located in a value range of 0 (not similar) to 1 (exact match).
30 
The molecular graph can also be used for the calculation of ‘descriptors’, where a 
descriptor  is  “the  final  result  of  a  logic  and  mathematical  procedure  which  transforms 
chemical information encoded within a symbolic representation of a molecule into a useful 
number or the result of some standardized experiment”.
31 Descriptors can be distinguished by 
the  dimensionality  of  the  molecular  representation  that  they  are  calculated  from.  Table  2 
represents a short overview on these differences. ‘Fingerprints’ are the combination of several 
descriptors in a vector. As bitstrings they can indicate the absence and presence of certain 
features.  Holographic  fingerprints  on  the  other  hand  count  the  occurrences  of  certain 
substructures and / or properties. Fingerprints can be compared using several distance metrics   22!
(Manhatten distance, Euclidean distance) or similarity measures (Tanimoto coefficient, Dice 
coefficient,  Cosine  coefficient),  of  which  many  can  be  applied  to  binary  as  well  as 
holographic fingerprints.
33 
 
An abstraction from the molecular graph that is used for similarity assessment as well is the 
‘pharmacophore’.  The  term  was  first  used  by  Lemont  Kier
34  and  according  to  the 
International Union of Pure and Applied Chemistry (IUPAC) is “the ensemble of steric and 
electronic features that is necessary to ensure the optimal supramolecular interactions with a 
specific biological target structure and to trigger (or to block) its biological response”.
35 It is 
a purely abstract concept and does not describe a real molecule. The pharmacophore can be 
considered as the set of interactions in the correct spatial configuration that is necessary for 
the activity of a molecule. As a consequence of this definition, not all functional groups and 
the corresponding interaction possibilities present in a particular molecule might be part of the 
pharmacophore.  Those  are  named  ‘potential  pharmacophoric  points’  (PPPs)  because  it  is 
unknown  a  priori  which  of  them  actually  contribute  to  the  ligand-receptor  interaction.
36 
Typical  interaction  types  considered  potential  pharmacophoric  points  are  hydrogen-bond 
donors,  hydrogen-bond  acceptors,  positive  and  negative  charges  and  lipophilic  as  well  as 
aromatic features. The first interaction pattern published under the term pharmacophore is 
shown in Figure 4. 
Table 2. Classification of descriptors by the dimensionality of their molecular representation. Adapted 
from Gasteiger & Engel 2003.
32 
!
Dimension  Description  Examples 
0  Properties independent from atom 
connectivity and spatial arrangement 
Atom Counts, bond counts, 
molecular mass, sum of vand-wer-
Waals volumes 
1  Properties depending on local atom 
neighborhoods 
Fragment counts like primary, 
secondary, tertiary and 
quarternary sp3 hybridized carbon 
atoms 
2 
Properties depending on atom 
connectivity but invariant to spatial 
arrangement 
Zagreb index, Wiener path index, 
molecule radius, molecule 
diameter 
3  Properties depending on the spatial 
arrangement of atoms 
Radius of gyration, solvent-
accessible surface volume 
!
!  23!
An  abstraction  describing  a  molecule  employing  these  six  interaction  types  or 
combinations between them is a blurred characterization, as different functional groups can be 
responsible for the same interaction possibilities. Hence, molecules with different structures 
can exhibit the same pattern of potential pharmacophoric points. This potential for ‘Scaffold 
Hopps’  is  extremely  valuable  in  the  hit  identification  phase  because  it  generates  a  more 
diverse set of unrelated starting points compared to methods measuring structural similarity. 
The same concepts of descriptors and fingerprints calculated from the molecular graph can be 
applied  to  the  pattern  of  potential  pharmacophoric  points  as  well.  Several  successful 
applications of virtual screening methods have been reported.
37,38 
 
4.4 - Line Notations 
 
Besides descriptors and fingerprints, the molecular graph can be described as an alphanumeric 
sequence. Compared to descriptors and fingerprints they do not only describe the presence 
and absence of structural features but can also mirror their topological or spatial arrangement 
if the respective property influenced the linearization procedure. An example every chemist is 
familiar with is the systematic IUPAC name of a compound. But several other line notations 
were developed for compound storage, substructure search and duplicate detection. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. The first published pharmacophore model, by L. B. Kier, for muscarinic agonists. Adapted 
from Kier 1971.
34 
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4.4.1 - Wiswesser Line-Formula Notation 
 
A first version of the ‘Wiswesser Line-Formula Notation’ (WLN) was published in 1954.
39 
The WLN assigns symbols to atoms or substructures of a molecular graph. For many atoms 
the WLN symbol is equal to the atomic symbol in the periodic table. Functional groups, ring 
systems,  positions  of  ring  substituents  and  positions  of  condensed  rings  are  assigned  to 
symbols or combinations of symbols. Definitions are chosen in a way that ensures frequently 
met substructures are encoded with only one symbol to keep linear representations short.
40 
This way the WLN facilitates searches for particular substructures and functional groups. 
Symbols used for WLN coding of chemical structures are listed in Table 3.
41 Examples for 
OH
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Table 3. Symbols used for WLN coding of chemical structures. Symbols are listed with increasing 
priority used for unambiguity. 
!
Symbol  Usage 
Capital letters A-Z  Elements, substructures, branches, bonds, ring 
positions 
Numbers 0-9  Length of alkyl chains, ring number 
“&”; “/”; “-“; “ “  Rings and substitution positions 
!
!
Table 4. Examples for substructure codes used in WLN. 
 
Structure  WLN    Structure  WLN 
  5      Q 
  9      O 
 
U   
 
V 
  UU   
 
VH 
 
X   
 
VQ 
 
Y   
 
VO 
 
R 
 
substituent 
positions 
B C D E F 
 
 
N 
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coded fragments are shown in Table 4. Starting from different atoms in the molecular graph, 
many  representations  of  the  same  molecule  in  WLN  are  possible.  Unambiguity  of  WLN 
representations  is  achieved  through  a  simple  rule-based  prioritization  of  possible  starting 
points. Coding begins at the element with highest priority based on prioritization order shown 
in Table 3.
41 After the starting point is selected, the WLN notation is determined by the 
topology  of  the  molecular  graph.  Linear  representations  of  molecules  in  WLN  are  very 
compact, since complete substructures are condensed to only one symbol. Examples of WLN 
usage are the application to indexing the Chemical Substructure Index (CSI) at the Institute 
for  Scientific  Information  and  the  CROSSBOW  (Computer  Retrieval  of  Organic 
SubStructures by means of Wiswesser) System of Imperial Chemical Industries.
42,43 In 1982 
an advanced version of the WLN (AWLN) was published that utilizes more than the 40 WLN 
symbols and has an extended rule set.
41 
 
4.4.2 - Representation of Organic Structures Description Arranged Linearly 
 
The ‘Representation of Organic Structures Description Arranged Linearly’ (ROSDAL) syntax 
was developed at the Beilstein institute in 1985 for the Beilstein DIALOG system.
44 The 
ROSDAL  generation  process  is  straightforward:  Integer  numbers  beginning  from  1  are 
assigned to all non-hydrogen atoms randomly, and paths through the molecular graph are 
written in linear order. Atoms are written as their index followed by the element symbol. 
Carbon atoms are an exception to this rule. They are represented just by digits because of 
their  high  frequency  in  drug-like  compounds.  Bonds  are  represented  by  symbols 
corresponding to their bond order. Symbols used for ROSDAL coding of chemical structures 
are listed in Table 5. ROSDAL is used as data exchange format in the Beilstein DIALOG-
system. 
Table 5. Symbols used for ROSDAL coding of chemical structures. 
 
Symbol  Usage 
Integer numbers  Indicate paths through the labelled graph 
Element symbols  Element types, carbon atoms are only 
referenced to by their index 
- / = / # / ?  Single / double / triple / any bond 
,  Delimiter for sequences generated from 
separated branches 
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4.4.3 - Simplified Molecular Input Line Entry System 
 
David Weininger developed the ‘Simplified Molecular Input Line Entry System’ (SMILES) 
while working at the United States Environmental Research Laboratory in 1986.
45 SMILES 
are human understandable and very compact. A molecule graph is transformed into a line 
notation following six simple rules: 
$  Hydrogen  atoms  are  omitted,  they  automatically  saturate  free 
valences 
$  Atoms are represented by their corresponding atomic symbols 
$  Neighboring  atoms  in  the  molecular  graph  stand  next  to  each 
other in the line notation 
$  Single bonds are represented by “-“, double bonds by “=” and 
triple bonds by “#” 
$  Branches are represented by parentheses 
$  Rings  are  indicated  by  identical  digits  following  the  element 
symbol of the atoms closing the ring 
 
SMILES generation can start at any vertex in the molecular graph, resulting in a large 
number  of  possible  valid  SMILES  describing  the  same  molecule.  An  unambiguous  line 
notation  named  ‘canonical  SMILES’  can  be  created  using  a  two-step  algorithm  proposed 
under  the  name  CANGEN:
46  First,  canonical  labels  are  assigned  to  the  vertices  in  the 
molecule graph. The second step is a depth-first search visiting the vertices with low indices 
with highest priority that concatenates symbols of atoms and bonds and inserts symbols for 
branching and ring closures. The SMILES line notation was subject to several extensions 
designed for special purposes, such as substructure description and reaction notation. 
 
4.4.4 - IUPAC International Chemical Identifier 
 
The  ‘IUPAC  International  Chemical  Identifier’  (InChi,  originally  ‘IChI’  for  ‘IUPAC 
Chemical Identifier’) was developed from 2000 to 2005 as a project of the IUPAC chemical 
nomenclature and structure representation division and the National Institute of Standards and 
Technology (NIST).
47 The objective of the project was the development of a non-proprietary 
identifier for chemical substances than can be used in print media and electronic data sources.   27!
Every  InChi  starts  with  the  fragment  “InChi=”  followed  by  the  version  number 
(currently  1).  Structural  information  is  organized  in  six  layers  and  sub-layers,  describing 
different aspects of a molecule.
48 InChi layers are listed and described in Table 6. The InChi 
generation process has three steps: 
$  Normalization: removes redundant information, disconnects salts and metals, 
eliminates radicals if possible 
$  Canonization: creates canonical labels for atoms, ensures unambiguity 
$  Serialization: generates the actual InChi string 
 
A  special  form  of  line  notation  as  structure  representation  is  InChiKey.  It  is a  
condensed  version  created  from  InChi through hashing using the  Secure Hash Algorithm 
(SHA-256).
48,49 InChiKey has a fixed length of 27 characters: The first 14 symbols result 
Table 6. InChi layers, their identification characters and meaning. 
 
Layer  Sublayer 
Symbol  Sublayer  Description 
Main 
/ 
/c 
/h 
chemical formula 
connectivity 
hydrogen 
Specifies  bonds  separatly  for  non-
hydrogen and hydrogen-atoms 
Charge  /q 
/p 
charge 
proton ballance 
Specifies  absolute  charge  and 
protonation alterations necessary for 
representation  without  regard  to 
protonation 
Stereochemical 
/b 
/t 
/m 
/s 
double bond 
sp3 
sp3 
sp3 
Specifies  E/Z- a n d  t e t r a h e d r a l  
stereochemical  properties  of  a 
molecule 
Isotopic  /i  isotopic  Specifies  aberrations  from  the 
majoritarian isotopes 
Fixed-H  /f  fixed-H 
Hydrogen-atoms  mobile  due  to 
tautomerism can be bound to specific 
atoms  in  the  original  structure 
molecule;  if  these  changes  affect 
earlier  layers,  appropriate  changes 
are added to this layer 
Reconnected  /r  reconnected 
Used  for  the  handling  of 
organometallic  compounds; 
represents  such  as  one  large 
structure  instead  of  two  individual 
components; if these changes affect 
earlier  layers,  appropriate  changes 
are added to this layer 
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from  a  hash  of  the  connectivity  information,  followed  by  a  hyphen  and  8  characters 
representing the remaining layers (except charge), 1 for the InChi version and a checksum 
character. Separated by a hyphen the last character describing the protonation layer. They 
were developed to facilitate easy searching. InChi and InChiKey are currently used by several 
public  and  commercial  databases  (for  example  the  Pubchem  project,  the  United  States 
National Cancer Institute Database and the Chemical Entities of Biological Interest database 
of the European Bioinformatics Institute) as well as scientific journals like Nature Chemical 
Biology and the Beilstein Journal of Organic Chemistry. 
 
Examples for the described line notations are shown in Figure 5.  
!
!
!
!
!
!
!
Trivial Name:    Chlorpromazine 
IUPAC Name:     3-(2-chlorophenothiazin-10-yl)-N,N-dimethylpropan-1-amine 
WLN:       T C666 BN ISJ B3N1&1 EG 
ROSDAL:    1-2N-3-4-5-6N-7=8-9=10-11=12-13S-14-15=16-17=18-19-6, 7-12, 14=19, 2-
20, 17-21Cl 
SMILES:     CN(C)CCCN1C2=CC=CC=C2SC3=C1C=C(C=C3)Cl 
InChi:    InChI=1S/C17H19ClN2S/c1-19(2)10-5-11-20-14-6-3-4-7-16(14) 21-17-9-8-
13(18)12-15(17)20/h3-4,6-9,12H,5,10-11H2,1-2H3 
InChiKey:    ZPEIMTDSQAKGNT-UHFFFAOYSA-N 
!
!
!
!
!
!
!
!
 
Trivial Name:    Acetylpromazine 
IUPAC Name:    1-[10-[3-(dimethylamino)propyl]phenothiazin-2-yl]ethanone 
WLN:      T C666 BN ISJ B3N1&1 EV1 
ROSDAL:    1-2N-3-4-5-6N-7=8-9=10-11=12-13S-14-15=16-17=18-19-6, 7-12, 14=19, 2-
20,17-21-22, 21=23O 
SMILES:    CC(=O)C1=CC2=C(C=C1)SC3=CC=CC=C3N2CCCN(C)C 
InChi:    InChI=1S/C19H22N2OS/c1-14(22)15-9-10-19-17(13-15)21(12-6-11-
20(2)3)16-7-4-5-8-18(16)23-19/h4-5,7-10,13H,6,11-12H2,1-3H3 
InChiKey:    NOSIYYJFMPDDSA-UHFFFAOYSA-N 
!
Figure  5. S t r u c t u r e  d i a g r a m s  a n d  c o r r e s p o n d i n g  l i n e  n o t a t i o n s  o f  c h l o r p r o m a z i n e  a n d  
acetylpromazine. I U P A C  n a m e  g e n e r a t e d  b y  C h e m B i o D r a w  U l t r a  ( v 1 2 . 0 ,  C a m b r i d g e S o f t ,  
Cambridge,  USA),  SMILES  generated  by  MOE  (Molecular  Operating  Environment  v2009.10, 
Chemical Computing Group, Montreal, QC, Canada), InChi and InChiKey generated by IUPAC 
InChi generator v1.02. 
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4.5 - Virtual Screening employing Line Notations 
 
None of the described line notations was developed for virtual screening. That is why most of 
them are not suitable for this purpose. 
ROSDAL has the major disadvantage that it is not unambiguous. The same molecule 
can  be  represented  by  several  ROSDAL  sequences  without  any  string  similarity  measure 
being able to detect even identical structures. That makes it unsuitable for virtual screening, as 
even identical molecules could not be recognized as such. 
WLN is unambiguous, but the sequence generation process is complicated. Computer 
programs for the automated input and output of molecules in WLN were developed,
50,-52 but 
the full set of rules could not be implemented and the automated sequence generation process 
was  prone  to  errors.
32  Furthermore  the  substructure  encoding  system  of  WLN  has  the 
disadvantage  that  insertions  and  deletions  of  one  vertex  to  the  molecular  graph  are  not 
necessarily reflected by additions or deletions of only one symbol in WLN notation. As a 
consequence, there is no one-to-one correspondence in the severity of molecule differences 
between their molecular graph and WLN sequence. This is a clear disadvantage for a virtual 
screening method. 
Due to its layered structure, there are different possible InChi representations of the 
same  structure  despite  the  fact  that  InChi  is  unambiguous.  And  depending  on  the  way  a 
molecule is drawn, in some cases the generation of certain layers is not possible, for example 
the stereo layer from a structure diagram without specified stereochemistry. InChiKey is a 
hashed  version  of  InChi  with  fixed  length.  Different  structures  yield  different  InChiKey 
representations. But comparing structures by their InChiKey strings is unreasonable, as small 
modifications cause drastic differences at least in the first part of InChiKey because of the has 
operation. The only meaningful result from the comparison of InChiKey representations of 
molecules is the identification of identical molecules. 
SMILES are an unambiguous description of the molecular graph. Except for changes 
in  branching  and  ring  closures  they  mirror  modifications  to  the  molecular  graph  by  the 
addition or deletion of the same number of symbols as non-hydrogen atoms are inserted or 
deleted  in  the  graph.  These  properties  make  them  the  best  choice  of  the  described  line 
notations for the development of virtual screening methods. But as well as the other line 
notations, SMILES is a description of the molecular graph, not of its interaction possibilities. 
The  following  sections  describe  the  two  known  virtual  screening  approaches  based  on 
SMILES.   30!
4.5.1 - LINGO 
 
LINGO is based on the comparison of absolute word frequencies calculated from SMILES 
representations of molecules.
53,54 The term ‘LINGO’ refers to a SMILES substring of length 
q.  To  compare  two  molecules 
! 
M1  and 
! 
M2  with  lengths 
! 
m1  and 
! 
m2  their  corresponding 
canonical SMILES are generated and the following preprocessing steps are applied to ensure 
each feature of the molecule is represented by only one symbol: Cl is altered to L, Br is 
altered to R, all numbers indicating ring closures are replaced by 0. Then, all 
! 
(m1 "(q "1)) 
substrings of 
! 
M1 and 
! 
(m2 "(q "1)) substrings of 
! 
M2 in modified SMILES representation are 
collected and condensed to a unique set of size l while counting the occurrences of each 
unique LINGO in each SMILES. For similarity assessment LINGO frequencies are used to 
calculate the integral Tanimoto coefficient of the form (Equation 1) 
 
! 
T C =
1"
NM1,i " NM 2,i
NM1,i + NM 2,i i=1
l
#
l
                (1) 
 
where 
! 
NM1,i is the frequency of LINGO 
! 
i in 
! 
M1 and 
! 
NM 2,i is the frequency of LINGO 
! 
i in 
! 
M2. Calculated similarities are bound between 0 and 1. Besides virtual screening,
54 
LINGO has been successfully applied to the calculation of biophysical properties.
53 
 
4.5.2 - Comparison by Compression 
 
The  Kolmogorov  complexity  of  a  sequence 
! 
X (
! 
K(X)),  is  defined  as  the  shortest  binary 
program  that  computes 
! 
X  on  a  computer.
55  The  conditional  Kolmogorov  complexity 
! 
K(X |Y) is the shortest binary program that computes 
! 
X from 
! 
Y . These definitions can be 
used  for  the  calculation  of  a  distance  between 
! 
X  and 
! 
Y,  the  ‘Normalized  Information 
Distance’ (NID) defined in Equation 2.
56 It returns values between 0 and 1. 
 
! 
NID(X,Y) =
max K(X |Y),K(Y | X) { }
max K(X),K(Y) { }             (2)
 
 
The Kolmogorov complexity is noncomputable. But it can be approximated by the size of 
compressed  representations 
! 
C(X)  and 
! 
C(Y)  of 
! 
X  and 
! 
Y.  The  DEFLATE  algorithm  (a   31!
combination of LZ77 compression
57 and Huffman coding
58) has been successfully used in a 
virtual screening approach to compress SMILES representations of molecules and calculate 
their similarity as given in Equation 3
59 
 
! 
S(X,Y) =1"
min C(XY),C(YX) { }"min C(X),C(Y) { }
max C(X),C(Y) { }         (3)
 
 
  where 
! 
C(XY) (
! 
C(YX)) is the size of the compressed representation of 
! 
X and 
! 
Y  (
! 
Y 
and 
! 
X) concatenated. The only necessary preprocessing step identified was the duplication of 
SMILES to overcome storage overhead effects of the compression algorithm. 
 
4.5.3 - General String Metrics 
 
There  are  other  string  metrics  that  could  be  applied  to  the  comparison  of  line  notation 
representations of molecules. The Levenshtein distance between two sequences is defined as 
the minimum number of edit operations necessary to transform one sequence into the other 
with  insertion,  deletion  and  substitution  of  a  single  symbol  being  the  allowed  edit 
operations.
60  The  Damerau-Levenshtein  distance  uses  an  additional  edit  operation: 
transpositions of neighboring symbols.
61 Dice’s coefficient can be applied to strings based on 
bigram (substrings of length 2) counts as shown in Equation 4
62 
 
! 
S(X,Y) =
2nt
nX + nY                   (4)
 
 
  where 
! 
nt is the number of bigrams common to both strings, 
! 
nX is the number of 
bigrams found only in 
! 
X and 
! 
nY is the number of bigrams found only in 
! 
Y . 
   32!
5 - Study Objective 
 
The  described  line  notations  are  linear  representations  of  the  molecular  graph,  and  as  a 
consequence  capture  only  structural  properties.  But  the  hit  generation  phase  of  a  drug 
discovery campaign relies on a preferably diverse set of hits representing independent starting 
points.  With  ligand-based  approaches  in  virtual  screening,  these  can  be  generated  using 
pharmacophore  methods,  whereas  techniques  comparing  molecule  structures  are  more 
suitable during the development of lead-series. That is why existing line notations are not 
ideal for the early stage of the drug development process and a way to encode the pattern of 
potential pharmacophoric points as alphanumerical sequence has to be developed, preferably 
with a one-to-one correspondence in the numbers of vertices in the molecular graph and 
symbols in line notation representation. 
The mentioned similarity measures applicable to strings only count symbol identities. 
Not identical symbols are not further distinguished. A line notation representing potential 
pharmacophoric points as symbols would clearly benefit from a similarity measure that is able 
to differentiate between several cases of dissimilarity, because the exchange of certain pairs of 
potential pharmacophoric points is more or less severe than others. A sequence comparison 
method that is sensitive to different cases of not identical symbols is sequence alignment used 
in biology and bioinformatics for the identification of homologue amino acid or nucleic acid 
sequences. So far sequence alignment has been parameterized for such biopolymers. Given 
the  existence  of  a  line  notation  describing  functional  properties  of  molecules,  a  new 
parameterization of global pairwise sequence alignment has to be undertaken before it can be 
used in virtual screening.  
 
5.1 - Pharmacophore Alignment Search Tool (PhAST) 
 
The  combination  of  a  line  notation  describing  a  linear  form  of  the  pattern  of  potential 
pharmacophoric points of a molecule and global pairwise sequence alignment as similarity 
measure between these sequences was developed under the name ‘Pharmacophore Alignment 
Search  Tool’  (PhAST).  It  represents  molecules  as  unambiguous  sequences  of  symbols 
describing their pattern of potential pharmacophoric points (PhAST-sequence), meaning that 
the program creates exactly the same sequence for the same molecule at every time. But this 
molecule might not be the only one leading to this sequence. Each symbol in a PhAST-  33!
sequence  describes  the  interaction  possibilities  of  a  non-hydrogen  atom  in  the  original 
molecule, thus corresponds to a potential pharmacophoric point. The ideal correspondence 
between the pattern of PPPs and the PhAST-sequence of a molecule is illustrated in Figure 6: 
The position of each symbol in the sequence should only depend on graph topology, not on 
PPP type. That way molecules with topologically identical PPP patterns diverging only in one 
PPP type yield identical PhAST-sequences except for the symbols representing the diverging 
PPP types. 
The textual representation of a molecule is created in three steps: 
 
1)  Categorization: A graph of potential pharmacophoric points is created, in which each 
non-hydrogen atom of the molecular graph is represented by a vertex. Each vertex is 
colored with a symbol describing the possible interaction of the original atom. This 
atom-typing  is  fragment-based,  employing  a  set  of  substructures  with  pre-defined 
assignments of potential pharmacophoric points to non-hydrogen atoms. Substructure 
searches  are  carried  out  using  the  Molecular  Query  Language  (MQL).
63  Types  of 
potential pharmacophoric points used in PhAST are listed in Table 7. MQL queries as 
representations of molecular fragments used for atom-typing an their corresponding 
assignments of potential pharmacophoric points are shown in Table 8. 
 
2)  Canonization: To ensure unambiguity of PhAST-sequences, vertices in the graph of 
potential pharmacophoric points have to get assigned a unique set of indices (called 
canonical labels) in the integer range from 1 to 
! 
n, where 
! 
n equals the number of 
vertices in the graph. 
 
 
 
 
 
 
 
 
 
 
 
Figure  6. O u t l i n e  o f  t h e  i d e a l  c o r r e s p o n d e n c e  b e t w e e n  m o l e c u l e  a n d  l i n e  n o t a t i o n .  E x c h a n g e s  o f  
potential pharmacophoric points from A to B (indicated by different shades of grey) only influence the 
PPP types in the line notation, but not the position where this information is coded. 
 
 
A)  B)  Molecule 
PhAST-sequence 
Molecule 
PhAST-sequence   34!
Table 7. Potential pharmacophoric points employed in PhAST and their corresponding symbols used in 
the line notation. 
 
Possible Interactions  Symbol 
hydrogen bond acceptor  A 
charge positive  P 
charge negative  N 
lipophilic  L 
aromatic  R 
hydrogen bond acceptor, hydrogen bond donor  E 
hydrogen bond acceptor, polar  Q 
hydrogen bond acceptor, hydrogen bond donor, polar  U 
no possible interactions  O 
 
 
Table 8. MQL
63 queries defining pharmacophoric points in PhAST. Symbols are assigned to atoms 
used in the queries from left to right. Queries are used in the given order from top to bottom. 
 
MQL Query  PPP Symbols 
c  R 
n  R 
*[charge<0]  N 
*[charge>0]  P 
C(=O)-O-H  O;N;E 
P(=O)-O-H  O;N;E 
S(=O)-O-H  O;N;E 
N[allHydrogens=0&totalConnections=3]  Q 
N[allHydrogens=1&totalConnections=3](-C')-C'  U 
N[allHydrogens=2&totalConnections=3]-C'  U 
N[allHydrogens=1&totalConnections=2]=C'  E 
N[allHydrogens=0&totalConnections=2](=C')-C'  A 
O-H  E 
C=O  O;A 
C[!bound(~N)&!bound(~O)]-*'[C|F|Cl|Br|I|S]  L 
Cl  L 
Br  L 
I  L 
S[!bound(~N)&!bound(~O)]~*'[C|H]  L   35!
 
 
3)  Concatenation: To finally create the PhAST-sequence as representation of a molecule, 
the symbols corresponding to the vertices in the graph of potential pharmacophoric 
points created in step (1) are concatenated in the order determined by the canonical 
labels generated in step (2). 
 
The  workflow  of  PhAST-sequence  generation  is  illustrated  in  Figure  7  using 
chlorpromazine as example. It is noteworthy that, unlike SMILES, a PhAST-sequence lacks 
any explicit description of branching and ring closures in a molecule. This information is only 
implicitly encoded if it was used in the canonization process. 
 
Pairwise sequence alignment was developed as sequence comparison method to answer the 
question whether two amino acid sequences are related.
64 To create the alignment of two 
sequences 
! 
X = x1,x2,...,xn and 
! 
Y = y1,y2,...,yn, their symbols are matched. In this, the symbol 
order is retained and gaps may be inserted to improve the matching (insertion of paired gaps 
is forbidden). Three cases exist: (i) 
! 
xi is aligned to 
! 
y j and 
! 
xi = y j (match), (ii) 
! 
xi is aligned 
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
Figure 7. Outline of the sequence generation process of PhAST. After all atoms are typed, vertices in 
the created graph of potential pharmacophoric points are canonically labeled. The generated indices 
dictate the order of symbol concatenation.   36!
to 
! 
y j and 
! 
xi " y j (mismatch), (iii) 
! 
xi is aligned to a gap in 
! 
Y  or 
! 
y j is aligned to a gap in 
! 
X. 
In protein sequence alignment, matches represent conserved residues; mismatches may arise 
from mutations, and gaps from insertions or deletions in an assumed evolutionary process of 
the  compared  sequences.  Consequently,  matches  are  rewarded  with  a  positive  score, 
mismatches  are,  depending  on  the  exact  case,  either  rewarded  with  a  positive  score  or 
penalized with a negative score, and gaps are penalized with a negative score. The score of 
the complete alignment is calculated as the sum of scores for matches, mismatches and gap 
penalties. The optimal alignment of two sequences is the alignment with the maximum score. 
This  way,  the  alignment  identifies  similar  regions  of  both  sequences,  and  from  these 
similarities the decision can be made whether significant homology exists or whether the 
observed similarities could have occurred by chance. 
There are two types of sequence alignments: global and local. Global alignments span 
the entire length of both sequences, aligning every symbol in each one with a symbol from the 
other sequence or a gap. Local alignments on the other hand identify only the most similar 
region between two sequences that can be highly divergent overall. If the compared sequences 
are very similar, global and local alignments are identical. PhAST-sequences represent whole 
molecules. As a consequence, in order to obtain similarity scores for the original molecules, 
PhAST employs global alignment. The standard technique for this purpose is the Needleman 
Wunsch algorithm based on dynamic programming.
64,65 The algorithm depends on a scoring 
function 
! 
s(xi,y j)  that  returns  scores  for  symbol  matches  and  mismatches.  The  original 
algorithm applicable to any gap cost function has complexity of 
! 
O(max(n,m)
3), but for the 
special case of affine gap penalties there is a simplified algorithm with complexity 
! 
O(nm) (
! 
" O(n
2)).
66 Affine means that the opening of a gap is penalized by a gap open penalty 
! 
d, the 
extension of a gap by one position with a gap extension penalty 
! 
e, with 
! 
d > e. The penalty 
! 
P 
of a gap with length 
! 
g can be calculated by Equation 5. 
 
! 
P(g) = "(d +(e(g "1))                (5) 
 
The algorithm calculates a two-dimensional matrix 
! 
F (‘alignment graph’) with three 
entries in each cell 
! 
Fi, j representing the score of the optimal alignment of initial subsequences 
! 
(x1,...,xi) and 
! 
(y1,...,y j) ending with the alignment of 
! 
xi and 
! 
y j (
! 
Fi, j
D), 
! 
xi aligned to a gap 
position in 
! 
Y (
! 
Fi, j
H) and 
! 
y j aligned to a gap position in 
! 
X (
! 
Fi, j
V ). The algorithm is divided 
into two phases: Initialization of border cells according to Equations 6 – 12 and the recursive   37!
calculation of remaining matrix elements according to Equations 13 –15. After all matrix 
elements are calculated, the optimal alignment score equals 
! 
max Fn,m
H ,Fn,m
D ,Fn,m
V { }. 
The actual sequence alignment can be assembled in a traceback procedure starting 
from the traceback step T0 that equals the alignment possibility of sequence ends 
! 
xn and 
! 
ym 
with the maximum score. The next step  (T1) back in the alignment graph towards sequence 
beginnings  is  determined  by  the  value  in  the  alignment  graph  that  was  used  in  the 
maximization  for  the  current  value.  The  traceback  procedure  with  corresponding 
maximization possibilities is outlined in Table 9. There might be different optimal alignments 
! 
F 1,1
D = s(x1,y1)
! 
Fi+1, j+1
D = s(xi+1,y j+1)+max Fi, j
D,Fi, j
H,Fi, j
V { }
! 
F 1, j
D = s(x1,y j) "(d +e(j "1))
! 
Fi+1, j
H = max Fi, j
D " d,Fi, j
H "e,Fi, j
V " d { }
! 
Fi,1
D = s(xi,y1) "(d +e(i "1))
! 
Fi, j+1
V = max Fi, j
D " d,Fi, j
H " d,Fi, j
V "e { }
! 
Fi,0
H = "(d +e(i "1))
! 
F 1, j
H = "(2d +e(j "1))
! 
F0, j
V = "(d +e(j "1))
! 
Fi,1
V = "(2d +e(i "1))
  (6)      (13) 
  (7)      (14) 
  (8)      (15) 
  (9)       
  (10)       
  (11)       
  (12)       
!
!
 
 
Table 9. Sequence alignment traceback. The traceback procedure is explained by the step from T0 to T1. 
Besides index adjustments, the procedure is the same for all following steps. From each possible T0 
there are three possibilities for T1. T1 is chosen as the possibility corresponding to the maximum of the 
three possible maxima listed for each T0. 
 
T0  T1 Possibilities  Necessary Maximum 
! 
Fn,m
H
 
! 
Fn"1,m
H
 
! 
Fn"1,m
H "e 
 
! 
Fn"1,m
D
 
! 
Fn"1,m
D " d 
 
! 
Fn"1,m
V
 
! 
Fn"1,m
V " d 
! 
Fn,m
D
 
! 
Fn"1,m"1
H
 
! 
Fn"1,m"1
H + s(xn,ym) 
 
! 
Fn"1,m"1
D
 
! 
Fn"1,m"1
D + s(xn,ym) 
 
! 
Fn"1,m"1
V
 
! 
Fn"1,m"1
V + s(xn,ym) 
! 
Fn,m
V
 
! 
Fn,m"1
H
 
! 
Fn,m"1
H " d 
 
! 
Fn,m"1
D
 
! 
Fn,m"1
D " d 
 
! 
Fn,m"1
V
 
! 
Fn,m"1
V "e 
!  38!
all yielding maximum score. To ensure that the algorithm always returns the same alignment 
for the same pair of sequences the three possibilities for the next step are always checked in 
the order 
! 
Fi, j
H, 
! 
Fi, j
D and 
! 
Fi, j
V , and a possibility is only accepted as next step if it has higher 
score. If only the alignment score is of interest, performing the traceback procedure is not 
necessary. 
 
Sequence alignments were developed for the comparison of amino acid sequences but are 
applied to nucleotide sequences (deoxyribonucleic acid and ribonucleic acid) as well. With an 
appropriate scoring scheme, each type of sequence can be compared using this technique. For 
protein  sequence  alignments  score  matrices  like  PAM
67  (point  accepted  mutations)  or 
BLOSUM
68 (block substitution matrix) are a common choice as scoring systems for matches 
and  mismatches.  These  matrices  were  calculated  from  multiple  reference  alignments  of 
sequences and the observed substitution frequencies of amino acids. Affine gap penalties 
described  in  Equation  5  are  the  standard  choice  in  most  applications  of  global  and  local 
sequence alignments. But other choices are possible, for example: 
$  constant gap penalty: any gap is penalized with penalty 
! 
p 
$  linear gap penalty: analogue to the affine gap penalty with 
! 
d = e 
$  logarithmic gap penalty: a gap of length g is penalized with 
! 
log(g) 
 
The steps and variable parameters of PhAST are described in Figure 8. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8. Major steps (dark grey) of PhAST and their variable parameters (light grey). 
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5.2 - Preliminary Parameterization 
 
In a preliminary study a first parameterization of PhAST was identified that exhibited basic 
screening capabilities.
69 In this version the Weininger algorithm for graph canonization
46 was 
used  for  canonical  labeling  of  the  graph  of  potential  pharmacophoric  points.  PhAST-
sequences were aligned by the Needleman-Wunsch algorithm.
64 
 
5.2.1 - Scoring System 
 
The scoring system used for matches and mismatches is shown Table 10. It is based on the 
idea of entropy scoring, assigning less frequent events higher scores or penalties, that way 
giving  them  higher  influence  on  the  calculated  sequence  alignment.
70  PPP  frequencies 
determined from the COBRA collection of bioactive reference compounds are: A = 4.95%, E 
= 1.44%, L = 19.95%, N = 1.22%, O = 24.63%, P = 1.8%, Q = 1.58%, R = 41.61%, U = 
3.11%. The idea of entropy scoring in PhAST is motivated by the fact that frequent PPP types 
like R, L and O form main parts of molecules, with their only function being to ensure other 
PPPs have the correct spatial arrangement. Matches and mismatches between these frequent 
PPP types could occur in an alignment just because of their overall frequency, not because 
they represent the same interaction at the same position in different molecules. 
PPP types can be separated in two groups: single-interaction and multiple-interaction 
PPPs.  Scores  for  single-interaction  PPPs  were  chosen  to  resemble  the  corresponding 
frequencies in drug-like molecules determined from the COBRA
11 collection of bioactive 
 
Table  10. S c o r i n g  s c h e m e  f o r  m a t c h e s  a n d  m i s m a t c h e s  o f  p o t e n t i a l  p h a r m a c o p h o r i c  p o i n t s .  F o r  a  
description of the interaction possibilities associated with a symbol see Table 7. 
 
  A  E  L  N  O  P  Q  R  U 
A  8  2  2  -1  -2  -4  4  -4  -2 
E    12  -4  -9  -4  -6  -4  -9  0 
L      2  -2  -2  -2  -4  1  -6 
N        10  -2  -6  -7  -4  -10 
O          2  -2  -4  -4  -6 
P            10  6  -5  4 
Q              14  -9  6 
R                3  -13 
U                  16 
   40!
reference compounds, so that the influence of less frequent PPPs increased. PPP types O and 
L are the most frequent ones. As a consequence the corresponding matches get only a reward 
of 2. The less common type A gets a match score of 8. Least frequent types E, N and P 
receive highest score of 10. These scores were chosen arbitrarily. 
Mismatch  scores  are  based  on  isofunctionality  of  mismatching  types.  P  and  N 
represent opposite interaction possibilities and this mismatch is scored with -6, just like A and 
D. Any mismatch involving O represents a loss of function and is scored with -2, so are 
mismatches of any type with L. N can partly act the same way A does, so this mismatch 
receives minimal penalty of -1. D on the other hand as opposite of A is scores with a higher 
penalty of -3 for the same reason. As A is negatively polarized, the mismatch with P is 
penalized with -4 – stronger than a mismatch with O, but weaker than the PN event. Aligning 
P to D is penalized by -2. 
Events involving multifunctional PPPs are scored following a straightforward scheme: 
All possible unique pairs of single-functional PPPs included in the multifunctional atom types 
are considered and their scores are added up to the final match or mismatch score. A special 
case is type R, as this PPP represents aromatic features. Those represent electron-rich regions 
in a molecule but behave close to lipophilic PPPs. Because of this relation between R and L 
the corresponding mismatch receives a small reward of 1 instead of a penalty despite the fact 
that lipophilic regions do not exhibit this electron-richness. 
Gap penalties for the affine penalty model were determined in a grid search with gap 
open penalty between 2 and 15 and gap extension penalty equal to any value lower than the 
gap open penalty. The combination of gap open penalty -3 and gap extension penalty -1 
showed best results. 
 
5.2.2 - Alignment Evaluation 
 
The global alignment of two sequences identifies similar parts as matched regions. But the 
alignment of symbols between sequences alone does not indicate homology. For this purpose 
alignment  evaluation  methods  have  to  be  used  that  calculate  a  similarity  based  on  the 
alignment. A simple and intuitive method is the calculation of ‘percent sequence identity’ 
(PID) between sequences. This method has been used successfully for the identification of 
homologue  proteins.
71,72  In  the  preliminary  parameterization  PhAST  assesses  similarity 
between  two  molecules  as  the  PID  calculated  from  the  alignment  of  their  corresponding 
PhAST-sequences as shown in Equation 16   41!
 
! 
PID(X,Y) =
M(A(X,Y))
L(A(X,Y))
                (16) 
 
  where 
! 
A(X,Y)  is  the  global  alignment  of  sequences  X  and  Y, 
! 
M(A(X,Y))  is  the 
number of matches in 
! 
A(X,Y) and 
! 
L(A(X,Y)) is the length of the 
! 
A(X,Y), that is the length 
of either sequence including gapped positions. This definition is based on a measure proposed 
by  Doolittle,71  but  in  contrast  to  that  first  idea  of  sequence  identity  calculated  from 
alignments it does not exclude terminal gaps.
73 This modification is necessary as PhAST is 
supposed to calculate the similarity between complete molecules. The exclusion of regions 
aligned  to  gapped  positions  would  confine  similarity  assessment  only  to  fractions  of 
molecules and as a consequence calculated similarities would no longer describe relationships 
between complete structures. 
 
5.3 - Retrospective Evaluation 
 
5.3.1 - Dataset 
 
Screening performance of different PhAST configurations and other virtual screening 
methods w a s  a s s e s s e d  through  retrospective  virtual  screenings  employing  the  COBRA
11 
collection  of  bioactive  compounds  as  reference  dataset  that  contains  active  and  inactive 
compounds for different targets. The COBRA library was used in version 6.1 containing 
8,311 molecules with target receptor information compiled from selected scientific journals. 
Retrospective screenings were performed on six targets listed in Table 11. 
 
5.3.2 - Performance Measure 
 
In the scenario retrospective virtual screenings it is known which molecules are active 
against  the  same  biological  target  as  the  query.  The  enrichment  capabilities  of  a  virtual 
screening method, meaning the assignment of better ranks to actives than to inactives,  can be 
assessed by the ranks of actives assigned in the screening. Several metrics for this purpose 
have been proposed. Virtual screening aims at enrichment of active compounds on early ranks 
in the ranked screening library. As a consequence, performance on the first part of the ranked   42!
library is of special interest and a good performance measure should be able to detect such 
‘early enrichment’. 
The ‘enrichment factor’ (EF) is one of the simplest performance measures for virtual 
screening.
74 It compares the ratio of actives to inactives within the first 
! 
n ranked samples to 
uniform distribution. Typical values for 
! 
n are 1% and 5% of the library size. The enrichment 
factor is calculated according to Equation 17. 
 
! 
EF(n) =
n
+
n
N
+
N
                  (17) 
 
  where 
! 
n
+ is the number of actives in the first 
! 
n ranked samples, 
! 
N
+ is the total 
number of actives in the library and 
! 
N is the total number of compound in the library. The 
enrichment factor is easy to calculate and to interpret but has several drawbacks. It depends 
on the number of actives. For the same 
! 
n and 
! 
N, increasing 
! 
N
+ lowers the range of possible 
enrichment factors. Choosing 
! 
n is critical for the enrichment factor. It is calculated based on 
the number of high ranked compounds instead of the number of different ranks, so it does not 
consider ties. Furthermore the order of actives within the first 
! 
n compounds does not matter, 
but  cases  where  the 
! 
n
+ s a mples  are  ranked  on  the  first 
! 
n
+  positions  should  clearly  be 
preferred. 
Table 11. Targets in the COBRA library version 6.1 used for retrospective virtual screenings. Shown 
are abbreviations used in this study as well as the number of active compounds. The total number of 
molecules in the COBRA library is 8,311. 
 
Target  Abbreviation  No. Actives 
Angiotensine-converting enzyme  ACE  34 
Cyclooxygenase 2  COX2  136 
Dihydrofolat-reductase  DHFR  64 
Factor Xa  FXA  228 
Peroxisome-proliferator activated receptor "  PPAR"  44 
Thrombin  THR  183 
Total    689 
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The receiver ‘operating characteristic’ (ROC) curve plots the true positive rate over 
the false positive rate.
75 But the visual comparison of a multitude of ROC curves would not be 
feasible. The corresponding are under the curve (ROCAUC) is easy to calculate and became 
an  established  performance  measure  for  ranking  methods.  ROCAUC  can  be  calculated 
according to Equation 18. 
 
! 
ROCAUC =
1
(nN)
Fa(k) Fi(k) " Fi(k "1) [ ]
k=2
N
#           (18) 
 
where 
! 
N is the library size, 
! 
n is the number of actives, 
! 
Fi(k) is the cumulative count 
of inactives at rank 
! 
k and 
! 
Fa(k) is the cumulative count of actives at rank 
! 
k. It equals the 
probability of ranking a randomly chosen positive sample better than a randomly chosen 
negative  sample.  Early  enrichment  is  visible  in  ROC  curves,  but  ROCAUC  fails  in  the 
detection  of  such  behavior.  The  ROCAUC  score  of  a  random  model  that  has  to  be 
outperformed, corresponding to uniform distribution of actives in the screening library is, 0.5. 
The  ‘Boltzmann-enhanced  discrimination  of  receiver  operating  characteristic’ 
(BEDROC)  is  based  on  the  idea  of  an  exponential  weighting  according  to  rank.
13  It 
emphasizes the beginning of the ranked list, giving more weight to early ranked samples. The 
exponential weighting function can be influenced through an ‘early recognition parameter‘ 
! 
" 
determining the range from the beginning of the ranked list with most influence: higher values 
for 
! 
" correspond to fewer early ranks dominating the BEDROC score. 20 is suggested as 
default value for 
! 
".
13 BEDROC is calculated according to Equation 19 
 
! 
BEDROC =
e
"#ri N
i=1
n
$
Ra
1"e
"#
e
# N "1
% 
& 
' 
( 
) 
* 
+
Ra sinh(# 2)
cosh(# 2) "cosh(# 2 "#Ra)
+
1
1"e
#(1"Ra )     (19) 
 
  where 
! 
N is the number of compounds in the library, 
! 
ri is the rank of the 
! 
i-th active 
and 
! 
Ra is the ratio of actives. Because of its ability to detect early recognition, in this work 
BEDROC was used for performance evaluation inretrospective screenings, with 
! 
" = 20. The 
BEDROC score of a random model that has to be outperformed, corresponding to uniform 
distribution of actives in the screening library, is 
! 
1 " = 0.05 for 
! 
" = 20. 
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5.3.3 - Significance Assessment 
 
When  two  virtual  screening  methods  or  different  parameterizations  of  the  same 
method perform different in retrospective virtual screenings, indicated by different scores 
received from the performance measure of choice, the question is whether this difference is 
significant. The most powerful solution to the problem of significance assessment found so 
far is a paired permutation test.
76,77 It has the null hypothesis that virtual screening method P 
performs  significantly  better  than  method  Q.  Assuming  p  and  q  are  rank  lists  of  actives 
resulting  from  the  virtual  screening  methods,  the  null  hypothesis  requires  that  –  with 
BEDROC as example – BEDROC(p) > BEDROC(q). As each active has two ranks, one in p 
and one in q, new rank lists p* and q* can be created by swapping its rank in p with its rank in 
q for each active with probability 1/2. This was repeated 10
4 times and the frequency of the 
event that BEDROC(p) – BEDROC(q) is less than BEDROC(p*) – BEDROC(q*), the type I 
error rate for the null hypothesis, was used as p-value for significance estimation. 0.05 and 
0.01 were used as significance levels.   45!
6 - Influence of Canonical Atom Labeling on Similarity Searching 
 
This section discusses the publication listed as Appendix A. 
 
6.1 - Motivation 
 
The preliminary parameterization of PhAST employed the Needleman-Wunsch algorithm for 
global  sequence  alignment.
64  Other  alignment  algorithms  have  been  proposed.  A  faster 
algorithm described in Durbin et al. 1998 (referred to as FSM algorithm) gains computational 
speed through simplifications made for the alignment process: The introduction of subsequent 
gaps in both sequences is forbidden, they have to be separated by at least one match or 
mismatch.
78 The assumption of two insertions or deletions not following directly onto each 
other is biologically valid and reduces the number of necessary computations. The alignments 
obtained  with  this  algorithm  are  guaranteed  to  be  identical  to  those  calculated  by  the 
Needleman  Wunsch  algorithm  if  the  sum  of  both  gap  penalties  is  lower  than  the  lowest 
mismatch score.
78 If that is not the case, resulting alignments might differ slightly. The FSM 
and  Needleman-Wunsch  algorithm  were  compared  in  this  study  in  a  set  of  689  virtual 
screenings (vide supra). Similarity of results was assessed by the respective retrospective 
performance measured using BEDROC and the correlation of rankings obtained with each 
algorithm for the same screening. Both algorithms were compared in the same preliminary 
paramaterization (vide supra). 
 
The preliminary parameterization of PhAST had two drawbacks that conflicted with the ideal 
case of line notation and sequence comparison. 
First, it employed the Weininger algorithm for graph canonization
46 as linearization 
method applied to the pattern of potential pharmacophoric points (PPPs) associated with a 
molecule. Many properties used for vertex prioritization in this algorithm depend on atom 
types in the original molecule: atomic symbol, number of neighbors, number of connected 
vertices and the number of connected vertices that are non-hydrogen atoms. Because this 
conflicts with the idea of a line notation that depends only on graph topology (cf. Figure 6), 
several other methods for graph canonization were investigated. In addition to the Weininger 
algorithm two other algorithms developed for canonical atom labeling of chemical structures   46!
were included in this survey: The Jochum-Gasteiger algorithm
79 and the method developed by 
Prabhakar and Balasubramanian.
80 All three algorithms were evaluated in an implementation 
adapted to the problem of indexing vertices in a graph of potential pharmacophoric points 
instead of a molecular graph. In a second implementation, each algorithm was modified in a 
way that prioritization criterions depending on the atom type or potential pharmacophoric 
point were excluded from the prioritization process. Besides these algorithms originating from 
molecular  graphs,  methods  developed  for  dimensionality  reduction  were  investigated  for 
graph linearization. They can be applied to this problem by embedding the graph of potential 
pharmacophoric points in one dimension, yielding a linear sequence of vertices from which 
canonical labels are deduced. Methods investigated were Principal Component Analysis,
81 
Laplacian  Eigenmaps,
82  Isomap
83  and  Minimum  Volume  Embedding.
84  The  necessity  of 
graph canonization was proven by comparison to a random model for symbol concatenation. 
Second,  percent  sequence  identity  (PID)
71  is  not  sensitive  to  different  types  of 
mismatches. Sequence alignment itself is sensitive to these differences as they are scored 
differently. But calculating PID for alignment evaluation, these differences are neglected. The 
alignment score on the other hand depends directly on these scores. Furthermore it was shown 
for protein sequence alignments that the alignment score is more suitable to the detection of 
homologues compared to PID.
85 Due to these reasons the alignment score as method for 
evaluation  of  global  alignments  of  PhAST-sequences  was  investigated,  comparing  two 
variants of PID and three measures derived from the alignment score. All combinations of 
canonization algorithm and  alignment evaluation measure  were evaluated in a set of 689 
retrospective virtual screenings, optimizing gap penalties in a grid-search.  
 
Algorithms  used  for  graph  canonization  compared  in  this  study  employed  diverging 
principles.  The  Jochum-Gasteiger  algorithm  assigns  vertices  based  on  burriedness,  the 
Weininger  algorithm  creates  equivalence  classes  based  on  toplogical  properties  and  the 
Prabhakar-Balasubramanian  method  labels  subsequent  vertices  on  uninterrupted  paths 
through a graph. Methods for dimensionality reduction applied to graph linearization included 
linear  as  well  as  non-linear  methods.  An  ideal  canonization  algorithm  would  mirror 
modifications to the molecular graph in the corresponding PhAST-sequence without changes 
to subsequences originating from unchanged subgraphs. In order to assess to what degree the 
compared  algorithms  comply  with  this  ideal  case,  PhAST-sequences  generated  from 
molecules with small topological and functional alterations were compared with regard to 
neighborhood relations between vertices and symbols.   47!
6.2 - Discussion 
 
Changing  the  alignment  algorithm  from  Needleman-Wunsch  to  FSM  was  a  significant 
improvement for PhAST as virtual screening method. With FSM, calculated alignments were 
not the exact optimal alignments in some cases, but high correlation between ranked lists 
obtained in screenings indicated that the method still was suitable for virtual screening. The 
comparison speed more than doubled. Both, retrospective and prospective applications benefit 
from this speed-up: The number of parameterizations that can be evaluated in retrospective 
experiments increases as well as the size of libraries that can be screened for hits in the same 
time. 
 
Graph  canonization  was  shown  to  be  a  necessary  step  in  PhAST-sequence  generation. 
Retrospective performance significantly increased if the Weininger algorithm for canonical 
labeling was employed instead of randomized symbol concatenation. But differences between 
canonization  algorithms  measured  by  their  retrospective  performance  were  dominated  by 
those caused by the alignment score as alignment evaluation measure. This outcome was not 
expected.  PID  and  the  alignment  score  evaluate  the  same  alignments,  but  the  alignments 
themselves  are  altered  if  PhAST-sequences  are  generated  using  different  canonization 
algorithms.  So  the  expectation  was  for  the  variable  influencing  generation  of  PhAST-
sequences to have higher influence. 
Although differences between alignment evaluation methods were more severe, the 
canonization algorithm influenced retrospective performance as well. Highest retrospective 
performance  was  observed  with  Minimum  Volume  Embedding  employing  a  Diffusion 
Kernel.  This  technique  of  non-linear  dimensionality  reduction  relies  only  on  distances 
between  vertices  in  the  graph  of  potential  pharmacophoric  points  measured  based  on 
topological distances. This way it is independent from atom types in the molecular graph and 
corresponding  types  of  PPPs.  This  way,  it  is  consistent  with  an  the  concept  of  an  ideal 
canonization algorithm. 
 
The analysis of canonization robustness against modifications to the molecular graph showed 
that none of the compared algorithms retained PhAST-sequence subsequences corresponding 
to  identical  subgraphs  unaltered.  Nevertheless  all  canonization  algorithms  succeed  in 
generating  PhAST-sequences  yielding  enrichment.  This  indicated  that  global  sequence 
alignment  as  sequence  comparison  method  was  flexible  enough  to  compensate  for  these   48!
deficiencies. Comparison of canonization algorithms by their ability to retain symbol order 
revealed  similarities  between  methods.  Dimensionality  reduction  methods  exhibited  a 
diverging behavior compared to methods specifically designed for canonical atom labeling. 
But  computational  cost  for  this  analysis  was  higher  than  actually  performing  a  complete 
retrospective  comparison  due  to  the  large  number  of  altered  molecular  graphs.  As  a 
consequence,  this  kind  analysis  is  suitable  for  the  comparison  of  algorithms.  But  for 
assessment of screening performance, retrospective experiments remain the method of choice. 
 
Findings of this study helped to point further investigations and development of PhAST into 
promising directions. Findings for the alignment of amino acid sequences have been affirmed 
for PhAST-sequences as well: The alignment score was more suitable for the detection of 
similarities (amino acid sequences: homologues) than PID. Differences between PID and the 
alignment score were significant. In combination these results encourage the implementation 
and evaluation of further alignment evaluation measures. For proteins, it has been shown that 
measures  based  on  significance  estimation  are  more  suitable  for  reliable  homologue 
identification than both, PID and alignment score.
85 Several approaches for the calculation of 
p-values have been published with regard to local alignments only.
86-89 But only methods 
applicable to global alignments can be investigated in PhAST. 
 
Concluding,  PhAST  was  significantly  improved  in  this  study.  The  parameterization  with 
highest observed retrospective performance was: 
 
•  Canonization:     Minimum Volume Embedding, Diffusion Kernel 
(diffusion parameter 0.4), covalent connectivity 
•  Gap Open Penalty:     5 
•  Gap Extension Penalty:   1 
•  Alignment Evaluation:   Alignment score normalized to alignment length 
 
This parameterization was used as basis of all further investigations.   49!
7  -  Influence  of  the  Third  Dimension  on  Text-based  Similarity 
Searching 
 
This section discusses the publication listed as Appendix B. 
 
7.1 - Motivation 
 
Descriptors  calculated  from  two-dimensional  (2D)  molecular  representations  have  been 
successfully  applied  in  virtual  screening  campaigns.
37,38  But  bioactive  conformations  of 
compounds  are  three-dimensional,  as  receptor  structures  are  three-dimensional  as  well. 
Because  of  this  fact,  virtual  screening  methods  handling  three-dimensional  (3D) 
conformations  should  yield  better  results,  manifesting  in  higher  enrichment  observable  in 
retrospective  experiments.  This  should  at  least  be  true  if  the  bioactive  conformation  of 
molecules is known. For most compounds this ideal case does not apply, but computational 
methods  for  the  generation  of  low-energy  3D  conformations  have  been  developed.  Until 
today there is no agreement whether 2D or 3D descriptors should generally be preferred.
90,91 
In  order  to  investigate  whether  PhAST  can  benefit  from  the  application  to  three-
dimensional conformations of molecules, the canonization process was modified. All methods 
for  dimensionality  reduction  employed  as  canonization  algorithms  were  applied  to  3D 
conformations  and  systematic  2D  structure  diagrams  in  order  to  assess  differences  in 
screening performance. In case of Minimum Volume Embedding, additional kernel functions 
were  investigated  for  this  purpose.  Because  computational  cost  increases  with  increasing 
number of compared molecules, only the best performing version identified in the application 
to  single  3D  conformations  was  evaluated  in  retrospective  experiments  with  multiple 
conformations per molecule. 
Another  step  in  PhAST  that  can  be  modified  to  exploit  3D  information  is  the 
alignment  algorithm  itself.  For  protein  sequence  alignment  scoring  systems  have  been 
proposed that reward structural instead of functional similarity. These methods succeed in the 
identification  of  similar  proteins  by  shape  comparison.  Six  different  parameterizations  of 
PhAST employing such a technique named ‘Double Dynamic Programming’ (DDP)
92 were 
compared for the evaluation of the applicability of this method to the comparison of small 
organic molecules. 
   50!
There are a multitude of available virtual screening techniques. New methods are only 
useful  if  they  yield  new  chemical  entities  on  early  ranks.  The  novelty  of  PhAST  in  this 
context was assessed in comparison to common methods. For this comparison, retrospective 
performance (measured by BEDROC) including the significance of differences in enrichment 
capability  and  ranks  of  actives  measured  by  rank  correlation
93  were  used  as  similarity 
measures.  Data  fusion,  the  combination  of  complementary  screening  methods,  has  been 
reported to enhance screening perfomance.
94 But to the best of knowledge, so far no criterion 
for  the  selection  of  such  fusion  candidates  was  proposed.  This  study  investigated  rank 
correlation  for  this  purpose  by  celecting  a  suitable  method  that  was  then  combined  with 
PhAST. 
 
7.2 - Discussion 
 
Retrospective comparison of different canonization algorithms employed in PhAST applied to 
2D and 3D representations of molecules demonstrated that the dimensionality of molecular 
representations  influences  screening  behavior.  But  differences  were  observed  mostly  in 
compound  ranking,  not  in  overall  enrichment.  The  application  of  Minimum  Volume 
Embedding employing a Diffusion Kernel in combination with covalent connectivity to 2D 
structure  layouts  still  displayed  best  screening  performance.  Screening  performance  was 
increased  by  usage  of  multiple  3D  conformations.  But  compared  to  the  increase  in 
computational cost, the increase was too small to justify this rise in cost. 
  PhAST was shown to have screening performance comparable or superior to other 
screening approaches. But the comparison of ranked lists obtained with different screening 
methods  revealed  that  rankings  calculated  with  PhAST  were  dissimilar  to  those  of  other 
methods. As a consequence, PhAST ranks active compounds on early ranks that are missed 
by other methods. This underlined the novelty of the PhAST concept. 
Descriptions of data fusion methods for virtual screenings mostly describe fusion rules 
or results from combined descriptors that were chosen by intuition. But they do not suggest 
selection  criteria  for  methods  selection.  In  this  study,  rank  correlation  was  shown  to 
successfully identify promising fusion candidates. ‘Pseudoreceptor Point Similarity’ (PRPS)
95 
was selected as candidate for data fusion with PhAST. The observed increase in retrospective 
performance was assessed as significant. 
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The  application  of  structural  instead  of  functional  scoring  systems  to  the  alignment  of 
PhAST-sequences for similarity assessment of small molecules yielded enrichment better than 
random active distribution in most cases. But only for cyclooxygenase-2, functional scoring 
systems  was  outperformed.  Due  to  a  small  binding  pocket,  most  of  the  actives  in  the 
screening  dataset  are  small  and  possess  a  common  structural  element.  Only  the  query 
molecule  sharing  this  element  achieved  high  enrichment.  This  indicated  that  structural 
similarity assessment through sequence alignment is intolerant to structural variations. Further 
investigations of structural scoring schemes and combinations with functional score matrices 
should concentrate on this observation by comparing retrospective results for targets with 
similar  constraints  for  active  molecules.  Furthermore,  distances  are  measured  without  a 
directional  component  in  the  evaluated  approach.  For  amino  acid  sequence  alignments, 
improvements have been developed that place coordinate systems on every residue, enabling 
comparison of directions as well as distances. These methods improved structural scoring for 
proteins and should be evaluated for small molecules as well. 
 
The comparison of PhAST with other methods clearly showed that there is no method for 
virtual screening that performs best on each target used in the comparison. These findings 
suggest that in prospective applications methods should be chosen, evaluated and fine-tuned 
for the application to a particular target to maximize screening success.  
 
Using 3D molecular representations could not increase screening performance in  areasonable 
manner.  That  is  why  after  this  study  the  recommended  parameterization  of  PhAST  for 
prospective application remained: 
 
•  Canonization:     Minimum Volume Embedding, Diffusion Kernel 
(diffusion parameter 0.4), covalent connectivity 
•  Gap Open Penalty:     5 
•  Gap Extension Penalty:   1 
•  Alignment Evaluation:   Alignment score normalized to alignment length   52!
8  -  Influence  of  Scoring  Systems  on  Text-based  Similarity 
Searching 
 
This section discusses the publication listed as Appendix C. 
 
8.1 - Motivation 
 
Scoring system for protein sequence alignments are based on mutation rates manifesting in 
observed amino acid exchanges.
67,68 Given a set of multiple sequence alignments, scores can 
be calculated systematically using an established and well-founded framework. Scores in the 
PhAST  score  matrix  for  potential  pharmacophoric  points  (PPPs)  on  the  other  hand  were 
chosen only from conceptual isofunctionality of types and observed frequencies in drug-like 
molecules. A modification of the underlying atom-typing would change those frequencies and 
could  affect  the  applicability  of  the  existing  scoring  scheme.  Minor  changes  in  the 
assignments of PPPs to substructures would reflect in altered PPP frequencies. Major changes 
like  the  introduction  of  completely  new  interaction  types  (for  example:  so  far  no  purely 
hydrogen-bond donor functionality has been assigned) would require an extended scoring 
scheme including all new types of matches and mismatches. Systematic approaches to score 
calculations are preferable to intuition-based scoring because they enable rapid computation 
of new score matrices and their evaluation. Because of these reasons principles from score 
calculations in amino acid score matrices were evaluated for PPPs of drug-like molecules in 
this study based on the six compound classes in COBRA used for retrospective evaluation. 
The only concession necessary was the limitation to pairwise comparisons instead of 
multiple sequence alignment.
96 This was due to the sequence generation process including 
Minimum  Volume  Embedding:  Small  modifications  can  cause  the  one-dimensional 
coordinate system to invert. As a consequence, the correct comparison direction of a sequence 
pair is not known, and both possible combinations have to be evaluated. For n sequences there 
are 2
n possible combinations of orientations. Calculating this amount of multiple sequence 
alignments was not feasible, and it is unclear whether the correct one, in which all sequences 
have the correct orientation, can be identified at all. In addition to sequence alignments, a 
kernel-based  assignment  method
97 w a s  e valuated.  It  operates  on  graphs  and  circumvents 
mismatches  occurring  in  sequence  alignments  due  to  positioning  compromises  during 
linearization.   53!
Besides  systematic  approaches  for  score  calculation,  stochastic  optimization  was 
applied to match and mismatch scores. This optimization iteratively proposed and evaluated 
new solutions and generated derivatives of the most promising one. 
The application of the same score matrix to each position in a PhAST-sequence gives 
equals weight to all symbols of the same type. But as already implied by the definition of the 
term pharmacophore, this is not correct: The pharmacophore comprises only the interactions 
necessary  for  activity,  not  all  possible  interactions.  The  logical  consequence  was  the 
application  of  weights  to  symbols  in  PhAST-sequences  corresponding  with  interactions 
known to be essential for ligand-receptor-interaction, leading to position-specific scoring. The 
other way around, if screening performance increases with weights at particular symbols, their 
corresponding interactions are common to other actives and as a consequence most likely 
essential  for  activity.  Both  variants  of  weight  application  were  evaluated  in  retrospective 
screenings. 
 
8.2 - Discussion 
 
All three methods for score determination yielded score matrices that performed superior to a 
simple uniform scoring scheme. The original scoring system remains significantly superior, 
but the two non-stochastic approaches generated reproducible and comprehensible scores. 
Therefore they are ideal methods for the standardized generation of score matrices that can be 
used for the evaluation of modifications to the interaction types and assignments employed in 
the atom-typing step of PhAST in future studies. Independent runs of stochastic optimizations 
returned similar but not identical matrices that perform not as good as those generated with 
the systematic approaches.  
Two datasets were used in the stochastic optimization of the score matrix employed in 
PhAST. Optimization was stopped after a fixed number of iterations. A better solution would 
have been to use three datasets: Training, test and validation data. The training dataset that is 
subject to the optimization. Retrospective performance on this compound collections serves as 
fitness function for matrix evaluation. Screening performance on a test dataset can serve as 
stop criterion for the optimization: If performance further increases on the training data but 
decreases on the test data, scores are overfitted to the training dataset and optimization should 
be stopped. This way the test data influences optimization, and a third dataset is needed for 
objective evaluation. Retrospective performance on a validation dataset that at no point is 
used for optimization serves as unbiased performance measure. But publicly available and   54!
well-curated datasets for ligand-based virtual screening methods rare. The maximum unbiased 
validation dataset (MUV)
98 was designed to eliminate analogue bias (high structural similarity 
between actives) and artificial enrichment (actives structurally too dissimilar from inactives), 
both leading to too optimistic estimations of screening performance. The resulting dataset 
turned out to be too hard for well-established screening methods.
99 Furthermore the binding 
modes of compounds are unknown and inactivity of presumed inactive compounds is not 
confirmed. That way MUV is not suitable as any one of test, training or validation dataset. 
The COBRA
11 and the Krier
100 dataset used in this study have unequal numbers of actives 
(and as a consequence: of presumed inactives). For some targets the number of compounds is 
high enough for saturation effects to occur.
13 For others it is too low for cross-validation 
approaches to represent generalized performance estimation in a fold. Facing these facts, the 
performed optimization was a knowingly chosen compromise that yielded acceptable results. 
COBRA was chosen as test dataset because it has been used for performance assessment of 
previous  parameterizations  of  PhAST,  providing  a  large  set  of  results  that  allow  a 
comparative  interpretation  of  new  results.  This  demonstrates  the  need  for  well-built  and 
curated datasets. 
The application of weights to certain PPPs increased screening performance of PhAST 
significantly.  So  far  general  screening  performance  of  PhAST  was  comparable  to  other 
established  methods.  But  with  the  possibility  to  incorporate  target-  and  query-specific 
knowledge about receptor-ligand interaction PhAST becomes superior to these methods. But 
even more important, the reversed application of weights allows the identification of essential 
features.  This  way  PhAST  cannot  only  be  used  as  virtual  screening  method  but  also  for 
pharmacophore  elucidation  and  information  mining  in  the  elucidation  of  ligand-receptor 
interaction.  
 
The recommended parameterization of PhAST remained: 
 
•  Canonization:     Minimum Volume Embedding, Diffusion Kernel 
(diffusion parameter 0.4), covalent connectivity 
•  Gap Open Penalty:     5 
•  Gap Extension Penalty:   1 
•  Alignment Evaluation:   Alignment score normalized to alignment length 
 
Weights have to be chosen based on the particular target and query structure.   55!
9 - Comparison of Text-Based Virtual Screening Techniques 
 
The  known  text-based  virtual  screening  techniques  LINGO
53,54  and  ‘Comparison  by 
Compression’ (referred to as CbC)
59 are based on SMILES
45,46 representations of molecules. 
In order to show the novelty of the PhAST concept compared to these two methods, they were 
compared  in  retrospective  studies  on  the  COBRA
11  collection  of  bioactive  reference 
compounds. Criteria were retrospective screening performance measured by BEDROC scores 
(calculated with # = 20)
13 and Kendall’s rank correlation coefficient
93 calculated from ranked 
lists condensed to active compounds. LINGO and CbC were evaluated as described earlier. 
SMILES were generated with MOE (Molecular Operating Environment, v2010.06, Chemical 
Computing  Group  Inc.,  Montreal,  Canada).  PhAST  was  used  in  the  identified 
parameterization  with  best  screening  performance:  Canonization  with  Minimum  Volume 
Embedding,  Diffusion  Kernel  (diffusion  parameter  0.4)  and  covalent  connectivity,  the 
original  scoring  scheme  for  PPPs,  gap  open  penalty  =  5,  gap  extension  penalty  =  1  and 
alignment  evaluation  by  alignment  score  normalized  to  alignment  length.  Results  are 
presented in Table 12 to Table 14. 
  PhAST  and  LINGO  both  exhibited  higher  averaged  retrospective  performance 
compared to CbC (Table 12). For both, these differences were significant in more than 50% 
of  all  screenings  at  both  tested  significance  levels  (Table  13).  LINGO  displayed  higher 
retrospective performance than PhAST. But whereas the superiority of LINGO to CbC was 
significant in 78% (76%) of all screenings at 0.05 (0.01) significance level, the difference to 
PhAST  was  significant  only  in  53%  (51%).  The  other  way  around,  CbC  performed 
significantly better than LINGO in 17% (15%) of all screenings, but PhAST significantly 
excelled LINGO in 43% (42%). As a consequence, the superiority of LINGO to CbC was 
more prominent as that to PhAST. LINGO and PhAST outperformed each other in nearly 
 
 
Table  12. R e t r o s p e c t i v e  p e r f o r m a n c e  o f  P h A S T ,  L I N G O  a n d  C b C .  S c r e e n i n g  p e r f o r m a n c e  w a s  
measured as averaged BEDROC score per target calculated with # = 20. The first column presents the 
averaged result for all targets. 
 
  Ø  ACE  COX2  DHFR  FXA  PPAR"  THR 
PhAST  0.40  0.40  0.40  0.57  0.42  0.25  0.36 
LINGO  0.41  0.59  0.47  0.36  0.39  0.25  0.38 
CbC  0.35  0.50  0.43  0.27  0.31  0.23  0.35 
 
   56!
identical percentages of screenings. The averaged rank correlation between methods (Table 
14) indicated that rankings created by PhAST were complementary to those of the other 
methods. The rank correlation to CbC was 0.37, that to LINGO was 0.41. Rankings created 
by CbC and LINGO were more similar, with an averaged rank correlation of 0.57. This seems 
reasonable, as both methods use the same representation of molecules (SMILES).  
  In conclusion, the comparison of PhAST to LINGO and CbC proved the usefulness of 
PhAST. It has comparable retrospective to the better performing one of both other methods 
(LINGO).  At  the  same  time  the  created  rankings  of  active  compounds  diverge.  In  a 
prospective application this effect would manifest in ranking novel chemotypes at early ranks, 
generating new ideas in the early stage of a drug design campaign. 
 
Table 13. Significance of difference in retrospective performance between PhAST, LINGO and CbC. 
For  each  method  pair  and  target  the  percentage  of  screenings  is  presented  one  method  performs 
significantly better than the other at 0.05 (0.01) significance level. The first column reports the averaged 
result for all targets. 
 
  Ø  ACE  COX2  DHFR  FXA  PPAR"  THR 
PhAST  61 (59)  15 (6)  38 (36)  97 (97)  66 (65)  52 (43)  72 (69) 
CbC  33 (31)  71 (62)  58 (58)  2 (2)  29 (27)  27 (23)  24 (23) 
               
PhAST  43 (42)  3 (3)  23 (23)  92 (92)  32 (31)  43 (39)  60 (58) 
LINGO  53 (51)  94 (85)  74 (71)  5 (3)  65 (63)  43 (36)  35 (34) 
               
LINGO  78 (76)  97 (97)  68 (68)  81 (81)  86 (85)  55 (50)  76 (74) 
CbC  17 (15)  0 (0)  27 (26)  13 (9)  11 (8)  18 (7)  21 (21) 
 
 
Table  14. R a n k  c o r r e l a t i o n  b e t w e e n  P h A S T ,  L I N G O  a n d  C b C .  R a n k i n g s  w e r e  p u r g e d  o f  inactive 
compounds  before c a l c u l a t i n g  K e n d a l l ’ s  r a n k  c o r r e l a t i o n  c o e f f i c i e n t .  T h e  f i r s t  c o l u m n  s h o w s  t h e  
averaged result for all targets. 
 
  Ø  ACE  COX2  DHFR  FXA  PPAR"  THR 
PhAST / CbC  0.37  0.44  0.30  0.41  0.35  0.36  0.37 
PhAST / LINGO  0.41  0.43  0.35  0.48  0.38  0.41  0.40 
CbC / LINGO  0.57  0.71  0.60  0.50  0.54  0.54  0.56 
 
   57!
10 - Significance-Assesment in Global Sequence Alignment 
 
10.1 - Motivation 
 
Virtual screening yields a ranked list of molecules, with those ranked best that are most likely 
to have desired properties. Ranks of compounds are determined by their similarity to the 
query structure. This poses a perturbing problem: Every VS method will rank any collection 
of  molecules,  even  if  the  dataset  does  not  contain  a  single  molecule  with  the  desired 
biological  activity.
101  The  similarity  scores  of  most  methods  are  a  poor  measure  of 
significance, as analysis of multiple HTS runs revealed: Even molecules with a Tanimoto 
score
102 calculated from Daylight binary fingerprints
103 above 0.85 to an active compound 
have only a 30% chance to be active against the same target.
104 Similarity measures fail to 
predict that there are no actives in the dataset. Only for structural fingerprints (binary vectors 
coding  the  presence  /  absence  of  structural  features)  the  problem  of  significance  was 
addressed recently,
105 yielding a framework for significance estimation.  
PhAST  employs  sequence  alignment  for  molecule  comparison.  In  the  original 
application to amino acid sequences, the significance of local alignments is expressed through 
E-values (the expected number of hits with a score equal or higher to the observed score 
under a random sequence model) or p-values (the probability of a hit with score at least as 
high as the observed score under a random sequence model) for a score 
! 
s. Efficient methods 
for the calculation of p-values for local alignments have been proposed.
86-89,106 
The calculation of significance estimates was investigated under the assumption that it 
might  improve  PhAST  in  two  ways:  First,  it  was  shown  that  for  PhAST  the  effect  of 
alignment  evaluation  on  screening  performance  even  excels  that  of  the  canonization 
algorithm.
107  Screening  performance  of  PhAST  employing  sequence  identity  was  inferior 
compared to the normalized alignment score. Significance as ranking criterion (with highest 
significance ranked best) might be beneficial to PhAST as ranking method, even though for 
protein alignments it has been empirically found that ranked lists generated by alignment 
score  and  significance  estimates  are  fairly  similar.  Second,  significance  estimates  could 
identify screening libraries containing only molecules that most likely do not possess the 
desired  biological  activity,  thus  saving  assay  capacity  in  a  screening  campaign  only  for 
significant  screening  hits.  For  alignments  of  amino  acid  sequences,  this  effect  already 
improved the identification of homologue proteins.
85   58!
 
10.2 - Calculation of p-values 
 
The idea behind the calculation of p-values for sequence alignments is illustrated in Figure 9: 
If two sequences 
! 
X and 
! 
Y of lengths 
! 
m and 
! 
n yield alignment score 
! 
s, the significance of 
! 
s 
can be determined if the statistical distribution of alignment scores form the alignment of 
! 
X 
with random sequences of length 
! 
n is known. The p-value for score 
! 
s equals the area under 
the curve above 
! 
s. For protein sequence alignments, in the case of gapless local alignments of 
long sequences, empirical studies suggest a Gumbel distribution.
108-111 Approximations for the 
more realistic scenario of gapped local alignments have been developed.
112,113 Unfortunately, 
only little is known about the random distribution of optimal global alignment scores.
114 But 
score distribution of gapless local alignments, gapped local alignments and global alignments 
are all accessible through sampling in a random sequence model. 
All investigated sampling approaches utilize symbol frequencies 
! 
fi determined from 
the COBRA library of reference compounds in version 6.1, containing 8,311 compounds. 
These are: A = 4.95%, E = 1.44%, L = 19.65%, N = 1.22%, O = 24.63%, P = 1.80%, Q = 
1.58%,  R  =  41.61%  and  U  =  3.11%.  Significance  estimates  in  form  of  p-values  were 
calculated for not-normalized alignment scores that performed best with gap open penalty = 7 
and  gap  extension  penalty  =  1.  All  sampling  approaches  are  explained  using  chlor-  and 
acetylpromazine displayed in Figure 10 as example. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9. Visualization of p-value calculation. If the distribution of scores is known, the p-value of 
score s equals the area under curve above s (highlighted in dark grey). 
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10.2.1 - Simple Sampling 
 
In simple sampling the query sequence 
! 
X is aligned to a large number (e.g. 10
5) of random 
sequences of length 
! 
n. The resulting score histogram can be used for the calculation of p-
values. The problem with this approach is that only the region of alignment scores with high 
probabilities is sampled. The rare-event tail (high scores, low probability) is not accessible 
with this technique. Figure 11 shows score distributions obtained with simple sampling: The 
PhAST-sequence generated from chlorpromazine was aligned to random sequences of length 
23, corresponding to the length of the PhAST-sequence of acetylpromazine. The numbers of 
generated scores are 10
4, 10
5, 10
6 and 10
7. This practical example illustrates the drawbacks of 
simple  sampling:  The  alignment  of  PhAST-sequences  of  chlor-  and  acetylpromazine  has 
score 64. The highest score with simple sampling (59) was generated with 10
7 samples. As 
this maximum sampled score is below the actual alignment score, the p-value calculated for 
the alignment of chlor- and acetylpromazine would be 0. A Lilliefors test
115 with the null 
hypothesis of the data coming from a normal distribution was performed with each sampled 
distribution. In each test the null hypothesis was rejected with a p-value below 2.2*10
-16. This 
is  a  strong  argument  that  the  distribution  of  scores  obtained  from  global  alignments  of 
PhAST-sequences is not of the family of normal distributions. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure  10. C o m p a r i s o n  o f  c h l o r - a n d  a c e t y l p r o m a z i n e  u s i n g  P h A S T .  A )  c h l o r p r o m a z i n e  w i t h  
corresponding  PhAST-sequence.  B)  acetylpromazine  with  corresponding  PhAST-sequence.  C) 
alignment  of  PhAST-sequences  shown  in  (A)  and  (B).  PhAST-sequences  were g e n e r a t e d  u s i n g  
Minimum  Volume  Embedding  with  Diffusion  Kernel  (diffusion  parameter  0.4)  and  covalent 
connectivity.  Sequence  alignment  was c a l c u l a t e d  b y  t h e  F S M  a l g o r i t h m  u s i n g  t h e  o r i g i n a l  
PhASTscoring system for potential pharmacophoric points, gap open penalty = 7 and gap extension 
penalty = 1. Alignment score is 64. 
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10.2.2 - Sampling of Rare Events 
 
The rare-event tail of the distribution of alignment scores is accessible using the Metropolis-
Hastings algorithm.
116,117 A method implementing this concept in a Marcov Chain Monte 
Carlo (MCMC) Simulation, that will be referred to as ‘Rare Event Sampling’, was proposed 
by Hartmann.
89,118 In this work, it was evaluated for the calculation of p-values in PhAST. 
The original method has successfully been applied to significance estimations of amino acid 
sequence  alignments.  It  uses  the  idea  of  Importance  Sampling
119  to  estimate  a  particular 
distribution while having samples generated from another one. The probability distribution 
from which scores are sampled is altered in a way such that the region of interest is sampled 
with high probability. 
The algorithm is based on a Marcov Chain with states 
! 
Ci and transition probabilities 
! 
pCi ,C j between them. The Marcov Chain has to be ergodic, meaning that from one state of the 
chain each other state is accessible through other states in finite time. In this application each 
state of the Marcov Chain represents a global alignment of the query sequence 
! 
X and a 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure  11. S i m p l e  s a m p l i n g  a l i g n m e n t  s c o r e  d i s t r i b u t i o n s .  P h A S T -sequence  generated  from 
chlorpromazine was aligned with 10
4 (A), 10
5 (B), 10
6 (C) and 10
7 (D) random sequences of length 23. 
This  length  corresponds  to  the  PhAST-sequence  of  acetylpromazine.  The  alignment  of  PhAST-
sequences generated for chlor- and acetylpromazine has score 64. Logarithmic Y-axis for improved 
visualization of low relative frequencies. 
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random sequence 
! 
Yi with associated score 
! 
si. If the Marcov Chain is in 
! 
Ct with score 
! 
st at 
time 
! 
t, a new state 
! 
C* with score 
! 
s* is proposed. It is accepted as state 
! 
Ct+1 with the 
Metropolis  probability 
! 
min 1,exp "s T ( ) [ ],  where 
! 
"s = s*#st.  If 
! 
C*  is  accepted, 
! 
s*  is 
counted as sampled score. If 
! 
C* is rejected, 
! 
Ct is accepted as 
! 
Ct+1 and 
! 
st is counted as 
sampled score 
! 
st+1. Random sequences 
! 
Y * in states 
! 
C* are generated from sequence 
! 
Yt as 
follows:  One  position  in 
! 
Yi  is  chosen  and  deleted  by  random  with  all  positions  being 
equiprobable. A new symbol at this position is chosen according to symbol frequencies 
! 
fi. 
Choice  of 
! 
T  has  consequences  for  the  region  that  is  sampled:  With  high 
! 
T  the 
sampling  tends  towards  low  scores,  with  low 
! 
T  towards  high  scores.  To  describe  the 
distribution of scores over a wide range, simulations must be carried out with several choices 
of 
! 
T.  For  each  run,  the  unbiased  distribution  of  scores  is  obtained  by  scaling  relative 
frequencies of scores with 
! 
exp "s T ( ). Histograms calculated with different temperatures can 
be patched together empirically, yielding the final distribution: Simulations with different 
! 
T 
have overlapping regions. Starting with simple sampling and the simulation with maximum 
! 
T 
for each pair of distributions a rescaling factor can be calculated from overlapping regions 
such that the difference between shared scores in the distributions is minimal.  
Equilibration of Marcov Chains can be determined empirically: Two simulations are 
started simultaneously with each combination of sequence length of the random sequence and 
temperature. The first simulation starts from high alignment scores, the second from low 
alignment scores. Equilibration is reached when for the last 
! 
t 2 steps of both simulations 
averaged scores agree within error bars and this is true for the rest of the simulation. 
The original method employs a Marcov Chain with two random sequences instead of 
one fixed sequence (the query) and one random sequence. The described modification allows 
sampling from a more realistic scenario: During searches in databases and libraries the query 
remains always identical. As a consequence the score distribution of this particular query 
sequence  and  random  sequences  should  be  used  for  significance  assessment  (Hartmann, 
personal communication). 
Rare  event  sampling  was  illustrated  using  the  exemplary  case  of  chlor-  and 
acetylpromazine, results are displayed in Figure 12. With 
! 
T = 2.5, equilibration as defined 
above was reached for the first time after 30 steps (Figure 12A), where the interval between 
sampled steps equals 1000 generated alignment scores. But both chains diverged again after 
ten more steps. Equilibration was reached again 8 steps later (step 48) and maintained for the 
remaining samples. Figure 12B illustrates the effect of different choices for 
! 
T. With low    62!
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 12. Rare Event Sampling. Illustrated is the example of the PhAST-sequence of chlorpromazine and 
random sequences of length 23, corresponding to the PhAST-sequence of acetylpromazine. A) Equilibration 
time determination for two Marcov Chains sampling with T = 2.5, one starting from high alignment scores, 
the other starting from low alignment scores. Number of alignment scores in steps of size 1000. Dashed lines 
indicate steps where equilibration was reached. After step 48, equilibration was maintained for the complete 
sampling process. B) Sampled distributions with different choices for T. C) Distribution of alignment scores 
sampled  with  Rare  Event  Sampling  and  fits  of  Gaussian a n d  G u m b e l  d i s t r i b u t i o n s .  G a u s s ian 
parameterization: a = 0.0398, b = -4.963, c = 14.11; Gumbel parameterization: µ = -7.396, $ = 9.2920. 
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values  for 
! 
T,  high  scores  are  preferred.  Figure  12C  presents  the  final  distribution  of 
alignment scores obtained for the PhAST-sequence of chlorpromazine and random sequences 
of length 23. A Gaussian distribution as shown in Equation 20 
 
! 
f (x) = a*e
"
x"b
c
# 
$ 
% 
& 
' 
( 
2
                  (20) 
 
and a Gumbel distribution as defined in Equation 21 
 
! 
f (x) =
1
"
*e
#
x#µ
"
#e
#
x# µ
"
                 (21)
 
 
were fitted to this distribution using the Levenberg-Marquart algorithm.
120 Fits were 
evaluated by the root mean squared error (RMSE) calculated according to Equation 22 
 
! 
RMSE(G,H) =
gi " hi ( )
2
i=1
n
#
n
              (22) 
 
where 
! 
G and 
! 
H are two distributions and n is the respective number of samples. The 
region  where  probabilities  are  high  agreed  well  in  all  three  distributions,  resulting  in  an 
RMSE of 3.9*10
-4 for Rare Event Sampling and the fitted Gaussian distribution and 2*10
-3 
for Rare Event Sampling and the fitted Gumbel distribution. Both values indicate good fits. 
But for the calculation of p-values, the low probability region is of particular interest, so the 
RMSEs were recalculated based on logarithmic values. The recalculated RMSEs were 1.2 for 
Rare Event Sampling and Gaussian and 2.4 for Rare Event Sampling and Gumbel, indicating 
increased divergence in regions with low probability. As illustrated in Figure 12C, the p-value 
for the highest sampled alignment score 69 that was determined as 1.7*10
-11 using Rare Event 
Sampling would be 4.6*10
-14 in the fitted Gaussian distribution (overestimation by factor 10
3) 
and 2.9*10
-5 in the fitted Gumbel distribution (underestimation by factor 10
6). These findings 
prove that the alignment scores obtained from global alignment of PhAST-sequences follow 
neither a Gaussian nor a Gumbel distribution, and as a consequence, that efficient sampling 
approaches like Rare Event Sampling are necessary for significance determination in PhAST. 
The  p-value  calculated  for  the  original  alignment  of  PhAST-sequences  corresponding  to 
chlor- and acetylpromazin with score 64 using Rare Event Sampling was 1.8*10
-9.   64!
10.3 - Retrospective Evaluation 
 
Rare Event Sampling for p-value calculation was evaluated in a retrospective screening on the 
COBRA dataset with lisinopril (Figure 13) as query that is known to be active against the 
angiotensin-converting enzyme (ACE).
121 Calculated p-values were used as ranking criterion 
with  those  molecules  ranked  best  that  receive  lowest  p-values.  The  final  ranking  was 
evaluated  using  the  BEDROC  metric  and  compared  to  alignment  evaluation  methods 
described  earlier  (PID1,  PID2,  S1,  S2  and  S3;  see  section  Appendix  A  for  detailed 
descriptions).  Significance  of  differences  in  retrospective  performance  was  assessed  in  a 
paired permutation test with 10
6 permutations. Ranked lists were compared by their rank 
correlation. 
 
10.3.1 Parameterization 
 
Simulations were carried out for the PhAST-sequence generated from lisinopril and each of 
the  85  sequence  lengths  encountered  in  the  COBRA  library  (cf.  Figure  2)  with  12 
temperatures  (0.4,  0.5,  0.7,  1.0,  1.5,  2.0,  2.5,  3.0,  4.0,  6.0,  8.0,  infinity).  With  each 
parameterization, one simulation starting from high scores and one starting from low scores 
was performed as follows: The first simulation started from high alignment scores. If 
! 
m > n, 
! 
Y0 equaled the first 
! 
n symbols of 
! 
X; if 
! 
m < n, 
! 
Y0 consisted of a copy of 
! 
X, the remaining 
! 
n " m symbols were all of type L to minimize mismatch penalties. The second simulation 
started from low alignment scores. If 
! 
m > n, 
! 
Y0 equaled a ‘negative copy’ of the first 
! 
n 
symbols of 
! 
X, where for each symbol in 
! 
X the symbol with maximum mismatch penalty was 
chosen according to the scoring scheme. If 
! 
m < n, 
! 
Y0 consisted of a negative copy of 
! 
X, the 
remaining 
! 
n " m symbols were all of type L. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 13. Molecular structure diagram and PhAST-sequence of lisinopril. This compound is a known 
active for the acetyl-converting enzyme. 
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Each simulation sampled 10
9 scores, but only each 10
3-th score was used to avoid 
correlations between scores that occur in Marcov Chain Monte Carlo sampling in contrast to 
fully  random  sequences.  This  resulted  in  2,040  simulations,  each  returning  10
6  scores. 
Equilibration was assessed after termination, and both simulations with the same combination 
of sequence lengths and 
! 
T were combined after equilibration was reached. 
 
10.3.2 - Results and Discussion 
 
Equilibration was reached in all simulations after at most 149,316 steps, with an averaged 
equilibration time of 868 steps. As a consequence, all distributions were calculated from at 
least 1.7*10
6 scores. 
BEDROC scores calculated with different alignment evaluation methods as similarity 
measure are reported in Table 15. Retrospective performance of p-values was comparable to 
the other alignment evaluation methods with exception of PID2 that had significantly lower 
enrichment.  Highest  retrospective  performance  resulted  from  S2  as  alignment  evaluation 
method. These results show that p-values used for similarity assessment do not perform better 
than the so far best alignment evaluation method (S2), but yield comparable enrichment. But 
the observed difference was not significant at 0.01 or 0.05 significance level. 
  Ranked lists obtained from the same virtual screening setup with different alignment 
 
Table 15. Retrospective comparison of p-value and other alignment evaluation methods. Reported are 
BEDROC  scores  and  p-values  assessing  significance  of  differences  in  retrospective  performance. 
BEDROC scores were calculated with # = 20. p-values were calculated with 10
6 permutations in a 
paired permutation test. 
 
  PID1  PID2  S1  S2  S3  p-value 
BEDROC  0.4413  0.1239  0.4587  0.4708  0.4468  0.4579 
             
PID1  -  < 10
-6  0.1175  0.0136  0.3807  0.1090 
PID2    -  < 10
-6  < 10
-6  < 10
-6  < 10
-6 
Score1      -  0.0732  0.1386  0.4864 
Score2        -  0.0013  0.0917 
Score3          -  0.1226 
p-value            - 
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evaluation  methods  were  compared  by  their  rank  correlation.  The  calculated  correlation 
matrix  is  shown  in  Table  16.  Rank  correlation  coefficients  indicated  closest  similarity 
between p-value and the three variant of alignment scores. Within these, the not-normalized 
alignment  score  has  closest  relation  to  p-value.  This  is  not  surprising,  as  p-values  are 
calculated based on this score. 
The p-value calculated for the top-ranked compound in the performed retrospective 
screening was 1.05*10
-14. In order to obtain the same value through simple sampling, at least 
10
14 alignments would have had to be calculated – with no guarantee that at least one of the 
sampled scores would be equal or higher to the original score. For the calculation of all 
necessary p-values for retrospective evaluation, 85*12*2*10
9 = 2.04*10
12 alignments were 
calculated. So the evaluation of all alignments with Rare Event Sampling was 100 times faster 
than the calculation of only one single p-value with simple sampling. This real-life example 
emphasizes the usefulness of Rare Event Sampling. 
Significance estimates in form of p-values can be used for the estimation of thresholds 
that maximize hitrates (ratio of active to inactive compounds) and reduce costs in prospective 
screenings. As shown in Figure 14, the early region of the ranked list, where p-values are low, 
was mostly populated with active compounds. Figure 14C presents retrospective hitrates: If 
10
-9  would  be  chosen  as  threshold  to  indicate  promising  candidates  for  a  prospective 
screening,  this  would  result  in  a  hitrate  of  50%  (7  actives  in  14  compounds).  The 
determination of a threshold depends upon the cost associated with making a mistake. A 
threshold of 0.01 means that an error occurs with 1% probability. Whether this is stringent 
enough depends on the actual cost of mistakes, for example the evaluation of a screening 
compound from a prospective application in an assay.  
 
Table 16. Comparison of alignment evaluation methods based on rank correlation coefficients. Rank 
correlation was calculated from ranked lists obtained from virtual screenings of lisinopril against the 
COBRA collection of bioactive compounds with the respective alignment evaluation methods. 
 
  PID1  PID2  S1  S2  S3  p-value 
PID1  -  0.1221  0.5350  0.5467  0.5650  0.4894 
PID2    -  0.1430  0.1183  0.0381  0.1662 
S1      -  0.8732  0.7484  0.8862 
S2        -  0.7653  0.8243 
S3          -  0.6624 
p-value            - 
   67!
10.4 - Calculation of E-values 
 
The number of low p-values that has to be expected by chance increases with the number of 
comparisons.  This  variable  cannot  be  included  in  the  calculation  of  p-values.  As  a 
consequence, the p-value for a score 
! 
s has to be modified to account for the number of 
comparisons,  yielding  an E -value.  In  statistics,  the  Bonferroni  correction  can  be  used  to 
address the problem of multiple comparisons:
122 If a statistical test is performed 
! 
n times at 
significance level 
! 
", this level may be appropriate for each individual comparison, but not for 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 14. Distribution of p-values resulting from screening lisinopril against the COBRA dataset. A) 
Number of compounds with a certain p-value. B) Number of active compounds with a certain p-value. 
C) Retrospective hitrates calculated for certain p-value thresholds. 
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the set of all comparisons. Due to the increased number of observations, the chance of a 
significant  event  occurring  by  chance  increases.  According  to  Bonferroni,  the  actual 
significance  level  can  be  calculated  as 
! 
1"(1"#)
n.  Another  possibility  to  account  for  the 
number of comparisons being performed is to lower the alpha value for each test. This can be 
achieved  by  dividing  the  significance  level  by  the  number  of  tests  performed,  hence 
! 
"actual = " n. The converse of this approach is the correction of the p-value by multiplication 
with the number of tests and has already been used in adapted forms for the correction of p-
values in sequence alignment.
123 This operation yields an E-value. The relation of p-value and 
E-value of score 
! 
s is described in Equation 23. 
 
! 
E(s) = N " p(s)                  (23) 
 
  Several choices for 
! 
N have been reported or seem reasonable: i) library size 
! 
n (the 
original Bonferroni correction), ii) 
! 
sc(L) where 
! 
sc is the count of symbols and 
! 
L is the 
library (suggested if variation in sequence lengths is large)
123, iii) 
! 
sc(L) sc(q)where 
! 
q is the 
query sequence, iv) 
! 
k " sc(q) " sc(L) , (
! 
0 < k <1). Figure 15 presents the same statistic as 
Figure 14C but with several choices for rescaling. Corrections (i) and (iii) behave nearly 
identical. Which variant of p-value correction is most suitable for prospective application and 
whether a choice 
! 
k "1 for correction (iv) is necessary can only be determined in additional 
retrospective and prospective applications. For the time being, there is no reason in evidence 
to deviate from the original Bonferroni correction. Consequently, a general and reusable E-
value threshold of 1*10
-5 seems reasonable. With this threshold, 15 compounds would have to 
be evaluated for their activity in the given example. The retrospective hitrate would be 50%. 
Both are acceptable values. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 15. Retrospective hitrates for certain E-value thresholds resulting from screening lisinopril 
against the COBRA dataset. 
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10.5 - Discussion 
 
The local alteration of sequences based on symbol frequencies during Marcov Chain Monte 
Carlo simulations is an adequate model for protein sequences. But it does not account for 
local  constraints  due  to  protein  structure  or  function,  which  could  influence  exchange 
frequencies in certain parts of a protein. Drug-like molecules are subject to even more severe 
constraints that make some symbol combinations in PhAST-sequences impossible. Examples 
are a number of R symbols (aromatic) that does not fulfill Hückel’s ‘
! 
4n +2’ rule
124,125 and 
high quantity of positive (P) or negative (N) charges: In the COBRA collection of bioactive 
reference compounds the respective maximum numbers were 8 Ps in a sequence of length 36 
and 8 Ns in a sequence of length 84. The assignment of O symbols in most cases depends on 
the interaction types of the adjacent vertices, which is also ignored in the current approach. 
For  application  with  PhAST,  a  more  realistic  model  would  be  to  use  PhAST-sequences 
generated from random molecules with a fixed number of non-hydrogen atoms. This would 
require  the  development  of  a  framework  for  randomized  and  chemically  meaningful 
alterations to molecules of fixed size. 
Equilibration time could be reduced by the application of parallel tempering, yielding 
a  Metropolis-coupled  Marcov  Chain  Monte  Carlo  simulation  (MCMCMC).
126  There, 
simulations  are  performed  with  different 
! 
T  in  parallel  (
! 
T 1 < T2 < ...< Tmax).  After  each 
simulation  step  a  pair 
! 
Ti,Ti+1 ( )  is  chosen  by  random  and  sequence  configurations  are 
exchanged with probability 
! 
pe according to Equation 24. But given the observed equilibration 
times this does not seem necessary. 
 
! 
pe = min 1,exp "
1
Ti
"
1
Ti+1
# 
$ 
% 
& 
' 
( ) Si " Si+1 ( )
# 
$ 
% 
& 
' 
( 
# 
$ 
%  % 
& 
' 
(  (             (24) 
 
The published version of Rare Event Sampling involves two randomized sequences, 
whereas the implementation proposed in this work leaves the query sequence fixed. Both 
variants have certain advantages and disadvantages. 
With  a  fixed  query  sequence,  score  distributions  have  to  be  calculated  in  each 
screening.  On  first  sight,  this  is  a  clear  disadvantage  because  of  the  time  necessary  for 
simulations. But in this scenario it is possible to adapt the sampling process to a particular 
screening setup. First, the application of position weights remains possible. Second, symbol 
frequencies  used  in  the  generation  of  random  PhAST-sequences  can  be  adjusted  to  the   70!
screening library. Table 17 presents relative PPP frequencies determined from seven different 
molecule repositories, three for small drug-like compounds, one for lead-like compounds and 
three collections of natural products. The corresponding correlation matrix is shown in Table 
18. Low and in some cases not significant correlation (at 0.05 significance level) is observed 
between members of the two different groups of molecule collections, whereas correlation is 
high and significant at 0.05 and 0.01 significance levels within these groups. Despite the 
argued differences between drug-like and lead-like compounds (vide supra), the distributions 
of  PPPs  observed  in  the  corresponding  subsets  of  ZINC  are  fairly  similar.  Pairwise  Chi
2 
tests
128  performed  on  absolute  frequencies  indicate  significant  differences  between  each 
dataset pair with a p-value below 2.2*10
-16 as well as a test performed on all datasets at once. 
In case of the Chi
2 test, calculated significance is most likely due to the large number of 
samples.  But  these  findings  point  to  large  and  relevant  deviations  of  symbol  frequencies 
especially  between  repositories  for  drug-like  molecules  and  natural  products.  These 
differences can be incorporated into significance estimations if score distributions for the 
random model are calculated for each screening. Related to this topic is the atom-typing in 
general: If the atom-typing is changed in the future, new symbols and symbol frequencies can 
be used in the random model. 
With two randomized sequences on the other hand, score distributions can not be 
adapted to symbol frequencies, new symbol types and position weights. But they can be pre-
calculated. Molecules from the COBRA dataset yield PhAST-sequences with 85 different 
lengths.  During  retrospective  evaluations  in  this  dataset,  3,655  combinations  of  sequence 
Table  17. R e l a t i v e  s y m b o l  f r e q u e n c i e s  i n  s i x  m o l e c u l e  r e p o s i t o r i e s .  Collections  of  drug-like 
compounds: COBRA
11 collection of bioactive reference compounds, Specs vendor catalogue for small 
compounds in version 08/2010 (Sepcs, Delft, the Netherlands), ZINC
127 drug-like subset, ZINC
127 lead-
like subset. Collections of natural products: Specs vendor catalogue for natural products in version 
08/2010, Analyticon purified natural products of microbial origin release 100915, Anlyticon purified 
natural products of plant origin release 100915 (Analyticon, Potsdam, Germany). Absolut numbers of 
PPPs are: COBRA = 244,505; Specs SC = 4,828,971; ZINC drug-like = 261,917,160; ZINC lead-like = 
30,348,012; Specs NP = 13,460; MEGXm = 33,780; MEGXp = 615,769. 
 
  COBRA 6.1  Specs SC  ZINC drug-like  ZINC lead-like  Specs N  MEGXm  MEGXp 
A  4.95  4.84  6.30  6.52  4.99  7.83  4.05 
E  1.44  0.49  0.14  0.50  3.47  7.45  12.60 
L  19.65  15.53  15.50  16.56  38.57  36.28  27.59 
N  1.22  0.48  0.13  0.50  0.51  1.58  0.63 
O  24.63  20.83  25.90  24.66  27.42  29.37  37.29 
P  1.80  0.34  0.16  0.23  0.65  0.10  0.06 
Q  1.58  1.69  2.26  1.92  0.30  0.82  0.04 
R  41.61  53.08  46.16  44.88  23.73  14.83  17.66 
U  3.11  2.71  3.46  4.22  0.35  1.73  0.08 
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lengths in alignments are possible. With the corresponding pre-calculated score distributions, 
significance assessment would only require the look-up of the correct distribution for a certain 
combination of sequence lengths. The calculation of all distributions would be costly in terms 
of time, but with an increasing number of performed retrospective and prospective screenings 
this initial investment would amortize. The pre-calculation of score distributions would enable 
the large number of screenings that is necessary to establish reliable E-value thresholds. 
 
In this work, choices for 
! 
T employed in Rare Event Sampling were based on preliminary 
experiments that determined values suitable for the application of this method to PhAST-
sequences. But nevertheless, different 
! 
T were chosen more or less arbitrarily. Wang and 
Landau proposed a Monte Carlo algorithm that is independent from choices of 
! 
T.
129,130 There, 
acceptance of a proposed step depends on the inverse density of states starting from a uniform 
distribution: The more times a state was visited in the past, the less likely is its acceptance in 
the  future.  The  complete  distribution  is  sampled  within  defined  minimum  and  maximum 
values in one single simulation. This method can be further enhanced by performing multiple 
random walks in parallel with overlapping minimum and maximum values distributed in the 
interval of the minimum and maximum value of the complete distribution. This sampling 
method would render significance estimations independent from fixed choices of T. 
Table  18. C o r r e l a t i o n  o f  P P P  f r e q u e n c i es  between  six  molecule  repositories.  Shown  is P e a r s o n ’ s  
correlation coefficient and the corresponding p-value, the latter in parentheses. Collections of drug-like 
compounds: COBRA
11 collection of bioactive reference compounds, Specs vendor catalogue for small 
compounds in version 08/2010 (Sepcs, Delft, the Netherlands), ZINC
127 drug-like subset, ZINC
127 lead-
like subset. Collections of natural products: Specs vendor catalogue for natural products in version 
08/2010, Analyticon purified natural products of microbial origin release 100915, Anlyticon purified 
natural products of plant origin release 100915 (Analyticon, Potsdam, Germany). 
 
  Specs SC  ZINC 
druglike 
ZINC 
leadlike  Specs N  MEGXm  MEGXp 
COBRA 
6.1 
0.98 
(1.03*10
-05) 
0.99 
(3.52*10
-07) 
0.99 
(1.13*10
-07) 
0.79 
(1.13*10
-02) 
0.65 
(4.70*10
-02) 
0.71 
(3.05*10
-02) 
Specs 
SC  -  0.99 
(1.20*10
-06) 
0.99 
(9.52*10
-07) 
0.66 
(4.55*10
-02) 
0.49 
(1.26*10
-01) 
0.55 
(9.18*10
-02) 
ZINC 
drug-like    -  1.00 
(5.93*10
-11) 
0.72 
(2.79*10
-02) 
0.57 
(8.23*10
-02) 
0.65 
(5.03*10
-02) 
ZINC 
lead-like      -  0.73 
(2.42*10
-02) 
0.58 
(7.57*10
-02) 
0.65 
(4.90*10
-02) 
Specs N        -  0.97 
(2.77*10
-05) 
0.90 
(1.32*10
-03) 
MEGXm          -  0.94 
(2.91*10
-04) 
 
   72!
The  Bonferroni  correction  used  for  p-value  adjustment  distributes  the  significance 
level equally on all tests (in this case: alignments). As a consequence it is very conservative, 
because a p-value has to be very low to be still significant after the correction. It controls the 
probability of false positives but increases the probability for false negatives. More recent 
methods  for  p-value  adjustments  try  to  overcome  this  drawback.  Examples  are  the 
Bonferroni-Holm procedure
131 and the Benjamini-Hochberg method.
132 Which method is best 
for significance estimation of chemical similarity with PhAST has to be determined in future 
studies.   73!
11 - Prospective Application 
 
During its development, PhAST was parameterized and compared to other state-of-the-art 
virtual screening methods in retrospective experiments. During this process and after the best-
performing parameterization was determined, PhAST was employed in prospective virtual 
screenings  for  the  identification  of  compounds  that  possess  certain  activity  of  biological 
interest. 
 
11.1 - Bacterial Thymidinkinase of Staphylococcus aureus 
 
This  section  discusses  the  publication  listed  as  Appendix  D.  Methicillin-resistant 
Staphylococcus  aureus  is  a  widespread  pathogenic  bacterium.
133,134  The  combination  of 
trimethoprim and sulfamethoxazole (SXT) has antimicrobial activity, as it inhibits the folic 
acid pathway, eventually blocking the bacterial synthesis of deoxythymidine monophosphate 
(dMTP) by thymidylate synthase. But S. aureus possesses a second pathway for the synthesis 
of  dMTP  by  uptake  of  extracellular  thymidine  and  subsequent  phosphorylation  via 
Thymidinekinase.
135,136  In  the  presence  of  high  extracellular  levels  of  thymidine,  a 
combination of halogenated 2’-deoxyuridine derivates (see Figure 16) has been reported to 
exhibit synergistic antimicrobial activity against S. aureus.
137,138 The downside of nucleoside 
analogues  as  inhibitors  of  bacterial  thymidine  kinase  is  their  cytotoxicity.  If  they  are 
phosphorylated to triphosphates and incorporated into DNA, they can lead to single-strand 
breaks.
139,140  Therefore,  screening  for  non-nucleoside  analogues  as  inhibitors  of  bacterial 
Thymidinekinase was of special interest for this work. 
 
 
 
 
 
 
 
 
 
Figure  16. S t r u c t u r e  d i a g r a m s  o f  two  halogenated  2’-deoxyuridine  derivates.  A)  5-iodo-2’-
deoxyuridine, B) 5-chloro-2’-deoxyuridine. Both are known to have antimicrobial activity against S. 
aureus in combination with SXT with minimal inhibitory concentrations of 0.0625 mgL
-1 for S. aureus 
strains ATCC 700699 and ATCC 29213. 
!
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  PhAST was used in a ligand-based virtual screening for non-nucleoside inhibitors of S. 
aureus thymidine kinase in the version performing best in retrospective experiments at that 
point in development: For graph canonization PhAST employed the Prabhakar algorithm,
80 
sequence alignments were calculated with gap open penalty = 5 and gap extension penalty = 
1. The screening library combined the vendor catalogues of Specs (v01/2009, Specs, Delft, 
The Netherlands) and Asinex Gold and Platinum collections (v11/2008, Asinex, Moscow, 
Russia).  All  compounds  were  protonated  using  the  ‘wash‘  function  of  MOE  (v2008.10, 
Chemical  Computing  Group,  Montreal,  Canada).  5-chloro-2’-deoxyuridine  was  used  as 
query. From the resulting ranked list, four compounds were selected and evaluated for their 
activity.
141 Minimal inhibitory concentrations (MICs) of all selected candidate compounds 
were  determined  in  combination  with  SXT  against  S.  aureus  strains  ATCC  700699 
(methicillin resistant) and 29213 (not methicillin resistant) in the presence of thymidine.  
Obtained  results  are  presented  in  Table  19.  The  only  molecule  with  measured 
inhibitory activity was compound 2. With MICs of 32 mgL
-1 (ATCC 700699) and 64 mgL
-1 
(ATCC 29213) activity was 50 and 100 fold lower compared to the query compound. Despite 
the decreased activity, PhAST succeeded in the identification of an active compound that is 
not a nucleoside-analog. Compound 2 is a purine-dione whereas the query is a pyrimidine-
dione. This non-nucleoside-analog inhibitor could be further optimized in future studies. 
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Table 19. Results of virtual screening with PhAST for non-nucleoside inhibitors of bacterial thymidine 
kinase. MIC values represent the median of three experiments. 
 
MIC [mgL
-1] 
Structure  Rank 
ATCC 700699  ATCC 29213 
1 
 
2  128  128 
2 
 
8  32  64 
3 
 
18  128  128 
4 
 
41  128  128 
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11.2 - Application to "-Secretase 
 
"-Secretase (GS) is an integral membrane protein. Among other substrates it processes the 
amyloid precursor protein (APP) as subsequent step to its proteolytic cleavage by !-Secretase. 
During this process it produces preferably amyloid-! (A!) peptides of length 40 and 42.
142,143 
A!42  fragments  are  prone  to  oligomerize,  eventually  forming  neurotoxic  extracellular 
amyloid  plaques,  which  are  characteristically  found  in  brains  of  patients  suffering  from 
Alzheimer’s  disease  (AD).
144  The  process  of  A!42  oligomerization  and  the  extracellular 
deposition  of  amyloid  plaques  are  believed  to  be  a  major  disease-causing  step  in  the 
pathology  of  AD.  This  so  called  amyloid  hypothesis  served  as  the  rationale  for  the 
development  of  GS  inhibitors  (GSIs)  (in  order  to  treat  AD).
145  As  GS  processes  ca.  80 
peptidic substrates (e.g. the NOTCH receptor), the inhibition of GS has severe consequences 
besides inhibition of APP processing. Only recently (August 2010), Eli Lilly had to stop the 
development of the unselective GSI semagacestat (Figure 17) that reached phase III clinical 
trials.
146  The  compound  failed  to  slow  progression  of  Alzheimer’s  disease.  Furthermore, 
declines  in  cognitive  function  and  a  greater  risk  of  skin  cancer  appeared  as  side  effects. 
Consequently, NOTCH-sparing approaches of %!42 reduction are of urgent need. 
One  of  these  alternative  approaches  besides  GS  inhibition  is  GS  modulation.  "-
Secretase modulators (GSMs) cause a product shift during APP processing at the expense of 
A!42 to shorter and non-toxic fragments, such as A!38.
147 Importantly, they do not influence 
the processing of other GS substrates.
148-150 Four examples of GSMs characterized by their 
A!42 inhibitory concentration 50% (A!42 IC50) are reported in Table 20. Compounds 5-7 are 
‘non-steroidal anti-inflammatory drugs’ (NSAIDs) that constituted the first class of GSMs. 
They combine a carboxylic head group with lipophilic aromatic substrutures. They exhibit 
 
 
 
 
 
 
 
 
 
Figure 17. Structure diagram of semagacestat. This "-Secretase inhibitor was developed by Eli Lilly. 
Development  was  stopped  in  2010  after  phase  III  clinical  trials  revealed  its  inability  to  stop  the 
progression of Alzheimer’s disease. 
 
 
H
N
OH
O
O
N
H
N
O  76!
only  weak  inhibition  of  A!42  production,  but  are  reported  to  be  highly  active  against 
cyclooxygenase (COX).
147 As a consequence, their long-term use is associated with COX-
mediated  side  effects  such  as  gastrointestinal  ulceration  and  increased  cardiovascular 
morbidity. Despite its weak activity (305 mM), compound 5 ((R)-Flurbiprofen) reached phase 
III clinical development, where the compound failed to show any beneficial effects.  Its low 
potency and weak blood-brain-barrier permeability are discussed as major reasons for the 
failure.
153,154 These problems with NSAIDs therapeutically applied as GSMs emphasize the 
need for not-NSAID-like GSMs.
155 
COOH
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Table  20.  Known  "-Secretase  modulators  and  their  in  vitro  activity. A c t i v i t i e s  f o r  c o m p o u n d s  5 -7 
according to Peretto et al. 2008,
151 activity for compound 8 according to Kimura et al. 2005.
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PhAST  was  used  in  a  ligand-based  virtual  screening  for  GSMs  with  the  best-
performing parameterization identified in this study: Canonization through Minimum Volume 
Embedding  employing  the  Diffusion  Kernel  with  diffusion  parameter  0.4  and  covalent 
connectivity,  gap  open  penalty  =  5,  gap  extension  penalty  =  1  and  the  alignment  score 
normalized to alignment length for alignment evaluation. The screening library combined the 
vendor catalogues of Specs (v01/2010, Specs, Delft, The Netherlands) and Asinex Gold and 
Platinum collections (v11/2008, Asinex, Moscow, Russia). All compounds were protonated 
using the ‘wash‘ function of MOE. Compound 8 listed in Table 20 was used as query. From 
the  resulting  ranked  list,  four  compounds  were  selected  and  evaluated.  Activity  was 
determined in an ELISA as described elsewhere.
156 The results are presented in Table 21. 
Three  of  the  four  tested  compounds  (9,  11  and  12)  were  inactive  at  100  µM. 
Compound 10, that was ranked thirteenth, exhibited inhibition of A!42 production with an 
IC50 of 10 µM without influencing A!40 and A!38. It is topologically identical to the inactive 
compound 9. The molecular graphs differ only in the exchange of an aromatic carbon atom to 
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Table 21. Results of virtual screening with PhAST for GSMs. ‘-‘ indicates no activity at 100 µM.  
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a  nitrogen  atom  from  9  to  10,  indicating  a  steep  structure-activity  relationship.  As  a 
consequence, compounds 9 and 10 were assigned adjacent ranks with identical scores due to 
the fact that the graphs of potential pharmacophoric points created during the atom-typing 
step of PhAST are identical. Both are based on a bipyridine framework that is substituted with 
two additional aromatic ring systems. None of them has a carboxylic head group known from 
NSAIDs. Furthermore, they diverge from the linear assembly of four ring systems that can be 
observed in non-acidic GSMs.
155 These findings show that the identified active compound is 
pharmacologically disjunct from other classes of GSMs known so far. 
Compound 10 has a 30-fold increased activity compared to compound 5 that reached 
phase  III  clinical  trials.  As  compound  8  shows,  molecules  with  even  higher  activity  are 
known.  But  those  are  highly  optimized  structures.  PhAST  is  meant  as  aid  in  the  hit-
identification phase of the drug development process. Promising compounds will be subject to 
further optimization in following stages. As hit, compound 10 is interesting because of its new 
pharmacology, and with its already acceptable activity it has high potential for optimization. 
PhAST succeeded in the identification of a promising GSM with a novel chemotype.   79!
12 - Conclusions 
 
This work prove that the concept of molecule comparison by global sequence alignment, until 
now applied to sequences of amino acids and nucleic acids, can be successfully used for the 
comparison small drug-like molecules. The obstacle of proteins and nucleic acids being linear 
and directed structures in contrast to small molecules that contain branches and cyclic systems 
was  overcome  by  canonical  atom  labeling.  Meaningful  scoring  systems  for  potential 
pharmacophoric points were calculated based on concepts developed for amino acids. The 
implementation of these methods lead to the development of the Pharmacophore Alignment 
Search  Tool  (PhAST).  This  concept  was  successfully  applied  to  prospective  screening 
scenarios. 
 
This work investigated several concepts for graph linearization. Algorithms most suitable for 
PhAST were originally developed for dimensionality reduction. To the best of knowledge, 
this  work  represents  the  first  application  of  these  methods  to  the  problem  of  graph 
linearization.  The  superiority  of  these  methods  to  algorithms  developed  for  calculating 
canonical sets of atom labels was significant. 
  It was shown that screening performance of PhAST is comparable to that of methods 
already  applied  in  drug  development  campaigns.  At  the  same  time,  PhAST  was 
complementary to those methods, meaning that it ranked compounds in a unique order. This 
way, it can be applied to prospective scenarios along with other methods, generating a diverse 
set of hit candidates. The incorporation of knowledge about ligand-receptor interactions in the 
screening process by the application of position weights in the query sequence significantly 
increased screening performance of PhAST compared to the standard version. The concept of 
positional  weights  wa  used  for  pharmacophore  elucidation:  the  determination  of  key 
interactions common to a diverse set of active compounds. 
  Double Dynamic Programming was developed to calculate alignments of amino acid 
sequences  based  on  structural  similarity.  In  this  work,  this  technique  was  successfully 
transferred to the comparison of line notations of small molecules. This way it was shown that 
a linear molecular representation is sufficient for shape comparison. 
  The  significance  of  similarity  scores  is  of  great  importance,  as  the  exclusion  of 
insignificant  hits  obtained  in  a  virtual  screening  from  subsequent  activity  assessment  can 
reduce time and cost of early stages in drug design campaigns. For the most methods used in   80!
drug discovery, there are no proposed or established ways of significance estimation. PhAST 
employs  sequence  alignment  for  similarity  assessment,  where  this  problem  has  been 
investigated  for  nearly  40  years.  As  a  consequence,  methods  developed  for  significance 
assessment of amino acid alignment scores were re-used for alignments of small molecule 
line  notations.  In  this  work,  a  technique  for  the  sampling  of  rare  events  was  applied 
successfully to the determination of alignment score distributions of PhAST-sequences. These 
distributions were used for the calculation of p-values, yielding E-values after a Bonferroni 
correction for library size. This way, PhAST can be used for the identification of significant 
hits. 
PhAST  was  applied  successfully  in  prospective  screening  campaigns.  In  both 
applications, to "-Secretase and bacterial Thymidinkinase, active compounds with a structural 
distinction to the query structure were identified. These results prove that PhAST is a suitable 
and  valuable  method  for  the  identification  of  diverse  hits  in  the  early  stages  of  drug 
development campaigns. 
 
Besides their impact for the development of PhAST, the results of this work disclosed general 
coherences important to virtual screening and drug design in general. The incorporation of 
ligand-receptor interactions in the screening process has high impact and helps to build more 
realistic models. There is no single-best screening method for all drug targets. The application 
of only one screening technique is inferior compared to data fusion approaches or screening 
cascades. As illustrated in the thymdine kinase project, the identification and refinement of 
hits with a diverse set of methods can lead to more potent compounds than one method alone. 
This is due to the multifaceted nature of biological activity. 
 
This  work  evidenced  the  capabilities  of  text-based  virtual  screening  and  the  effects  of 
alterations to its components. The calculation of significance estimates of similarity scores, 
the  flexible  scoring  scheme,  the  possibility  to  apply  weights  to  key  interaction,  its 
pharmacophore elucidation capabilities and the unique rank order of compounds set PhAST 
apart from other screening techniques. Because of these reasons, PhAST has the potential to 
be a valuable asset to any drug development campaign.   81!
13 - Outlook 
 
During the development of PhAST it was shown that sequence alignment, developed for the 
comparison of amino acid sequences and nucleic acids, can be applied to the comparison of 
drug-like molecules as well. This analogy was not limited to the general concept of sequence 
alignment but applied in a variety of specific findings such as:  
•  the alignment score is an indicator for similarity superior to percent sequence identity, 
•  sequence alignment can be used for the comparison of three-dimensional structures, 
•  the efficient calculation of p-values is possible through Marcov Chain Monte Carlo 
methods. 
 
These  pronounced  similarities  give  plausible  reason  to  the  hope  that  improvements  to 
sequence alignment and special variants of this technique developed for the application to 
amino acid sequences and nucleic acids are applicable to PhAST as well. 
Sequence  alignment  algorithms  can  be  adapted  to  specific  hardware  features.  An 
implementation tailored to the Intel SSE2 extension calculated alignments 13 times faster.
157 
Using field programmable gate arrays (FPGAs), 160-fold acceleration was observed.
158,159 
Sequence alignment is an embarrassingly parallel problem, as different sequence pairs can be 
aligned  on  different  processing  units  without  any  necessary  interprocess  communication. 
Several implementations of sequence alignment algorithms that exploit this fact have been 
reported. Using the multi-core Cell processor embedded in the Sony Playstation 3, 36-fold 
speedup was achieved.
160 Graphics processing units (GPUs) can be used for parallelization as 
well, due to their large number of highly specialized processors. Using the OpenGL interface 
calculations could be accelerated by factor 5.
161 An adaption to the ‘compute unified device 
architecture’  (CUDA)  resulted  in  reported  increases  of  2-30-fold  and  23-fold.
162,163 
Parallelization cannot only be achieved by distributing sequence alignment tasks to a large 
number of processing units. Another possibility is the modification of the alignment algorithm 
to  calculate  single  alignments  using  several  processors  in  parallel.  So  far,  this  strategy 
resulted in 2- to 16-fold increase depending on sequence length.
164 Besides parallelization 
alignment algorithms can be improved by the usage of ‘query-profiles’ that circumvent the 
time-consuming look-up of scores in the score matrix.
157,165 Using heuristics instead of exact 
solutions  for  the  optimal  alignment  problem  results  in  50-fold  increase.
163  PhAST  could 
benefit from increased throughput in two ways: First, the number of parameterizations that   82!
can be evaluated in retrospective screenings would increase. Especially with regard to time-
consuming calculations such as Double Dynamic Programming and Rare Event Sampling this 
would be a major improvement. Second, the number of screened compounds in prospective 
applications  could  be  increased.  Again,  Double  Dynamic  Programming  and  significance 
estimation through Rare Event Sampling would benefit most, because these calculations take 
hours to days in the current implementation.  
  The capabilities of PhAST to compare three-dimensional molecular structures through 
Double Dynamic Programming have to be further investigated. The current implementation 
cannot differentiate between atoms that diverge in their directional component. For protein 
structures  it  has  been  reported  that  accounting  for  directional  differences  improves 
equivalency  detection.  The  second  level  of  dynamic  programming  could  be  eliminated  if 
spatial equivalence was evaluated with a measure different from sequence alignment. This 
would  significantly  reduce  computational  costs.  In  addition  to  calculations  of  molecular 
similarity, matches in the generated alignments could be used as seeds in the calculation of 
molecular alignments.
166,167 
  Homologue searches applied to amino acid sequences can be refined in an iterative 
process that calculates a position specific score matrix for the query sequence, as shown with 
the  ‘Position-Specific  Iterated  Basic  Local  Alignment  Search  Tool’  (PSI-BLAST).
168 
Sequences  considered  for  position-specific  score  calculations  are  selected  based  on  a 
significance threshold. The availability of p-values and E-values permits such strategies in 
PhAST as well, if meaningful thresholds can be determined. Threshold determination goes 
hand in hand with further investigation of the significance of global alignments of PhAST-
sequences.  The  impact  of  symbol  frequency  adaption  to  screening  libraries  as w e l l  a s  
compound classes and effects of alternative sampling methods should be investigated for that 
matter. 
  So far multiple sequence alignment
96 seemed infeasible for pharmacophore elucidation 
because of the large number of possible sequence orientation combinations and because of 
multiple sequence alignment being a NP-complete problem.
169-171 A simple heuristic could 
solve this problem: One sequence is defined as origin, the remaining sequences are integrated 
in the multiple sequence alignment in the orientation that yields highest alignment score to the 
first one. 
  This  work  investigated  pairwise  optimal  global  sequence  alignments  for  the 
comparison  of  drug-like  molecules.  For  nucleotide  or  amino  acid  sequences  the  optimal 
alignment may not necessarily reflect the correct biological alignment. Since in most cases the   83!
true  alignment  is  unknown,  methods  that  generate  ‘suboptimal’  alignments  close  to  the 
optimal one have been developed.
172-175 An alignment score within a certain score difference 
to  the  optimal  alignment  characterizes  these  suboptimal  alignments.  Future  studies  could 
investigate  the  applicability  of  suboptimal  alignments  to  the  comparison  of  drug-like 
molecules. 
The current implementation of PhAST compares linear representations that are created 
from molecules in one single step. The disadvantage of this approach is that features from 
different  domains  of  a  molecule  might  end  up  represented  by  adjacent  symbols  in  the 
corresponding line notation. This behavior makes PhAST a non-additive similarity function. 
A fragment-based transformation of molecules to line notations would constrain this effect 
locally. Such a ‘Fragment Alignment Search Tool’ (FAST) could increase the sensitivity for 
local similarity. An important variable in this concept is the fragmentation strategy. A strict 
scaffold-and-side-chain-based set of rules as proposed by Bemis and Murcko
176,177 requires 
the possibility of meaningful prioritization between sidechains. Alternatives are substructure 
prioritizations  analogue  to  systematic  compound  name  generation
178  or  the  step-wise 
decomposition of molecular structures as proposed by Schuffenhauer et al..
179 If preservation 
of locality is strong enough, the application of local sequence alignment as similarity measure 
might be possible.
180 
Algorithms utilized for canonization so far either were developed for molecular graphs 
or  belong  to  the  field  of  dimensionality  reduction.  A  field  not  investigated  so  far  with 
similarities to dimensionality reduction is the projection of vertices to monster curves, such as 
the Hilbert space-filling curve.
181 This approach might circumvent disadvantages observed in 
Principal Component Analysis, that places vertices with large distances in between orthogonal 
to the principal component adjacent in the one-dimensional projection. 
The identified modulator of "-Secretase and its inactive structural analogue point to a 
weakness in the pharmacophore model of PhAST as they have identical graphs of potential 
pharmacophoric points: Heteroatoms in aromatic rings get assigned no interaction possibility 
besides aromaticity. In addition, only recently,
182 a statistical evaluation of hydrogen-bond 
donors and acceptors has been published than can be incorporated in a more meaningful 
pharmacophore model. 
 
The multitude of aspects and concrete starting points for future investigation underline the 
flexibility  of  the  PhAST  concept  and  give  confidence  that  this  approach  can  be  further 
enhanced in future studies.   84!
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Abstract: Previously, (Ha ¨hnke et al., J Comput Chem 2009, 30, 761) we presented the Pharmacophore Alignment
Search Tool (PhAST), a ligand-based virtual screening technique representing molecules as strings coding pharmaco-
phoric features and comparing them by global pairwise sequence alignment. To guarantee unambiguity during the
reduction of two-dimensional molecular graphs to one-dimensional strings, PhAST employs a graph canonization
step. Here, we present the results of the comparison of 11 different algorithms for graph canonization with respect
to their impact on virtual screening. Retrospective screenings of a drug-like data set were evaluated using the BED-
ROC metric, which yielded averaged values between 0.4 and 0.14 for the best-performing and worst-performing can-
onization technique. We compared ﬁve scoring schemes for the alignments and found preferred combinations of can-
onization algorithms and scoring functions. Finally, we introduce a performance index that helps prioritize canoniza-
tion approaches without the need for extensive retrospective evaluation.
q 2010 Wiley Periodicals, Inc. J Comput Chem 31: 2810–2826, 2010
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Introduction
The Pharmacophore Alignment Search Tool (PhAST) is a string-
based approach to virtual screening.
1 It reduces each molecule
to an unambiguous linear representation describing its pharma-
cophore—called ‘‘PhAST-sequence’’—in three steps: (i) each
nonhydrogen atom in the structure graph is replaced by a poten-
tial pharmacophoric point symbol, hydrogen atoms are removed;
(ii) vertices of this pharmacophore graph are canonically labeled
by the algorithm of Weininger et al.
2; and (iii) vertex symbols
are concatenated into a string in increasing order of their canoni-
cal labels. For virtual screening, both the screening compound
collection (‘‘library") and the query molecules are converted,
and the resulting PhAST-sequences are compared using pairwise
global sequence alignment.
3 As a result, molecular similarity
values are computed from the alignment, which can be used for
the retrieval of pharmacophorically similar molecules from a
compound database.
Here, we present some modiﬁcations to the original method.
To speed up the alignment process, we exchanged the Needle-
man Wunsch algorithm
3 with an algorithm proposed by Durbin
et al.
4 that has the same asymptotic runtime complexity but a
lower constant, i.e., it runs faster in practice. We compared the
retrospective virtual screening performance of both algorithms
using BEDROC scores
5 with Pearson’s q
6 and complete ranked
result lists with Kendalls’s s as rank-correlation coefﬁcient.
7
We further investigated alternatives for the evaluation of
sequence alignments, namely the alignment score and the nor-
malized alignment score. This was motivated by a previous
comparison of these methods for determination of homology of
protein sequences.
8 There, sequence identity was inferior to the
(normalized) alignment score, and both performed worse
than signiﬁcance-based evaluation methods like the E-value
measure.
9
The focus of the present work lies in comparison with differ-
ent canonical labeling algorithms in step (ii) (vide supra) of
Additional Supporting Information may be found in the online version of
this article.
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q 2010 Wiley Periodicals, Inc.PhAST. We demonstrate the necessity of this canonization step,
which improves performance over random symbol ordering. In
addition to the algorithms proposed by Weininger et al.
2 and
Jochum and Gasteiger,
10 we implemented a third canonization
algorithm for molecular graphs suggested by Prabhakar and
Balasubramanian.
11 All three algorithms were tested in their
original version and in a modiﬁed version that excludes some of
the original vertex prioritization rules. In addition, we used sev-
eral dimensionality reduction methods, namely linear principal
component analysis
12 (PCA) and the nonlinear methods Lapla-
cian Eigenmaps,
13 Isomap,
14 and minimum volume embedding
15
(MVE) to reduce two-dimensional graphs to one-dimensional
representations.
We compared the different canonization methods by retro-
spective virtual screening of a collection of drugs and lead com-
pounds (collection of bioactive reference analogues
(COBRA)).
16 For statistical evaluation, we used BEDROC
5
scores (with a 5 20 as suggested as default value for evalua-
tion
5), the permutation test proposed by Zhao et al.,
17 and the
Kolmogorov–Smirnov test.
18 Finally, we investigated properties
of the canonization algorithms related to their impact on virtual
screening performance. To this end, we quantiﬁed the extent to
which neighborhoods of graph vertices are preserved by the
algorithms. Because the small structural modiﬁcations of mole-
cules should result in similar PhAST-sequences, we investigated
the effect of adding small fragments to the original molecules.
Methods
Deﬁnitions of pharmacophoric points used in step (i) of PhAST
are shown in Tables 1 and 2. We use the original PhAST ver-
sion
1 as baseline with the only modiﬁcation being a gap open
penalty of three instead of ﬁve. The reason for this was a change
in preprocessing of compounds [‘‘washing’’ with MOE (Molecu-
lar Operating Environment, version 2010.06, Chemical Comput-
ing Group, Montreal, Canada) instead of using fully protonated
structures], resulting in best retrospective performance for the
new gap penalty. All retrospective screens were performed using
the COBRA library
16 (version 6.1, 8311 bioactive compounds;
see Table 3 for a list of the selected targets).
Sequence alignment is used in bioinformatics to decide how
related two sequences (deoxyribonucleic acid (DNA), ribonu-
cleic acid (RNA), and amino acid sequences) are. To create the
alignment of two sequences X 5 x1x2...xn and Y 5 y1y2...ym,
their symbols are matched. The symbol order is retained, and
gaps may be inserted to improve the matching (insertion of
paired gaps is forbidden). Three cases exist: (i) xi is aligned to
yj and xi 5 yj (match), (ii) xi is aligned to yj and xi = yj (mis-
match), (iii) xi is aligned to a gap in Y, or yj is aligned to a gap
in X. In protein sequence alignment, matches represent con-
served residues, mismatches may arise from mutations, and gaps
from insertions or deletions in an assumed evolutionary process
of the sequences. Consequently, matches are rewarded with a
positive score, mismatches are either rewarded with a positive
score or penalized with a negative score (depending on the par-
ticular scoring scheme), and gaps are penalized with a negative
score. The optimal alignment is the one with the highest overall
score (summed over the whole alignment). It can be computed
using dynamic programing.
3
Table 1. Potential Pharmacophoric Points Used in PhAST.
Possible interactions PPP symbol
Hydrogen bond acceptor A
Charge positive P
Charge negative N
Lipophilic L
Aromatic R
Hydrogen bond acceptor, hydrogen bond donor E
Hydrogen bond acceptor, charge positive Q
Hydrogen bond acceptor, hydrogen bond donor,
charge positive
U
No possible interactions O
Table 2. Pharmacophoric Point Deﬁnitions in Terms of Molecular Query
Language (MQL)
19 Queries.
MQL query PPP symbols
CR
NR
*[charge \ 0] N
*[charge [ 0] P
C(   O)   O   H O;N;E
P(   O)   O   H O;N;E
S(   O)   O   H O;N;E
N[allHydrogens50&totalConnections53] Q
N[allHydrogens51&totalConnections53](   C0)   C0 U
N[allHydrogens52&totalConnections53]   C0 U
N[allHydrogens51&totalConnections52]   C0 E
N[allHydrogens50&totalConnections52](   C0)   C0 A
O   HE
C   O O;A
C[!bound(  N)&!bound( O)]-*0[C|F|Cl|Br|I|S] L
Cl L
Br L
IL
S[!bound( N)bound( O)] *0[C|H] L
Symbols are assigned to atoms in the query from left to right; queries
are used from top to bottom.
Table 3. Targets, Taken From the COBRA Library (Version 6.1,
n 5 8,311).
Target Abbreviation
No. of
actives
Angiotensine-converting enzyme ACE 34
Cyclooxygenase 2 COX2 136
Dihydrofolate-reductase DHFR 64
Factor Xa FXA 228
Peroxisome-proliferator-activated
receptor type c
PPARc 44
Thrombin THR 183
Total 689
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Wunsch algorithm
3 for sequence alignment by PhAST.
1 The
algorithm was adapted to the afﬁne gap penalty model with a
ﬁxed gap open and gap extension penalty.
4 This version runs in
O(nm) instead of the original O(nm(n1m)) for any gap penalty
model. To further speed up virtual screenings, we implemented
the global pairwise sequence alignment algorithm conceived by
Durbin et al.,
4 hereafter referred to as ﬁnite-state-machine
(‘‘FSM") algorithm. It has the same O(nm) runtime but runs
noticeably faster in practice. In some cases, the two algorithms
alignments are not identical, because the FSM algorithm prohib-
its the insertion of a gap in Y directly following a gap in X. This
simpliﬁcation reduces computational cost and causes the
speedup, but it does not change the asymptotic runtime.
To assess whether this inﬂuences results, we conducted the
same retrospective virtual screenings twice, once for each algo-
rithm. For each target (Table 3), each active was used as query,
resulting in 689 ranked lists for each of the two alignment algo-
rithms. For each list, the BEDROC score
5 was calculated (with
a 5 20). The correlation between the two sets of BEDROC
scores was determined using Pearson’s q.
6 Statistical signiﬁ-
cance of the observed correlation was estimated from the p-
value of a t test under the null hypothesis that the correlation
equals zero.
The BEDROC score is based on ranks and thus invariant
under permutations of the actives’ ranks. To investigate differen-
ces in the complete ranked lists produced by both algorithms,
we compared the two ranked lists of each query with Kendall’s
s
7 as rank-correlation coefﬁcient. Because ties can occur, we
used sb, which corrects for this scenario. The signiﬁcance of the
observed rank correlation was calculated as the p-value of a z
test under the null hypothesis that the correlation equals zero.
The focus of this work is on the inﬂuence of the canonization
step on PhAST performance. We compared canonization meth-
ods as follows: With each method and for each target, each
active was used as query in a retrospective virtual screening,
resulting in 689 ranked lists. For each ranked list, the BEDROC
score was calculated (a 5 20). The mean BEDROC score was
used as overall performance index. For each canonization
method and target, gap open and extension penalties were opti-
mized using a grid search (starting from gap open penalty 5 2
and gap extension penalty 5 1, each combination with gap
extension penalty lower than gap open penalty was tested,
resulting in 190 penalty combinations), as it is hard to choose
them by intuition.
20 Gap penalties greater than 20 seem unrea-
sonable as they exceed the highest mismatch penalties.
To prove that the canonization step is essential, we compared
baseline PhAST (Weininger canonization) against PhAST with
random labeling in step (ii) of the algorithm. To avoid bias
(default gap penalties are optimized for Weininger algorithm),
we used the same simple scoring scheme for both labeling
methods: Matches are rewarded with 11, mismatches are penal-
ized with 21, and both gap penalties are 1. For random label-
ing, we generated 100 pairs of PhAST-sequences for each pair
of molecules and used the average score as ﬁnal similarity
value.
To assess whether two different versions of PhAST have sig-
niﬁcantly different performance, we used the permutation test
proposed by Zhao et al.
17 It has the null hypothesis that virtual
screening method P performs signiﬁcantly better than method Q.
Assuming p and q are rank lists of actives resulting from the vir-
tual screening methods, the null hypothesis requires that BED-
ROC(p) [ BEDROC(q). As each active has two ranks, one in p
and one in q, new rank lists p* and q* can be created by swap-
ping its rank in p with its rank in q for each active with proba-
bility 1/2. This is repeated 10,000 times and the frequency of
the event that BEDROC(p)–BEDROC(q) is less than BED-
ROC(p*)–BEDROC(q*) is recorded. The frequency of this event
is the type I error rate for the null hypothesis. In addition, we
used a Kolmogorov–Smirnov test
18 for the same purpose. Both
methods were used to assess the signiﬁcance of the difference
between using the Weininger algorithm for graph canonization
and using random concatenation of symbols and to assess the
improvement from baseline PhAST to the best combination of
algorithms identiﬁed in this work. In both cases, calculations
were based on the 689 BEDROC scores resulting from each ver-
sion of PhAST.
Canonization Algorithms
The atom-typing step in PhAST yields a graph of potential phar-
macophoric points that has the same topology as the molecular
graph with suppressed hydrogen atoms. Each vertex is colored
with a symbol (Table 1) that represents a potential pharmaco-
phoric point. Edges represent covalent bonds. Canonization is
the labeling of the vertices with the natural numbers 1,2,3... In
a previous study,
1 we compared the canonization algorithms of
Weininger et al.
2 and Jochum and Gasteiger
10; we reevaluate
them, here, because of changes in molecule preprocessing. In
contrast to these two algorithms, the one by Prabhakar and Bala-
subramanian
11 is based on paths, a property thought to be bene-
ﬁcial for PhAST. We modiﬁed all algorithms by using pharma-
cophoric points as prioritization criterion instead of the element
number.
Jochum–Gasteiger Method
The canonical labels created by the Jochum and Gasteiger algo-
rithm
10 are in most cases identical to those obtained by the Mor-
gan
21 algorithm.
10 The ﬁrst step is the separation of all vertices
into two sets—terminal vertices (vertices with exactly one single
bond) and core vertices (all others). All core vertices with the
same buriedness are members of the same equivalence class.
The algorithm divides the vertices of each class further using a
set of prioritization criteria, until only one atom remains that
gets the next label, starting from the vertices in the most buried
class. Prioritization criteria are (i) priority of the potential phar-
macophoric point (atom number in the original application) and
(ii) number of free electrons. In both cases, the vertex with the
highest value has priority. The next criteria involve the environ-
ment of the vertices organized in spheres around each vertex.
The vertex with the highest of these values in his neighborhood
gets priority: (iii) number of vertices, (iv) priority of potential
pharmacophoric points, (v) number of free electrons, (vi) num-
ber of bonds in the next sphere, (vii) bond order of these bonds,
(viii) neighborhood to an already labeled vertex, and (ix) bond
2812 Ha ¨hnke et al. • Vol. 31, No. 15 • Journal of Computational Chemistry
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ter (ix), all of them are marked as indistinguishable and the
remaining vertices have priority over them. After all distinguish-
able vertices are labeled, (viii) is used to label the undistinguish-
able vertices. After all core vertices are prioritized, terminal ver-
tices are prioritized by criteria (i) and (viii).
Weininger Method
The canonization algorithm by Weininger et al. was proposed as
part of canonical simpliﬁed molecular input line entry system
(SMILES) generation.
2 Its idea is to assign vertices to topologi-
cal symmetry classes. It ﬁrst assigns a property vector to each
vertex that consists of different atomic invariants mainly based
on the original molecular graph: (i) number of connected verti-
ces, (ii) number of connected nonhydrogen atoms, (iii) priority
of the pharmacophoric point (atom number in the original ver-
sion), (iv) sign of charge, (v) absolute charge, and (vi) number
of connected hydrogen atoms. Vertices with identical vectors
form an equivalence class, and all vertices are sorted ascending
by this vector. For each vertex, its extended connectivity is cal-
culated as follows: Beginning with the equivalence class with
the lowest index, the vertices in each class are assigned the
same prime number, starting with 2. For each vertex in the
graph, the product of the primes of its neighbors is calculated.
These product values deﬁne new equivalence classes on the ver-
tices. Each equivalence class, in order of product values, is
assigned an index, starting from 1. This process is repeated until
the number of equivalence classes does not change in a step. If,
after extended connectivity calculation, an equivalence class
contains two or more vertices, these ties are broken by an addi-
tional step: the index of each equivalence class is doubled, and
one vertex from the equivalence class with the lowest index is
randomly chosen to form an own equivalence class with the
index of its original equivalence class lowered by 1. After that,
all equivalence classes are renumbered starting from 1. These
two steps (computing the extended connectivity and breaking
ties) are alternated until the number of equivalence classes
equals the number of vertices in the graph.
Prabhakar–Balasubramanian Method
The canonization algorithm by Prabhakar and Balasubramanian
11
uses more graph-based prioritization rules than the other two
algorithms and progresses along paths through the graph. First,
the number of incident bonds with respect to bond order is
determined for each vertex (cn). As with the Jochum and Gas-
teiger algorithm, vertices are divided into two sets, terminal ver-
tices (cn 5 1) and core vertices (cn [ 1). Labeling starts with
the core atoms. Using the following prioritization rules, they are
divided into smaller subsets, until only one atom (which will get
the next canonical label) remains: (i) number of incident bonds,
(ii) number of incident bonds with respect to bond order, and
(iii) pharmacophoric point priority (atom number in the original
version of the algorithm). In these cases, the vertex with the
highest value has priority. If more than one atom with highest
priority remains, copies of the original graph are created, called
‘‘fragments.’’ If there are n vertices left for prioritization, n21
copies of the original graph are created for each vertex v. In
each copy, the ﬁrst bond in the shortest path between v and one
of the other competing vertices is deleted. Only the part of the
copy that includes v is retained. The remaining prioritization
rules are applied to these fragments; a vertex has the highest pri-
ority, if one of his fragments has a higher priority than the frag-
ments created for all other vertices: (iv) the length of the path
starting in the competing vertex and following the highest pre-
computed cn values, until it reaches a vertex already visited or
labeled, (v) number of loops, (vi) length of the longest path in
the fragment, (vii) number of pharmacophoric points not lipo-
philic, aromatic or no interaction, (viii) summed symbol prior-
ities of vertices in the fragment, (ix) averaged distances between
all vertices not lipophilic, aromatic, or no interaction in the frag-
ment. In all cases except the last one, the fragment with the
highest value has priority. If there remains more than one vertex
and there is no already labeled vertex, one of them is chosen
arbitrarily and has priority over all other vertices. If there is al-
ready at least one labeled vertex, (x) the label of the connected
vertex is used. These rules are used in a depth-ﬁrst search. All
neighbors of the last labeled vertex are the potential candidates
for the next label. If this search reaches an end point, all vertices
adjacent to an already labeled vertex are candidates for the next
label. After all core vertices are labeled, terminal vertices are
labeled according to criteria (ii), (iii), and the label of the
neighboring core atom.
Irrespective of the canonization method used, the PhAST-
sequences created from two identical graphs of pharmacophoric
points are identical. If a pharmacophoric point is changed, but
the topology remains the same, the relative order of symbols in
the PhAST-sequence should remain unchanged as well. Yet all
three algorithms use pharmacophoric point priority as a prioriti-
zation criterion. Consequently, the changes in a PhAST-sequence
because of exchange of a single vertex symbol can be more
severe than intended. To attenuate this, each canonization algo-
rithm was tested in a modiﬁed version:
  In the Jochum and Gasteiger algorithm, clipping of terminal
atoms was omitted, and the criteria symbol priority and num-
ber of free electrons were eliminated.
  For the Weininger algorithm, the creation of the initial priori-
tization vector was changed: the priority of the pharmaco-
phoric point, the total number of neighbors, and the number
of neighboring hydrogen vertices were omitted and both
charge criteria.
  For the Prabhakar algorithm, the initial clipping of terminal
vertices was omitted. The priority of the pharmacophoric
point, the number of pharmacophoric points not lipophilic, ar-
omatic or no interaction in a fragment and averaged distances
between all vertices not lipophilic, aromatic or no interaction
in a fragment were removed.
Canonization by Dimensionality Reduction
An alternative approach to canonization that to our knowledge
has not been used before for canonization and does not suffer
from the mentioned drawbacks is the use of dimensionality
reduction algorithms. We implemented four such methods.
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Principal component analysis
12 is a linear dimensionality reduc-
tion method often used to visualize high-dimensional data. We
used PCA to calculate one-dimensional coordinates from two-
dimensional graph layouts generated by the 2D depiction algo-
rithm of MOE (version 2010.06, Chemical Computing Group,
Montreal, Canada). Therefore, the coordinates of the vertices in
each graph were mean-centered, and the covariance matrix
between the position vectors of all vertices calculated. The com-
putation of the eigenvectors and eigenvalues of the covariance
matrix gives the loading vectors that are used for the computa-
tion of the new coordinates of the vertices. To get the one-
dimensional coordinate for each vertex, the dot product between
its original position vector and the loading vector with the high-
est absolute eigenvalue was calculated. Beginning with the ver-
tex with lowest one-dimensional coordinate, we assigned labels
in ascending order. For identical one-dimensional coordinates,
we used their coordinate in the second dimension of the princi-
pal component space as prioritization criterion. In all cases, the
vertex with the lowest coordinate had the highest priority.
PCA ﬁnds a low-dimensional embedding of data points that
best preserves their variance. However, PCA fails when a data set
contains nonlinear structures. Nonlinear approaches that overcome
this problem start with the assignment of vertex neighborhoods by
using a connectivity algorithm like k-nearest neighbors,
22 b-
matching
23 (each vertex gets assigned exactly b neighbors), or e-
balls (a vertex is connected to all vertices within distance e),
resulting in a neighborhood graph with edges between neighboring
vertices. We directly used the topology of the molecular graph
instead of connectivity algorithms. In the embedding, these meth-
ods aim at preserving the pairwise distances between neighbors.
Laplacian Eigenmaps
Laplacian Eigenmaps
13 start by calculating three matrices from
the neighborhood graph: the weight matrix W with [eq. (1)]
Wij  
1 if i and j are connected
0 else
 
; (1)
the degree weight matrix D with the column sums of W as
entries [eq. (2)],
Dii  
X
j
Wij; (2)
and the positive semideﬁnite Laplacian matrix L [eq. (3)] with
L   D   W: (3)
Then, the eigenvalues and eigenvectors of the generalized
eigenvector problem [eq. (4)] are calculated.
Lf   kDf (4)
Eigenvectors (f) are sorted according to their eigenvalues (k)
in ascending order. The ﬁrst eigenvector with k 5 0 is omitted.
The next d eigenvectors are used for embedding. In our case,
the second eigenvector contains the coordinates for the one-
dimensional embedding.
Isomap
The Isomap algorithm by Tenenbaum et al.
14 uses the neighbor-
hood graph to estimate geodesic distances between the vertices.
A matrix D of shortest distances between all vertices is com-
puted, e.g., using the Floyd–Warshall algorithm.
24,25 Using D,
the matrix s(D) is calculated as [eq. (5)]:
s D    1
2   HSH (5)
where S is the matrix of squared distances [eq. (6)]
Sij   D2
ij (6)
and H the centering matrix [eq. (7)]:
Hij   dij  
1
n
(7)
with dij the Kronecker delta and n the number of vertices. The
eigenvectors and eigenvalues of s(D) are computed. To embed
in d dimensions, the ﬁrst d eigenvectors sorted according to their
eigenvalues in decreasing order are used. If kp is the pth eigen-
value of s(D) and v
i
p is the ith component of the pth eigenvec-
tor, then the pth component of the d-dimensional coordinate vec-
tor of a vertex is equal to
     
kp
p
vi
p.
Minimum Volume Embedding
The two previous methods lose all information contained in the
eigenvectors that are not used for the embedding. None of them
aims at minimizing the amount of information lost this way.
MVE
15 preserves as much information as possible in the d
dimensions used for embedding. This is achieved by an iterative
process based on semi-deﬁnite programing (SDP). First, an afﬁn-
ity matrix A is calculated for the vertices using a kernel function
k. A is positive semideﬁnite and must be centered. This matrix
is used in the neighborhood deﬁnition process (instead of given
vertex coordinates) to obtain a binary connectivity matrix C.A
third matrix K is set equal to A. The following procedure is
repeated until convergence: (i) Calculate the eigenvectors fi and
eigenvalues ki of K, sort the fi descending to their corresponding
ki. (ii) Calculate the matrix B using eq. (8),
B   
X d
i 1
fif T
i  
X N
i d 1
fif T
i (8)
(iii) use SDP to solve eq. (9)
K   argmin
K2K
tr KB  (9)
under constraints K deﬁned by Shaw and Jebara,
15 tr denotes the
matrix trace (sum of the diagonal elements).
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26 is performed with K to get
the d eigenvectors used for embedding. MVE works with any
positive semideﬁnite kernel k. We used MVE with two different
kernel functions. The ﬁrst one is a diffusion kernel.
27 For each
pair of vertices mi and mj, it returns the probability that a random
walk starting in mi will be in mj after an inﬁnite number of steps,
with only a low probability of leaving the current vertex in each
step. The kernel matrix can be calculated according to eq. (10).
28
K   e  bL  (10)
where L is the Laplacian matrix introduced in (3) and b is the
diffusion parameter. If b equals 0, no diffusion is allowed and K
equals the unit matrix.Kis computed by matrix exponentiation,
which is different from componentwise exponentiation. We used
12 values for b to determine its inﬂuence on PhAST: 0.01, 0.1,
0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.9, 1.0, and 10. The second ker-
nel function calculates inner products from the Euclidean coordi-
nates of the vertices. It is deﬁned as given in eq. (11).
k x;y  
1
2
   x kk
2   y kk
2  x   y kk
2 : (11)
To obtain Euclidean coordinates for each vertex, as for PCA,
we used the 2D depiction algorithm of MOE. This particular ker-
nel is parameter free.
When using dimensionality reduction methods, slight modiﬁ-
cations of a molecule can switch the direction of the axis of the
one-dimensional coordinate system. We addressed this issue by
repeating every sequence comparison during the virtual screen-
ing with one of the sequences inverted, if dimensionality reduc-
tion was involved. We used the higher of the two resulting val-
ues as similarity measure.
Evaluation of the Alignment
In addition to canonization methods, we analyzed the effect of
different alignment evaluation methods. The alignment of nucleic
or amino acid sequences is a traditional ﬁeld in bioinformatics
and well analyzed. It was shown that there are methods to deter-
mine peptide sequence homology from pairwise alignments that
yield better results than the sequence identity used in PhAST.
8
These methods are alignment scores and signiﬁcance estimations
of alignments. We evaluated two variants of sequence identity
and three variants of alignment scores. There is no signiﬁcant
overhead compared with sequence identity calculation.
Sequence Identity
The original PhAST used the percent identity (PID1) between
two sequences X and Y [eq. (12)],
PID1  
M A X;Y  
L A X;Y  
(12)
with A(X,Y) the alignment of X and Y, M(A(X,Y)) the number of
matches in the alignment, and L(A(X,Y)) the length of the align-
ment (including all gaps). Comparing two sequences of mole-
cules active on the same target but of different size might result
in a low PID1, because the global alignment has to extend the
shorter sequence to the length of the longer one with gaps. To
counteract this effect, we correct for the size of the sequences:
We ﬁrst calculate the maximum reachable PID1 of two sequen-
ces by inserting the maximum number of matches (length of the
shorter sequence) and the minimum length of the alignment
(length of the longer sequence) into eq. (12). We then normalize
PID1 according to eq. (13):
PID2  
actual PID1
max PID1
(13)
Alignment Score
Besides sequence identity, we investigated alignment scores as
evaluation measures. The raw alignment score S1 is the sum of
matches, mismatches, and gap penalties. Alignments of long
sequences tend toward higher scores, so S1 depends on sequence
similarity and length. We normalize S1 by dividing through the
length of the alignment, yielding S2. The resulting score meas-
ures the average contribution of each event in the alignment
(match, mismatch, or gap). S1 can also be normalized by divid-
ing through the length of the shortest original sequence, yielding
S3, a measure of the maximum averaged contribution of each
symbol in a sequence. All alignment score methods are meas-
ures of the similarity between aligned sequences, but are no lon-
ger bounded by 0 and 1.
Alignment evaluation methods involving alignment length or
the number of occurrences of an event suffer from the drawback
that there can be more than one optimal alignment of two
sequences, which one is found depends on implementation
details. The alignment of the sequence pair (X,Y) can, therefore,
differ from that of (Y,X) in length, number of matches, number
of mismatches, number of gaps, and gap length. To ensure the
symmetry of our method, i.e., identical scores for A(X,Y) and
A(Y,X), we modiﬁed the affected evaluation methods. In case of
PID1, we compute A(X,Y) and A(Y,X), and use the average PID1
as ﬁnal evaluation measure. This correction is used in the calcu-
lation of actual PID1 for PID2 as well. In case of S2, we align
both sequence pairs and use the averaged alignment length for
normalization.
In total, we compared 11 graph canonization methods com-
bined with ﬁve alignment evaluation methods and 190 gap pen-
alty combinations by conducting 689 virtual screenings for each
combination and averaging the resulting BEDROC scores (a 5
20). To assess whether our modiﬁcations lead to signiﬁcant
improvements of PhAST, we used the permutation test proposed
by Zhao et al.
17 and a Kolmogorov–Smirnov test.
18
Canonization Analysis
To further quantify the differences between canonization meth-
ods, we determined how well the neighborhood relations in the
original pharmacophoric point graph are retained and repre-
sented in the resulting PhAST sequences. We did this by count-
ing how often the vertices, which are neighbors in the graph, are
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ecule in the COBRA library of reference compounds.
16 For all
graph neighbors that are not neighbored in the one-dimensional
representation, we counted how many vertices were inserted
between them, resulting in a histogram of these distances. As
each pair of neighboring vertices was viewed twice, once from
each vertex as origin, the resulting counts were divided by 2.
For use with PhAST, canonization algorithms should be ro-
bust against small changes in molecular structure, i.e., similar
molecules should have similar PhAST-sequence. This in turn
means that neighbors in the PhAST-sequences of a molecule
should remain neighbors even if the molecule is slightly modi-
ﬁed. To test this, the compounds in the COBRA library were
modiﬁed by attaching small fragments. After conversion to
PhAST-sequence, we counted (i) neighboring vertices in the
original PhAST-sequence that are neighbors in the modiﬁed
PhAST-sequence, (ia) with their relative orientation as in the
original PhAST-sequence, (ib) with their relative orientation
changed; (ii) neighboring vertices in the original PhAST-
sequence that are not neighbors in the modiﬁed PhAST-
sequence, (iia) with their relative orientation as in the original
PhAST-sequence, (iib) with their relative orientation changed. If
two vertices of the same type that are neighbors in the original
PhAST-sequence are still neighbors in the modiﬁed PhAST-
sequence, but changed their relative orientation, this event is
counted as (ia) because the change of positions has no effect on
the PhAST-sequence due to identical types. Cases (ib) and (iib)
present a problem for global sequence alignment as a string
comparison method. As the relative position of symbols cannot
be changed, the only two operations that can be reconstructed in
the alignment process are mutations (a symbol changed to
another one) and insertion/deletions (compensated by gaps). A
transversion, i.e., the swapping of two different symbols, cannot
be properly modeled by only one event.
Figure 1 presents the six used fragments. Three fragments
consist only of carbon atoms that are typed as L in the atom typ-
ing step. The other three are topologically identical to the ﬁrst
three fragments, with one carbon changed to nitrogen typed as
U. This way, the algorithms are confronted with topological
modiﬁcations and changes in vertex priorities. Fragment attach-
ment points should not change the atom typing. We used carbon
atoms that were typed as L, R, or O in the original molecule
and were connected to at least two hydrogen atoms. One of the
hydrogen atoms was replaced by the ﬁrst atom of the fragment.
Molecules (1612/8311) from COBRA were omitted, because
they had less than 10 possible attachment points. Each single
fragment attachment was repeated ﬁve times at random posi-
tions. In addition, each possible combination between fragments
(resulting in 21 unique pairs) was used ﬁve times as well, again
at random positions. In total, each molecule was compared to
135 variants of itself.
All modiﬁcations were undertaken in a single preprocessing
of the COBRA compound collection to ensure that all algo-
rithms are compared with the same modiﬁed molecules. The
resulting molecular graphs were depicted using MOE, because
one variant of MVE depends on Euclidean distances. In the case
of dimensionality reduction methods, again both possible canoni-
zation results were used in the analysis, and we used the one
with a higher preservation of neighborhood relationships. This is
justiﬁed, because for these methods, both orientations of the
PhAST-sequence are used during a virtual screen.
All programing was done using the Java Programing Lan-
guage (version 6). Eigen decompositions were done with the
java linear algebra package (JLAPACK) library.
29 SDP problems
were solved with the c semi-deﬁnite programming library
(CSDP) solver.
30 Productive runs and calculations were per-
formed on a Linux cluster with 40 advanced micro devices
(AMD) Opteron 8214 processors and 320 gigabyte (GB) random
access memory (RAM).
Results and Discussion
Choice of Alignment Algorithm
To determine whether the exchange of the alignment algorithm
of Needleman and Wunsch by the faster FSM algorithm affected
the performance of PhAST, we determined the correlation of
BEDROC scores obtained from virtual screening with each
active as reference (n 5 689). The Pearson-correlation coefﬁ-
cient was 0.9996 with a p-value of below 10
21051. To quantify
the differences within the complete ranked lists, Kendall’s s was
computed (see Fig. 2). The minimum correlation observed was
0.945, the maximum correlation observed was 0.998, and the
average correlation observed was 0.984. The p-value for each s
was below 0:5   erfc
82;779;141;588    
2
p
109;242;709
  
. The FSM algorithm used
only 40% of the runtime of the Needleman Wunsch algorithm.
On the basis of the gain in computation speed and the high
correlations, we decided to employ the FSM algorithm for all
experiments in this study.
Necessity for Canonization
To verify the importance of the canonization step, we compared
BEDROC values (a 5 20) of baseline PhAST and PhAST with
random labeling (average of 100 random labeling procedures
Figure 1. Fragments for the comparison of modiﬁed molecules.
* Denotes the attachment point. Shown are molecular fragments
(left) and corresponding pharmacophoric point graphs (right).
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ties 5 1).
Figure 3 presents the distribution of BEDROC scores per tar-
get. There is almost no overlap, with the exception of cyclooxy-
genase 2 (COX2). The latter can be explained by the distribution
of pharmacophoric points: As given in Table 4, COX2 ligands
have 56% pharmacophoric points of type R. Random concatena-
tions of pharmacophoric points of the same type do not change
the resulting PhAST sequence (more symbols of the same type
only result in fewer possible sequences). The global sequence
alignment matches regions of identical symbols between sequen-
ces, resulting in a high score. Subsequences of different lengths
are compensated by gaps, lowering the score. PhAST-sequences
of COX2 ligands have shortest average length and standard
deviation, i.e., they are least affected by this effect because they
are of comparable length. In agreement with this reasoning, the
target with second largest overlap, peroxisome-proliferator-acti-
vated receptor typec (PPARc), is also second in type R symbols
(51%) and of comparatively small size.
Table 5 presents the results of the Zhao permutation test.
PhAST with Weininger canonization performed signiﬁcantly bet-
ter than random labeling in 91% of all screenings at a signiﬁ-
cance level of 0.05. In 5% of the screens, random labeling per-
formed better. The latter cases are dominated by screenings on
COX2. A Kolmogorov–Smirnov test showed that the difference
between these two methods is signiﬁcant with a p-value of
1.0835 3 10
278. We conclude that the canonization step is nec-
essary for PhAST.
Comparison of Canonization Methods
We compared 11 canonization algorithms, ﬁve alignment evalua-
tion methods, and 190 gap penalty combinations for their effect
on PhAST in a set of virtual screening experiments employing
Figure 2. Box-whisker plots of rank correlation coefﬁcients
between the ranked lists obtained using the Needleman–Wunsch and
the FSM algorithm for sequence alignment per target (n 5 34, 136,
64, 228, 44, and 183). Shown are 5th/95th (points), 10th/90th
(whiskers), 25th/75th (box borders) percentiles, median (solid line),
and mean (dashed line).
Figure 3. BEDROC (a 5 20) scores of Weininger versus random
canonization. A simple alignment scoring system with 11( 21) for
matches (mismatches) and gap open and extension penalty of 1. For
random canonization, the mean similarity of 100 random sequences
was used. Shown are 5th/95th (points), 10th/90th (whiskers), 25th/
75th (box borders) percentiles, median (solid line), and mean
(dashed line).
Table 4. Symbol Frequencies in the COBRA Library.
ACE COX2 FXA PPARc DHFR THR
Ø Symbols 27.12 24.61 34.34 28.57 27.34 35.95
r 7.43 3.17 5.28 7.03 5.71 7.90
A 8.89 2.27 4.87 5.73 4.91 6.99
E 0 0.24 0.28 0.08 0.29 1.08
L 23.64 17.99 9.45 17.10 13.83 21.01
N 6.40 0.69 0.46 3.10 2.57 00.43
O 23.64 22.80 25.57 19.97 17.49 29.47
P 3.25 0.09 2.85 0.56 0.97 3.02
Q 1.74 0.18 2.92 0.88 0.74 2.60
R 31.45 55.48 48.43 51.31 49.94 29.21
U 0.98 0.27 5.17 1.27 9.26 6.19
‘‘Ø Symbols’’ and ‘‘r’’ indicate the average number of pharmacophoric
points per molecule and the standard deviation.
Table 5. Permutation Test Results for Weininger Canonization Versus
Random Canonization.
No. of queries Weininger Random
ACE 34 100 (100) 0 (0)
COX2 136 70 (68) 22 (21)
DHFR 64 95 (95) 2 (2)
FXA 228 98 (98) 1 (1)
PPARc 44 84 (84) 7 (5)
THR 183 97 (97) 0 (0)
Total 689 91 (91) 5 (5)
Shown are the percentages of cases where one contestant performs sig-
niﬁcantly better than the other at a signiﬁcance level of 0.05 (0.01).
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Journal of Computational Chemistry DOI 10.1002/jccFigure 4. BEDROC (a 5 20) scores for combinations of alignment evaluation methods and gap pen-
alties. (a) Jochum and Gasteiger algorithm, (b) modiﬁed Jochum and Gasteiger algorithm, (c) Wei-
ninger algorithm, (d) modiﬁed Weininger algorithm, (e) Prabhakar algorithm, (f) modiﬁed Prabhakar
algorithm, (g) MVE with diffusion kernel and diffusion parameter 0.4, (h) MVE with Euclidean dis-
tance kernel, (i) Laplacian Eigenmaps, (j) Isomap, and (k) PCA.
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pounds. For each combination of canonization, alignment, and
gap penalties, each active molecule of each target was used as
query in a virtual screening. Screening success was assessed by
average (n 5 689) BEDROC (a 5 20) scores. For MVE with
diffusion kernel, we compared 12 values of the diffusion param-
eter b. Only the best performing version with b 5 0.4 that
reaches the highest averaged BEDROC score is included in the
Figure 4. (Continued)
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are presented in Figure S1 (cf. Supporting Information). Figure
4 presents the outcome of the comparison.
For each canonization algorithm, alignment evaluation meth-
ods and gap penalty combinations have similar effects. For the
algorithms of Weininger, Prabhakar, and Jochum–Gasteiger, the
respective modiﬁed versions display a retrospective performance
that is comparable to the original versions of the algorithms.
Our modiﬁcations, therefore, neither worsened nor improved
their performance. For MVE, the effect of different kernel func-
tions is minor. The best parameterization of the diffusion kernel
was slightly superior to the Euclidean distance kernel. Isomap
and Laplacian Eigenmaps performed comparably but with
slightly lower BEDROC scores. Among the dimensionality
reduction methods, PCA performed worst. Considering the com-
parison of baseline PhAST with random labeling, we conclude
that having a canonization method at all is more important than
the particular method used.
PID1 is the original alignment evaluation method, PID2
penalizes differences in sequence lengths to a lesser extent than
PID1, and performs worse than PID1 manifesting in lower aver-
aged BEDROC scores (see Fig. 4). We introduced PID2 to com-
pensate for the difference in sequence lengths of actives of the
same target. Although PID2 yielded greater similarity values
than PID1, it also did so for sequences from different targets.
This effect generates false positives, thereby, diminishing
screening performance.
The evaluation methods S1, S2, and S3 are all based on the
alignment score with different normalization techniques. They
perform similar and all of them appear to be superior to align-
ment evaluation methods based on sequence identity. We
explain this observation by the improved weighting of matches
and mismatches. Sequence identity is inﬂuenced only by the
number of (mis)matches. The alignment score, however, is inﬂu-
enced by the exact type of match or mismatch depending on the
symbols involved. For similar numbers of matches and mis-
matches, this enables a more differentiated evaluation of the
alignment.
All combinations of canonization and alignment evaluation
strongly depend on the gap penalties used. Retrospective
results for one particular combination of canonization algo-
rithm and alignment evaluation method show strong variation
with different penalty combinations. For each gap open pen-
alty, retrospective performance decreases with increasing gap
extension penalty. This can be explained by the alignment pro-
cess itself. The optimal alignment is the combination of posi-
tive scores for matches and negative scores for mismatches
and gaps that is highest in sum. If gap penalties exceed mis-
match scores, gaps will decrease the alignment score more
than mismatches, thus increasing the number of mismatches.
This results in alignments dominated by mismatches due to
this effect and not because of the exchange of functional
groups in the molecular graph. The resulting alignments do
not reﬂect molecular similarity anymore and decrease virtual
screening accuracy.
The averaged BEDROC score of the best performing gap
penalty combination is given in Table 6 for each canonization
algorithm and alignment evaluation method. The performance of
baseline PhAST (Weininger canonization, gap open penalty 5
3, gap extension penalty 5 1, alignment evaluation PID1) is
0.29 (bottom left in the table). The best performance was 0.40
[MVE canonization using the diffusion kernel (b 5 0.4), gap
open penalty 5 5, gap extension penalty 5 1, alignment evalua-
tion S2]. To see whether this improvement is signiﬁcant, we per-
formed the permutation test proposed by Zhao. Table 7 presents
the results per target. The lowest fraction of signiﬁcantly
improved screenings is for angiotensine-converting enzyme
(ACE) with  24%. On average, the performance was signiﬁ-
cantly increased in 71% of all screening experiments. Baseline
PhAST performs better only in 21%. In combination with the
increased average BEDROC scores, we conclude that the
improvement of our method is signiﬁcant. This is supported by
a Kolmogorov–Smirnov test producing a p-value of 1.37 3
10
221.
Average BEDROC performance for the globally optimal gap
penalty combination and gap penalties optimized for each target
Table 6. BEDROC Scores (a 5 20).
Scoring scheme
PID1 PID2 S1 S2 S3
Jochum Gasteiger 0.26 (3, 2) 0.17 (20, 1) 0.35 (5, 1) 0.36 (4, 1) 0.35 (4, 2)
Jochum Gasteiger modiﬁed 0.24 (3, 2) 0.15 (20, 1) 0.35 (4, 1) 0.35 (2, 1) 0.35 (3, 2)
Isomap 0.28 (20, 1) 0.19 (20, 1) 0.39 (8, 1) 0.39 (7, 1) 0.38 (8, 1)
Laplacian Eigenmaps 0.28 (20, 1) 0.18 (20, 1) 0.38 (8, 1) 0.38 (7, 1) 0.38 (9, 1)
MVE diffusion kernel 0.4 0.29 (3, 2) 0.20 (20, 1) 0.39 (7, 1) 0.40 (5, 1) 0.39 (6, 2)
MVE Euclidean kernel 0.27 (3, 2) 0.16 (20, 1) 0.37 (7, 1) 0.37 (5, 1) 0.37 (5, 2)
PCA 0.24 (3, 2) 0.14 (20, 1) 0.27 (4, 2) 0.35 (3, 1) 0.26 (4, 3)
Prabhakar 0.27 (13, 2) 0.16 (20, 1) 0.37 (6, 1) 0.37 (5, 1) 0.37 (7, 1)
Prabhakar modiﬁed 0.26 (3, 2) 0.17 (20, 1) 0.26 (6, 1) 0.36 (4, 1) 0.36 (6, 1)
Weininger 0.31 (3, 1) 0.20 (20, 1) 0.36 (7, 2) 0.37 (6, 1) 0.37 (7, 2)
Weininger modiﬁed 0.29 (3, 2) 0.17 (29, 1) 0.36 (5, 2) 0.37 (4, 1) 0.37 (5, 2)
The best gap open/gap extension penalties are shown in parentheses.
Higher scores indicate better virtual screening performance.
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for COX2. We conclude that the global optimum (gap open pen-
alty 5 5, gap extension penalty 5 1) provides reasonable default
values for practical applications.
We varied two major components of PhAST, the canoniza-
tion algorithm and the alignment evaluation method. Changing
both improved baseline PhAST signiﬁcantly. But which of these
two variables is more important? The lowest score achieved
with PID1 (baseline PhAST) is 0.24 (modiﬁed Jochum–Gasteiger
canonization), the highest score is 0.31 (Weininger canoniza-
tion). With S2 (best performance), even the lowest score of 0.35
(PCA canonization) lies above the highest score of PID1. The
highest score with S2 for alignment evaluation is 0.40 (MVE
canonization with diffusion kernel, b 5 0.4). In 32 of 33 cases,
the alignment evaluation methods based on the alignment score
yield higher values with the same canonization algorithm than
PID1. For PID2, this is true for all 33 cases. In Table 6, the
mean coefﬁcient of variation (r/l)
6 of the columns is 0.09,
whereas that of the rows is 0.27. Varying the alignment evalua-
tion method, therefore, inﬂuences the performance three times
stronger than varying the canonization method. We conclude
that the choice of the alignment evaluation method is more im-
portant than the choice of the canonization algorithm.
Neighborhood Preservation
As an example, Figure 5 presents the canonical labels generated
for chlorpromazine with each of the 11 compared canonization
algorithms. Both versions of the Prabhakar algorithm have a
tendency to label consecutive paths in the graph. For both ver-
sions of the Gasteiger algorithm, the ground concept of number-
Table 7. Permutation Test Results for MVE (b 5 0.4) Canonization with
S2 Versus Weininger Canonization With PID1.
No. of queries
MVE 0.4
S2 (5, 1)
Weininger
PID1 (3, 1)
ACE 34 24 (24) 59 (56)
COX2 136 56 (56) 40 (40)
DHFR 64 95 (95) 3 (3)
FXA 228 67 (64) 22 (21)
PPARc 44 64 (61) 16 (14)
THR 183 90 (90) 6 (5)
Total 689 71 (70) 21 (20)
Shown are the percentages of cases where one contestant performs sig-
niﬁcantly better than the other at a signiﬁcance level of 0.05 (0.01).
Table 8. BEDROC Scores (a5 20) Per Target for Global and
Target-Optimal Gap Penalties.
Average BEDROC
with global optimum
gap penalties (5, 1)
Average BEDROC
with optimum gap
penalties per target
ACE 0.4034 0.4081 (2, 1)
COX2 0.4011 0.4251 (11, 2)
DHFR 0.5654 0.5704 (9, 1)
FXA 0.3563 0.3676 (2, 1)
PPARc 0.2612 0.2612 (5, 1)
THR 0.4130 0.4165 (2, 1)
Global optimum gap penalties are gap open penalty 5 and gap extension
penalty 1. The best performing gap penalties per target are shown in
parentheses. Higher scores indicate better virtual screenings performance.
Figure 5. Canonical labels for (a) chlorpromazine with (b) PCA, (c)
Jochum and Gasteiger algorithm, (d) modiﬁed Jochum and Gasteiger
algorithm, (e) Weininger algorithm, (f) modiﬁed Weininger algo-
rithm, (g) Prabhakar algorithm, (h) modiﬁed Prabhakar algorithm,
(i) MVE with diffusion kernel and diffusion parameter 0.4, (j) MVE
with Euclidean distance kernel, (k) Laplacian Eigenmaps, and (l)
Isomap.
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nizable. The other methods tend to spread the labels in a non-
intuitive manner. To further assess the differences between can-
onization algorithms, we analyzed to which extent each method
is capable of preserving neighborhood relations during the
reduction of the two-dimensional graph of potential pharmaco-
phoric points to its one-dimensional form, the PhAST-sequence.
For each method, 264,220 neighborhood relations were checked.
The results are summarized in Table 9.
The large number of preserved neighborhoods with both var-
iants of the Prabhakar algorithm (original: 62%, modiﬁed: 66%)
is no surprise as both perform a depth-ﬁrst search with a com-
plex set of rules to decide which vertex is visited next. The crea-
tion of paths of consecutive canonical labels is inherent to this
approach. The modiﬁed version preserves even more neighbor-
hoods as the original algorithm, because it lacks the removal of
terminal atoms as initial steps. As a consequence, paths through
the molecule can include more atoms, and the fragments with
consecutive canonical labels may be elongated.
Both variants of the Jochum–Gasteiger algorithm preserve
least neighborhoods (original: 8%, modiﬁed: 9%). This is no
surprise as well, because originating from the most buried verti-
ces in the graph, they work in spheres around this centre. In this
approach, it cannot be anticipated that the resulting canonical
labels reﬂect neighborhoods to a high extent. If a vertex mi in a
sphere with ni vertices receives canonical label x, all adjacent
vertices from the next sphere of size nj will get assigned canoni-
cal labels that are bound between x 1 1 and x 1 (ni21) 1 nj.
But the algorithm does not guarantee that these canonical labels
will be directly subsequent to x or to each other. As with the
Prabhakar algorithm, the modiﬁed version preserves more neigh-
borhoods because of the fact that the terminal atoms were not
treated separately.
As the number of connected vertices is the main criterion
used for prioritization in the Weininger algorithm, it tends to
work its way from the outside to the inside of a molecule. The
initial equivalence classes are created based on further properties
regarding all atoms at once, not limited to a certain subset as the
vertices connected to the last labeled vertex as in the Prabhakar
algorithm or atoms with the same buriedness as the Jochum–Gas-
teiger method. So, it does not group atoms by their afﬁliation to
a certain region of the molecule but by the similarity of their
overall properties. Further on, the algorithm divides vertices from
the same equivalence class into unique subsets comprising only
one vertex, so this initial partition cannot be reversed. This
behavior is reﬂected in the low preservation of neighborhoods
with 9% for the original and 10% for the modiﬁed version.
All methods for dimensionality reduction only moderately
preserve the neighborhoods. For MVE (diffusion kernel: 30%,
Euclidean distance kernel: 31%), Isomap (40%), and Laplacian
Eigenmaps (49%), this was expected, as they were developed to
preserve local distances between neighboring points in datasets
as good as possible. They do not work in a greedy approach like
the depth-ﬁrst search used by the Prabhakar algorithm. By
preserving the distances between neighboring pairs, distances
between nonadjacent vertices may be changed. So, it was antici-
pated that the degree of preservation is lower than for the Prab-
hakar algorithm. For PCA (34%), however, this result is surpris-
ing. During PCA projection neighborhoods of vertices are not
regarded explicitly, and different parts of a molecule may col-
lapse in the same region of the PhAST-sequence, merging verti-
ces from different parts of a molecule in the process.
MVE with the diffusion kernel that performed best in the ret-
rospective comparison does not perform best in neighborhood
preservation. The Prabhakar algorithm, which in the modiﬁed
version preserves the most neighborhoods, does not perform best
in the retrospective comparison. Pearson’s correlation coefﬁcient
between the retrospective results using the best performing
alignment evaluation method S2, and the percentage of preserved
neighborhoods during the reduction of the two-dimensional
graph to a PhAST-sequence is 0.46. So, despite the fact that dif-
ferent approaches for graph canonization yield notably different
results in this analysis; the percentage of preserved neighbor-
hoods seems unsuited to explain why MVE performed best in
the retrospective comparison.
For each vertex pair in the two-dimensional graph of pharma-
cophoric points, we checked whether their corresponding sym-
bols are adjacent to each other in the PhAST-sequence. If not,
Table 9. Preserved Neighborhood Relations.
Algorithm
No. of preserved
neighborhoods
%
Preservation
Jochum Gasteiger 20,587 8
Jochum Gasteiger modiﬁed 22,801 9
Laplacian Eigenmaps 129,082 49
Isomap 105,152 40
MVE diffusion kernel 0.4 79,289 30
MVE Euclidean kernel 82,363 31
PCA 89,465 34
Prabhakar 163,691 62
Prabhakar modiﬁed 174,861 66
Weininger 24,734 9
Weininger modiﬁed 25,866 10
Figure 6. Number of inserted vertices between vertex pairs that are
neighbors in the molecule graph, but not the PhAST-sequence.
X-axis logarithmic to emphasize the interval in which the behavior
of the canonization algorithms diverges most.
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is presented in Figure 6, exact values are available from Table
S1 in the Supporting Information. Overall, all methods for
dimensionality reduction behave similarly. They separate neigh-
boring vertices in the graph more often by only one vertex in
the PhAST-sequence compared to the other canonization algo-
rithms. For separations consisting of more than ﬁve vertices,
they have the lowest count of occurrence among all methods. As
both variants of the Prabhakar algorithm have the highest neigh-
borhood preservation, their overall count of insertions between
neighboring vertices is the lowest. They perform a depth-ﬁrst
search, and only reaching a dead end in this search can cause an
event counted in this experiment. In case of these two algo-
rithms, the number of vertices inserted between neighboring ver-
tices gives the path length from a dead end in the depth-ﬁrst
search and the next unlabeled vertex.
The Jochum–Gasteiger algorithm works in spheres around
the most buried vertex. Vertices from the same sphere receive
consecutive labels. This explains why both variants of the algo-
rithm have a high number of insertions with less than 10
inserted vertices. Most molecules analyzed here do not possess
enough vertices to create spheres of more than 10 members, so
the count of insertions of this size is very low.
Both variants of the Weininger algorithm lead to a medium
number of insertions of sizes 1–7, but from thereon, they have
the highest count for insertions. MVE performs best in retro-
spective studies for our method. But as well as the percent of
preserved neighborhoods, the number of vertices inserted
between originally neighboring vertices in the graph during the
generation of the PhAST-sequence seems not to be suitable to
explain this good performance.
We have demonstrated that different approaches for graph
canonization show different behavior regarding the number of
vertices they insert between vertices in the PhAST-sequences
that were connected in the two-dimensional graph of pharmaco-
phoric points. MVE with diffusion kernel turned out to be the
best performing method in the retrospective comparison.
Robustness Against Structural Modiﬁcation
We tested the robustness of the compared canonization methods
by comparing the PhAST-sequence generated from a molecule
with that generated from a molecule similar to the original but
with a slight structural modiﬁcation. For each pair of neighbor-
ing vertices in the original sequence, we checked whether they
remain adjacent in the modiﬁed PhAST-sequence and whether
they changed their relative orientation. We used six fragments
for chemical structure modiﬁcation (see Fig. 1) that were
attached individually and in pairs. Each original PhAST-
sequence was compared with 135 variants, 6699 molecules from
the COBRA molecule library were investigated that way. The
results are presented in Table 10.
Both variants of the Jochum–Gasteiger algorithm preserve
around 40% of the neighborhoods from the original PhAST-
sequence in the modiﬁed variants. Nearly all of these preserved
relationships are kept in the original orientation, only a small
amount of transversions is generated (original: 0.65%, modiﬁed:
1.17%). Nonpreserved neighborhoods are kept mostly in the
original orientation as well (original:  45%, modiﬁed:  46%),
enabling the global sequence alignment to compensate these
changes by inserting gaps. Only around 12% of all neighborhood
relations are not kept and transversed at the same time.
All methods for nonlinear dimensionality reduction keep
more neighborhood relations but introduce transversions at the
same time to a higher extent, foremost MVE in combination
with the diffusion kernel with over 22% transversions. In case
of disrupted neighborhoods, the fraction of created transversions
is as high as for the Jochum–Gasteiger algorithm or even higher.
The aim of these algorithms for nonlinear dimensionality
reduction is to keep pairwise distances between neighboring
points while embedding a set of data points in a lower-dimen-
sional space. So, they only consider relationships between pairs
of points. Distances between two points are kept even if these
points switch coordinates. So, these methods introduce a high
amount of transversions, because this is a valid operation in their
functioning. PCA preserves the least neighborhoods from the
Table 10. Percentages of Neighborhood Relations Preserved and Changed Between PhAST-Sequences When
Modifying a Molecule by Attaching Fragments.
%
Preserved
% Preserved
original
orientation
% Preserved
transversed
orientation % Changed
% Changed
original
orientation
% Changed
transversed
orientation
Jochum Gasteiger 43.41 42.76 0.65 56.59 44.64 11.95
Jochum Gasteiger modiﬁed 40.65 39.47 1.17 59.35 46.43 12.93
Laplacian Eigenmaps 69.86 53.61 16.24 30.14 23.99 23.99
Isomap 64.63 43.25 21.38 35.37 24.55 10.82
MVE diffusion kernel 0.4 65.52 42.70 22.82 34.48 22.84 11.64
MVE Euclidean kernel 53.62 36.54 17.07 46.38 29.47 16.91
PCA 38.42 29.46 8.96 61.58 44.61 16.97
Prabhakar 75.60 72.76 2.84 24.40 19.25 5.15
Prabhakar modiﬁed 81.54 77.81 3.74 18.46 14.24 4.22
Weininger 62.03 62.01 0.01 37.97 36.75 1.22
Weininger modiﬁed 56.18 55.21 0.97 43.82 40.31 3.51
For both cases, the percentage of neighborhood relations in original orientation and in transversed orientation is
shown in addition.
2823 Pharmacophore Alignment Search Tool
Journal of Computational Chemistry DOI 10.1002/jccoriginal to the modiﬁed PhAST-sequence, but most of them in
original orientation, not as transversions. It introduces transver-
sions in the disrupted neighborhoods to an extent comparable to
the nonlinear methods for dimensionality reduction.
Both variants of the Weininger algorithm introduce the
lowest fraction of transversions (original version: 1%, modiﬁed
version: 4%). Neighborhood preservation is well above the
Jochum–Gasteiger method.
Preservation of neighborhoods between related PhAST-
sequences is highest for both variants of the Prabhakar algorithm
(original version 76%, modiﬁed version 82%). This indicates
that paths in the original and altered molecules are very similar.
This is in perfect agreement with the low-transversion rate in
preserved (3% and 5%) and nonpreserved neighborhoods (4%
and 4%).
The correlation between retrospective results using the best
performing alignment evaluation method S2 and (i) the percent-
age of preserved neighborhoods is 0.57, (ii) the percentage of
kept but transversed neighborhoods is 0.65, and (iii) the percent-
age of neighborhoods that are disrupted and transversed is 0.09.
This indicates that transversions do not affect performance as
drastically as we expected. The sequence alignment uses only
mutations and insertions/deletions; a transversion can, thus, be
treated by two mismatches or a combination of gap and mis-
match. This explanation is backed up by (iii). None of the corre-
lations is sufﬁciently strong to qualify the corresponding prop-
erty as necessary for ‘‘good’’ retrospective results. However,
when both variants of the Prabhakar algorithm are omitted as
outliers, the correlation (i) increases to 0.93. We interpret this
observation as an indication that the Prabhakar algorithm differs
from the other canonization approaches (omitting other algo-
rithms does not increase correlation as much: without the Joc-
hum–Gasteiger algorithms: 0.39, without the Weininger algo-
rithms: 0.57, and without the methods for nonlinear dimensional-
ity reduction: 0.65). Indeed, there is such a difference: The
subset of vertices from which the next vertex is chosen is the
smallest of all approaches because of the depth-ﬁrst like canoni-
zation process of the Prabhakar algorithm. The number of candi-
dates is four or even less in most cases because of the distribu-
tion of vertex degrees in molecular graphs.
31 The Jochum–Gas-
teiger algorithm limits the number of candidates by the size of
the current sphere, which is potentially larger than four levels.
For the Weininger algorithm, the limit is given by the number
of vertices with the same properties, which typically exceeds
four as well. For the dimensionality reduction methods, the next
vertex can potentially be chosen from all remaining vertices.
Until this point, we have combined the results for single and
pairwise modiﬁcations of molecules. Treating both cases sepa-
rately does not dramatically change the picture (Tables S3 and
S4 of the Supporting Information). Both the Jochum–Gasteiger
and the Weininger algorithms introduce the fewest transversions.
Both versions of the Prabhakar algorithm preserve neighbor-
hoods best, followed closely by the methods for nonlinear
dimensionality reduction that preserve most neighborhood rela-
tions but not in the original orientation. PCA preserves neighbor-
hoods least but does not introduce as many transversions as the
nonlinear methods. Calculating Pearson’s correlation coefﬁcient
between the retrospective evaluation scores and the percentage
of neighborhoods kept in original orientation, kept in transversed
orientation, and neighborhoods changed and transversed at the
same time reveals in both cases a slightly different relationship
as the combined evaluation. Using only the results of single
(double) modiﬁcations, the correlation coefﬁcient between retro-
spective performance and percentage of neighborhoods pre-
served is 0.57 (0.57). In case of transversed neighborhoods, the
correlation coefﬁcient is 0.64 (0.66). The major difference to the
combined case is the relationship between retrospective perform-
ance and percentage neighborhoods changed and transversed,
which correlates with 20.24 (20.27).
In summary, transversions in the PhAST sequences of similar
molecules do not affect the performance to a great extent. None
of the investigated properties correlate strongly with retrospec-
tive virtual screening performance.
Canonization Time
Computational efﬁciency is important for rapid virtual screening.
We compared our implementation of the canonization algorithms
with respect to the time needed to process the COBRA library
on a single central processing unit (CPU) of our cluster, atom
typing excluded (Table 11). With only  2 s for all 8311 mole-
cules, PCA was fastest. Both variants of the Weininger algo-
rithm are fast with a time requirement of about 4 s. The
Jochum–Gasteiger algorithm and all methods for nonlinear
Table 11. Time (Seconds) to Canonize the COBRA Library (Version 6.1, n 5 8,311) on a Single CPU.
Total Mean Max Min r
Jochum Gasteiger 95.61 0.01150 2.93918 0.00007 0.07857
Jochum Gasteiger modiﬁed 116.65 0.01404 2.85762 0.00009 0.08386
Laplacian Eigenmaps 21.48 0.00258 0.08001 0.00019 0.00327
Isomap 20.32 0.00245 0.07376 0.00017 0.00320
MVE diffusion kernel 0.4 9639.19 1.15981 96.29566 0.08336 2.72437
MVE Euclidean kernel 10045.93 1.20875 101.30420 0.09399 2.86952
PCA 2.02 0.00024 0.03797 0.00013 0.00073
Prabhakar 35904.97 4.32017 3159.95603 0.00005 66.66446
Prabhakar modiﬁed 135843.44 16.34502 23524.26899 0.00005 402.00449
Weininger 4.46 0.00054 0.01046 0.00006 0.00048
Weininger modiﬁed 4.51 0.00054 0.07926 0.00006 0.00098
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For a prospective application, the Prabhakar algorithm might be
too slow. For a medium-sized screening library with 0.5 3 10
6
compounds, canonization with this algorithm would take 25
days for the original and 95 days for the modiﬁed version (not
including atom-typing). MVE with the diffusion kernel (best ret-
rospective performance) would need  7 days.
Conclusions and Outline
The canonization algorithm inﬂuences the performance of
PhAST in virtual screening, although to a minor extent. None of
the investigated properties of canonization algorithms seems use-
ful as an a priori indicator of retrospective virtual screening per-
formance by PhAST. The best retrospective performance was
achieved using MVE with the diffusion kernel (b 5 0.4), gap
open penalty 5 5, and gap extension penalty 5 1. Different ker-
nel functions vary MVE performance only slightly. Future work
could investigate alternative canonization approaches based on
the molecular graph
32 or MVE using other kernels like p-step
random walks
33 to further improve performance. Kernels operat-
ing on the graph topology (as opposed to spatial vertex coordi-
nates) have the advantage of being independent from the used
layout/conformation algorithm. We used covalent bonds to
deﬁne atom neighborhoods. In the original applications of these
algorithms, neighborhoods were deﬁned by connectivity algo-
rithms like k-nearest neighbors,
22 b-matching,
23 or e-balls. Using
these instead of covalent bonds would render PhAST-sequences
independent from the original connectivity, possibly increasing
the chance for scaffold-hopping. The recently developed struc-
ture preserving embedding method by Shaw and Jebara
34 pre-
serves global connectivity and might be a promising candidate
for further investigation. This technique already showed good
results in embedding 3D structures into two dimensions.
34
MVE inserts many transversions into PhAST-sequences of
similar molecules. Global sequence alignment can treat these
only by mutations and insertions/deletions, and thus might not
be the best metric in this situation. Other string metrics such as
the Damerau–Levenshtein-distance
35 that are capable of using
transversions as well as mutations and insertions/deletions might
be promising alternatives, not only for PhAST but also for other
string representations like SMILES.
Our study demonstrated that the alignment evaluation method
inﬂuences performance more than the canonization algorithm.
For all canonization methods, the alignment evaluation by align-
ment score yielded better results than the sequence identity cal-
culated from the alignment. This has also been observed by
studies on the alignment of protein sequences
8; there, signiﬁ-
cance-based methods perform even better than the actual align-
ment score. Some techniques originally developed for local
alignments seem promising for global alignments also.
36–38 A
ﬁrst simple step in this direction could be the use of Z-scores.
1,39
Until recently, one had to create a population of alignment
scores by shufﬂing and realigning the originally compared
sequences to estimate mean and standard deviation of alignment
scores from alignments of random sequences. Booth et al.
showed that it is possible (for the ungapped case) to calculate
mean and standard deviation efﬁciently, avoiding the time-con-
suming realignment step.
40
An important parameter of PhAST that was not changed in
our study is the score matrix used to score matches and mis-
matches in the alignments. It directly inﬂuences the alignments,
and thus the similarity score as well. The systematic develop-
ment of a new score matrix that no longer depends on chemical
intuition alone will be the subject of our future studies. Krier
and Hutter
41 recently proposed a process for building a scoring
scheme based on aligning SMILES of molecular fragments.
Their score matrix reﬂects the frequencies of chemical replace-
ments in pharmaceutical substances. For PhAST, a similar
approach might be possible based on pharmacophoric points,
resulting in a score matrix close to the original concept of Dayh-
off et al.
42 Modiﬁcation of the pharmacophoric points is another
option, one should address at the same time.
With the alignment score as a measure for the evaluation of
global alignments (instead of percent identity) the weighting of
the inﬂuence of certain pharmacophoric points seems reasonable.
These points could represent interactions that are necessary for
binding. By upweighting the match and mismatch scores of im-
portant pharmacophoric points, one could force isofunctional
points to be matched. If no such points exist, key interactions
are missing resulting in a low score. Incorporating domain
knowledge in this way could further improve the performance of
PhAST.
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Figure S1 a-f BEDROC (!=20) scores for combinations of alignment evaluation methods 
and gap penalties for Minimum Volume Embedding with different settings for the diffusion 
parameter ". a) " = 0.01, b) " = 0.1, c) " = 0.2, d) " = 0.3, e) " = 0.4, f) " = 0.5. 
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Figure S1 g-l BEDROC (!=20) scores for combinations of alignment evaluation methods 
and gap penalties for Minimum Volume Embedding with different settings for the diffusion 
parameter ". g) " = 0.6, h) " = 0.7, i) " = 0.8, j) " = 0.9, k) " = 1.0, l) " = 10. 
 
 
 
 
 
 
 
 Table S2 Number of inserted vertices between vertex pairs neighbored in the molecular 
graph but not in the PhAST-sequence (COBRA library, n=8,311).  The highest number of 
inserted vertices observed was 110. JG (m) = Jochum and Gasteiger algorithm (modified), LE 
= Laplacian Eigenmaps, Iso = Isomap, MVE (D 0.4) [E] = Minimum Volume Embedding 
(diffusion kernel with diffusion parameter 0.4) [euclidean distance kernel], PCA = principal 
component analysis, P (m) = Prabhakar algorithm (modified), W (m) = Weininger algorithm 
(modified). 
 
No. 
Inserted 
Vertices 
JG  JGm  LE  Iso  MVE D 
0.4  MVE E  PCA  P  Pm  W  Wm 
1  33368  35263  89758  92706  84852  98122  90823  3000  453  26429  27637 
2  49765  44516  25799  39531  52831  49390  44994  3542  2463  16662  18500 
3  51027  43826  9996  15597  28625  22973  23575  5697  3934  17894  19349 
4  41708  38830  4236  6390  11451  7835  10105  16258  13478  13439  14756 
5  27821  29045  2206  2606  4557  2549  3500  4237  2729  13821  14510 
6  17127  20340  1316  1211  1705  746  1265  5500  4706  12159  12575 
7  9484  12578  872  521  561  193  365  4157  3373  11835  12486 
8  5126  7505  439  228  203  37  90  3890  3656  10228  11123 
9  2658  4159  224  142  91  8  33  3626  3506  9436  10403 
10  1597  2484  141  71  36  4  4  3645  3635  8127  9548 
11  958  1176  68  38  9  0  1  3316  3278  7488  9571 
12  580  727  34  10  6  0  0  3284  3220  6506  8548 
13  344  386  25  6  2  0  0  2943  3016  6041  7521 
14  312  241  13  2  0  0  0  2981  3010  5540  6473 
15  241  116  5  1  2  0  0  2755  2734  5526  6072 
16  181  88  0  3  0  0  0  2587  2615  5182  5237 
17  155  43  3  3  0  0  0  2524  2713  5372  5066 
18  110  31  1  1  0  0  0  2366  2551  4902  4565 
19  130  18  0  1  0  0  0  2186  2298  4796  4075 
20  92  13  0  0  0  0  0  2020  2115  4477  3728 
21  113  11  1  0  0  0  0  1951  2045  4254  3344 
22  94  7  1  0  0  0  0  1822  1800  3958  3071 
23  87  3  0  0  0  0  0  1625  1650  3530  2576 
24  62  4  0  0  0  0  0  1565  1572  3342  2182 
25  80  5  0  0  0  0  0  1430  1416  3059  2010 
26  43  4  0  0  0  0  0  1349  1229  2740  1723 
27  64  0  0  0  0  0  0  1181  1199  2562  1537 
28  37  0  0  0  0  0  0  1079  1087  2178  1386 
29  46  0  0  0  0  0  0  1012  965  2257  1205 
30  29  0  0  0  0  0  0  852  873  1763  973 
31  28  0  0  0  0  0  0  724  723  1630  863 
32  23  0  0  0  0  0  0  668  688  1511  808 
33  21  0  0  0  0  0  0  588  558  1389  718 
34  14  0  0  0  0  0  0  570  530  1122  587 
35  14  0  0  0  0  0  0  476  474  1108  388 
36  7  0  0  0  0  0  0  399  409  884  348 
37  14  0  0  0  0  0  0  403  286  801  352 
38  4  0  0  0  0  0  0  280  272  694  289 
39  8  0  0  0  0  0  0  255  284  564  234 
40  4  0  0  0  0  0  0  220  214  466  151 
41  9  0  0  0  0  0  0  164  169  417  223 
42  9  0  0  0  0  0  0  142  172  331  170 
43  8  0  0  0  0  0  0  155  138  372  161 
44  13  0  0  0  0  0  0  87  143  232  153 No. 
Inserted 
Vertices 
JG  JGm  LE  Iso  MVE D 
0.4 
MVE E  PCA  P  Pm  W  Wm 
45  0  0  0  0  0  0  0  111  106  240  129 
46  2  0  0  0  0  0  0  75  82  197  125 
47  2  0  0  0  0  0  0  86  80  228  57 
48  3  0  0  0  0  0  0  55  62  165  51 
49  1  0  0  0  0  0  0  75  58  143  68 
50  3  0  0  0  0  0  0  49  49  141  43 
51  3  0  0  0  0  0  0  51  40  93  34 
52  0  0  0  0  0  0  0  41  45  72  41 
53  0  0  0  0  0  0  0  52  55  74  60 
54  1  0  0  0  0  0  0  44  30  62  22 
55  1  0  0  0  0  0  0  38  39  83  16 
56  0  0  0  0  0  0  0  26  32  82  27 
57  0  0  0  0  0  0  0  28  34  40  28 
58  0  0  0  0  0  0  0  16  27  75  30 
59  0  0  0  0  0  0  0  22  21  68  14 
60  0  0  0  0  0  0  0  23  30  75  29 
61  0  0  0  0  0  0  0  18  19  46  39 
62  0  0  0  0  0  0  0  13  20  36  24 
63  0  0  0  0  0  0  0  18  9  39  25 
64  0  0  0  0  0  0  0  19  12  14  16 
65  1  0  0  0  0  0  0  14  16  45  26 
66  0  0  0  0  0  0  0  22  14  33  16 
67  0  0  0  0  0  0  0  11  14  20  25 
68  0  0  0  0  0  0  0  11  10  76  35 
69  0  0  0  0  0  0  0  10  10  41  19 
70  0  0  0  0  0  0  0  12  8  14  12 
71  0  0  0  0  0  0  0  7  3  11  39 
72  0  0  0  0  0  0  0  12  5  10  10 
73  0  0  0  0  0  0  0  7  2  7  11 
74  0  0  0  0  0  0  0  6  3  17  2 
75  0  0  0  0  0  0  0  2  2  32  11 
76  0  0  0  0  0  0  0  1  7  28  4 
77  0  0  0  0  0  0  0  4  7  19  35 
78  0  0  0  0  0  0  0  3  3  12  0 
79  0  0  0  0  0  0  0  3  1  30  0 
80  0  0  0  0  0  0  0  3  5  1  0 
81  0  0  0  0  0  0  0  4  2  0  1 
82  0  0  0  0  0  0  0  4  1  9  0 
83  0  0  0  0  0  0  0  1  2  0  0 
84  0  0  0  0  0  0  0  1  3  1  0 
85  0  0  0  0  0  0  0  2  3  4  0 
86  0  0  0  0  0  0  0  1  0  5  0 
87  0  0  0  0  0  0  0  1  0  23  0 
88  0  0  0  0  0  0  0  1  1  8  0 
89  0  0  0  0  0  0  0  1  0  1  0 
90  1  0  0  0  0  0  0  1  0  2  0 
91  0  0  0  0  0  0  0  0  2  0  0 
92  0  0  0  0  0  0  0  1  0  0  0 
93  0  0  0  0  0  0  0  0  1  1  9 
94  0  0  0  0  0  0  0  2  0  4  4 
95  0  0  0  0  0  0  0  0  0  0  0 
96  0  0  0  0  0  0  0  1  1  0  13 No. 
Inserted 
Vertices 
JG  JGm  LE  Iso  MVE D 
0.4 
MVE E  PCA  P  Pm  W  Wm 
97  0  0  0  0  0  0  0  0  0  0  4 
98  0  0  0  0  0  0  0  2  0  0  0 
99  0  0  0  0  0  0  0  1  0  5  1 
100  0  0  0  0  0  0  0  1  0  0  3 
101  0  0  0  0  0  0  0  0  0  0  0 
102  0  0  0  0  0  0  0  1  2  2  0 
103  0  0  0  0  0  0  0  0  0  3  1 
104  0  0  0  0  0  0  0  1  0  12  0 
105  0  0  0  0  0  0  0  0  0  11  0 
106  0  0  0  0  0  0  0  1  2  0  0 
107  0  0  0  0  0  0  0  0  0  1  0 
108  0  0  0  0  0  0  0  1  0  0  0 
109  0  0  0  0  0  0  0  0  0  1  0 
110  0  0  0  0  0  0  0  1  0  0  0 
 Table S3 Percentages of neighborhood relations preserved and changed between PhAST-
sequences  when  modifying  a  molecule  by  attaching  one  fragment.  For  both  cases,  the 
percentage of neighborhood relations in original orientation and in transversed orientation is 
shown in addition. 
 
 
% 
preserved 
% 
preserved 
original 
Orientation 
% 
preserved 
transversed 
orientation 
% 
changed 
% 
changed 
original 
orientation 
% 
changed 
transversed 
orientation 
Jochum 
Gasteiger  53.18  52.67  0.51  46.82  37.32  9.50 
Jochum 
Gasteiger 
modified 
51.04  50.06  0.98  48.96  38.67  10.29 
Laplacian 
Eigenmaps  74.78  57.57  17.21  25.22  20.11  5.11 
Isomap  70.34  46.14  24.20  29.66  20.57  9.08 
MVE diffusion 
kernel 0.4  70.67  44.66  26.01  29.33  19.25  10.08 
MVE euclidean 
kernel  57.73  38.73  19.00  42.27  26.71  15.55 
PCA  44.28  33.89  10.39  55.72  40.16  15.56 
Prabhakar  78.84  76.73  2.11  21.16  16.82  4.35 
Prabhakar 
modified  85.14  82.06  3.08  14.86  11.48  3.37 
Weininger  71.31  71.30  0.01  28.69  27.98  0.72 
Weininger 
modified  67.50  66.76  0.74  32.50  0.74  2.20 
 
 Table S4 Percentages of neighborhood relations preserved and changed between PhAST-
sequences  when  modifying  a  molecule  by  attaching  two  fragments.  For  both  cases,  the 
percentage of neighborhood relations in original orientation and in transversed orientation is 
shown in addition. 
 
 
% 
preserved 
% 
preserved 
original 
Orientation 
% 
preserved 
transversed 
orientation 
% 
changed 
% 
changed 
original 
orientation 
% 
changed 
transversed 
orientation 
Jochum 
Gasteiger  40.62  39.93  0.69  59.38  46.73  12.65 
Jochum 
Gasteiger 
modified 
37.68  36.45  1.23  62.32  48.64  13.68 
Laplacian 
Eigenmaps  68.45  52.48  15.97  31.55  25.10  6.45 
Isomap  62.99  42.43  20.57  37.01  25.69  11.32 
MVE diffusion 
kernel 0.4  64.04  42.14  21.91  35.96  23.86  12.09 
MVE euclidean 
kernel  52.44  35.92  16.52  47.56  30.26  17.30 
PCA  36.75  28.19  8.56  63.25  45.88  17.37 
Prabhakar  74.67  71.62  3.05  25.33  19.95  5.38 
Prabhakar 
modified  80.51  76.59  3.92  19.49  15.03  4.46 
Weininger  59.38  59.36  0.02  40.62  39.25  1.37 
Weininger 
modified  52.95  51.92  1.03  47.05  43.17  3.89 
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ABSTRACT 
 
Previously (Hähnke et al., J Comput Chem 2010, 31, 2810) we introduced the concept of non-
linear  dimensionality  reduction  for  canonization  of  two-dimensional  layouts  of  molecular 
graphs as foundation for text-based similarity searching using our Pharmacophore Alignment 
Search Tool (PhAST), a ligand-based virtual screening method. Here we apply these methods 
to three-dimensional molecular conformations and investigate the impact of these additional 
degrees  of  freedom  on  virtual  screening  performance  and  assess  differences  in  ranking 
behavior. Best-performing variants of PhAST are compared to 16 state-of-the-art screening 
methods with respect to significance estimates for differences in screening performance. We 
show that PhAST sorts new chemotypes on early ranks without sacrificing overall screening 
performance. We succeeded in combining PhAST with other virtual screening techniques by 
rank-based  data  fusion,  significantly  improving  screening  capabilities.  We  also  present  a 
parameterization  of  double  dynamic  programming  for  the  problem  of  small  molecule 
comparison,  which  allows  for  the  calculation  of  structural  similarity  between  compounds 
based on one-dimensional representations, opening the door to a holistic approach to molecule 
comparison based on textual representations. 
 
 
KEYWORDS 
 
Double dynamic programming; Global alignment; Line notation; Molecular graph; Similarity; 
Virtual screening 
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INTRODUCTION 
 
The Pharmacophore Alignment Search Tool (PhAST) is a string-based approach to virtual 
screening  utilizing  topological  molecule  information.
1,2  It  reduces  each  molecule  to  an 
unambiguous linear representation describing its pharmacophore in three steps: i) each non-
hydrogen atom in the structure graph is replaced by a potential pharmacophoric point symbol 
and hydrogen atoms are removed, ii) vertices of this pharmacophoric feature graph receive 
canonic labels, and iii) vertex symbols are concatenated as a string according to their canonic 
labels. For virtual screening, both the screening compound collection (‘library’) and the query 
molecules are converted, and the resulting PhAST-sequences are compared using pairwise 
global sequence alignment.
3 Molecular similarity is calculated as the ratio of the alignment 
score and the alignment length for the retrieval of pharmacophorically similar molecules from 
the compound library. 
Previously,
2  we  introduced  the  concept  of  canonizing  molecular  graphs  with 
dimensionality  reduction  algorithms.  In  retrospective  experiments  we  identified  minimum 
volume embedding
4 employing a combination of diffusion kernel
5 with diffusion parameter 
0.4 and covalent connectivity between potential pharmacophoric points as the best-performing 
canonization algorithm for the application to two-dimensional (2D) molecular graphs. Here, 
we  expand  this  concept  by  applying  canonization  algorithms  to  three-dimensional  (3D) 
conformations. In addition, we investigate new algorithms for dimensionality reduction in 
combination with connectivity algorithms defining the edges of the graph created in step (i) of 
PhAST. The canonization algorithm that performs best for single conformations is evaluated 
with regard to the impact of multiple conformations on screening performance. In contrast to 
our previous studies,
2 we did not perform an optimization of gap penalties for each algorithm 
but used fixed preferred penalty combinations. 
  All canonization algorithms and screening methods are evaluated using the COBRA 
collection  of  drugs  and  lead  compounds.
6  For  statistical  evaluation  we  use  Boltzmann-
enhanced discrimination of receiver operating characteristic (BEDROC) scores (! = 20),
 7 a 
paired  permutation  test  for  significance  assessment,
8  and  Kendall’s  "  as  rank  correlation 
coefficient.
9 Differences in PhAST-sequences generated by the same canonization algorithm 
from two-dimensional layouts and three-dimensional conformations of the same molecule are 
quantified by calculating their Levenshtein
10 and Damerau-Levenshtein distances.
11 
  Information about the spatial arrangement of pharmacophoric points deduced  from 
three-dimensional conformations can be used in the sequence comparison step of PhAST as 
well. For this purpose we parameterized double dynamic programming,
12 which – to the best 
of  our  knowledge  –  until  now  has  only  been  used  for  the  calculation  of  global  pairwise 
sequence alignments based on structural residue-equivalence of protein sequences. 
  The  main  objectives  of  this  study  were  to  i)  assess  the  screening  performance  of 
PhAST  with  different  canonization  algorithms  applied  to  2D  molecular  layouts  and  3D 
conformations, ii) quantify the impact of conformer structure on screening performance, iii) 
investigate the effect of multiple conformations per molecule, iv) assess the novelty of PhAST 
compared to established 2D and 3D virtual screening techniques, and v) investigate the effect 
of using structural information for sequence comparison in PhAST through double dynamic 
programming. 
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METHODS 
 
Canonization 
 
The atom-typing step of PhAST yields a graph of potential pharmacophoric points. It has the 
same topology as the original molecular graph without hydrogen atoms yielding a total of n 
vertices. Each vertex is colored with a symbol corresponding to one out of nine potential 
pharmacophoric features. Edges correspond to covalent bonds. Canonization is the labeling of 
the vertices with the natural numbers 1,2,3,… ,n. The algorithms compared in this work are 
described  in  detail  in  the  supplemental  material.  Short  descriptions  are  presented  in  the 
following paragraph. 
Centroid linearization prioritizes vertices by their distance to the geometric centre of a 
molecule. Performing principal component analysis
13 (PCA) on vertex coordinates yields the 
first principal component as a one-dimensional coordinate system. Deterministic non-linear 
methods  for  dimensionality  reduction  applied  to  2D  layouts  and  3D  conformations  of 
molecules are Laplacian eigenmaps,
14 Isomap
15 and minimum volume embedding
4 (MVE). 
The latter employs a kernel function. Kernels evaluated in this work are a diffusion kernel
5,16 
(DK), a p-step random walk kernel (PRW),
17 a method for calculating inner products from 
Euclidean coordinates
2 (referred to as ‘Euclidean distance kernel’ (EDK)) and a Gaussian 
radial  basis  function  kernel  (RBF).
18  All  non-linear  methods  rely  on  neighborhood 
relationships between vertices. As connectivity algorithms used for neighborhood assignment 
we evaluated covalent bonds (cov) and k nearest neighbors (kNN).
19 Proximity embedding 
was compared to the deterministic embedding algorithms in a stochastic variant
20 (SPE) and 
based  on  canonical  indices  pre-calculated  with  MVE  (MVEPE).  These  algorithms  were 
compared amongst each other and to results obtained with algorithms that are independent 
from layouts and conformations of molecular structures. These are the Jochum-Gasteiger,
21 
Weininger,
22 and Prabhakar algorithm
23 implemented as described previously.
2 
 
 
Sequence Alignment 
 
Sequence alignment is used in bioinformatics to decide how related two sequences (DNA, 
RNA, amino acid sequences) are. To create the alignment of two sequences X = x1x2…xn and 
Y = y1y2…ym, their symbols are matched. Thereby the symbol order is retained and gaps may 
be inserted to improve the matching (insertion of paired gaps is forbidden). Three cases exist: 
(i) xi is aligned to yj and xi  = yj (match), (ii) xi is aligned to yj and xi ! yj (mismatch), (iii) xi is 
aligned to a gap in Y, or yj is aligned to a gap in X. In protein sequence alignment, matches 
represent conserved residues; mismatches may arise from mutations, and gaps from insertions 
or deletions in an assumed evolutionary process of the compared sequences. Consequently, 
matches are rewarded with a positive score, mismatches are -- depending on the specific case 
-- either rewarded with a positive score or penalized with a negative score, and gaps are 
always penalized with a negative score. The optimal alignment is the one with the highest 
score (summed over the whole alignment). It can be computed using dynamic programming.
24 
Instead  of  the  original  Needleman-Wunsch
24  algorithm  we  employed  a  faster  method 
described in Durbin et al..
3 It can be derived from a simple finite state machine and therefore 
will  be  referred  to  as  ‘FSM  algorithm’.  We  could  show  that  it runs  60%  faster  than  the 
Needleman-Wunsch algorithm and the calculated alignments are nearly identical.
2 
Gap Penalties. Previously,
1,2 we optimized gap penalties in a grid search with 190 
penalty  combinations.  Here  all  retrospective  screenings  were  carried  out  with  only  one 
combination: Gap open penalty = -5 and gap extension penalty = -1. This decision was made 
based  on  earlier  findings.
2  Of  all  gap  open  penalties  of  best-performing  combinations 
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Hähnke et al.     5  
involving the alignment score for alignment evaluation, -5 is the median value of the three 
values with the highest frequency and so it is least extreme. Gap extension penalty -1 (-2) [-3] 
occurs with a frequency of 70% (27%) [3%]. As differences in retrospective performance 
between  top-performing  combinations  are  marginal  when  other  parameters  remain 
unchanged,  the  combination  we  chose  is  an  educated  guess  with  minor  sacrifice  in 
performance if wrong. 
  Alignment  Evaluation.  In  previous  studies
2  we  identified  the  alignment  score 
normalized to the alignment length to be the best performing alignment evaluation method so 
far. For this reason we only considered this evaluation method for comparison of PhAST 
screening performance with different canonization algorithms. 
 
 
Library Preparation 
 
We used the COBRA library of reference compounds
6 as screening library (version 6.1, 8311 
compounds). Each compound was protonated using the ‘wash’ function of MOE (Molecular 
Operating Environment, v2010.06, Chemical Computing Group Inc., Montreal, Canada). 2D 
layouts were created for each compound using the ‘depict’ algorithm of MOE. Single 3D 
conformations were created for each compound using CORINA (v3.46, Molecular Networks 
GmbH,  Erlangen,  Germany)  invoking  the  ‘canon’  option.  Ten  3D  conformations  were 
generated for each compound using our stochastic conformer generator SOCGER.
25 
  The only publicly available dataset compiled specifically for the evaluation of ligand-
based virtual screening methods is the ‘maximum unbiased validation’ (MUV) dataset.
26 It 
was shown that many methods fail in achieving any significant enrichment for most of the 
targets present in MUV.
27 MUV therefore disqualified as a reference dataset for retrospective 
comparisons of PhAST with other methods. The ‘directory of useful decoys’ (DUD) contains 
actives  and  decoys  for  40  targets.
28  DUD  was  especially  designed  for  the  evaluation  of 
docking methods. In an attempt to remove analogue bias in the sets of active molecules, only 
actives  were  filtered  according  to  certain  criteria,  causing  some  artificial  enrichment.
29 A  
second approach processed both, active and decoy  compounds,
30 but still, a high ratio of 
actives to decoys renders it unfavorable for virtual screening.
7 In addition, DUD targets are 
limited to structurally resolved proteins, and for example GPCRs are excluded. So we relied 
on our own collection of bioactive reference compounds (COBRA)
6. COBRA exhibits the 
same degree of scaffold diversity as trade drugs (1.7 compounds per graph scaffold) and may 
thus be considered as a druglike compound set also from a structural perspective. Both MUV 
(3.8)  and  DUD  (6.3)  contain  more  compounds  per  scaffold  on  average.  Scaffolds  were 
determined as graph frameworks defined by Bemis and Murcko.
31,32 
 
 
Screening Protocol 1 
 
PhAST in combination with each canonization algorithm was used in a series of retrospective 
screenings. For each target (Table 1) each active was used once as query, resulting in 689 
screenings. Each screening run was evaluated with the Boltzmann-enhanced discrimination of 
receiver operating characteristic (BEDROC) metric.
7 BEDROC scores were calculated with ! 
= 20, the suggested default value for evaluation.
7 We first evaluated screening performance 
for  each  target  by  averaging  the  corresponding  BEDROC  scores.  Final  retrospective 
performance is expressed as the mean of these averages. We used the mean of averages to 
give equal weight to each target although the COBRA library contains unequal numbers of 
actives for different targets. Each canonization algorithm described in the Methods section 
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Hähnke et al.     6  
was tested on 2D graph layouts. Except for MVE DK and MVE PRW all versions were 
evaluated on single 3D conformations as well. 
To assess whether differences in screening performance are significant we employed a 
paired  permutation  test
8  that  was  recently  found  to  be  the  most  powerful  available 
significance test for this purpose.
33 It has the null hypothesis that virtual screening method P 
performs  significantly  better  than  method  Q.  Assuming  p  and  q  are  rank  lists  of  actives 
resulting from the virtual screening methods, the null hypothesis requires that BEDROC(p) > 
BEDROC(q). As each active has two ranks, one in p and one in q, new rank lists p* and q* 
can be created by swapping ranks in p with corresponding ranks in q for each active with a 
probability  of  50%.  This  was  repeated  10,000  times  and  the  frequency  of  the  event  that 
BEDROC(p) – BEDROC(q) is less than BEDROC(p*) – BEDROC(q*) is the type I error rate 
for the null hypothesis used as p-value for significance estimation. As significance levels we 
used 0.05 and 0.01. 
 
 
Assessment of Novelty 
 
Each  canonization  algorithm  based  on  Euclidean  coordinates  of  vertices was  used  on  2D 
layouts of molecular graphs and on 3D single conformations of the complete COBRA library. 
Besides  the  retrospective  screening  performance  we  assessed  differences  between 
canonization  algorithms  in  two  and  three  dimensions  based  on  differences  in  compound 
rankings and PhAST-sequences. 
  Ranking  Differences:  Screening  protocol  1  yielded  689  ranked  lists  for  each 
canonization algorithm. Rankings of actives were compared using Kendall’s rank correlation 
coefficient.
9 Before calculating Kendall’s ", ranked lists resulting from a virtual screening 
were reduced by eliminating all inactive compounds, yielding a ranking only of actives. These 
reduced lists were used to calculate "b that corrects for ties. We first calculated the average 
rank correlation per target and used the mean of these averages as final measure to express 
how similar PhAST ranks actives with two different canonization algorithms to give equal 
weight to each target although the COBRA library contains unequal numbers of actives for 
different targets.  
  Sequence Differences. Applying each canonization method on a 2D layout and a 3D 
conformation of the same molecule yields two PhAST-sequences. If the additional degrees of 
freedom in three instead of two dimensions have big impact on the canonization process, 
these  two  PhAST-sequences  should  be  dissimilar.  We  measured  sequence s i m i l a r i t y  
employing the Levenshtein distance.
10 It is defined as the minimum number of edit operations 
necessary to transform one sequence into the other with insertion, deletion and substitution of 
a  single  symbol  being  the  allowed  edit  operations.  To  compare  sequences  of  the  whole 
COBRA library obtained with the same canonization algorithm applied to 2D layouts and 3D 
conformations we calculated the Levenshtein distance for all 8,311 pairs of PhAST-sequences 
generated from the same molecule and used the average of these values as final measure of 
dissimilarity. As observed earlier,
2 MVE in particular tends to introduce a fourth kind of 
events in PhAST-sequences of similar molecules: transpositions, defined as the exchange of 
position between neighboring symbols. Accounting for this fact we used an extension to the 
original Levenshtein distance, the Damerau-Levenshtein distance
11 that allows transpositions 
as edit operations. As the Damerau-Levenshtein distance uses an additional edit operation the 
calculated  distances  should  be  smaller  compared  to  Levenshtein  distances.  We  used  both 
distances and compared obtained results because it is unknown which one is more suitable for 
our purpose. 
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Hähnke et al.     7  
Clustering of Canonization Methods 
 
The  averaged  rank  correlation,  the  averaged  Levenshtein  and  the  averaged  Damerau-
Levenshtein distance were used to quantify the difference between versions of PhAST with 
different canonization algorithms. Using these distances we performed a Ward clustering
34 of 
the different PhAST versions to assess the similarity between canonization algorithms and to 
get an idea whether screening behavior and sequence generation are more influenced by the 
dimensionality  of  molecular  representation  (2D  layouts  vs.  3D  conformations)  or  the 
canonization  algorithm.  Therefor  we  first  selected  a  representative  of  each  canonization 
algorithm  from  the  possible  parameterizations  by  using  the  retrospective  performance 
averaged  over  both  dimensionalities  as  selection  criterion.  In  case  of  the  Kendall  rank 
correlation we used (1 – ") as distance measure. 
 
 
Data Fusion 
 
Retrospective results obtained with the top-performing canonization algorithms applied to 2D 
layouts  and  3D  conformations  were  combined  using  data  fusion.  This  way w e  a s s e s s e d  
whether the combination of topological and spatial information can further improve screening 
performance  of  PhAST.  To  do  so,  each  screening  described  in  screening  protocol  1  was 
performed with both versions of PhAST. To avoid complications with different ranges of 
similarity values and re-scaling steps we chose a data fusion approach that combines the ranks 
of each compound in both ranked lists.
35 To combine two methods, a new ranked list was 
created according to Eq (1). 
 
ri
* # min(ri
m1,ri
m2)                 (1) 
 
with m1 the first screening method, m2 the second screening method and ri the rank of 
the i-th compound. This version of PhAST is referred to as PhAST DF. 
 
 
Multiple Conformations 
 
The retrospective performance of PhAST applied to 3D conformations  of molecules with 
different canonization algorithms was assessed using single 3D conformations generated for 
each  molecule  in  the  COBRA  library.  But  there  is  more  than  one  possible  low-energy 
conformation  for  most  molecules.
36  This  is  why  the  canonization  algorithm  with  best 
retrospective  performance  on  single  3D  conformations  was  re-evaluated  with  ten 
conformations per molecule. The retrospective analysis was similar to screening protocol 1 
with one modification: All ten conformations of each query molecule were compared to all 
ten conformations of each screening compound, and the maximum of these 100 similarity 
scores  per  molecule  comparison  was  used  as  final  similarity  measure.  To  quantify  the 
influence of the additional degrees of freedom in three dimensions on the generation process 
of PhAST-sequences we again used alternative sequence distance measures. We calculated 
the  Levenshtein  and  Damerau-Levenshtein  distance  for  each  single  conformations  of  a 
molecule in the COBRA library to the corresponding ten multi-conformations. 
 
 
Other Virtual Screening Methods 
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Hähnke et al.     8  
The  best-performing  versions  of  PhAST  applied  to  2D  layouts  and  3D  conformations  of 
molecules were compared to other popular virtual screening methods in the same series of 
retrospective screenings as described in screening protocol 1.  
(i) MDL MACCS substructural search keys
37 were originally developed to encode 
common substructure features found in organic molecules. Each molecule is represented as a 
vector of 166 bits corresponding to a predefined set of 166 features, where each ‘on’ bit 
indicates the presence of the corresponding feature. We used the implementation of MACCS 
keys available in MOE, and binary vectors were compared using the Tanimoto coefficient.
38 
(ii) LINGO
39,40 is based on the fragmentation of SMILES into overlapping words of 
length  q  (LINGOs).  Counts  of  LINGOs  generated  by  the  fragmentation  of  SMILES 
representations of two molecules were used to quantify molecular similarity between 0 and 1. 
SMILES were generated using MOE. These were modified by unitizing ring numbers as well 
as replacing ‘Cl’ with ‘L’, and ‘Br’ with ‘R’ as suggested for preprocessing.
39 We used q = 4 
as this value showed highest retrospective performance in a comparison of lengths between 1 
and 20 (data not shown). 
(iii) ESshape3D and ESshape3D HYD are eigenvalue shape fingerprints implemented 
in MOE. ESshape3D compares 3D shapes made from heavy atoms of a molecule, ESshape3D 
HYD those from hydrophobic heavy atoms. Both are based on the calculation of eigenvalues 
for  the  Euclidean  distance  matrix  between  atoms,  encoding  this  eigenspectrum  into  a 
fingerprint and using the inverse distance between fingerprints as similarity score. 
(iv) The property vector referred to as SIMPLE was used during the creation of the 
MUV dataset.
26 It contains the number of all atoms, heavy atoms, boron, bromine, carbon, 
chlorine,  fluorine,  iodine,  nitrogen,  oxygen,  phosphorus,  and  sulfur  atoms,  the  number of 
acceptors, donors, logP, the number of chiral center and the number of ring systems in a 
molecule. For comparison the Euclidean distance between these vectors was calculated. 
(v)  The  TGD/TGT/TAD/TAT  fingerprint  family  of  MOE  is  based  on  a  common 
definition  of  pharmacophoric  points.  Each  atom  is  typed  either  as  donor,  acceptor,  polar, 
anion, cation or hydrophobe. TGD (TGT) codes all pairs (triplets) of atoms by their types and 
topological  distance  as  features.  TAD  and  TAT  use  Euclidean  distance  between  atoms. 
Fingerprints were compared using the Tanimoto coefficient. 
(vi)  The  *piDAPH#  group  of  fingerprints  in  MOE  is  based  on  a  more  elaborate 
pharmacophore model. Each atom is assigned a type from the eight possible combinations 
between ‘in pi system’, ‘is donor’ and ‘is acceptor’. GpiDAPH3 codes triplets of atoms by 
their  types  and  topological  distances.  piDAPH3  (piDAPH4)  is  the  spatial  analogue  using 
inter-atomic distances between triplets (quadruplets). Fingerprints were compared using the 
Tanimoto coefficient. 
(vii) CATS (Chemically Advanced Template Search),
41 (viii) LIQUID (Ligand-based 
Quantification  of  Interaction  Distributions),
42  and  (ix)  PRPS  (Pseudoreceptor  Point 
Similarity)
43 are in-house implementations of the correlation vector concept.
44 For CATS, 
each atom is assigned one type of donor, acceptor, anion, cation and lipophilic. For all 15 
pairs between these types, their occurrence in topological distances from zero to nine bonds 
was counted, yielding the ‘raw’ version of CATS. The sensitive (‘sens’) variant scales these 
values by the sum of involved atom type counts. LIQUID uses only three atom types (donor, 
acceptor, lipophilic) and creates a 3D pharmacophore model. Pharmacophoric points were 
clustered with cluster radius 2 Å and used to create feature densities modeled by trivariate 
Gaussians. The correlation vector was calculated between all six possible atom pairs in binned 
distances between one and 20 Å (or more) in steps of 1 Å. Finally, values were scaled so that 
the sum of the 20 bins for each pair equals 1. PRPS models a pseudoreceptor around each 
ligand  based  on  known  interaction  directions  with  interaction  types  donor,  acceptor  and 
lipophilic. These interaction possibilities were translated into a correlation vector analogous to 
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Hähnke et al.     9  
LIQUID with bins from 1 to 15 Å in 1 Å steps. For all correlation vectors we used the 
Euclidean distance for similarity assessment. 
 
 
Clustering of Virtual Screening Methods 
 
In order to identify similarities between virtual screening methods, to assess the novelty of 
PhAST applied to molecular representations of different dimensionality compared to already 
existing virtual screening techniques, and to quantify the influence of the dimensionality of 
the molecular representation we performed a Ward clustering. As distance measures we used 
the averaged Kendall rank correlation as well as significance estimates for the superiority of 
one method over another. For this purpose we calculated the average percentage of virtual 
screens one method performs significantly better than the other in the paired permutation test 
at significance levels 0.05 and 0.01 for each target. We used the average of these per-target-
values  to  assess  the  significance  of  differences  in  retrospective  performance  between 
methods, yielding an asymmetric distance measure. Using Eq. (2) 
 
ds(mi,m j) # da(mi,m j) $da(m j,mi)           (2) 
 
with m a screening method, da the asymmetric distance between methods and ds the 
symmetric distance between methods we calculated a symmetric distance matrix. 
 
 
Double Dynamic Programming 
 
Besides  the  canonization  algorithm  during  generation  of  PhAST-sequences  spatial 
information can be used for scoring in the alignment process. This technique called ‘double 
dynamic  programming’  (DDP)  has  proven  to  be  successful  in  the  comparison  of  protein 
structures  as  alternative  to  structure  superposition.
12,45,46  We  will  first  describe  the  DDP 
alignment algorithm for proteins. Then we will explain our modifications to apply DDP to 
textual representations of small molecules. 
Algorithms calculating the optimal pairwise global sequence alignment use dynamic 
programming.
3,24 During the alignment process matches and mismatches of residues have to 
be scored. Typically these scores come from score matrices like PAM
47 or BLOSUM
48 and 
relate to the functional similarity of residues. Using DDP these scores are calculated by a 
second level of dynamic programming based on structural instead of functional similarity. We 
will refer to these two levels as ‘residue level’ for the dynamic programming level equal to 
the normal dynamic programming and ‘distance level’ for the dynamic programming level 
calculating the scores for the residue level. The simplest approach for proteins is to consider 
only C! atoms in these calculations. 
When sequences X = x1x2…xn and Y = y1y2…ym are aligned and the score for aligning 
residues xi and yj on residue level have to be calculated, a position-specific distance score 
matrix D
ij with entries [Eq. (3)] 
 
Dkl
ij #
a
Xdi,k $Yd j,l %b
                 (3) 
 
is created where  Xdi,k  is the Euclidean distance between xi and xk, Yd j,l  is the Euclidean 
distance  between  yj  and  yl,  b  prevents  division  by  0  and  the  ratio  of  a  to  b  defines  the 
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Hähnke et al.      10 
maximum score where k = i and l = j. This matrix is used as score matrix for the distance level 
alignment. This alignment is calculated under the assumption that that xi and yj are structurally 
equivalent, hence the alignment of xi and yj has to be part of the distance level alignment.
12,49 
The alignment score of the distance level alignment is used as score for the alignment of xi 
and yj on residue level. As dynamic programming has complexity O(n
2), and in each step 
dynamic programming has to be performed to calculate the score of the alignment of two 
residues with again O(n
2), DDP has complexity O(n
4). 
The  parameterization  of  DDP  poses  some  new  problems  compared  to  standard 
dynamic programming. Three parameterization solutions are described in the supplemental 
material. As they mainly differ in the determination of gap penalties used on distance level, 
they  are  referred  to  as  ‘static’,  ‘flexible’  and  ‘dynamic’,  based  on  the  particular  penalty 
choices. 
  We  evaluated  our  implementation  of  DDP  with  the  best-performing  canonization 
algorithms based on 2D and 3D information that were identified in this study. This way we 
wanted  to  assess  whether  the  combination  of  2D  or  3D  canonization  with  3D  sequence 
comparison is advantageous.  
 
 
Screening Protocol 2 
 
As  DDP  has  a  complexity  of  O(n
4)  and  we  implemented  it  using  the  exact  but  slower 
Needleman-Wunsch algorithm, average screenings as described in screening protocol 1 would 
take huge amounts of time. For evaluation we used a protocol proposed earlier
1 with two 
queries per target taken from PDB
50 structures (see Table 2 for detailed query list). Each 
query  is  used  in  a  retrospective  screening  and  the  resulting  ranked  list  is  evaluated  by 
calculating their BEDROC score with ! = 20, the suggested default value for evaluation.
7 
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RESULTS AND DISCUSSION 
 
Canonization algorithms 
 
We  compared  the  retrospective  performance  of  PhAST  employing  different  canonization 
approaches applied to 2D layouts and 3D conformations of molecules in a series of virtual 
screens.  Canonization  algorithms  with  highest  retrospective  performance  in  PhAST  are 
minimum volume embedding (MVE) combined with the diffusion kernel (diffusion parameter 
0.4) and covalent connectivity for 2D molecular representations (averaged BEDROC = 0.40) 
and MVE combined with the Gaussian radial basis function kernel (& = 2
2) and k nearest 
neighbors connectivity with k = 3 (averaged BEDROC = 0.39). These versions of PhAST will 
be referred to as ‘PhAST 2D’ and ‘PhAST 3D’. Full results of all canonization algorithms are 
provided in the supplemental material.  
  The  difference  in  screening  performance  between  PhAST  2D  and  PhAST  3D  is 
significant  in  more  than  50%  of  all  screenings  at  the  0.05  and  0.01  significance  level. 
Compared to all methods evaluated in this study, PhAST 2D performs significantly better in 
50% of all screenings in 98% (84%) of all cases at a significance level of 5% (1%). This 
demonstrates that MVE in combination with a diffusion kernel (diffusion parameter = 0.4) 
and  covalent  connectivity  is  an  appropriate  canonization  algorithm  for  the  generation  of 
molecule linearizations for sequence alignment. 
 
 
Impact of dimensionality on PhAST-sequences 
 
Table 3 presents the results of comparing the application of the same canonization algorithm 
to 2D layouts and 3D conformations of molecules by differences in PhAST-sequences and 
active  ranks.  The  average  difference  between  the  averaged  Levenshtein  and  Damerau-
Levenshtein  distance  is  0.66,  indicating  that  transpositions  allowed  as  additional  edit 
operation in the Damerau-Levenshtein distance are not used very often to explain differences 
in PhAST-sequences generated from different representations of the same molecules. For all 
canonization algorithms utilizing a neighborhood definition of vertices, the biggest difference 
in PhAST-sequences is observed using k nearest neighbor neighborhoods with k = 2. This 
shows that the changes in vertex neighborhoods introduced by the additional dimension using 
3D conformations are only slight displacements of the same groups of vertices. Looking at 
only the two nearest neighbors, these displacements may results in selecting two different 
nodes, but as the number of considered neighbors increases, the shared fraction of nearest 
neighbors increases resulting in less distant PhAST-sequences. At the same time lowest rank 
correlation is observed for the same group of canonization algorithms with k = 2 as well. 
Lowest distance between PhAST-sequences and highest rank correlation are observed when 
identical connectivity is used in form of neighborhoods defined by covalent bonds. 
The rank correlation of actives varies between 0.71 and 0.36 with a mean of 0.59. 
Pearsons’s correlation coefficient
65 between Levenshtein (Damerau-Levenshtein) distance and 
Kendall’s " is -0.95 (-0.96). This shows that whenever a canonization algorithm generates 
very  dissimilar  PhAST-sequences  from  molecular  representations  with  different 
dimensionalities, this results in very dissimilar rankings of actives. 
 
 
Comparison 2D vs. 3D 
 
For all 42 canonization algorithms and parameterizations applied to molecular representations 
in  both  dimensionalities,  the  application  to  2D  layouts  (3D  conformations)  has  higher 
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averaged performance in 15 (27) cases. Focusing on the number of cases where more than 
50% of all screenings have significantly better averaged retrospective performance this is true 
in 2 (14) cases at 0.05 and only 0 (4) cases at 0.01. This implied superiority of using three-
dimensional molecular representations in general does not hold necessarily for a particular 
target. Table 4 lists the number of cases where the application to one dimensionality results in 
significantly higher retrospective performance compared to the other in more than 50% of 
performed screenings per target at both significance levels. By that criterion, more than 50% 
of the compared canonization algorithms have significantly higher retrospective performance 
when applied to 3D conformations on THR at 0.01. On this target, the application to 2D 
layouts is superior in only 7%. On COX2 both representations excel the other in 45%. On 
ACE in 43% of the compared cases the application on 3D conformers yields significantly 
better results with only 5% the other way. Nearly identical percentages are obtained for both 
dimensionalities on DHFR, FXA and PPAR'. These results demonstrate that the usage of 3D 
conformations seems to be advantageous only in some cases, but not in general. This is in 
agreement with other studies evaluating 2D and 3D methods.
63,64 
  The similarity of results obtained from 2D and 3D representations can be explained by 
the  similarity  of  the  molecular  representations.  A  comparison  of  MOE  2D  layouts  and 
CORINA single 3D low-energy conformations for the COBRA compounds by calculation of 
their pairwise root mean square deviation (RMSD) revealed that they  are similar with an 
averaged  RMSD  of  1.9  Å  (standard  deviation  0.9  Å).  This  high  similarity  between 
representations is most likely due to a large number of atoms being part of arene systems. As 
PhAST employs the Hueckel definition of aromaticity, all atoms typed as aromatic are part of 
such planar systems. An analysis of PPP frequencies in the COBRA library reveals that 42% 
of all atoms are typed as aromatic. As a consequence, on average 42% of all non-hydrogen 
atoms present in a molecule have identical conformation in 2D and 3D, and slight differences 
occur  only  due  do  different  positioning  of  these  fragments.  As  a  result  of  this  limited 
difference between representations, Euclidean and topological distances between vertices are 
highly  correlated.  The  Pearson  correlation  coefficient
65  of  the  Euclidean  and  topological 
distances  between  all  vertex  pairs  in  all  molecules  of  the  COBRA  library  is  r  =  0.94. 
Linearization of structures based on distances from 2D and 3D representations with the same 
canonization  algorithm  results  in  smaller  differences  in  the  generated  PhAST-sequences 
compared to the same  molecular representation being processed by  different  canonization 
algorithms. This observation motivated the next part of our study, namely a comparison of 
canonization algorithms by the similarity of their corresponding PhAST-sequences. 
 
 
Canonization Clustering 
 
In order to assess general differences between algorithmic concepts, to categorize algorithms 
and to quantify the impact of the dimensionality of molecular representation in comparison to 
algorithmic differences we clustered the canonization algorithms compared in this study by 
different distance measures. Therefore, we first selected a representative from every group of 
canonization algorithm that was evaluated in more than one parameterization. As selection 
criterion we used the averaged retrospective performance obtained in the application to both 
dimensionalities of molecular representation. To get a more complete picture, we included 
results  obtained  with  algorithms  compared  previously.  As  distance  measures  we  utilized 
Kendall’s  rank  correlation  of  actives  averaged  over  all  targets  as  well  as  the  averaged 
Levenshtein and Damerau-Levenshtein distance between PhAST-sequences generated from 
the  same  molecular  representation  with  different  algorithms.  As  in  contrast  to  distance 
measures high rank correlation indicates similar behavior, we used (1 – ") as distance. We 
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Hähnke et al.      13 
used Ward’s algorithm to create a hierarchic clustering. Distance matrices are available in the 
supplemental material. 
The dendrogram obtained using Kendall’s rank correlation coefficient as distance is 
shown in Figure 1A. The algorithms explicitly designed for the canonization of molecular 
graphs (Jochum Gasteiger, Prabhakar, Weininger) are grouped in a sub-tree. Despite the fact 
that the Jochum Gasteiger algorithm labels vertices in spheres around the most buried one, the 
Prabhakar algorithm labels long paths through the graph and the Weininger algorithm groups 
vertices  with  similar  properties  in  equivalence  classes,  they  are  more  dissimilar  to  the 
approaches using dimensionality reduction then among themselves. That may be due to the 
fact that all three algorithms in the end use functional and topological vertex properties for 
prioritization  instead  of  topological  or  spatial  distances.  Within  this  substructure  lie  both 
variants of centroid linearization. This is an expected result as they are the spatial analogue to 
the  topological  procedure  performed  by  the  Jochum  Gasteiger  algorithm  that  lies  next  to 
them.  Besides  centroid  linearization,  there  is  no  case  where  both  variants  of  the  same 
algorithm applied to 2D and 3D molecular representations are grouped together. This implies 
that the dimensionality of molecular representation has bigger impact on rank orders than 
algorithmic differences. With MVE DK and MVE PRW both variants of MVE based on a 
kernel performing a random walk on the graph are grouped together. They form a sub-tree 
with covalent variants of Isomap and laplacian eigenmaps. Identical algorithm versions with 
different connectivity are never direct neighbors in the tree, showing that results obtained with 
chemical reasonable connectivity differ from those originating from close proximity between 
vertices.  PCA  and  SPE,  both  independent  from  neighborhood  definitions,  behave  similar, 
whereat differences between algorithms are of lesser importance compared to dimensionality 
of molecular representation for our problem to embed structures in only one dimension. For 
each connectivity variant and dimensionality of molecular representation, MVE variants EDK 
and RBF are grouped together, meaning they result in similar rankings of actives. This is 
reasonable,  as  both  kernels  depend  on  the  same  distances  and  coordinates  for  vertices  in 
Euclidean space. 
These observations are substantiated by the dendrograms created with the averaged 
Levenshtein  and  Damerau-Levenshtein  distances  (dendrograms  are  identical)  presented  in 
Figure 1B: i)  Dimensionality of molecular representation results in smaller differences  as 
using  different  algorithms  (except  for  centroid  linearization)  as  does  using  covalent 
connectivity instead of k nearest neighbors, ii) MVE EDK and MVE RBF behave similar, iii) 
dimensionality  reduction  algorithms  used  for  graph  canonization  result  in  active  rankings 
quite dissimilar from those obtained with algorithms explicitly designed for this purpose. 
Cluster analysis of canonization algorithms revealed equivalent behavior of MVE RBF 
and MVE EDK. Furthermore, it emphasizes differences between ‘traditional’ algorithms for 
graph canonization and our approach using dimensionality reduction algorithms and between 
chemical reasonable connectivity and connectivity implied by spatial adjacency. These results 
approve  the  novelty  of  our  concept  of  using  dimensionality  reduction  for  molecule 
linearization. Our findings indicate a difference in results obtained with molecules represented 
in 2D and 3D. However, the observed differences again do not result in significant differences 
of screening performance. 
 
 
PhAST data fusion 
 
PhAST 2D and PhAST 3D were combined in a data fusion approach based on compound 
ranks, yielding PhAST DF. The averaged rank correlation of actives between results obtained 
with  PhAST  2D  and  PhAST  3D  respectively  is  0.69.  Table  5  shows  the  averaged 
retrospective  performance  per  target,  the  percentages  of  screenings  in  which  one  method 
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performed significantly better than the other per target and the averaged rank correlation per 
target. 
Judging from the averaged BEDROC scores per target, PhAST DF performs better 
than  both  original  versions  of  PhAST  only  on  THR  and  FXA.  Taking  into  account  the 
percentage of screenings one method outperforms the other significantly approves this result: 
Only  on  these  two  targets  PhAST  DF  performs  significantly  better  than  PhAST  2D  and 
PhAST 3D in more than 50% of all screenings at both significance levels. On other targets at 
least one of the other methods has at least the same percentage at 0.05. But on all targets and 
as consequence averaged over all targets retrospective performance did not increase enough 
(39% to baseline PhAST with 31% for the opposite case) to justify the computational cost of 
calculating 2D layouts and 3D single conformations for each molecule and conducting each 
screening twice, once in each dimensionality.  
The averaged rank correlation between PhAST DF and PhAST 2D (PhAST 3D) is 
0.85 (0.84). This shows that while PhAST DF ranks actives slightly better than PhAST 2D or 
PhAST 3D, it retains the order of actives relatively good with regard to these two PhAST 
versions and so does not introduce any novelty in chemotypes retrieved at higher ranks. 
  In  general,  the  data  fusion  approach  could  not  further  improve  the  screening 
performance of PhAST and does not succeed in bringing any novelty to obtained screening 
results.  As  on  the  other  hand  it  requires  additional  computational  effort,  we  do  not 
recommend this procedure for prospective application with the current versions of PhAST. 
 
 
Multiple Conformations 
 
We investigated the benefits of using PhAST with multiple 3D conformations (PhAST 3D 
MC) compared to 3D single conformations (PhAST 3D SC) in retrospective screenings with 
MVE RBF (& = 2
2, kNN k = 3) as canonization algorithm. This variant of MVE performed 
best  for  3D  single  conformations.  Ten  conformations  were  created  for  each  molecule. 
BEDROC scores and results from the paired permutation test are presented in Table 6.  
Averaged retrospective performance shows only a minor increase for PhAST 3D MC 
(0.41) compared to the SC variant (0.39) and PhAST 2D (0.40) in general. This is backed up 
by averaged significance estimations: At the 0.05 significance level PhAST 3D MC performs 
significantly  better  than  PhAST  2D  or  PhAST  3D  SC  judged  by  the  percentage  of 
significantly better screenings averaged over all targets. These are 51% for PhAST 3D MC in 
both cases. At 0.01 the averaged percentages only slightly decrease to 48% and 47%. The 
opposite is true only in 35% (PhAST 2D) and 33% (PhAST 3D) at 0.05 significance level and 
31% for both at 0.01. On particular targets on the other hand differences are more distinct, as 
the results for ACE and FXA indicate. The averaged BEDROC score for ACE increases from 
0.37 for single conformers to 0.45, with that increase being significant in 79% (71%) at 0.05 
(0.01) and the single conformer version being significantly better in 0% at both levels. For 
FXA retrospective performance is raised from 0.35 to 0.40 with significantly better results in 
82%  at  both  significance  levels.  On  COX2  PhAST  3D  MC  performs  worse  than  the  SC 
variant, with this decrease in retrospective performance being significant in 65% at 0.05 and 
61% at 0.01. So in some cases taking the maximum of all similarity values calculated in the 
comparison of all pairs of conformations as final similarity value is misleading and increases 
the number of false positives. 
As  an  attempt  to  quantify  the  influence  of  different  conformations  on  the 
corresponding  PhAST-sequences  we  calculated  Levenshtein-  and  Damerau-Levenshtein 
distances  between  PhAST-sequences  of  single  conformations  and  their  ten  corresponding 
multiple  conformations.  PhAST-sequences  generated  from  different  conformations  of  the 
same  molecule  can  be  quite  dissimilar  with  4.98  (4.26)  being  the  mean  Levenshtein 
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(Damerau-Levenshtein) distance and standard deviation of 5.43 (5.32). As Table 7 shows this 
is most likely explained by the degrees of freedom each molecule has in three dimensions, 
measured by the averaged number of rotatable single bonds per target (descriptor b_1rotN in 
MOE).  The  Pearson  correlation  coefficient  between  these  averages  and  the  averaged 
Levenshtein  (Damerau-Levenshtein)  distance  between  each  single  conformation  and  its 
corresponding multiple conformation is 0.93 (0.87). Differences in retrospective performance 
between PhAST 3D SC and MC per target on  the other hand do not correlate  well with 
sequence differences (Pearson correlation coefficient of 0.31 for Levenshtein distance and 
0.35  for  Damerau-Levenshtein  distance).  This  agrees  with  weak  correlation  between 
differences in retrospective performance and the averaged number of rotatable single bonds 
(0.28).  So  the  generation  process  of  PhAST-sequences  is  sensitive  enough  to  changes  in 
vertex placements to capture molecule flexibility and mirror it. At the same time, differences 
in  retrospective  performance  between  the  SC  and  MC  variant  of  PhAST  3D  can  not  be 
explained by this behavior. 
  This  analysis  strongly  suggests  that  the  usage  of  multiple  conformations  can  be 
beneficial  on  some  targets.  This  is  in  agreement  with  other  studies  evaluation  screening 
methods with single and multiple conformations.
63 Still, it should be kept in mind that the 
increased computational cost (here: for 10 conformation per molecule, an approximately 100-
fold increase) motivates 2D methods as a first choice. 
 
 
Comparison to other screening methods 
 
We  compared  PhAST  2D  and  PhAST  3D  to  other  virtual  screening  methods  by  their 
retrospective performance, significance of differences in retrospective results and active ranks 
measured by Kendall’s rank correlation coefficient. 
  Table  8  gives  the  averaged  retrospective  performance  per  target  for  each  method. 
PhAST  2D  and  PhAST  3D  have  the  fourth  and  fifth  highest  averaged  retrospective 
performance  (0.40  for  PhAST  2D,  0.39  for  PhAST  3D)  with  0.42  being  the  maximum 
performance in this comparison obtained with GpiDAPH3. The MOE fingerprints ESshape 
3D  and  ESshape  3D  HYD  perform  even  worse  than  the  SIMPLE  vector  of  molecule 
properties (0.13 and 0.12 in contrast to 0.21). Calculating ranks for each method on each 
target based on retrospective performance and averaging these ranks results in placing PhAST 
2D fifth and PhAST 3D eighth. Top-ranked according to this measure is LINGO that has 
second-highest  retrospective  performance  (0.41).  In  general,  PhAST  succeeds  in  creating 
enrichment comparable to other established methods. 
The  significance  between  retrospective  results  was  assessed  using  a  paired 
permutation test. We calculated a symmetric distance matrix based on the average percentage 
of screenings one method performed significantly better than the other and used it to create a 
dendrogram using Ward’s algorithm. The calculated symmetric distance matrix can be found 
in the supplemental material. The dendrograms received with significance levels 0.05 and 
0.01 are shown in Figure 2A and Figure 2B. Clustering two methods together means the 
difference between these methods is significant in less cases than between any other pairs of 
methods,  so  these  two  methods  show  only  insignificant  differences  in  retrospective 
performance in most cases. The dendrogram created from significance estimation at level 0.05 
mirrors the ranking order of methods by their averaged retrospective performance. From the 
seven top performing methods, six form a sub-tree with piDAPH4 (third-highest averaged 
retrospective  performance)  being  excluded  from  this  cluster.  PhAST  2D  is  grouped  with 
GpiDPH3, the method with highest averaged retrospective performance, but ranked at fifth 
position by this measure. This shows that differences between methods implied by averaged 
performance are caused by the summation of small insignificant differences. The five worst 
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performing  methods  form  a  substructure  of  their  own  as  well.  The  tree  created  from 
significance data at 0.01 is nearly identical. The only difference is clustering MACCS with 
the TAD / TGD / CATS sens sub-tree and placing the complete structure farther away from 
the best performing screening methods. PhAST 2D is grouped again with the best performing 
GpiDAPH3  method.  So  despite  the  fact  that  PhAST  2D  has  only  fifth-highest  averaged 
performance,  it  has  least  significant  differences  in  retrospective  screenings  to  the  best 
performing method. 
Motivated by these findings we analyzed in how many of the 689 screenings each 
method  significantly  outperforms  each  other  method.  The  results  per  target  are  shown  in 
Table 9. The results are nearly identical at both significance levels. At 0.01, LINGO has the 
highest  percentage  of  screenings  in  which  it  significantly  outperforms  each  other  method 
(15%). The per-target-analysis reveals that this superiority mostly comes from screenings on 
FXA. PRPS dominates on DHFR and is ranked second best with 12% in total. Our method 
PhAST 2D is ranked third (9% at 0.01 significance level) with peak superiority on THR, 
whereat this significant higher performance is not as distinct compared to LINGO on FXA 
and PRPS on DHFR. 
All significance analysis justify usage and further development of PhAST as it exhibits 
enrichment comparable or superior to established methods with these improvements being 
significant in a great number of cases. 
Kendall’s rank correlation coefficient calculated based on active ranks was used as 
distance measure to create hierarchical clusterings of the compared methods using Ward’s 
algorithm. The calculated distance matrices can be found in the supplemental material, the 
dendrogram is presented in Figure 2C. 
Using the inversed rank correlation the two methods based solely on structural features 
are grouped together (MACCS, LINGO). All our in-house implementations of the correlation 
vector  concept  (CATS,  LIQUID,  PRPS)  are  grouped  with  MOE  pharmacophore  based 
fingerprints (TGD, TAD, TGT, TAT) without mixing these two groups. For these methods, 
dimensionality  of  molecular  representations  seems  to  be  of  lesser  importance  than 
methodological  differences  between  as  in  these  groups  variants  applied  to  different 
dimensionalities are grouped together. This is also true for MOE fingerprints GpiDAPH3, 
piDAPH3 and piDAPH4 which use a more elaborate definitions of pharmacophoric points as 
TGD, TAD, TGT  and  TAT (eight potential pharmacophoric points instead of six). Using 
quadruplets (piDAPH4) instead of triangles (piDAPH3) seems to make a smaller difference in 
ranking  actives  than  using  only  topological  information  (GpiDAPH3).  The  three  worst 
performing methods (ESshape3D, ESshape3D HYD, SIMPLE) form their own sub-tree. All 
methods succeed in creating rankings of actives that are dissimilar from those. PhAST 2D and 
3D are grouped together with methods solely based on structural features (MACCS, LINGO) 
and pharmacophoric points (piDAPH3, piDAPH4, GpiDAPH3). This high similarity between 
MACCS / LINGO and the piDAPH family of fingerprints is remarkable and surprising, as the 
general assumption is that pharmacophore methods create rankings different from structural 
methods. But the closeness of MACCS keys and pharmacophore methods can be explained by 
the fact that besides structural features (for example the presence of rings of different sizes) 
the substructures coded in a MACCS key represent functional groups responsible for certain 
interactions, i.e. determining the pharmacophore. LINGOs on the other hand are a flexible 
way of describing atom environments that as well describe functional groups responsible for 
interactions. The interaction information implicitly compared by these methods seems to be 
quite similar to the 8-point pharmacophore model of MOE and to each other. In the end, the 
dendrogram shows a clustering by complexity of pharmacophore models: The sparse models 
used in CATS, LIQUID and PRPS form one group, methods based on the five-point model of 
MOE another one, and the complex models with eight atom-types in MOE, nine atom-types 
in PhAST and even more types in MACCS and LINGO are grouped together as well. 
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Analysis  on  ranking  behavior  with  regard  to  actives  further  justifies  usage  and 
development of PhAST as we succeeded in creating a method introducing new chemotypes at 
early ranks without diminishing enrichment capability. 
Compared by runtime, other methods are superior to PhAST: The conversion of the 
complete COBRA library (8,311 compounds) to PhAST-sequences (30 minutes) is more than 
250 times slower as substructure fingerprint generation, correlation vector calculation, and 
SMILES  which  need  only  about  20  seconds  for  this  operation.  There  is  no  significant 
difference between the kernel functions employed by PhAST 2D and PhAST 3D with regard 
to calculation speed. On average, screening the COBRA library takes three times longer with 
PhAST  (3  seconds)  than  with  our  in-house  implementation  of  LINGO  (1  second)  or 
substructure fingerprints (about 1 second averaged over all fingerprints). But even fingerprints 
are outperformed 200-fold by screening correlation vector representations of molecules with 
Euclidean distance (0.005 seconds). As drastic as these differences appear, even with PhAST 
10
6 compounds can be screened in approximately six minutes on a single core computer, once 
molecules have been converted to PhAST-sequences. The time-consuming step of molecule 
conversion  is  ‘embarrassingly  parallel’  and  can  easily  be  distributed  to  several  cores  and 
computers. 
 
 
Inter-method data fusion 
 
Following the principle of data fusion in virtual screening, we combined PhAST 2D with a 
method  based  on  three-dimensional  molecule  representations  to  see  if  we  could  further 
improve screening performance. We selected the second screening method by two criteria: 
The  rank  correlation  with  PhAST  2D  should  be  low  and  the  averaged  retrospective 
performance high at the same time. Following these guidelines we selected PRPS (" = 0.23, 
averaged BEDROC 0.37) and combined both methods by ranking each compound with the 
minimum rank received with each method. Averaged retrospective performance per target, the 
percentages of significantly better screenings and the averaged rank correlation with each of 
the original methods per target are shown in Table 10. 
The gain in screening performance is significant. Averaged retrospective performance 
increases from 0.40 (0.37) for PhAST 2D (PRPS) to 0.45. And even at the most rigorous 
significance  level  this  improvement  is  significant  in  50%  (59%)  of  all  cases  for  PhAST 
(PRPS). With averaged rank correlation of 0.53 to PRPS the ranking of actives is changed 
considerably, but relatively  close to PhAST ("  = 0.70). Hence we succeeded in selecting 
candidates for successful data fusion screenings based on easy to calculate properties. 
  In the comparison with other virtual screening methods PhAST exhibits comparable or 
superior screening capabilities and qualifies as a valuable tool in screening campaigns through 
the introduced novelty of chemotypes at good ranks and the distinct difference to other virtual 
screening method enabling successful data fusion. 
 
 
Double Dynamic Programming 
 
We  adopted  and  parameterized  the  double  dynamic  programming  (DDP)  approach  for 
calculating sequence alignments based on structural properties for the comparison of PhAST-
sequences. It was applied to PhAST-sequences created using MVE DK applied to 2D layouts 
and MVE RBF (& = 2
2, kNN with k = 3) applied to 3D single conformations in three different 
parameterizations.  Table  11  presents  the  retrospective  performance  for  each  of  these  six 
combinations with that of PhAST 2D and PhAST 3D for comparison. 
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Regardless of the canonization algorithm, the simplest parameterization of DDP hand-
built from a single example performs best in this comparison. With MVE DK for canonization 
before using DDP, PhAST 2D and 3D are outperformed in 1 of the 12 screenings (query S58), 
with  MVE  RBF  in  2  screenings  (queries  DIF  and  S58).  Enrichment  better  than  random 
(BEDROC score 0.05) is achieved in most cases. We did not perform significance estimations 
because  divergences  between  functional  and  structural  versions  of  PhAST  are  distinct. 
Despite the fact that the faster versions of PhAST that score functional similarity and employ 
normal dynamic programming perform better in most screenings, these results show that the 
comparison  of  PhAST-sequences  based  on  structural  instead  of  functional  properties  is 
possible and succeeds in enrichment of actives, but the structural information available in the 
current  implementation  of  DDP  alone  is  not  sufficient  for  general  high  enrichment.  The 
implemented version of DDP is comparable to the first one applied to protein sequences
12 and 
has obvious flaws like the disability to regard differences in direction for vertices with the 
same distance. But since its first implementation, DDP for protein sequences was subject to 
numerous modifications and improvements addressing especially this deficit,
 12,45,46,49 and we 
are certain that these improvements will increase performance in the comparison of PhAST-
sequences as well. As for DDP for protein sequences, the structural similarity score could be 
combined with the functional scores from our functional score matrix, or these functional 
scores could be calculated on the fly from pre-calculated properties as hydrogen-bond-donor 
and acceptor potentials, resulting in a holistic approach to molecular comparison, no longer 
dependent  of  a  pharmacophoric  point  definition.  Alignment  speed  could  be  improved  by 
switching  to  the  FSM  algorithm  as  for  PhAST  2D  and  PhAST  3D,  but  differences  in 
alignments  introduced  this  way  would  have  to  be  carefully  monitored.  Reasons  why  the 
dynamic parameterization is inferior to fixed gap penalties remain unclear at this moment but 
will be the subject of further investigations. 
The runtime of DDP is high compared to standard dynamic programming: On average, 
screening of the COBRA library takes 160 minutes on a single core of an Intel Xeon with 
2.26 GHz. The query size has a strong impact on the computing time (asymptotic runtime of 
O(n
4)). With 14 symbols in the query sequence the complete COBRA set of 8,311 compounds 
is screened in 46 minutes. An increase in query size to 41 symbols increases screening time to 
735 minutes. For the time being, this renders PhAST DDP only applicable to small, focused 
subsets that have been pre-selected by other methods. 
  We succeeded in the first time application of DDP to the calculation of structural 
similarity scores of small molecules. Adopting existing improvements of this approach to the 
comparison of textual representations of small molecules will be part of future studies. 
Page 18 of 39
John Wiley & Sons, Inc.
Journal of Computational Chemistry
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60For Peer Review
Hähnke et al.      19 
CONCLUSIONS AND OUTLINE 
 
In this study, we investigated the impact of using three-dimensional conformations instead of 
two-dimensional layouts of molecular graphs for our PhAST screening method. Canonizing 
CORINA single conformations with MVE combining radial basis function kernel (& = 2
2) and 
k nearest neighbor connectivity (k = 3) has retrospective performance only slightly below the 
application of MVE with a diffusion kernel (( = 0.4) and covalent connectivity to molecular 
graphs,  but  requires  conformer  generation.  Despite  of  an  observable  difference  in  the 
retrieved  actives  (complementarity  of  PhAST  2D  and  PhAST  3D),  combining  these  two 
methods  through  data  fusion  could  not  further  improve  overall  screening  performance. 
Nevertheless,  using  multiple  conformations  in  PhAST  significantly  increases  screening 
performance for individual targets. 
We could show that, for non-linear dimensionality reduction, the applied connectivity 
algorithm has high impact on screening performance. A further method for the definition of 
neighborhoods not yet investigated is b-matching.
66 There, exactly b neighbors are assigned to 
each vertex. This technique has been already been shown to be beneficial to other applications 
of  MVE.
67  We  showed  that  our  approach  using  dimensionality  reduction  for  graph 
canonization yields PhAST-sequences and active rankings different from those obtained with 
canonization  algorithms  developed  for  molecular  graphs.  Further  we  demonstrated  that 
PhAST ranks actives dissimilar to other methods without sacrificing screening performance, 
introducing novel chemotypes at earlier ranks. This proves that our approach of text-based 
virtual screening is worthy of further investigation and development. As PhAST MVE DK is 
still the best performing variant of PhAST and this difference is evidentially significant, we 
advise the usage of this method for prospective application. 
  We successfully applied double dynamic programming to the comparison of PhAST-
sequences,  calculating  structural  similarity  scores.  In  most  of  our  test  cases  calculating 
functional similarity resulted in better screening performance, but compared to PhAST DDP, 
PhAST 2D and PhAST 3D are highly optimized and their superior performance had to be 
expected. But these first results with PhAST DDP are very promising. There are many known 
improvements to DDP we are confident will improve performance and speed of PhAST DDP 
as well. As the second layer of dynamic programming in DDP is only used to assess structural 
equivalence, a faster method for this purpose would speed up the calculation of sequence 
alignments  based  on  structural  similarity.  One  could,  for  example,  adopt  of  the  idea  of 
ultrafast shape recognition.
68 There, distance distributions are characterized by their first three 
moments.  The  difference  between  these  values  can  be  used  to  assess  the  similarity  of 
distributions, and as a consequence, structural similarity. The combination of structural and 
functional similarity will lead to a holistic approach of molecule comparison based on one-
dimensional textual representations. 
  Retrospective  comparison  of  methods  with  regard  to  significance  of  performance 
differences  revealed  that  in  some  cases  a  ranking  of  methods  based  solely  on  averaged 
performance  is  misleading.  These  differences  may  be  caused  by  the  summation  of 
insignificant differences. Because of this discovery we highly encourage the calculation of 
significance estimates. 
  Results  from  the  comparison  of  PhAST  3D  applied  to  single  and  multiple 
conformations of molecules support our findings from a previous analysis of the robustness of 
canonization algorithms against topological modifications of molecular graphs,
2 that PhAST 
can not be used as additive scoring function for de novo design of compounds. Even small 
changes  in  the  spatial  arrangement  of  potential  pharmacophoric  points  cause  measurable 
changes  in  corresponding  PhAST-sequences.  As  the  distance  measures  we  used  to  assess 
these differences are insensitive to the exchange of positions between equal symbol types, 
these changes might be more severe than observed. So small changes in graph topology as 
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well in spatial arrangement of potential pharmacophoric points cause changes in the PhAST-
sequence as representation of a molecule, which makes them non-additive. 
  Graph canonization through dimensionality reduction showed at the example of PCA 
that the projection on one single straight axis does not yield good results. An alternative could 
be the projection on space-filling curves like Hilbert-,
69 Peano-,
70 or Koch-curves
71. As these 
curves are space-filling they have the ability to de-skew the projection created by PCA. Of 
course, this method would again depend on the generation of vertex coordinates. 
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Legends to the figures 
 
Figure  1  Dendrograms  of  canonization  algorithms  created  using  Ward‘s  algorithm.  A) 
distance measure: (1-") where " is the averaged Kendall rank correlation of active ranks in 
retrospective virtual screenings, B) distance measure: averaged Levenshtein distance between 
PhAST-sequences generated for molecules in the complete COBRA library using different 
canonization  algorithms.  Using  Damerau-Levenshtein  distance  results  in  the  same 
dendrogram as B). Lengths of edges are solely for visualization, with no respect to actual 
distances. Distances matrices are available in the supplemental material. 
 
Figure  2  Dendrograms  of  virtual  screening  methods  created  using  Ward‘s  algorithm.  A) 
distance measure: percentage of significant differences in retrospective screenings at level 
0.05, b) distance measure: percentage of significant differences in retrospective screenings at 
level 0.01, C) distance measure: (1-") where " is the averaged Kendall rank correlation of 
active ranks in retrospective virtual screenings. Lengths of edges are solely for visualization, 
with  no  respect  to  actual  distances.  Distances  matrices  are  available  in  the  supplemental 
material. 
Page 23 of 39
John Wiley & Sons, Inc.
Journal of Computational Chemistry
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60For Peer Review
Hähnke et al.      24 
Text for Graphical Abstract 
 
We  applied  non-linear  dimensionality  reduction  to  the  problem  of  linearizing  three-
dimensional  conformations  of  molecules.  These  linear  representations  are  compared  by 
functional and structural properties using our virtual screening method PhAST. 
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Table 1. Targets in the COBRA library version 6.1 used for retrospective virtual screenings. 
Shown are abbreviations used in this study as well as the number of active compounds. The 
total number of molecules in the COBRA library is 8311. 
Target  Abbreviation  No. Actives 
Angiotensine-
converting 
Enzyme 
ACE  34 
Cyclooxygenase 2  COX2  136 
Dihydrofolat-
reductase  DHFR  64 
Factor Xa  FXA  228 
Peroxisome-
proliferator activated 
receptor ! 
PPAR!  44 
Thrombin  THR  183 
Total    689 
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Table 2. Targets, query structure IDs in the PDB
50 and the identifier of the PDB structures 
they were taken from used for single screening evaluations. 
 P D B   C o d e   L i g a n d   I D  
ACE  1o86
51 L P R  
 1 u f z
52 M C O  
COX2  1pxx
53 D I F  
 6 c o x
54 S 5 8  
DHFR  1dg5
55 T O P  
 1 h f r
56 M O T  
FXA  1ezq
57 R P R  
 1 f j s
58 Z 3 4  
PPAR! 1 f m 9
59 5 7 0  
 1 z g y
60 B R L  
THR  3eq0
61 2 T S  
 1 o 0 d
62 1 6 3  
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Table  3.  Comparison  of  canonization  algorithms  applied  to  two-dimensional  layouts  and 
three-dimensional  conformations of molecular  graphs. Differences between algorithms are 
quantified  by  the  averaged  Levenshtein  and  Damerau-Levenshtein  distance  between 
generated PhAST-sequences for the complete COBRA library and the averaged Kendall rank 
correlation  coefficient  calculated  pairwise  from  ranks  of  actives  between  689  virtual 
screenings performed with each algorithm. 
 
Levenshtein 
Distance 
Damerau-
Levenshtein 
Distance 
Kendall’s " 
  Ø  #$ Ø  # Ø   # 
Centroid Linearization  9.90  6.54  9.32  6.62  0.52  0.15 
Isomap kNN k = 2  11.64  7.74  11.31  7.82  0.36  0.16 
Isomap kNN k = 3  8.29  5.46  7.55  5.47  0.60  0.12 
Isomap kNN k = 4  8.60  5.57  8.00  5.57  0.60  0.11 
Isomap kNN k = 5  8.04  5.78  7.41  5.76  0.62  0.13 
Laplacian Eigenmaps kNN k = 2  10.77  7.49  10.40  7.57  0.38  0.16 
Laplacian Eigenmaps kNN k = 3  7.46  5.29  6.60  5.24  0.63  0.12 
Laplacian Eigenmaps kNN k = 4  7.47  5.43  6.70  5.42  0.64  0.12 
Laplacian Eigenmaps kNN k = 5  6.80  5.32  6.01  5.26  0.66  0.12 
PCA  7.65  6.50  7.05  6.48  0.57  0.16 
MVE EDK covalent  5.57  4.88  4.69  4.75  0.70  0.11 
MVE EDK kNN k = 2  7.92  6.20  7.35  6.21  0.58  0.14 
MVE EDK kNN k = 3  6.55  5.51  5.83  5.47  0.65  0.12 
MVE EDK kNN k = 4  6.46  5.62  5.78  5.55  0.65  0.13 
MVE EDK kNN k = 5  6.74  5.98  6.13  5.92  0.62  0.14 
MVE RBF # = 2
-1 covalent  7.66  6.67  7.03  6.76  0.52  0.17 
MVE RBF # = 2
-1 kNN k = 2  11.22  7.43  10.84  7.50  0.42  0.15 
MVE RBF # = 2
-1 kNN k = 3  9.45  6.60  8.85  6.71  0.49  0.17 
MVE RBF # = 2
-1 kNN k = 4  9.71  6.77  9.14  6.87  0.47  0.16 
MVE RBF # = 2
-1 kNN k = 5  10.28  7.36  9.79  7.51  0.41  0.19 
MVE RBF # = 2
0 covalent  6.47  5.90  5.69  5.90  0.62  0.14 
MVE RBF # = 2
0 kNN k = 2  9.83  7.22  9.37  7.27  0.45  0.16 
MVE RBF # = 2
0 kNN k = 3  7.77  6.18  7.05  6.23  0.60  0.14 
MVE RBF # = 2
0 kNN k = 4  8.09  6.19  7.38  6.23  0.57  0.14 
MVE RBF # = 2
0 kNN k = 5  7.71  6.30  7.00  6.34  0.58  0.15 
MVE RBF # = 2
1 covalent  5.44  4.82  4.55  4.67  0.70  0.11 
MVE RBF # = 2
1 kNN k = 2  8.57  6.64  8.06  6.67  0.54  0.15 
MVE RBF # = 2
1 kNN k = 3  6.51  5.53  5.77  5.48  0.65  0.13 
MVE RBF # = 2
1 kNN k = 4  6.61  5.56  5.90  5.51  0.66  0.12 
MVE RBF # = 2
1 kNN k = 5  6.48  5.67  5.75  5.61  0.65  0.13 
MVE RBF # = 2
2 covalent  5.42  4.65  4.53  4.48  0.71  0.11 
MVE RBF # = 2
2 kNN k = 2  8.05  6.31  7.49  6.31  0.58  0.14 
MVE RBF # = 2
2 kNN k = 3  6.36  5.38  5.61  5.29  0.65  0.12 
MVE RBF # = 2
2 kNN k = 4  6.26  5.46  5.56  5.39  0.66  0.11 
MVE RBF # = 2
2 kNN k = 5  6.10  5.61  5.40  5.52  0.66  0.13 
MVE RBF # = 2
3 covalent  5.51  4.81  4.63  4.67  0.70  0.11 
MVE RBF # = 2
3 kNN k = 2  7.77  6.20  7.18  6.20  0.60  0.13 
MVE RBF # = 2
3 kNN k = 3  6.47  5.47  5.74  5.41  0.65  0.12 
MVE RBF # = 2
3 kNN k = 4  6.27  5.56  5.59  5.49  0.66  0.12 
MVE RBF # = 2
3 kNN k = 5  6.22  5.76  5.57  5.69  0.65  0.13 
SPE  6.82  6.19  6.18  6.13  0.60  0.14 
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MVEPE  8.37  6.41  7.91  6.40  0.52  0.13 
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Table  4.  Number  of  canonization  algorithms  that  perform  significantly  better  on  two-
dimensional  layouts  (three-dimensional  conformations)  compared  to  three-dimensional 
conformations (two-dimensional layouts) in more than 50% of the performed retrospective 
virtual screenings. The total number of algorithms compared is 42. Results are shown for 
significance levels 0.05 and 0.01 per target and for the averaged percentages for all targets. 
 p   <   0 . 0 5   p   <   0 . 0 1  
 2 D   3 D   2 D   3 D  
ACE  2  24  2  18 
COX2  19  19  19  19 
DHFR  19  15  13  12 
FXA  18  15  16  11 
PPAR! 3  1 2  0  4  
THR  5  26  3  25 
Ø  1  14  0  4 
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Table 5. Retrospective results attained from data fusion between PhAST 2D (canonization: 
MVE DK, covalent connectivity) and PhAST 3D (canonization: MVE RBF # = 2
2, kNN 
connectivity with k = 3). Shown are the averaged retrospective performance measured by 
averaged  BEDROC  scores  per  target  and  averaged  over  all  targets,  the  percentage  of 
significantly  improved  screenings  at  significance  level  0.05  (0.01)  and  the  averaged  rank 
correlation of active ranks between each of the original methods and the method resulting 
from rank-based data fusion per target (PhAST DF). 
   A C E   C O X 2   D H F R   F X A   P P A R ! T H R   Ø  
PhAST DF  0.40  0.43  0.55  0.38  0.26  0.43  0.41 
PhAST 2D  0.40  0.40  0.57  0.36  0.25  0.42  0.40  BEDROC 
PhAST 3D  0.37  0.43  0.51  0.35  0.27  0.41  0.39 
PhAST DF  35 
(21) 
66 
(62) 
5 
(5) 
65 
(61) 
36 
(34) 
55 
(51) 
44 
(39) 
PhAST 2D  35 
(24) 
21 
(17) 
86 
(78) 
26 
(24) 
27 
(18) 
30 
(27) 
38 
(31) 
PhAST DF  74 
(65) 
31 
(27) 
70 
(79) 
81 
(79) 
14 
(14) 
63 
(61) 
55 
(53) 
% p < 0.05 
(% p < 0.01) 
PhAST 3D  9 
(9) 
46 
(43) 
16 
(9) 
12 
(11) 
52 
(41) 
27 
(25) 
27 
(23) 
PhAST 2D / 
PhAST DF  0.82  0.83  0.93  0.82  0.86  0.85  0.85 
Kendall's "  PhAST 3D / 
PhAST DF  0.77  0.86  0.87  0.82  0.88  0.84  0.84 
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Table 6. Retrospective Comparison of PhAST with canonization algorithm MVE RBF # = 2
2, 
kNN connectivity with k = 3 (PhAST 3D) applied to single (SC) and multi conformations 
(MC) generated for the COBRA library. Using multiple conformations, each molecule was 
represented  by  10  conformations.  Shown  are  the  averaged  retrospective  performance 
measured  by  averaged  BEDROC  scores  per  target  and  averaged  over  all  targets  and  the 
percentage of significantly improved screenings at significance levels 0.05 and 0.01. 
   A C E   COX2  DHFR  PPAR! T H R   F X A   Ø  
PhAST 3D MC  0.45  0.41  0.51  0.28  0.42  0.40  0.41 
PhAST 2D  0.40  0.40  0.57  0.25  0.42  0.36  0.40  BEDROC 
PhAST 3D SC  0.37  0.43  0.51  0.27  0.41  0.35  0.39 
PhAST 3D MC  74 
(62) 
49 
(48) 
9 
(9) 
57 
(52) 
45 
(44) 
71 
(71) 
51 
(48) 
PhAST 2D  3 
(0) 
38 
(38) 
78 
(75) 
23 
(11) 
48 
(45) 
20 
(18) 
35 
(31) 
PhAST 3D MC  79 
(71) 
19 
(16) 
30 
(27) 
43 
(36) 
49 
(48) 
82 
(82) 
51 
(47) 
% p < 0.05 
(% p < 0.01) 
PhAST 3D SC  0 
(0) 
65 
(63) 
48 
(47) 
32 
(20) 
44 
(42) 
12 
(11) 
33 
(31) 
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Table 7. Retrospective comparison of PhAST 3D (canonization: MVE RBF # = 2
2, kNN 
connectivity with k = 3) applied to single conformations (SC) and 10 conformations (MC). 
Shown are the retrospective performance of each method measured by averaged BEDROC 
scores  per  target  and  averaged  over  all  targets,  the  difference  between  retrospective 
performance, the averaged Levenshtein and Damerau-Levenshtein distance between PhAST-
sequences generated from single conformations and the 10 conformations generated for the 
same molecule for each target as well as the averaged number of rotatable single bonds in 
molecules per target. 
 A C E   C O X 2   D H F R   P P A R ! T H R   F X A  
PhAST 3D MC  0.45  0.41  0.51  0.28  0.42  0.40 
PhAST 3D SC  0.37  0.43  0.51  0.27  0.41  0.35 
$% BEDROC  0.08  -0.02  0.00  0.02  0.01  0.05 
Ø Levenshtein distance  6.24  2.32  3.62  3.54  8.61  6.25 
Ø Damerau-Levenshtein distance  5.43  2.04  2.66  2.85  7.72  6.25 
Ø No. Rotatable Bonds  9.06  3.91  6.78  7.00  10.51  7.63 
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Table  8.  Retrospective  comparison  of  virtual  screening  methods.  Shown  are  averaged 
BEDROC scores per target, the averaged BEDROC score averaged over all targets and the 
averaged rank of each method based on per target method rankings. 
  BEDROC 
 A C E   C O X 2   DHFR  FXA  PPAR!  THR  Ø  Ø Rank 
CATS 2D raw  0.43  0.25  0.20  0.18  0.17  0.24  0.24  14.17 
CATS 2D sens  0.51  0.27  0.44  0.26  0.34  0.39  0.37  6.83 
Esshape 3D  0.11  0.23  0.10  0.17  0.07  0.12  0.13  17.33 
Esshape 3D HYD  0.09  0.23  0.11  0.14  0.07  0.10  0.12  17.33 
GpiDAPH3  0.61  0.55  0.49  0.26  0.29  0.32  0.42  5.50 
LINGO  0.59  0.47  0.36  0.39  0.25  0.38  0.41  5.50 
LIQUID  0.41  0.22  0.19  0.19  0.16  0.35  0.26  14.00 
MACCS  0.48  0.47  0.44  0.29  0.26  0.33  0.38  7.50 
PhAST 2D  0.40  0.40  0.57  0.42  0.25  0.36  0.40  6.67 
PhAST 3D  0.37  0.43  0.51  0.41  0.27  0.35  0.39  7.17 
piDAPH3  0.45  0.50  0.51  0.20  0.28  0.25  0.37  8.67 
piDAPH4  0.49  0.56  0.55  0.28  0.28  0.29  0.41  6.17 
PRPS  0.33  0.54  0.70  0.25  0.20  0.20  0.37  9.83 
SIMPLE  0.24  0.30  0.20  0.21  0.12  0.20  0.21  14.50 
TAD  0.59  0.38  0.28  0.28  0.33  0.34  0.37  7.50 
TAT  0.56  0.37  0.35  0.33  0.34  0.38  0.39  5.83 
TGD  0.60  0.39  0.28  0.26  0.32  0.37  0.37  6.83 
TGT  0.52  0.32  0.35  0.24  0.25  0.36  0.34  9.67 
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Table 9. Number of screenings a screening method performs significantly better than every 
other method in the comparison. Results for significance levels 0.05 and 0.01, the latter in 
parentheses.  Per  target  the  number  of  screenings  is  presented,  the last  column  shows  the 
percentage of all 689 screenings performed for comparison. 
 A C E   C O X 2   D H F R   F X A   P P A R ! T H R   Ø   %  
MACCS  1  (0)  10  (10)  4  (3)  35  (35)  0  (0)  0  (0)  7  (7) 
CATS2D raw  0  (0)  2  (2)  0  (0)  0  (0)  0  (0)  0  (0)  0  (0) 
CATS2D sens  0  (0)  0  (0)  0  (0)  1  (1)  9  (7)  26  (25)  5  (5) 
ESshape3D  0  (0)  1  (1)  0  (0)  0  (0)  0  (0)  0  (0)  0  (0) 
ESshape3D HYD  0  (0)  0  (0)  0  (0)  1  (1)  0  (0)  5  (5)  1 ( 1 )  
GpiDAPH3  2  (1)  41  (39)  1  (1)  3  (2)  4  (4)  4  (4)  8  (7) 
LINGO  1  (1)  2  (2)  0  (0)  94  (89)  0  (0)  12  (12)  16  (15) 
LIQUID  2  (2)  0  (0)  0  (0)  0  (0)  0  (0)  10  (10)  2  (2) 
PRPS  0  (0)  22  (21)  50  (50)  4  (4)  2  (2)  5  (5)  12  (12) 
PhAST_2D  0  (0)  0  (0)  1  (1)  20  (19)  1  (1)  45  (41)  10  (9) 
PhAST_3D  0  (0)  1  (0)  0  (0)  12  (12)  0  (0)  28  (25)  6  (5) 
SIMPLE  0  (0)  3  (3)  0  (0)  6  (4)  2  (2)  1  (1)  2  (1) 
TAD  2  (2)  0  (0)  0  (0)  13  (12)  3  (2)  1  (1)  3  (2) 
TAT  1  (0)  0  (0)  0  (0)  11  (11)  5  (3)  12  (11)  4  (4) 
TGD  4  (1)  2  (2)  0  (0)  2  (2)  0  (0)  7  (7)  2  (2) 
TGT  2  (2)  9  (9)  0  (0)  0  (0)  0  (0)  7  (7)  3  (3) 
piDAPH3  0  (0)  5  (5)  1  (1)  1  (1)  1  (0)  0  (0)  1  (1) 
piDAPH4  0  (0)  2  (2)  4  (4)  1  (1)  0  (0)  0  (0)  1  (1) 
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Table 10. Retrospective results attained from data fusion between PhAST 2D (canonization: 
MVE  DK,  covalent  connectivity)  and  PRPS.  Shown  are  the  averaged  retrospective 
performance measured by averaged BEDROC scores per target and averaged over all targets, 
the percentage of significantly improved screenings at significance level 0.05 (0.01) and the 
averaged rank correlation between each of the original methods and the method resulting 
from rank-based data fusion per target (referred to as ‘Fused’). 
   A C E   C O X 2   D H F R   F X A   P P A R ! T H R   Ø 
Fused  0.44  0.53  0.72  0.36  0.27  0.37  0.45 
PhAST 2D  0.40  0.40  0.57  0.42  0.25  0.36  0.40  BEDROC 
PRPS  0.33  0.54  0.70  0.25  0.20  0.20  0.37 
Fused  59 
(44) 
79 
(79) 
81 
(81) 
39 
(38) 
45 
(39) 
17 
(17) 
54 
(50) 
PhAST 2D  38 
(38) 
18 
(18) 
19 
(19) 
57 
(56) 
30 
(27) 
78 
(76) 
40 
(39) 
Fused  68 
(65) 
40 
(38) 
27 
(23) 
92 
(91) 
57 
(50) 
91 
(89) 
62 
(59) 
% p < 0.05 
(% p < 0.01) 
PRPS  3 
(3) 
49 
(46) 
45 
(45) 
8 
(8) 
27 
(20) 
7 
(7) 
23 
(22) 
Fused / PhAST 2D  0.76  0.56  0.67  0.79  0.65  0.79  0.70  Kendall’s " 
Fused / PRPS  0.42  0.63  0.71  0.48  0.59  0.34  0.53 
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Table 11. Retrospective results of PhAST employing double dynamic programming (DDP) as 
scoring  function  for  aligned  residues  instead  of  a  function-based  score  matrix.  Query 
compounds are named according to their PDB identifier. Each screening was evaluated by its 
BEDROC  score.  Retrospective  results  of  PhAST  2D  (canonization:  MVE  DK,  covalent 
connectivity) and PhAST 3D (canonization: MVE RBF # = 2
2, kNN connectivity with k = 3) 
are shown for comparison. For PhAST DDP, the 2D canonization algorithm is MVE DK with 
covalent  connectivity,  the  3D  canonization  algorithm  is  MVE  RBF  # =  2
2  with  kNN 
connectivity and k = 3. 
  PhAST DDP 
 C a n o n i z a t i o n   2 D   C a n o n i z a t i o n   3 D  
 
Query 
static  flexible  dynamic  static  flexible  dynamic 
PhAST 2D  PhAST 3D 
LPR  0.28  0.07  0.13  0.14  0.08  0.16  0.47  0.49  ACE 
MCO  0.06  0.05  0.03  0.13  0.08  0.05  0.28  0.43 
DIF  0.12  0.11  0.07  0.07  0.14  0.12  0.09  0.08  COX2 
S58  0.66  0.17  0.16  0.57  0.26  0.24  0.53  0.51 
TOP  0.19  0.09  0.16  0.17  0.17  0.12  0.70  0.69  DHFR 
MOT  0.30  0.12  0.17  0.26  0.30  0.12  0.73  0.66 
RPR  0.23  0.18  0.17  0.23  0.17  0.19  0.57  0.51  FXA 
Z34  0.19  0.23  0.13  0.18  0.12  0.15  0.44  0.52 
570  0.17  0.10  0.14  0.13  0.16  0.17  0.20  0.22 
PPAR! 
BRL  0.30  0.25  0.32  0.28  0.31  0.29  0.52  0.51 
2TS  0.23  0.13  0.16  0.19  0.13  0.17  0.54  0.58  THR 
163  0.24  0.08  0.14  0.10  0.08  0.14  0.34  0.30 
Ø    0.25  0.13  0.15  0.20  0.17  0.16  0.45  0.46 
 
 
Page 36 of 39
John Wiley & Sons, Inc.
Journal of Computational Chemistry
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60For Peer Review
  
 
 
!"#$%&'(''
()*+(,-..'/0--'+'0--'1234''
 
 
Page 37 of 39
John Wiley & Sons, Inc.
Journal of Computational Chemistry
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60For Peer Review
  
 
 
!"#$%&'(''
)*+,)-(..'/*++','*++'0123''
 
 
Page 38 of 39
John Wiley & Sons, Inc.
Journal of Computational Chemistry
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60For Peer Review
  
 
 
!"#$%&'()*$$
+,-+.//$0122$-$122$3456$$
 
 
Page 39 of 39
John Wiley & Sons, Inc.
Journal of Computational Chemistry
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60  1!
Canonization Algorithms 
 
The atom-typing step of PhAST yields a graph of potential pharmacophoric points. It has the 
same topology as the original molecular graph without hydrogen atoms yielding a total of n 
vertices. Each vertex is colored with a symbol corresponding to one out of nine potential 
pharmacophoric features. Edges correspond to covalent bonds. Canonization is the labeling of 
the vertices with the natural numbers 1,2,3,… ,n. In the following description of canonization 
methods, vertices are referred to as 
! 
vi with   and their coordinates in Euclidean space 
as 
! 
xvi . 
Centroid Linearization. Centroid linearization uses the distance of each vertex to the 
geometric centre of the complete graph as a prioritization criterion. The vertex with the lowest 
distance has highest priority and received the smallest canonical label. Vertices were labeled 
in ascending order. Centroid linearization was applied to 2D layouts and 3D conformations of 
molecular graphs. 
  Principal  Component  Analysis.  Principal  component  analysis
  (PCA)  is  a  linear 
dimensionality reduction method often used to visualize high-dimensional data.
1 We used 
PCA to compute one-dimensional (1D) coordinates from 2D graph layouts generated by the 
2D  depiction  algorithm  of  MOE  (Molecular  Operating  Environment,  v2010.06,  Chemical 
Computing Group, Montreal, Canada). For PCA coordinates of vertices are mean-centered. 
Eigenvectors  of  the  covariance  matrix  calculated  from  position  vectors 
! 
xvi   are  used  to 
compute new coordinates for all vertices. The dot product between the original position vector 
of a vertex and the eigenvector with highest eigenvalue yields a 1D coordinate. We assigned 
canonical labels in ascending order starting from the vertex with lowest 1D coordinate in 
principal  component  space.  PCA  was  applied  to  2D  layouts  and  3D  conformations  of 
molecular graphs. 
  Laplacian  Eigenmaps.  Laplacian  Eigenmaps
  rely  on  a  neighborhood  definition 
between  vertices  generated  through  a  connectivity  algorithm  (see  section  Connectivity 
Algorithms).
2  The  canonization  process  starts  by  calculating  three  matrices  from  the 
neighborhood graph: (i) the weight matrix W with (Eq. 1) 
 
! 
Wij =
1
0
if i and j are connected
else
" 
# 
$ 
,               (1) 
 
(ii) the degree weight matrix D with the column sums of W as entries (Eq. 2), 
 
! 
Dii = Wij
j
" ,                   (2) 
 
and (iii) the positive semidefinite Laplacian matrix L (Eq. 3) with 
 
! 
L = D"W  .                   (3) 
 
Then, the eigenvalues and eigenvectors of the generalized eigenvector problem (Eq. 4) 
are calculated. 
 
! 
Lf = "Df                   (4) 
 
Eigenvectors  (fi)  are  sorted  according  to  their  eigenvalues  (li)  in  ascending  order. 
Eigenvector f0 with l0 = 0 is omitted. The next d eigenvectors are used for embedding. In our 
! 
1" i " n  2!
case,  the  second  eigenvector  contains  the  coordinates  for  the  1D  embedding.  Laplacian 
eigenmaps were applied to 2D layouts and 3D conformations of molecular graphs. 
  Isomap.  Isomap  needs  a  neighborhood  definition  between  vertices.
3  The  algorithm 
uses the neighborhood graph to estimate geodesic distances between vertices. A matrix D of 
shortest distances between all vertices was computed using the Floyd-Warshall algorithm.
4,5 
Using D, the matrix 
! 
"(D) is calculated (Eq. 5): 
 
! 
"(D) = #
1
2 *HSH,                (5) 
 
where S is the matrix of squared distances (Eq. 6) 
 
! 
Sij = Dij
2
,                  (6) 
 
and H the centering matrix (Eq. 7) 
 
! 
Hij ="ij #
1
n                 
(7) 
 
with 
! 
"ij  the  Kronecker  delta  and  n  the  number  of  vertices.  The  eigenvectors  and 
eigenvalues of 
! 
"(D) are computed. To embed in d dimensions, the first d eigenvectors sorted 
according to their eigenvalues in decreasing order are used. If lp is the p
th eigenvalue of 
! 
"(D) 
and 
! 
fp
i  is  the  i
th  component  of  the  p
th  eigenvector,  then  the  p
th  component  of  the  d-
dimensional coordinate vector of a vertex is equal to 
! 
fp
i "p . Isomap was applied to 2D 
layouts and 3D conformations of molecular graphs. 
  Minimum Volume Embedding. Minimum volume embedding (MVE) is a non-linear 
dimensionality reduction algorithm.
6 It minimizes information loss during embedding in d 
dimensions. MVE requires two representations of the set of vertices: The affinity matrix 
! 
A 
calculated using a kernel function, and a symmetric binary connectivity matrix 
! 
C constructed 
through  the  application  of  a  connectivity  algorithm  to 
! 
A.  Dimensionality  reduction  is 
achieved by an iterative process based on semidefinite programming (SDP). A third matrix 
! 
K 
is set equal to 
! 
A and the following procedure is repeated until convergence: (i) calculate the 
eigenvectors fi and eigenvalues li of 
! 
K and sort the fi descending to their corresponding li. (ii) 
calculate the matrix 
! 
B using Eq. (8), 
 
! 
B = " fi fi
T + fi fi
T
i=d +1
N
#
i=1
d
#               (8) 
 
(iii) use SDP to solve Eq. (9) 
 
! 
K =
K"#
argmintr(KB)
               
(9) 
 
under constraints 
! 
" defined by Shaw and Jebara,
6 tr denotes the matrix trace (sum of 
the diagonal elements). After convergence, kernel PCA
7 is performed with 
! 
K to get the d 
eigenvectors used for embedding. 
We will now describe the kernel functions and connectivity algorithms we chose for 
our study. 
 
1. Diffusion Kernel   3!
The currently best-performing version of PhAST uses a diffusion kernel.
8 It is solely 
based on topological information, thus independent from spatial vertex coordinates. 
For each pair of vertices 
! 
vi,v j ( ) the diffusion kernel calculates the probability of a 
random walk starting in 
! 
vi ending in 
! 
v j after an infinite number of steps, with only a 
low probability of leaving the current vertex in each step. The diffusion kernel matrix 
is calculated according to Eq. (10)
9 
 
                (10) 
 
with  !  the  diffusion  parameter  and 
! 
L  the  Laplacian  matrix  (Eq.  3).  The  best 
performing version of PhAST so far uses ! = 0.4. The combination of MVE and the 
diffusion kernel will be referred to as ‘MVE DK’. MVE DK was applied only to 2D 
layouts of molecular graphs. 
 
2. P-Step Random Walk Kernel 
A kernel function that only depends on graph topology is the p-step random walk 
kernel.
10 It is calculated using the normalized Laplacian matrix   with entries (Eq. 
11) 
 
! 
˜  L  ij =
1
"
1
deg(vi) # deg(v j)
0
$ 
% 
&  & 
' 
& 
& 
if i = j
if vi adjacent v j
else
,
        (11) 
 
where deg is the degree of a vertex. The kernel matrix is calculated as Eq. (12) 
 
                (12) 
 
  with  .
10  We  investigate  p-step  random  walk  kernels  with  a  assuming 
values of 2, 4, 6, 8 and 10. For p we chose two values that automatically adjust to the 
current graph: We measure the distance between two vertices as the number of bonds 
along the shortest path. The eccentricity of a vertex is its distance to the farthest vertex 
in the graph.
11 Our first choice for p was the smallest eccentricity of a vertex in the 
graph,  referred  to  as  the  ‘graph  radius’.
11  The  second  choice  was  the  largest 
eccentricity of a vertex in the graph, referred to as the graph ‘diameter’.
11 Both were 
determined using the Floyd Warshall algorithm.
4,5 The combination of MVE and the 
p-step  random  walk  kernel  will  be  referred  to  as  ‘MVE  PRW’.  MVE  PRW  was 
applied only to 2D layouts of molecular graphs. 
 
3. Inner Products from Euclidean Coordinates 
As a first kernel function depending on Euclidean vertex coordinates we employed a 
method that calculates inner products from Euclidean coordinates of vertices referred 
to as ‘Euclidean distance kernel’ (Eq. 13). 
 
! 
Kij
euclidean =
1
2
" xvi
2
+ xv j
2
# xvi # xv j
2 $ 
% 
& 
' 
( 
) 
.          (13)
 
 
! 
K
diffusion = e
("#L)
! 
˜  L 
! 
K
pstep = aI " ˜  L  ( )
p
! 
a "2  4!
The combination of MVE and the Euclidean distance kernel will be referred to as 
‘MVE  EDK’.  MVE  EDK  was  applied  to  2D  layouts  and  3D  conformations  of 
molecular graphs. 
 
4. RBF Kernel 
As second kernel function depending on Euclidean coordinates is the Gaussian radial 
basis function (RBF) kernel (Eq. 14).
12 
 
 
! 
Kif
rbf = exp "
xvi " xv j
2
2#
2
$ 
% 
& 
&  & 
' 
( 
) 
)  ) 
,                (14) 
 
  with  "  the  standard  deviation.  We  parameterized  the  RBF  kernel  in  a  grid 
search with " chosen according to Eq. (15) 
 
,                  (15) 
 
where k was incremented in steps of 1. For 
! 
k < "1 the kernel matrix was mostly filled 
with zeros, and the eigenvalue problem is degenerated. For 
! 
k > 3 all matrix entries 
approached 1 for small molecules. The combination of MVE and the Gaussian radial 
basis function kernel will be referred to as ‘MVE RBF’. MVE RBF was applied to 2D 
layouts and 3D conformations of molecular graphs. 
 
Proximity Embedding. Proximity embedding (PE) utilizes pairwise distances between points 
to embed a dataset in arbitrary dimensions conserving the given distances. Given a pair of 
points 
! 
xvi,xv j ( ) the algorithm calculates their Euclidean distance 
! 
d(
txvi,
txv j ) in the target 
dimension  t  (in  our  case:  1).  This  distance  is  compared  to  the  corresponding  distance 
! 
d(
sxvi,
sxv j ) in the starting dimension s. If 
! 
d(
txvi,
txv j ) " d(
sxvi,
sxv j ), the position of 
! 
vi and 
! 
v j 
in the target dimension is updated using Eq. (16) and Eq. (17), respectively. 
 
! 
txvi
new=
txvi
old +
" d(
sxvi,
sxv j ) # d(
txvi
old,
txv j ) ( )
d(
txvi
old,
txv j )
*
txvi
old #
txv j ( )      (16) 
 
! 
txv j
new=
txv j
old +
" d(
sxvi,
sxv j ) # d(
txvi,
txv j
old) ( )
d(
txvi,
txv j
old)
*
txvi #
txv j
old ( )      (17) 
 
where l is a linear learning rate that controls the update step-size of the algorithm with 
! 
l =1 for the first iteration and 
! 
l = 0 for the last iteration. We used PE for the embedding from 
two and three dimensions in one dimension with 5000n iterations. After termination the order 
of  vertices  in  the  embedding  dimension  starting  from  the  lowest  coordinate  defines  the 
canonical order. We used PE in two different variants: In stochastic proximity embedding 
(SPE)
13 pairs of vertices are chosen randomly. We also evaluated a systematic algorithmic 
variation was in which all pairs of vertices were chosen 5000 times. To ensure the invariant 
ordering of vertices independent from molecule input, the molecular graph was canonically 
labeled with MVE DK before the application of PE. This version is referred to as ‘MVEPE’. 
SPE and MVEPE were applied to 2D layouts and 3D conformations of molecular graphs. 
! 
" = 2
k
! 
"1# k # 3  5!
Connectivity Algorithms 
 
Laplacian eigenmaps, Isomap and MVE in variants EDK and RBF depend on neighborhood 
definitions for each vertex. In this study, we compared results obtained with two different 
connectivity algorithms: (i) covalent bonds, and (ii) k nearest neighbors. 
  Covalent Bonds. The graph o potential pharmacophoric points has the same topology 
as the original molecular graph with suppressed hydrogen atoms. Edges represent covalent 
bonds.  Using  only  this  information  the  binary  connectivity  matrix 
! 
C  corresponds  to  the 
adjacency matrix of the graph. 
  k  Nearest  Neighbors.  Using  symmetric  k  nearest  neighbors  (kNN)
14  the  binary 
connectivity matrix 
! 
C was initialized with all entries 0. For each vertex 
! 
vi with 
! 
1" i " n, 
! 
Cij 
and 
! 
C ji were set to 1 if the distance calculated from 
! 
Aij is one of the top k values for 
! 
1" j " n
. For MVE, the k nearest neighbor algorithm was applied to distances the affinity matrix, not 
the original space. Due to the symmetry condition vertices can end up having more than k 
neighbors. For k we used 2, 3, 4 and 5. 
  MVE DK and MVE PRW were used only with covalent connectivity. This was due to 
the fact that in MVE the connectivity algorithm is applied to the kernel matrix, which in these 
cases is calculated using already defined neighborhoods. 
   6!
References 
 
1  Pearson, K. Philos Mag 1901, 2, 559. 
2  Belkin, M.; Niyogi, P. Neural Comput 2003, 15, 1373. 
3  Tenenbaum, J. B.; de Silva, V.; Langford, J. C. Science 2000, 290, 2319. 
4  Floyd, R. W. Comm ACM 1962, 5, 345. 
5  Warshall, S. J ACM 1962, 9, 11. 
6  Shaw, B.; Jebara, T. Proceedings of the Eleventh International Conference on Artificial 
Intelligence and Statistics; Omnipress: Madison, 2007. 
7  Schölkopf, B.; Smola, A.; Müller, K. Neural Comput 1998, 10, 1299. 
8  Kondor, R. I.; Lafferty, J. D. Proceedings of the Nineteenth International Conference on 
Machine Learning; Morgan Kaufmann Publishers Inc.: San Francisco, 2002. 
9  Tsuda, K.; Noble, W. S. Bioinformatics 2004, 20, 326. 
10  Smola,  A.  J.;  Kondor,  R.  I.  Proceedings  of  the  16th  Annual  Conference  on 
Computational  Learning  Theory  and  7th  Kernel  Workshop;  Springer:  Berlin  and 
Heidelberg, 2003. 
11  Petitjean, M. J Chem Inf Comput Sci 1992, 32, 331-337. 
12  Schölkopf,  B.;  Smola,  A.  J.  Learning  with  Kernels;  The  MIT  Press:  Cambridge 
(Massachusetts), London (England), 2002. 
13  Agrafiotis, D. K. J Comput Chem 2003, 24, 1215. 
14  Cover, T.; Hart, P. IEEE Trans Inform Theor 1967, 13, 21. Parameterization of Double Dynamic Programming 
 
In order to use DDP as sequence comparison step in PhAST we switched back to 
the slower Needleman-Wunsch-
1 instead of the FSM
2 algorithm because it calculates the 
exact optimal global pairwise sequence alignment. Using DDP, scores for the alignment of 
particular symbols are calculated by a second level of dynamic programming based on 
structural instead of functional similarity. We will refer to these two levels as ‘residue 
level’ for the dynamic programming level equal to the normal dynamic programming and 
‘distance level’ for the dynamic programming level calculating the scores for the residue 
level. The simplest approach for proteins is to consider only Ca atoms in these calculations. 
When  sequences  X = x1x2…xn  and  Y = y1y2…ym  are  aligned  and  the  score  for 
aligning  residues  xi  and  yj  on  residue  level  have  to  be  calculated,  a  position-specific 
distance score matrix 
! 
D
ij with entries [Eq. (1)] 
 
! 
Dkl
ij =
a
Xdi,k "Yd j,l +b
!! ! ! ! ! ! "#$
 
 
Because  of  experiences  with  DDP  for  protein  comparison
3  we  implemented  a 
slightly modified approach and modified Eq. (1) yielding Eq. (2) 
 
! 
Dk,l
i, j =
a
2b
2
a
Xdi,k "Yd j,l
# log(k "i + l " j +1)
if k = i,l = j
else
$ 
% 
& 
'  & 
.
    (2) 
 
To ensure that the alignment of xi and yj is included in the distance level alignment 
the score of this event was set to a
2b
2. The first part of the term in the ‘else’ case is the 
actual structural component of the score, expressing the structural similarity of xk and yl 
under  the  assumption  that  xi  and  yj  are  structurally  equivalent.  The  second  part  is  a 
sequence  distance  component  that  damps  the  contribution  from  near  neighbors  in  the 
sequence. The idea is that it is likely that the structural similarity is high if xk (yl) is close to 
xi (yj).
3 
 
With two levels of dynamic programming there are two sets of gap penalties accompanied 
by the new parameters a and b. In addition, all scores calculated during DDP are positive, 
because of the absolute value used in Eq. (20) and Eq. (21), respectively. As a result, gap 
penalties have to be low positive scores. Compared to sequence alignment with dynamic 
programming  the  scores  calculated  with  DDP  turned  out  to  be  huge  (not  shown).  We 
addressed all these problems as follows: 
To have an origin for parameterization we set a = 100 and b = 2 in the calculation 
of distance level score matrices. After calculation of distance level alignment scores, a
2b
2 
was  subtracted  as  this  value  was  only  used  to  attract  the  alignment  algorithm  to  the 
alignment of xi and yj in the calculation of the distance level alignment, but it dominates the 
calculated alignment score.  
For distance level gap penalties we implemented three different solutions: i) static 
gap  penalties  that  are  used  in  every  distance  level  alignment  for  every  sequence 
comparison, ii) flexible gap penalties that are determined for each sequence pair but used 
in every distance level alignment, and iii) dynamic gap penalties that are determined for 
each distance level alignment. At the same time we determined a ‘correction value’ that is 
subtracted from each distance level alignment score, translating these scores partially in the negative spectrum to make the scoring system comparable to functional score matrices. 
Gap penalties and correction values were calculated under some constraints deduced from 
the original PhAST (functional) score matrix
4 as template: 24% (64%) of the scores were 
below the gap open (gap extension) penalty of -5 (-1). Again, 64% of all scores were below 
0, so we used this ratio as guideline for the correction value. 
  Static Gap Penalties. We determined a gap open and a gap extension penalty using 
two  molecules  as  example.  We  chose  two  PPAR!  agonists  from  the  COBRA  library 
(Figure 1).
5 They exhibit partial structural similarity and differ only slightly in size. We 
calculated all distance level score matrices and merged them in one distribution. With gap 
open (gap extension) penalty 30 (53) the constraints of 24% (64%) of the scores in this 
distribution being smaller than the corresponding penalty were fulfilled. The constraint for 
the  correction  value  was  satisfied  with  a  value  of  m
2n
2*2.11.  With  this  model,  gap 
penalties are static, but the correction value depends on sequence lengths. We chose a non-
static correction value instead of one suitable for our toy example because preliminary 
results indicated higher retrospective performance with this choice. 
  Flexible  Gap  Penalties.  To  make  the  scoring  system  more  flexible,  we 
implemented a second penalty model. It is similar to the construction of the static model 
but applied to each sequence pair before its actual comparison. Before DDP was applied to 
a sequence pair, we constructed all distance level score matrices and merged all distance 
scores  into  a  single  distribution.  Gap  penalties  were  chosen  to  fulfill  constraints.  The 
correction  value  was  optimized  in  a  binary  search  approach:  starting  from  10,000  the 
fraction of scores below 0 obtained using this correction value was determined. If the 
correction value was too high (low), it was scaled with 0.5 (1.5). Starting from 10,000 
proved to be sufficient for all our test cases. 
  Dynamic Gap Penalties. For each distance score matrix the gap penalties were set 
to fulfill constraints. So each of the mn distance score matrices created in the comparison 
of two sequences used a different set of gap penalties. The correction value was calculated 
as described for flexible gap penalties. 
To further reduce distance level alignment scores after subtracting a
2b
2 and the 
correction value, each score si,j was transformed according to Eq. (22). 
 
,
              (22) 
 
where sign is the signum function and   is the golden ratio (1.618). Applying the 
logarithm to scores was already reported for DDP for protein sequence comparison
47 We 
used  the  golden  ratio  because  we  needed  a  small  base,  and  preliminary  results  were 
promising. Resulting scores spanned a range comparable to those calculated by PhAST 
using the original functional score matrix. Because of that fact we used gap open penalty -5 
and  gap  extension  penalty  -1,  and  as  final  similarity  measure  between  sequences  the 
residue level alignment score normalized to alignment length. 
 
 
 
 
 
 
 
 
 
 
! 
si, j
* = sign si, j ( )*log" si, j ( )
! 
" 
 
 
 
 
 
 
 
 
 
Figure 1. PPAR! agonists used for parameterization of double dynamic programming. A) 2D depiction 
of  the  molecular  graphs  revealing  parts  of  structural  identity,  depictions  generated  with  MOE 
(Molecular Operating Environment, v2010.06, Chemical Computing Group Inc., Montreal, Canada), B) 
MOE rigid body alignment of CORINA (v3.46, Molecular Networks GmbH, Erlangen, Germany) 3D 
conformations. Molecules were taken from the COBRA collection of drugs and lead compounds. 
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PhAST employing minimum volume embedding utilizing a diffusion kernel in combination 
with covalent connectivity exhibited highest retrospective screening performance so far. Due 
to this fact, this particular version of PhAST will be referred to as ‘baseline PhAST’. 
 
We  compared  the  retrospective  performance  of  PhAST  employing  different  canonization 
approaches applied to 2D layouts and 3D conformations of molecules in a series of virtual 
screenings.  Table  1  presents  the  results  evaluated  using  the  BEDROC  metric  (!  =  20). 
Corresponding p-values attained from the paired permutation test for significance assessment 
are given in Table 2 (significance level 0.05) and Table 3 (significance level 0.01). Table 4 to 
Table 7 give p-values for baseline PhAST compared to the other canonization algorithms 
listed in Table 3. In the following comparison, the application of a canonization algorithm to 
2D layouts is referred to as ‘2D version’, the application to 3D conformations as ‘3D version’. 
With an averaged BEDROC score of 0.3 centroid linearization performs significantly 
worse  than  baseline  PhAST.  This  is  true  for  both  dimensionalities  of  molecular 
representations. Results obtained from the application to 2D layouts and 3D conformations 
are not identical but not significantly different either: At significance level 0.05 retrospective 
performance with 2D layouts (3D conformations) performs significantly better in 43% (46%) 
of all screenings. At 0.01 these percentages decrease to 39% and 43%, respectively. Centroid 
linearization is clearly outperformed by baseline PhAST in 77% and 75% of the performed 
screenings at significance levels of 0.05 and 0.01, respectively. 
For Isomap the retrospective performance strongly depends on the value of k used in 
determination  of  neighborhood  relations.  Worst  performance  results  from  k  =  2  with  an 
averaged BEDROC of 0.28 for both dimensionalities. Best performance is observed with k = 
3, with an averaged BEDROC of 0.34 for 2D and 0.35 for 3D. Only with k = 2 the 2D version 
performs significantly better than 3D, admittedly in less than 50% of all screenings. For all 
other k the 3D version significantly outperforms the 2D version at both significance levels, at 
0.05 in more than 50% of all screenings. The same is true for laplacian eigenmaps: k = 2 
yields lowest BEDROC scores for both dimensionalities, with increasing performance for 
increasing k with a slight drop again at k = 4 for the 2D version. For both significance levels 
the 3D version outperforms the 2D version significantly in more cases than vice versa for all k 
except k = 2. Baseline PhAST outperforms all versions of Isomap and laplacian eigenmaps in 
more than 50% of all screenings in both dimensionalities at both significance levels. 
The mediocre performance achieved using PCA for canonization we already knew to 
be true for 2D layouts (0.35) was affirmed for the application to 3D conformations as well 
(0.34). 
With MVE EDK for canonization the best retrospective performance is achieved using 
covalent connectivity (0.38 for 2D, 0.39 for 3D) with significant differences in 54% (45%) of 
all screenings. As for Isomap and Laplacian Eigenmaps, starting from k = 2 in k nearest 
neighbors as connectivity algorithm, retrospective performance increases with increasing k. In 
all parameterizations tested, the 3D version has higher averaged performance. For k nearest 
neighbors, highest performance is achieved for both dimensionalities with k = 3. At both 
significance levels baseline PhAST performs significantly better than any variant of MVE 
EDK in more than 50% of all screenings. 
For MVE RBF we evaluated five s in combination with five connectivity variants. The 
question is: Which one of these variables has greater influence on screening performance with 
MVE RBF as canonization algorithm? To address this problem we analyzed retrospective 
results for both dimensionalities separately. We calculated mean and standard deviations of 
averaged  retrospective  performance  for  each  "  with  varying  connectivity  and  each connectivity with varying s. From these values we calculated the corresponding coefficient of 
variation  (standard  deviation  /  mean)  (CV).  For  fixed  "  (connectivity)  with  varying 
connectivity (s) the mean CV is 0.038 (0.049) for the 2D version. For 3D the corresponding 
values are 0.045 and 0.065. These results identify s to have a (slightly) bigger impact on 
retrospective performance, because divergence in retrospective results is higher if s varies. 
The best performing parameter combination for the application to 2D layouts is s = 2
2 and 
covalent  connectivity,  for  3D  conformations  s  =  2
2  k  nearest  neighbors  with  k  =  3.  The 
corresponding averaged BEDROC scores are 0.37 for the 2D version and 0.39 for 3D. For the 
25  variants  of  MVE  RBF  tested,  the  2D  (3D)  version  performs  better  than  the  3D  (2D) 
version in 10 (15) cases. If we use the number of times a dimensionality outperforms the other 
in  over  50%  of  the  performed  screenings  at  the  chosen  significance  level  as  superiority 
criterion instead of just the averaged performance, these numbers further decrease for 2D 
(3D) to 1 (6) at 0.05 and only 0 (1) at 0.01. These results indicate that the assumed superiority 
in averaged retrospective performance for the usage of 3D single conformations is caused by 
the summation of insignificant differences. Compared to all variants of MVE RBF, baseline 
PhAST performs significantly better in at least 57% (49%) of all screenings in 2D (3D) at 
0.05 and 53% (45%) at 0.01 with the opposite being true in only 29 (33%) and 26% (33%) of 
all cases. Baseline PhAST performs superior to PhAST with MVE RBF, and no advantage of 
using a certain dimensionality of molecular representation could be established. 
Both variants of proximity embedding have lower averaged retrospective performance 
than baseline PhAST and are outperformed in at least 70% (65%) of all screenings at 0.05 
(0.01) significance level. For both methods of choosing vertex pairs, the application on 2D 
layouts performs slightly better, but always in fewer than 50% of all screenings. 
No parameterization of MVE PRW performs better in PhAST than baseline PhAST. 
The best performing variant (p = radius, a = 4) is outperformed in 51% (47) of all screenings 
at 0.05 (0.01), but performs better than baseline PhAST in only 25% (27%). So despite the 
fact  that  both  kernels  are  based  on  random  walks,  this  new  variant  of  MVE  using  only 
topological information is no improvement. 
 Table  1. C o m p a r i s o n  o f  d i f f e r e n t  c a n o n i z a t i o n  a l g o r i t h ms  by  their a v e r a g e d  r e t r o s p e c t i v e  p e r f o r m a n c e .  
Algorithms were applied to molecular representations in two and three dimensions. Screenings were evaluated 
by their BEDROC score. As MVE DK and MVE PRW only use topological information, the application to 3D 
conformations yielded identical results and is not shown. 
  Ø BEDROC      Ø BEDROC 
  2D  3D      2D  3D 
Centroid Linearization  0.30  0.30    MVE RBF " = 2
1 kNN k = 3  0.37  0.39 
Isomap kNN k = 2  0.28  0.28    MVE RBF " = 2
1 kNN k = 4  0.36  0.37 
Isomap kNN k = 3  0.34  0.35    MVE RBF " = 2
1 kNN k = 5  0.36  0.37 
Isomap kNN k = 4  0.32  0.34    MVE RBF " = 2
2 covalent  0.37  0.38 
Isomap kNN k = 5  0.33  0.35    MVE RBF " = 2
2 kNN k = 2  0.35  0.35 
Laplacian Eigenmaps kNN k = 2  0.29  0.27    MVE RBF " = 2
2 kNN k = 3  0.37  0.39 
Laplacian Eigenmaps kNN k = 3  0.35  0.36    MVE RBF " = 2
2 kNN k = 4  0.37  0.37 
Laplacian Eigenmaps kNN k = 4  0.34  0.36    MVE RBF " = 2
2 kNN k = 5  0.37  0.36 
Laplacian Eigenmaps kNN k = 5  0.34  0.37    MVE RBF " = 2
3 covalent  0.37  0.39 
PCA  0.35  0.34    MVE RBF " = 2
3 kNN k = 2  0.35  0.36 
MVE EDK covalent  0.38  0.39    MVE RBF " = 2
3 kNN k = 3  0.37  0.39 
MVE EDK kNN k = 2  0.35  0.35    MVE RBF " = 2
3 kNN k = 4  0.37  0.37 
MVE EDK kNN k = 3  0.37  0.39    MVE RBF " = 2
3 kNN k = 5  0.37  0.37 
MVE EDK kNN k = 4  0.37  0.37    SPE  0.36  0.35 
MVE EDK kNN k = 5  0.36  0.36    MVEPE  0.32  0.32 
MVE RBF " = 2
-1 covalent  0.36  0.34    MVE DK (b = 0.4)  0.40   
MVE RBF " = 2
-1 kNN k = 2  0.32  0.31    MVE PRW diameter a = 2  0.37   
MVE RBF " = 2
-1 kNN k = 3  0.34  0.33    MVE PRW diameter a = 4  0.38   
MVE RBF " = 2
-1 kNN k = 4  0.32  0.32    MVE PRW diameter a = 6  0.39   
MVE RBF " = 2
-1 kNN k = 5  0.30  0.29    MVE PRW diameter a = 8  0.39   
MVE RBF " = 2
0 covalent  0.36  0.37    MVE PRW diameter a = 10  0.39   
MVE RBF " = 2
0 kNN k = 2  0.33  0.33    MVE PRW radius a = 2  0.38   
MVE RBF " = 2
0 kNN k = 3  0.36  0.38    MVE PRW radius a = 4  0.39   
MVE RBF " = 2
0 kNN k = 4  0.34  0.34    MVE PRW radius a = 6  0.39   
MVE RBF " = 2
0 kNN k = 5  0.34  0.35    MVE PRW radius a = 8  0.39   
MVE RBF " = 2
1 covalent  0.37  0.38    MVE PRW radius a = 10  0.38   
MVE RBF " = 2
1 kNN k = 2  0.35  0.35         Table  2. C o m p a r i s o n  o f  d i f f e r e n t  c a n o n i z a t i o n  a l g o r i t h m s  b y  e s t i m a t e d  s i g n i f i c a n c e  o f  d i f f e r e n c e s  i n  
retrospective performance. Algorithms were applied to molecular representations in two and three dimensions. 
For each algorithm applied to 2D and 3D representations of molecules the percentage of screenings is listed 
where this combination of algorithm and dimensionality significantly outperforms the same algorithm on the 
other dimensionality. Percentages may not add up to 100 because in some cases differences are not significant. 
Significance level: 0.05. 
  Ø  ACE  COX2  DHFR  FXA  PPAR#  THR 
  2D  3D  2D  3D  2D  3D  2D  3D  2D  3D  2D  3D  2D  3D 
Centroid Linearization  43  46  68  18  20  76  28  61  79  18  41  32  21  69 
Isomap kNN k = 2  45  40  9  74  44  41  56  31  66  25  39  34  57  37 
Isomap kNN k = 3  31  52  12  62  24  74  61  19  29  60  30  39  27  62 
Isomap kNN k = 4  30  55  24  56  24  70  50  41  33  60  16  50  32  56 
Isomap kNN k = 5  28  55  12  56  28  65  25  53  48  42  25  50  28  65 
Laplacian Eigenmaps kNN k = 2  51  37  12  79  64  32  61  30  81  16  30  36  59  31 
Laplacian Eigenmaps kNN k = 3  33  53  15  71  21  70  53  34  57  32  27  48  26  65 
Laplacian Eigenmaps kNN k = 4  25  57  15  65  26  64  28  50  42  50  20  39  19  73 
Laplacian Eigenmaps kNN k = 5  25  57  18  68  26  62  27  56  38  46  16  45  23  66 
PCA  46  38  26  47  60  30  50  39  76  21  20  39  40  52 
MVE EDK covalent  29  54  12  62  32  60  25  67  33  55  18  43  54  38 
MVE EDK kNN k = 2  43  42  18  71  60  32  59  22  44  50  43  23  33  55 
MVE EDK kNN k = 3  35  50  15  59  62  28  38  41  52  40  18  66  26  67 
MVE EDK kNN k = 4  38  44  21  56  68  19  34  33  48  47  23  50  33  60 
MVE EDK kNN k = 5  42  42  24  47  77  17  48  27  53  44  18  57  31  59 
MVE RBF " = 2
-1 covalent  50  36  71  9  26  60  50  31  78  19  43  34  29  62 
MVE RBF " = 2
-1 kNN k = 2  44  45  26  56  82  15  58  36  57  33  14  64  31  64 
MVE RBF " = 2
-1 kNN k = 3  45  43  32  53  66  28  61  30  75  20  14  59  23  68 
MVE RBF " = 2
-1 kNN k = 4  41  47  44  41  18  77  25  64  79  20  32  39  49  40 
MVE RBF " = 2
-1 kNN k = 5  43  41  32  15  26  67  55  38  57  37  16  70  72  21 
MVE RBF " = 2
0 covalent  38  44  32  26  32  60  22  70  42  45  48  25  50  37 
MVE RBF " = 2
0 knn k = 2  44  44  12  65  84  11  23  61  46  52  55  20  43  54 
MVE RBF " = 2
0 knn k = 3  33  51  18  68  63  27  19  73  38  48  20  41  38  49 
MVE RBF " = 2
0 knn k = 4  38  46  24  53  30  61  30  53  47  44  43  27  54  38 
MVE RBF " = 2
0 kNN k = 5  37  44  32  32  29  66  38  38  57  32  23  50  42  48 
MVE RBF " = 2
1 covalent  29  51  18  44  30  58  20  70  26  59  39  32  43  44 
MVE RBF " = 2
1 kNN k = 2  36  50  15  74  38  52  58  30  40  57  18  45  46  44 
MVE RBF " = 2
1 kNN k = 3  32  49  12  62  63  24  19  69  39  51  30  30  31  61 
MVE RBF " = 2
1 kNN k = 4  35  43  29  41  56  34  50  30  29  61  11  43  34  52 
MVE RBF " = 2
1 kNN k = 5  39  44  18  50  64  26  45  42  50  41  20  50  35  56 
MVE RBF " = 2
2 covalent  32  51  24  38  27  65  22  70  27  63  52  25  40  46 
MVE RBF " = 2
2 kNN k = 2  40  40  6  59  49  35  64  25  47  46  30  27  46  46 
MVE RBF " = 2
2 kNN k = 3  30  53  12  62  46  38  42  42  41  49  16  59  25  66 
MVE RBF " = 2
2 kNN k = 4  39  44  26  47  68  22  56  28  39  55  18  50  27  60 
MVE RBF " = 2
2 kNN k = 5  46  34  24  35  76  18  66  25  46  43  30  30  36  55 
MVE RBF " = 2
3 covalent  26  55  26  38  26  65  19  73  22  64  18  48  46  42 
MVE RBF " = 2
3 kNN k = 2  40  41  21  65  56  35  52  27  40  51  34  20  40  48 
MVE RBF " = 2
3 kNN k = 3  31  49  12  50  46  35  28  56  53  39  20  48  23  67 
MVE RBF " = 2
3 kNN k = 4  42  37  35  29  77  18  38  36  41  52  36  27  26  61 
MVE RBF " = 2
3 kNN k = 5  43  34  26  41  70  23  48  27  53  41  30  18  32  57 
SPE  45  34  18  44  57  31  50  31  51  38  50  16  45  44 
MVEPE  44  41  41  41  41  54  52  38  54  40  36  23  42  50 Table  3. C o m p a r i s o n  o f  d i f f e r e n t  c a n o n i z a t i o n  a l g o r i t h m s  b y  e s t i m a t e d  s i g n i f i c a n c e  o f  d i f f e r e n c e s  i n  
retrospective performance. Algorithms were applied to molecular representations in two and three dimensions. 
For each algorithm applied to 2D and 3D representations of molecules the percentage of screenings is listed 
where this combination of algorithm and dimensionality significantly outperforms the same algorithm on the 
other dimensionality. Percentages may not add up to 100 because in some cases differences are not significant. 
Significance level: 0.01. 
  Ø  ACE  COX2  DHFR  FXA  PPAR#  THR 
  2D  3D  2D  3D  2D  3D  2D  3D  2D  3D  2D  3D  2D  3D 
Centroid Linearization  39  43  59  18  18  76  28  58  79  18  30  20  20  69 
Isomap kNN k = 2  43  39  6  74  44  40  55  31  65  24  32  30  55  34 
Isomap kNN k = 3  28  47  9  50  23  74  59  14  28  59  25  25  26  59 
Isomap kNN k = 4  28  52  21  53  23  67  45  38  31  57  16  43  30  54 
Isomap kNN k = 5  24  48  12  47  26  64  22  48  48  39  14  30  24  63 
Laplacian Eigenmaps kNN k = 2  49  36  12  74  64  32  59  28  81  15  23  36  57  29 
Laplacian Eigenmaps kNN k = 3  30  48  12  53  19  68  50  30  53  30  20  41  23  63 
Laplacian Eigenmaps kNN k = 4  23  53  9  59  26  63  28  45  40  49  16  32  18  69 
Laplacian Eigenmaps kNN k = 5  22  54  18  68  24  59  19  55  36  44  14  34  21  66 
PCA  44  33  26  35  60  26  44  34  74  20  20  34  39  51 
MVE EDK covalent  25  45  3  35  31  56  25  61  30  51  16  32  48  34 
MVE EDK kNN k = 2  40  39  21  65  59  31  58  20  41  47  32  18  31  51 
MVE EDK kNN k = 3  32  44  12  41  56  26  36  34  50  38  14  57  23  66 
MVE EDK kNN k = 4  33  40  15  50  67  18  30  30  46  46  16  39  27  59 
MVE EDK kNN k = 5  38  38  15  47  75  15  45  23  51  43  14  45  27  56 
MVE RBF " = 2
-1 covalent  46  33  65  9  25  57  48  27  78  18  34  27  28  60 
MVE RBF " = 2
-1 kNN k = 2  42  41  18  44  80  15  58  36  56  33  11  52  28  63 
MVE RBF " = 2
-1 kNN k = 3  42  40  24  50  64  26  59  28  73  19  9  48  21  68 
MVE RBF " = 2
-1 kNN k = 4  39  44  38  32  17  75  25  61  77  20  27  36  48  40 
MVE RBF " = 2
-1 kNN k = 5  40  39  32  12  25  65  52  38  57  37  7  61  69  20 
MVE RBF " = 2
0 covalent  33  41  24  24  32  57  19  69  39  43  36  18  48  34 
MVE RBF " = 2
0 kNN k = 2  39  42  0  56  84  11  19  59  46  51  48  20  40  53 
MVE RBF " = 2
0 kNN k = 3  30  48  15  65  63  25  17  69  36  46  14  34  36  48 
MVE RBF " = 2
0 kNN k = 4  34  41  15  41  30  60  27  48  46  42  36  20  50  37 
MVE RBF " = 2
0 kNN k = 5  33  41  26  24  29  65  34  34  55  32  16  45  39  46 
MVE RBF " = 2
1 covalent  24  46  12  38  29  53  19  67  25  59  20  20  42  40 
MVE RBF " = 2
1 kNN k = 2  33  45  12  62  35  51  56  27  39  56  11  32  44  43 
MVE RBF " = 2
1 kNN k = 3  29  45  9  59  61  21  19  61  37  48  16  18  30  60 
MVE RBF " = 2
1 kNN k = 4  32  37  26  29  52  30  44  25  26  58  11  32  33  50 
MVE RBF " = 2
1 kNN k = 5  35  39  15  41  63  26  38  41  47  38  16  36  32  55 
MVE RBF " = 2
2 covalent  27  47  15  29  25  63  20  70  24  58  41  18  39  43 
MVE RBF " = 2
2 kNN k = 2  38  36  6  56  47  32  61  20  45  44  27  20  45  44 
MVE RBF " = 2
2 kNN k = 3  29  48  12  53  44  35  39  36  39  46  14  55  23  65 
MVE RBF " = 2
2 kNN k = 4  37  39  18  38  65  21  55  25  39  53  18  34  26  60 
MVE RBF " = 2
2 kNN k = 5  43  30  21  26  74  18  66  23  46  43  20  18  34  51 
MVE RBF " = 2
3 covalent  23  50  15  26  24  63  17  72  20  60  18  41  42  39 
MVE RBF " = 2
3 kNN k = 2  38  37  18  56  54  31  52  23  39  50  27  16  39  44 
MVE RBF " = 2
3 kNN k = 3  28  45  9  50  46  32  25  56  50  36  16  30  22  66 
MVE RBF " = 2
3 kNN k = 4  40  34  32  26  76  18  31  34  40  50  32  18  26  58 
MVE RBF " = 2
3 kNN k = 5  39  33  21  41  68  23  42  27  51  40  18  11  32  57 
SPE  41  31  15  35  57  29  47  31  51  37  34  11  43  42 
MVEPE  40  37  35  41  38  51  48  31  52  38  27  14  41  50 
 Table 4. Percentage of significantly better screenings per target for baseline PhAST and any other canonization 
algorithm. Dimensionality of molecular representation: 2D. Significance level 0.05. B = baseline PhAST MVE 
DK ($ = 0.4), C = candidate canonization algorithm named in first column. 
  Ø  ACE  COX2  DHFR  FXA  PPAR#  THR 
  B  C  B  C  B  C  B  C  B  C  B  C  B  C 
Centroid Linearization  77  13  62  18  69  24  88  9  78  18  77  2  90  6 
Isomap kNN k = 2  87  6  85  0  85  9  92  6  93  6  75  5  90  8 
Isomap kNN k = 3  72  15  74  9  57  35  89  3  78  15  52  9  81  16 
Isomap kNN k = 4  80  13  82  3  67  29  84  11  87  9  70  14  86  10 
Isomap kNN k = 5  76  15  79  3  54  38  88  11  82  15  68  11  85  14 
Laplacian Eigenmaps kNN k = 2  82  10  82  3  79  17  92  8  90  8  64  14  85  8 
Laplacian Eigenmaps kNN k = 3  67  22  79  12  29  61  91  3  64  28  55  16  83  14 
Laplacian Eigenmaps kNN k = 4  71  18  74  9  54  40  89  3  75  18  57  20  80  15 
Laplacian Eigenmaps kNN k = 5  69  21  76  18  36  55  91  6  72  21  55  14  85  13 
PCA  71  21  85  6  29  64  81  11  79  15  70  16  79  16 
MVE EDK covalent  59  26  74  12  47  34  81  11  61  31  20  43  72  24 
MVE EDK kNN k = 2  66  21  76  0  40  49  86  8  76  17  34  36  83  14 
MVE EDK kNN k = 3  60  25  82  6  26  66  80  11  63  25  43  11  67  28 
MVE EDK kNN k = 4  61  26  79  6  21  70  72  11  75  19  43  27  76  20 
MVE EDK kNN k = 5  65  25  74  12  18  77  80  9  80  14  59  20  78  18 
MVE RBF " = 2
-1 covalent  67  20  82  9  62  28  75  17  71  21  30  36  83  10 
MVE RBF " = 2
-1 kNN k = 2  76  14  85  0  60  33  89  6  82  13  52  23  87  8 
MVE RBF " = 2
-1 kNN k = 3  68  22  88  3  21  72  89  8  76  19  48  18  85  10 
MVE RBF " = 2
-1 kNN k = 4  75  12  74  6  71  21  89  9  88  8  39  18  87  10 
MVE RBF " = 2
-1 kNN k = 5  78  13  79  6  52  37  92  8  92  6  64  11  87  10 
MVE RBF " = 2
0 covalent  65  23  76  15  57  27  77  17  69  22  32  45  81  11 
MVE RBF " = 2
0 kNN k = 2  69  18  85  3  49  43  86  6  83  11  25  39  87  8 
MVE RBF " = 2
0 kNN k = 3  57  27  71  6  15  80  81  9  65  24  32  27  80  14 
MVE RBF " = 2
0 kNN k = 4  71  18  79  9  49  40  88  9  83  11  41  25  85  12 
MVE RBF " = 2
0 kNN k = 5  68  20  82  9  32  53  88  8  71  24  50  20  87  9 
MVE RBF " = 2
1 covalent  61  26  71  12  48  38  80  16  59  35  27  43  80  14 
MVE RBF " = 2
1 kNN k = 2  69  18  85  3  45  42  88  11  76  14  39  30  84  10 
MVE RBF " = 2
1 kNN k = 3  57  29  74  6  20  73  77  6  64  29  34  36  74  22 
MVE RBF " = 2
1 kNN k = 4  63  25  74  12  24  69  86  14  76  17  41  20  75  16 
MVE RBF " = 2
1 kNN k = 5  63  26  82  6  19  74  78  17  76  17  39  25  81  14 
MVE RBF " = 2
2 covalent  59  25  59  12  49  30  84  11  61  32  25  45  75  19 
MVE RBF " = 2
2 kNN k = 2  68  20  85  0  38  48  86  11  78  14  36  34  82  13 
MVE RBF " = 2
2 kNN k = 3  62  28  82  9  29  67  80  8  61  32  50  23  67  30 
MVE RBF " = 2
2 kNN k = 4  62  25  76  6  20  72  83  9  74  20  45  23  75  21 
MVE RBF " = 2
2 kNN k = 5  61  28  82  9  23  70  70  16  75  20  43  27  71  24 
MVE RBF " = 2
3 covalent  62  24  68  15  57  27  86  8  61  31  23  43  76  18 
MVE RBF " = 2
3 kNN k = 2  64  21  76  3  34  55  88  6  72  19  36  30  81  14 
MVE RBF " = 2
3 kNN k = 3  61  27  82  6  29  63  80  11  55  36  52  20  66  29 
MVE RBF " = 2
3 kNN k = 4  59  29  76  15  20  72  80  13  76  18  30  36  74  20 
MVE RBF " = 2
3 kNN k = 5  57  28  62  6  23  71  75  14  76  18  34  36  71  22 
SPE  69  20  88  3  40  53  80  14  76  18  52  18  78  16 
MVEPE  74  16  76  9  66  27  84  6  74  20  64  18  81  15 
MVE PRW diameter a = 2  59  23  56  12  63  22  84  8  40  48  36  32  73  16 
MVE PRW diameter a = 4  52  25  35  18  54  29  84  9  54  35  23  34  63  23 
MVE PRW diameter a = 6  52  25  41  21  52  31  83  11  46  37  32  27  57  24 
MVE PRW diameter a = 8  49  27  41  18  47  32  78  9  48  39  23  36  55  29 
MVE PRW diameter a = 10  51  28  53  21  51  29  78  9  46  40  20  41  58  27 
MVE PRW radius a = 2  55  25  50  15  52  32  86  8  52  36  27  32  62  25 
MVE PRW radius a = 4  51  27  38  24  47  37  83  9  49  39  30  30  61  24 
MVE PRW radius a = 6  53  29  44  21  54  29  80  11  52  38  27  45  58  27 
MVE PRW radius a = 8  51  26  41  32  53  26  78  9  48  38  30  20  57  28 
MVE PRW radius a = 10  54  25  53  12  50  33  77  9  47  38  39  30  57  29 Table 5. Percentage of significantly better screenings per target for baseline PhAST and any other canonization 
algorithm. Dimensionality of molecular representation: 3D. Significance level 0.05. B = baseline PhAST MVE 
DK ($ = 0.4), C = candidate canonization algorithm named in first column. 
  Ø  ACE  COX2  DHFR  FXA  PPAR#  THR 
  B  C  B  C  B  C  B  C  B  C  B  C  B  C 
Centroid Linearization  77  14  85  6  44  43  83  16  85  11  80  0  87  8 
Isomap kNN k = 2  77  13  41  24  83  10  86  13  90  8  68  20  91  4 
Isomap kNN k = 3  62  25  62  21  15  76  92  6  72  22  50  11  82  14 
Isomap kNN k = 4  65  23  59  21  25  71  91  6  85  11  52  18  81  13 
Isomap kNN k = 5  65  22  50  24  30  59  91  8  84  12  61  11  77  20 
Laplacian Eigenmaps kNN k = 2  80  12  71  18  83  15  89  8  96  3  55  18  89  8 
Laplacian Eigenmaps kNN k = 3  58  27  47  24  15  77  91  8  69  22  52  14  74  19 
Laplacian Eigenmaps kNN k = 4  61  26  62  21  24  65  91  9  69  22  50  14  68  24 
Laplacian Eigenmaps kNN k = 5  55  30  38  32  25  65  88  8  67  26  41  32  74  19 
PCA  72  18  85  6  35  56  78  11  88  10  68  11  78  16 
MVE EDK covalent  49  33  44  18  38  53  83  6  44  43  14  57  73  19 
MVE EDK kNN k = 2  64  22  50  24  50  38  88  8  69  25  45  30  84  10 
MVE EDK kNN k = 3  52  32  56  15  34  55  81  9  66  25  27  41  47  46 
MVE EDK kNN k = 4  61  27  71  15  41  51  84  11  77  15  27  41  64  29 
MVE EDK kNN k = 5  59  26  53  26  38  49  81  11  87  10  32  32  66  28 
MVE RBF " = 2
-1 covalent  66  24  82  12  44  46  83  16  89  9  32  36  68  23 
MVE RBF " = 2
-1 kNN k = 2  72  20  71  18  87  11  89  11  82  14  25  52  81  13 
MVE RBF " = 2
-1 kNN k = 3  60  31  59  26  31  63  86  13  87  11  25  52  75  21 
MVE RBF " = 2
-1 kNN k = 4  67  22  68  15  30  59  88  13  94  4  41  30  84  14 
MVE RBF " = 2
-1 kNN k = 5  69  23  82  6  33  59  91  8  92  6  27  52  90  6 
MVE RBF " = 2
0 covalent  58  25  68  21  44  48  61  14  65  30  32  25  81  11 
MVE RBF " = 2
0 kNN k = 2  67  20  56  21  82  15  67  17  64  30  48  27  89  7 
MVE RBF " = 2
0 kNN k = 3  53  32  59  15  22  68  67  22  66  24  27  45  75  17 
MVE RBF " = 2
0 kNN k = 4  65  20  68  18  24  66  86  13  86  8  41  7  86  11 
MVE RBF " = 2
0 kNN k = 5  62  28  65  15  27  69  84  9  79  17  34  41  81  17 
MVE RBF " = 2
1 covalent  49  29  50  21  32  54  69  6  41  48  25  30  74  14 
MVE RBF " = 2
1 kNN k = 2  58  27  35  35  42  48  88  5  60  32  36  32  85  8 
MVE RBF " = 2
1 kNN k = 3  50  32  65  21  24  62  56  20  58  33  27  41  72  17 
MVE RBF " = 2
1 kNN k = 4  59  27  74  6  28  65  86  9  66  28  25  39  77  18 
MVE RBF " = 2
1 kNN k = 5  58  27  65  12  26  64  78  11  76  17  27  36  75  19 
MVE RBF " = 2
2 covalent  54  30  59  18  32  59  86  6  40  52  36  25  73  19 
MVE RBF " = 2
2 kNN k = 2  62  23  47  21  51  38  84  3  67  25  39  43  86  11 
MVE RBF " = 2
2 kNN k = 3  49  36  59  15  21  66  83  6  57  34  23  57  50  39 
MVE RBF " = 2
2 kNN k = 4  57  28  68  12  28  58  86  9  71  23  23  39  67  26 
MVE RBF " = 2
2 kNN k = 5  62  26  68  12  40  50  86  9  75  20  36  36  67  26 
MVE RBF " = 2
3 covalent  51  32  56  18  33  56  86  6  43  45  16  52  74  16 
MVE RBF " = 2
3 kNN k = 2  63  23  50  24  43  50  88  5  62  28  50  25  84  8 
MVE RBF " = 2
3 kNN k = 3  52  33  59  18  24  58  78  9  65  29  39  39  48  43 
MVE RBF " = 2
3 kNN k = 4  58  26  71  9  43  45  83  9  63  27  30  39  62  29 
MVE RBF " = 2
3 kNN k = 5  58  27  59  18  33  57  84  6  81  13  25  41  63  30 
SPE  70  19  82  9  49  46  75  11  76  20  59  14  78  16 
MVEPE  76  14  71  9  68  27  86  13  79  17  75  7  79  14 Table 6. Percentage of significantly better screenings per target for baseline PhAST and any other canonization 
algorithm. Dimensionality of molecular representation: 2D. Significance level 0.01. B = baseline PhAST MVE 
DK ($ = 0.4), C = candidate canonization algorithm named in first column. 
  Ø  ACE  COX2  DHFR  FXA  PPAR#  THR 
  B  C  B  C  B  C  B  C  B  C  B  C  B  C 
Centroid Linearization  75  11  56  9  68  22  84  9  75  18  75  2  89  4 
Isomap kNN k = 2  82  5  74  0  85  8  92  6  92  5  64  5  87  7 
Isomap kNN k = 3  69  13  68  6  55  35  89  3  77  15  48  7  80  15 
Isomap kNN k = 4  77  11  74  3  66  27  84  11  86  8  64  9  85  7 
Isomap kNN k = 5  74  13  76  3  51  34  88  9  81  14  61  5  84  12 
Laplacian Eigenmaps kNN k = 2  81  8  79  0  78  17  92  5  89  7  61  14  85  8 
Laplacian Eigenmaps kNN k = 3  63  21  74  12  26  58  89  3  61  27  48  11  80  13 
Laplacian Eigenmaps kNN k = 4  69  15  74  6  51  38  89  3  73  17  50  14  79  12 
Laplacian Eigenmaps kNN k = 5  66  19  68  15  33  51  91  3  70  19  50  14  84  11 
PCA  69  20  82  3  28  62  80  11  79  13  66  16  78  16 
MVE EDK covalent  55  20  59  6  45  31  80  9  60  29  18  23  71  22 
MVE EDK kNN k = 2  63  19  71  0  37  49  84  6  73  17  30  30  82  11 
MVE EDK kNN k = 3  58  22  76  6  24  62  78  6  61  24  39  9  67  26 
MVE EDK kNN k = 4  58  24  76  6  20  68  67  9  75  17  34  23  74  18 
MVE EDK kNN k = 5  63  22  65  9  18  73  78  8  79  12  59  14  77  16 
MVE RBF " = 2
-1 covalent  64  18  79  9  59  26  73  13  70  21  23  27  82  10 
MVE RBF " = 2
-1 kNN k = 2  75  13  88  0  56  33  89  6  81  13  48  18  87  8 
MVE RBF " = 2
-1 kNN k = 3  63  20  82  3  20  71  88  8  75  18  30  14  85  9 
MVE RBF " = 2
-1 kNN k = 4  72  11  68  6  68  19  89  9  88  8  30  16  87  8 
MVE RBF " = 2
-1 kNN k = 5  75  12  74  6  51  32  92  6  92  6  52  9  87  10 
MVE RBF " = 2
0 covalent  60  19  56  15  54  23  75  14  68  21  25  30  80  10 
MVE RBF " = 2
0 kNN k = 2  69  16  85  0  48  42  86  6  82  10  25  34  87  6 
MVE RBF " = 2
0 kNN k = 3  53  24  68  6  13  79  81  9  62  23  16  16  79  13 
MVE RBF " = 2
0 kNN k = 4  68  15  74  9  46  39  86  8  83  9  32  18  85  10 
MVE RBF " = 2
0 kNN k = 5  65  18  79  3  30  53  86  6  71  23  36  18  87  8 
MVE RBF " = 2
1 covalent  58  21  68  12  40  35  80  9  57  33  25  23  79  13 
MVE RBF " = 2
1 kNN k = 2  68  15  82  0  45  40  86  9  73  13  36  20  84  9 
MVE RBF " = 2
1 kNN k = 3  54  26  74  6  18  71  72  6  62  28  23  25  73  21 
MVE RBF " = 2
1 kNN k = 4  58  23  68  12  21  67  81  13  75  15  27  14  74  15 
MVE RBF " = 2
1 kNN k = 5  59  24  82  6  16  72  78  13  74  17  25  25  79  13 
MVE RBF " = 2
2 covalent  56  20  50  12  45  29  84  8  60  32  23  20  74  16 
MVE RBF " = 2
2 kNN k = 2  62  17  68  0  37  45  78  9  77  13  30  25  81  13 
MVE RBF " = 2
2 kNN k = 3  56  25  71  6  26  64  78  8  58  30  34  16  67  27 
MVE RBF " = 2
2 kNN k = 4  58  23  68  3  19  71  83  9  72  18  32  20  75  19 
MVE RBF " = 2
2 kNN k = 5  55  25  68  9  21  70  66  13  74  20  34  18  70  21 
MVE RBF " = 2
3 covalent  58  19  59  9  51  24  86  8  60  30  18  27  75  15 
MVE RBF " = 2
3 kNN k = 2  63  18  74  3  34  51  88  6  71  17  32  23  81  11 
MVE RBF " = 2
3 kNN k = 3  56  25  79  6  24  63  78  8  53  33  36  11  65  28 
MVE RBF " = 2
3 kNN k = 4  56  25  71  6  19  71  75  9  75  16  25  27  73  18 
MVE RBF " = 2
3 kNN k = 5  53  26  53  3  22  71  73  13  75  17  25  30  70  21 
SPE  65  19  85  0  39  53  78  13  73  18  39  18  78  15 
MVEPE  71  14  62  3  63  27  81  6  74  18  64  16  81  15 
MVE PRW diameter a = 2  55  21  47  15  62  19  83  8  37  46  27  23  72  14 
MVE PRW diameter a = 4  49  22  26  18  53  25  84  9  51  32  20  25  61  21 
MVE PRW diameter a = 6  47  23  29  21  48  29  77  6  44  36  27  23  55  22 
MVE PRW diameter a = 8  45  23  32  15  46  29  75  5  45  38  16  27  54  26 
MVE PRW diameter a = 10  47  23  47  15  46  29  70  8  45  39  16  20  57  26 
MVE PRW radius a = 2  53  22  47  9  51  29  83  6  50  32  25  30  60  23 
MVE PRW radius a = 4  47  23  32  18  43  32  78  5  47  36  20  25  60  21 
MVE PRW radius a = 6  48  25  38  18  52  26  70  9  47  36  23  34  56  25 
MVE PRW radius a = 8  45  22  26  18  47  24  75  8  47  36  20  18  55  26 
MVE PRW radius a = 10  50  22  50  9  46  28  73  8  46  36  27  27  56  26 Table 7. Percentage of significantly better screenings per target for baseline PhAST and any other canonization 
algorithm. Dimensionality of molecular representation: 3D. Significance level 0.01. B = baseline PhAST MVE 
DK ($ = 0.4), C = candidate canonization algorithm named in first column. 
  Ø  ACE  COX2  DHFR  FXA  PPAR#  THR 
  B  C  B  C  B  C  B  C  B  C  B  C  B  C 
Centroid Linearization  76  13  85  6  43  43  81  16  84  10  77  0  87  7 
Isomap kNN k = 2  75  12  38  15  82  10  86  13  90  8  64  20  91  4 
Isomap kNN k = 3  60  24  59  21  14  72  92  6  71  21  43  9  81  13 
Isomap kNN k = 4  64  21  56  15  24  68  91  6  83  11  50  16  81  12 
Isomap kNN k = 5  63  20  50  21  27  55  91  8  83  12  52  5  77  19 
Laplacian Eigenmaps kNN k = 2  77  11  59  18  82  14  89  8  95  3  52  16  87  8 
Laplacian Eigenmaps kNN k = 3  56  24  41  12  15  76  89  8  68  21  48  9  73  17 
Laplacian Eigenmaps kNN k = 4  56  24  50  15  22  65  89  6  68  21  41  11  67  23 
Laplacian Eigenmaps kNN k = 5  53  27  35  32  24  63  86  6  66  25  36  20  73  17 
PCA  69  18  76  6  34  55  78  9  86  10  61  11  76  15 
MVE EDK covalent  45  30  32  15  35  50  78  6  43  43  9  50  73  18 
MVE EDK kNN k = 2  59  16  32  9  47  32  88  5  67  23  39  20  83  9 
MVE EDK kNN k = 3  49  29  56  9  30  52  80  9  62  24  23  36  44  44 
MVE EDK kNN k = 4  58  23  65  15  38  49  78  9  75  14  27  25  64  28 
MVE EDK kNN k = 5  58  23  53  21  37  48  81  8  86  9  25  25  65  27 
MVE RBF " = 2
-1 covalent  64  22  82  12  39  44  83  16  88  8  23  27  68  22 
MVE RBF " = 2
-1 kNN k = 2  70  19  65  18  86  11  89  11  80  14  20  48  80  13 
MVE RBF " = 2
-1 kNN k = 3  59  25  56  15  29  59  86  11  87  11  20  34  75  21 
MVE RBF " = 2
-1 kNN k = 4  65  21  68  15  29  58  88  11  93  4  30  23  84  14 
MVE RBF " = 2
-1 kNN k = 5  66  19  74  6  30  56  91  6  92  5  20  36  90  4 
MVE RBF " = 2
0 covalent  55  21  56  15  43  46  56  9  64  29  30  20  81  9 
MVE RBF " = 2
0 kNN k = 2  64  17  47  18  81  13  67  16  62  29  43  20  86  7 
MVE RBF " = 2
0 kNN k = 3  49  29  56  12  20  65  66  19  62  23  16  43  75  14 
MVE RBF " = 2
0 kNN k = 4  64  19  62  12  24  65  86  11  85  8  41  7  86  10 
MVE RBF " = 2
0 kNN k = 5  59  24  62  9  26  66  84  6  78  15  25  32  80  15 
MVE RBF " = 2
1 covalent  45  25  41  15  32  54  63  6  40  45  18  20  74  13 
MVE RBF " = 2
1 kNN k = 2  56  23  35  24  38  45  86  5  59  31  32  27  84  8 
MVE RBF " = 2
1 kNN k = 3  45  29  50  15  20  59  52  17  55  32  25  36  70  16 
MVE RBF " = 2
1 kNN k = 4  56  24  65  6  26  63  86  9  64  25  18  23  75  17 
MVE RBF " = 2
1 kNN k = 5  56  24  59  6  25  64  77  11  76  17  27  27  75  18 
MVE RBF " = 2
2 covalent  51  28  56  15  31  57  84  5  39  48  23  25  71  17 
MVE RBF " = 2
2 kNN k = 2  57  20  32  18  49  34  84  3  67  23  27  32  84  10 
MVE RBF " = 2
2 kNN k = 3  47  33  56  15  19  64  83  6  56  33  20  41  49  37 
MVE RBF " = 2
2 kNN k = 4  56  24  65  6  28  55  86  8  68  22  20  27  66  25 
MVE RBF " = 2
2 kNN k = 5  56  23  50  9  35  49  86  9  73  19  27  27  67  23 
MVE RBF " = 2
3 covalent  48  29  47  18  29  52  84  6  42  43  11  39  74  15 
MVE RBF " = 2
3 kNN k = 2  58  21  38  18  39  48  84  5  61  27  43  23  82  7 
MVE RBF " = 2
3 kNN k = 3  47  30  50  12  22  57  78  9  62  28  27  30  44  42 
MVE RBF " = 2
3 kNN k = 4  55  23  65  3  37  43  78  8  61  26  30  32  62  28 
MVE RBF " = 2
3 kNN k = 5  55  23  56  12  30  55  83  6  80  11  18  25  63  28 
SPE  66  18  71  9  48  43  73  9  74  18  55  11  77  15 
MVEPE  72  12  59  6  67  25  86  9  77  15  64  5  77  12 
 Distance Matrix of Canonization Algorithms based on inverted Rank Correlation
2d Centroid 0 0.496980497 0.510772104 0.488228082
0.503957085 0.511185162 0.486235448 0.50032099
0.491802748 0.488833117 0.502616403 0.501889473
0.488701195 0.521807802 0.490530671 0.515900596
0.478422992 0.511689047 0.511130136 0.488504634
0.501088578 0.490956754 0.493545762 0.52416884
0.522395745
Isomap covalent 0.496980497 0 0.378996396 0.458508794
0.246463172 0.354690934 0.298089549 0.29707767
0.341457998 0.264956194 0.297522189 0.342163988
0.381314454 0.483057401 0.349722565 0.481012662
0.520040054 0.32251361 0.321978721 0.283620418
0.30289588 0.28159221 0.276057175 0.402156969
0.383604759
2d Isomap knn 3 0.510772104 0.378996396 0 0.50509923
0.390453052 0.344200968 0.39413458 0.396625144
0.365666641 0.393984201 0.395130681 0.353021478
0.385407356 0.50197285 0.374118161 0.498911832
0.53851896 0.401731712 0.403302545 0.395917283
0.393374415 0.394182237 0.392053442 0.43105407
0.421828856
Jochum Gasteiger 0.488228082 0.458508794 0.50509923
0 0.466898568 0.496897665 0.444838698 0.465717264
0.485940856 0.457296208 0.463170683 0.48557129
0.514654573 0.516804985 0.48965819 0.497611635
0.515062613 0.481384974 0.483999782 0.449841614
0.463545655 0.447167491 0.462009664 0.516716131
0.500214114
Laplacian Eigenmaps 0.503957085 0.246463172 0.390453052
0.466898568 0 0.360324991 0.318617623 0.317358196
0.35841598 0.297405711 0.316473848 0.357940476
0.395055621 0.478400315 0.359093316 0.476726113
0.527684371 0.335252183 0.305636537 0.312378743
0.321750917 0.314060631 0.300440164 0.421110406
0.398477665
2d Laplacian Eigenmaps knn 30.511185162 0.354690934 0.344200968
0.496897665 0.360324991 0 0.377680509 0.374550085
0.346579722 0.371429636 0.373372588 0.347079866
0.386332689 0.492175069 0.360090857 0.481706574
0.541434638 0.372199231 0.36649396 0.363805329
0.365680239 0.365558541 0.361819427 0.416818391
0.402874735
MVE Diffsuion Kernel 0.486235448 0.298089549 0.39413458
0.444838698 0.318617623 0.377680509 0 0.281884397
0.34756358 0.275944392 0.283907676 0.353361281
0.388034421 0.473502037 0.359481728 0.467546257
0.514024982 0.363033772 0.358910958 0.291309425
0.311596497 0.289507096 0.307253763 0.4107496930.385917511
2d MVE E covalent 0.50032099 0.29707767 0.396625144
0.465717264 0.317358196 0.374550085 0.281884397
0 0.340435326 0.293995859 0.075205278 0.352693546
0.384055568 0.476890438 0.356042535 0.482288526
0.523531446 0.358570326 0.352631735 0.291306318
0.308966392 0.290366532 0.297266446 0.418154633
0.392746408
2d MVE E knn 3 0.491802748 0.341457998 0.365666641
0.485940856 0.35841598 0.346579722 0.34756358
0.340435326 0 0.348759598 0.344187713 0.278482182
0.345593931 0.481393518 0.333423843 0.485614487
0.520896856 0.385874746 0.375320943 0.346030902
0.348914189 0.347204214 0.348060262 0.405732552
0.393774533
MVE P r a 4 0.488833117 0.264956194 0.393984201 0.457296208
0.297405711 0.371429636 0.275944392 0.293995859
0.348759598 0 0.294860332 0.34456258 0.391480541
0.480634089 0.356574024 0.481999326 0.5241785
0.356414369 0.354115285 0.282399112 0.311183387
0.278234298 0.285554203 0.417881759 0.396704183
2d MVE R 2 pow 3 covalent 0.502616403 0.297522189 0.395130681
0.463170683 0.316473848 0.373372588 0.283907676
0.075205278 0.344187713 0.294860332 0 0.350627616
0.386192487 0.480407488 0.352695855 0.482994891
0.526049914 0.357410259 0.350761671 0.292126606
0.30929494 0.290203785 0.298881935 0.419339625
0.389994258
2d MVE R 2 pow 1 knn 3 0.501889473 0.342163988 0.353021478
0.48557129 0.357940476 0.347079866 0.353361281
0.352693546 0.278482182 0.34456258 0.350627616
0 0.365287401 0.494520575 0.339374166 0.496803235
0.532033454 0.387406004 0.377500675 0.343135159
0.355364276 0.342630566 0.344812567 0.415376467
0.398496446
2d PCA 0.488701195 0.381314454 0.385407356 0.514654573
0.395055621 0.386332689 0.388034421 0.384055568
0.345593931 0.391480541 0.386192487 0.365287401
0 0.499496446 0.308119927 0.498859058 0.533686158
0.408578971 0.402843106 0.387300633 0.393122484
0.390761287 0.38032514 0.421714835 0.419402161
Prabhakar 0.521807802 0.483057401 0.50197285 0.516804985
0.478400315 0.492175069 0.473502037 0.476890438
0.481393518 0.480634089 0.480407488 0.494520575
0.499496446 0 0.489634046 0.4320807 0.539480505
0.495862021 0.491699522 0.471603939 0.477466895
0.473223855 0.476877867 0.508450763 0.4975327
2d SPE 0.490530671 0.349722565 0.374118161 0.48965819
0.359093316 0.360090857 0.359481728 0.356042535
0.333423843 0.356574024 0.352695855 0.3393741660.308119927 0.489634046 0 0.485350132 0.529010549
0.382005305 0.376835955 0.354812862 0.354488483
0.357648292 0.349046544 0.415798623 0.391027612
Weininger0.515900596 0.481012662 0.498911832 0.497611635
0.476726113 0.481706574 0.467546257 0.482288526
0.485614487 0.481999326 0.482994891 0.496803235
0.498859058 0.4320807 0.485350132 0 0.531811959
0.481911828 0.482451904 0.473164284 0.480668831
0.472455797 0.472609061 0.497674349 0.490617
3d Centroid 0.478422992 0.520040054 0.53851896 0.515062613
0.527684371 0.541434638 0.514024982 0.523531446
0.520896856 0.5241785 0.526049914 0.532033454
0.533686158 0.539480505 0.529010549 0.531811959
0 0.547794871 0.536869229 0.510902101 0.514817961
0.515160777 0.522375432 0.504979745 0.500332951
3d Isomap knn 3 0.511689047 0.32251361 0.401731712
0.481384974 0.335252183 0.372199231 0.363033772
0.358570326 0.385874746 0.356414369 0.357410259
0.387406004 0.408578971 0.495862021 0.382005305
0.481911828 0.547794871 0 0.314889421 0.354632308
0.348373592 0.350040681 0.326446516 0.422770886
0.40267234
3d Laplacian Eigenmaps knn 30.511130136 0.321978721 0.403302545
0.483999782 0.305636537 0.36649396 0.358910958
0.352631735 0.375320943 0.354115285 0.350761671
0.377500675 0.402843106 0.491699522 0.376835955
0.482451904 0.536869229 0.314889421 0 0.345297011
0.342828314 0.345736237 0.325577557 0.421624943
0.396249839
3d MVE E covalent 0.488504634 0.283620418 0.395917283
0.449841614 0.312378743 0.363805329 0.291309425
0.291306318 0.346030902 0.282399112 0.292126606
0.343135159 0.387300633 0.471603939 0.354812862
0.473164284 0.510902101 0.354632308 0.345297011
0 0.278786695 0.062982505 0.280807416 0.399403378
0.374900179
3d MVE E knn 3 0.501088578 0.30289588 0.393374415
0.463545655 0.321750917 0.365680239 0.311596497
0.308966392 0.348914189 0.311183387 0.30929494
0.355364276 0.393122484 0.477466895 0.354488483
0.480668831 0.514817961 0.348373592 0.342828314
0.278786695 0 0.280908984 0.273267078 0.388621288
0.36003185
3d MVE R 2 pow 3 covalent 0.490956754 0.28159221 0.394182237
0.447167491 0.314060631 0.365558541 0.289507096
0.290366532 0.347204214 0.278234298 0.290203785
0.342630566 0.390761287 0.473223855 0.357648292
0.472455797 0.515160777 0.350040681 0.345736237
0.062982505 0.280908984 0 0.279500807 0.400397698
0.3737906543d MVE R 2 pow 1 knn 3 0.493545762 0.276057175 0.392053442
0.462009664 0.300440164 0.361819427 0.307253763
0.297266446 0.348060262 0.285554203 0.298881935
0.344812567 0.38032514 0.476877867 0.349046544
0.472609061 0.522375432 0.326446516 0.325577557
0.280807416 0.273267078 0.279500807 0 0.408098123
0.372169743
3d PCA 0.52416884 0.402156969 0.43105407 0.516716131
0.421110406 0.416818391 0.410749693 0.418154633
0.405732552 0.417881759 0.419339625 0.415376467
0.421714835 0.508450763 0.415798623 0.497674349
0.504979745 0.422770886 0.421624943 0.399403378
0.388621288 0.400397698 0.408098123 0 0.323786464
3d SPE 0.522395745 0.383604759 0.421828856 0.500214114
0.398477665 0.402874735 0.385917511 0.392746408
0.393774533 0.396704183 0.389994258 0.398496446
0.419402161 0.4975327 0.391027612 0.490617 0.500332951
0.40267234 0.396249839 0.374900179 0.36003185
0.373790654 0.372169743 0.323786464 0Distance Matrix of Canonization Algorithms based on Levenshtein Distance
2d Centroid 0 15.07111058 15.14306341 11.44555408
15.1767537 15.15016244 14.95487908 14.9951871
14.93045362 15.00553483 15.00072193 14.96739261
14.81217663 15.02911804 14.86162917 15.26386716
9.904223318 15.21333173 15.2517146 14.99735291
15.01347612 14.99843581 15.00048129 14.99254001
15.00360967
Isomap covalent 15.07111058 0 8.36866803 15.19492239
4.192034653 7.704367705 7.022740946 5.985200337
6.595475875 5.065575743 5.970280351 6.736493803
7.816508242 14.34749128 7.175069185 15.72012995
15.0749609 7.063169294 6.930212971 5.741427024
5.724581879 5.718084466 5.468655998 8.14161954
7.401395741
2d Isomap knn 3 15.14306341 8.36866803 0 15.33954999
8.514739502 6.602454578 9.403200578 8.835037902
7.938274576 8.843340152 8.787751173 7.704969318
8.337624835 14.80327277 8.199975936 15.94224522
15.1553363 8.28660811 8.537721093 8.996991938
8.787871496 8.977379377 8.77150764 9.20069787
8.941162315
Jochum Gasteiger 11.44555408 15.19492239 15.33954999
0 15.31223679 15.38154253 15.05763446 15.13548309
15.22079172 15.18529659 15.13825051 15.23017687
15.28059199 14.68583805 15.24377331 14.54782818
11.91613524 15.31319937 15.36397545 15.17386596
15.18168692 15.17663338 15.19660691 15.31753098
15.27168812
Laplacian Eigenmaps 15.1767537 4.192034653 8.514739502
15.31223679 0 7.318252918 7.434003128 6.650222597
6.865359163 5.577908796 6.642281314 7.051137047
8.049452533 14.22704849 7.210804957 15.61593069
15.20743593 7.01612321 6.086511852 6.39549994
6.121766334 6.393213813 5.869811094 8.35988449
7.323667429
2d Laplacian Eigenmaps knn 315.15016244 7.704367705 6.602454578
15.38154253 7.318252918 0 8.959090362 8.349897726
7.415232824 8.315605824 8.299723258 7.303814222
8.133437613 14.55023463 7.607869089 15.73950186
15.18132595 8.082781855 7.461316328 8.416436049
8.145951149 8.389724462 8.162315004 8.831307905
8.262062327
MVE Diffsuion Kernel 14.95487908 7.022740946 9.403200578
15.05763446 7.434003128 8.959090362 0 5.609433281
7.450126339 6.299482613 5.655035495 7.70508964
8.583202984 14.18481531 8.081337986 15.64673325
14.9657081 8.91601492 8.7568283 6.272891349
7.065816388 6.241607508 7.129106004 8.9525929498.303573577
2d MVE E covalent 14.9951871 5.985200337 8.835037902
15.13548309 6.650222597 8.349897726 5.609433281
0 6.370954157 5.620141981 0.829142101 6.894116232
7.820719528 14.27553844 7.349416436 15.6759716
14.99205872 8.403922512 8.224642041 5.568282998
6.23583203 5.532065937 6.282396823 8.52785465
7.843701119
2d MVE E knn 3 14.93045362 6.595475875 7.938274576
15.22079172 6.865359163 7.415232824 7.450126339
6.370954157 0 6.673926122 6.387077367 4.429069907
6.534953676 14.42750572 6.222115269 15.71904705
15.00890386 8.359643846 8.109613765 6.827337264
6.548911082 6.793045362 6.705691253 8.077487667
7.471784382
MVE P r a 4 15.00553483 5.065575743 8.843340152 15.18529659
5.577908796 8.315605824 6.299482613 5.620141981
6.673926122 0 5.58693298 6.79833955 8.050655757
14.28889424 7.522079172 15.6845145 15.02827578
7.911803634 7.7295151 5.386957045 5.695223198
5.353627722 5.416556371 8.555769462 7.826134039
2d MVE R 2 pow 3 covalent 15.00072193 5.970280351 8.787751173
15.13825051 6.642281314 8.299723258 5.655035495
0.829142101 6.387077367 5.58693298 0 6.807002767
7.805438575 14.2801107 7.289736494 15.67452773
14.99627 8.374684154 8.197328841 5.574780412 6.22704849
5.513776922 6.233425581 8.508001444 7.807484057
2d MVE R 2 pow 1 knn 3 14.96739261 6.736493803 7.704969318
15.23017687 7.051137047 7.303814222 7.70508964
6.894116232 4.429069907 6.79833955 6.807002767
0 7.124172783 14.47334857 6.758753459 15.77391409
14.98147034 8.477800505 8.251594273 7.062086392
6.905185898 7.029960294 6.514739502 8.320178077
7.742750572
2d PCA 14.81217663 7.816508242 8.337624835 15.28059199
8.049452533 8.133437613 8.583202984 7.820719528
6.534953676 8.050655757 7.805438575 7.124172783
0 14.57261461 5.363253519 15.77283119 14.94068103
8.827216941 8.668150644 8.089880881 7.794368909
8.072073156 7.990374203 7.652388401 7.657201299
Prabhakar 15.02911804 14.34749128 14.80327277 14.68583805
14.22704849 14.55023463 14.18481531 14.27553844
14.42750572 14.28889424 14.2801107 14.47334857
14.57261461 0 14.44146312 12.50607628 15.04812899
14.66923355 14.48887017 14.27734328 14.3427987
14.28372037 14.38130189 14.60871135 14.43231861
2d SPE 14.86162917 7.175069185 8.199975936 15.24377331
7.210804957 7.607869089 8.081337986 7.349416436
6.222115269 7.522079172 7.289736494 6.758753459
5.363253519 14.44146312 0 15.69401997 14.977740348.459631813 8.186259175 7.556371074 7.173865961
7.520635303 7.365178679 7.834797257 6.816147275
Weininger15.26386716 15.72012995 15.94224522 14.54782818
15.61593069 15.73950186 15.64673325 15.6759716
15.71904705 15.6845145 15.67452773 15.77391409
15.77283119 12.50607628 15.69401997 0 15.29394778
15.84983756 15.71952834 15.71940801 15.68403321
15.72783059 15.74864637 15.72337865 15.68030321
3d Centroid 9.904223318 15.0749609 15.1553363 11.91613524
15.20743593 15.18132595 14.9657081 14.99205872
15.00890386 15.02827578 14.99627 14.98147034 14.94068103
15.04812899 14.97774034 15.29394778 0 15.20021658
15.26579232 14.99578871 14.98905066 15.00625677
15.02635062 14.82120082 14.86367465
3d Isomap knn 3 15.21333173 7.063169294 8.28660811
15.31319937 7.01612321 8.082781855 8.91601492
8.403922512 8.359643846 7.911803634 8.374684154
8.477800505 8.827216941 14.66923355 8.459631813
15.84983756 15.20021658 0 5.788112141 8.217663338
7.913969438 8.196125617 7.586451691 8.969317772
8.461316328
3d Laplacian Eigenmaps knn 315.2517146 6.930212971 8.537721093
15.36397545 6.086511852 7.461316328 8.7568283
8.224642041 8.109613765 7.7295151 8.197328841
8.251594273 8.668150644 14.48887017 8.186259175
15.71952834 15.26579232 5.788112141 0 8.009024185
7.70605222 7.983515822 7.505594995 8.830104681
8.160510167
3d MVE E covalent 14.99735291 5.741427024 8.996991938
15.17386596 6.39549994 8.416436049 6.272891349
5.568282998 6.827337264 5.386957045 5.574780412
7.062086392 8.089880881 14.27734328 7.556371074
15.71940801 14.99578871 8.217663338 8.009024185
0 4.947659728 0.524004332 5.57273493 8.074359283
7.4199254
3d MVE E knn 3 15.01347612 5.724581879 8.787871496
15.18168692 6.121766334 8.145951149 7.065816388
6.23583203 6.548911082 5.695223198 6.22704849
6.905185898 7.794368909 14.3427987 7.173865961
15.68403321 14.98905066 7.913969438 7.70605222
4.947659728 0 5.009505475 4.4365299 7.729274456
6.999157743
3d MVE R 2 pow 3 covalent 14.99843581 5.718084466 8.977379377
15.17663338 6.393213813 8.389724462 6.241607508
5.532065937 6.793045362 5.353627722 5.513776922
7.029960294 8.072073156 14.28372037 7.520635303
15.72783059 15.00625677 8.196125617 7.983515822
0.524004332 5.009505475 0 5.536517868 8.056431236
7.391288654
3d MVE R 2 pow 1 knn 3 15.00048129 5.468655998 8.7715076415.19660691 5.869811094 8.162315004 7.129106004
6.282396823 6.705691253 5.416556371 6.233425581
6.514739502 7.990374203 14.38130189 7.365178679
15.74864637 15.02635062 7.586451691 7.505594995
5.57273493 4.4365299 5.536517868 0 8.231981711
7.454939237
3d PCA 14.99254001 8.14161954 9.20069787 15.31753098
8.35988449 8.831307905 8.952592949 8.52785465
8.077487667 8.555769462 8.508001444 8.320178077
7.652388401 14.60871135 7.834797257 15.72337865
14.82120082 8.969317772 8.830104681 8.074359283
7.729274456 8.056431236 8.231981711 0 5.890265913
3d SPE 15.00360967 7.401395741 8.941162315 15.27168812
7.323667429 8.262062327 8.303573577 7.843701119
7.471784382 7.826134039 7.807484057 7.742750572
7.657201299 14.43231861 6.816147275 15.68030321
14.86367465 8.461316328 8.160510167 7.4199254
6.999157743 7.391288654 7.454939237 5.890265913
0Distance Matrix of Canonization Algorithms based on Damerau Levenshtein 
Distance
2d Centroid 0 15.07111058 15.14306341 11.44555408
15.1767537 15.15016244 14.95487908 14.9951871
14.93045362 15.00553483 15.00072193 14.96739261
14.81217663 15.02911804 14.86162917 15.26386716
9.904223318 15.21333173 15.2517146 14.99735291
15.01347612 14.99843581 15.00048129 14.99254001
15.00360967
Isomap covalent 15.07111058 0 8.36866803 15.19492239
4.192034653 7.704367705 7.022740946 5.985200337
6.595475875 5.065575743 5.970280351 6.736493803
7.816508242 14.34749128 7.175069185 15.72012995
15.0749609 7.063169294 6.930212971 5.741427024
5.724581879 5.718084466 5.468655998 8.14161954
7.401395741
2d Isomap knn 3 15.14306341 8.36866803 0 15.33954999
8.514739502 6.602454578 9.403200578 8.835037902
7.938274576 8.843340152 8.787751173 7.704969318
8.337624835 14.80327277 8.199975936 15.94224522
15.1553363 8.28660811 8.537721093 8.996991938
8.787871496 8.977379377 8.77150764 9.20069787
8.941162315
Jochum Gasteiger 11.44555408 15.19492239 15.33954999
0 15.31223679 15.38154253 15.05763446 15.13548309
15.22079172 15.18529659 15.13825051 15.23017687
15.28059199 14.68583805 15.24377331 14.54782818
11.91613524 15.31319937 15.36397545 15.17386596
15.18168692 15.17663338 15.19660691 15.31753098
15.27168812
Laplacian Eigenmaps 15.1767537 4.192034653 8.514739502
15.31223679 0 7.318252918 7.434003128 6.650222597
6.865359163 5.577908796 6.642281314 7.051137047
8.049452533 14.22704849 7.210804957 15.61593069
15.20743593 7.01612321 6.086511852 6.39549994
6.121766334 6.393213813 5.869811094 8.35988449
7.323667429
2d Laplacian Eigenmaps knn 315.15016244 7.704367705 6.602454578
15.38154253 7.318252918 0 8.959090362 8.349897726
7.415232824 8.315605824 8.299723258 7.303814222
8.133437613 14.55023463 7.607869089 15.73950186
15.18132595 8.082781855 7.461316328 8.416436049
8.145951149 8.389724462 8.162315004 8.831307905
8.262062327
MVE Diffsuion Kernel 14.95487908 7.022740946 9.403200578
15.05763446 7.434003128 8.959090362 0 5.609433281
7.450126339 6.299482613 5.655035495 7.70508964
8.583202984 14.18481531 8.081337986 15.64673325
14.9657081 8.91601492 8.7568283 6.2728913497.065816388 6.241607508 7.129106004 8.952592949
8.303573577
2d MVE E covalent 14.9951871 5.985200337 8.835037902
15.13548309 6.650222597 8.349897726 5.609433281
0 6.370954157 5.620141981 0.829142101 6.894116232
7.820719528 14.27553844 7.349416436 15.6759716
14.99205872 8.403922512 8.224642041 5.568282998
6.23583203 5.532065937 6.282396823 8.52785465
7.843701119
2d MVE E knn 3 14.93045362 6.595475875 7.938274576
15.22079172 6.865359163 7.415232824 7.450126339
6.370954157 0 6.673926122 6.387077367 4.429069907
6.534953676 14.42750572 6.222115269 15.71904705
15.00890386 8.359643846 8.109613765 6.827337264
6.548911082 6.793045362 6.705691253 8.077487667
7.471784382
MVE P r a 4 15.00553483 5.065575743 8.843340152 15.18529659
5.577908796 8.315605824 6.299482613 5.620141981
6.673926122 0 5.58693298 6.79833955 8.050655757
14.28889424 7.522079172 15.6845145 15.02827578
7.911803634 7.7295151 5.386957045 5.695223198
5.353627722 5.416556371 8.555769462 7.826134039
2d MVE R 2 pow 3 covalent 15.00072193 5.970280351 8.787751173
15.13825051 6.642281314 8.299723258 5.655035495
0.829142101 6.387077367 5.58693298 0 6.807002767
7.805438575 14.2801107 7.289736494 15.67452773
14.99627 8.374684154 8.197328841 5.574780412 6.22704849
5.513776922 6.233425581 8.508001444 7.807484057
2d MVE R 2 pow 1 knn 3 14.96739261 6.736493803 7.704969318
15.23017687 7.051137047 7.303814222 7.70508964
6.894116232 4.429069907 6.79833955 6.807002767
0 7.124172783 14.47334857 6.758753459 15.77391409
14.98147034 8.477800505 8.251594273 7.062086392
6.905185898 7.029960294 6.514739502 8.320178077
7.742750572
2d PCA 14.81217663 7.816508242 8.337624835 15.28059199
8.049452533 8.133437613 8.583202984 7.820719528
6.534953676 8.050655757 7.805438575 7.124172783
0 14.57261461 5.363253519 15.77283119 14.94068103
8.827216941 8.668150644 8.089880881 7.794368909
8.072073156 7.990374203 7.652388401 7.657201299
Prabhakar 15.02911804 14.34749128 14.80327277 14.68583805
14.22704849 14.55023463 14.18481531 14.27553844
14.42750572 14.28889424 14.2801107 14.47334857
14.57261461 0 14.44146312 12.50607628 15.04812899
14.66923355 14.48887017 14.27734328 14.3427987
14.28372037 14.38130189 14.60871135 14.43231861
2d SPE 14.86162917 7.175069185 8.199975936 15.24377331
7.210804957 7.607869089 8.081337986 7.349416436
6.222115269 7.522079172 7.289736494 6.7587534595.363253519 14.44146312 0 15.69401997 14.97774034
8.459631813 8.186259175 7.556371074 7.173865961
7.520635303 7.365178679 7.834797257 6.816147275
Weininger15.26386716 15.72012995 15.94224522 14.54782818
15.61593069 15.73950186 15.64673325 15.6759716
15.71904705 15.6845145 15.67452773 15.77391409
15.77283119 12.50607628 15.69401997 0 15.29394778
15.84983756 15.71952834 15.71940801 15.68403321
15.72783059 15.74864637 15.72337865 15.68030321
3d Centroid 9.904223318 15.0749609 15.1553363 11.91613524
15.20743593 15.18132595 14.9657081 14.99205872
15.00890386 15.02827578 14.99627 14.98147034 14.94068103
15.04812899 14.97774034 15.29394778 0 15.20021658
15.26579232 14.99578871 14.98905066 15.00625677
15.02635062 14.82120082 14.86367465
3d Isomap knn 3 15.21333173 7.063169294 8.28660811
15.31319937 7.01612321 8.082781855 8.91601492
8.403922512 8.359643846 7.911803634 8.374684154
8.477800505 8.827216941 14.66923355 8.459631813
15.84983756 15.20021658 0 5.788112141 8.217663338
7.913969438 8.196125617 7.586451691 8.969317772
8.461316328
3d Laplacian Eigenmaps knn 315.2517146 6.930212971 8.537721093
15.36397545 6.086511852 7.461316328 8.7568283
8.224642041 8.109613765 7.7295151 8.197328841
8.251594273 8.668150644 14.48887017 8.186259175
15.71952834 15.26579232 5.788112141 0 8.009024185
7.70605222 7.983515822 7.505594995 8.830104681
8.160510167
3d MVE E covalent 14.99735291 5.741427024 8.996991938
15.17386596 6.39549994 8.416436049 6.272891349
5.568282998 6.827337264 5.386957045 5.574780412
7.062086392 8.089880881 14.27734328 7.556371074
15.71940801 14.99578871 8.217663338 8.009024185
0 4.947659728 0.524004332 5.57273493 8.074359283
7.4199254
3d MVE E knn 3 15.01347612 5.724581879 8.787871496
15.18168692 6.121766334 8.145951149 7.065816388
6.23583203 6.548911082 5.695223198 6.22704849
6.905185898 7.794368909 14.3427987 7.173865961
15.68403321 14.98905066 7.913969438 7.70605222
4.947659728 0 5.009505475 4.4365299 7.729274456
6.999157743
3d MVE R 2 pow 3 covalent 14.99843581 5.718084466 8.977379377
15.17663338 6.393213813 8.389724462 6.241607508
5.532065937 6.793045362 5.353627722 5.513776922
7.029960294 8.072073156 14.28372037 7.520635303
15.72783059 15.00625677 8.196125617 7.983515822
0.524004332 5.009505475 0 5.536517868 8.056431236
7.3912886543d MVE R 2 pow 1 knn 3 15.00048129 5.468655998 8.77150764
15.19660691 5.869811094 8.162315004 7.129106004
6.282396823 6.705691253 5.416556371 6.233425581
6.514739502 7.990374203 14.38130189 7.365178679
15.74864637 15.02635062 7.586451691 7.505594995
5.57273493 4.4365299 5.536517868 0 8.231981711
7.454939237
3d PCA 14.99254001 8.14161954 9.20069787 15.31753098
8.35988449 8.831307905 8.952592949 8.52785465
8.077487667 8.555769462 8.508001444 8.320178077
7.652388401 14.60871135 7.834797257 15.72337865
14.82120082 8.969317772 8.830104681 8.074359283
7.729274456 8.056431236 8.231981711 0 5.890265913
3d SPE 15.00360967 7.401395741 8.941162315 15.27168812
7.323667429 8.262062327 8.303573577 7.843701119
7.471784382 7.826134039 7.807484057 7.742750572
7.657201299 14.43231861 6.816147275 15.68030321
14.86367465 8.461316328 8.160510167 7.4199254
6.999157743 7.391288654 7.454939237 5.890265913
0Distance Matrix of Screening Methods based on inverted Rank Correlation
MACCS 0 0.691787486 0.604234896 0.81633558 0.825335532
0.524528856 0.545776535 0.716839538 0.763979141
0.621370817 0.626834628 0.758220312 0.596611071
0.549738521 0.586082362 0.609575465 0.566874258
0.609301341
CATS2D_raw 0.691787486 0 0.527810006 0.717152297
0.71301454 0.704920407 0.753227192 0.770079192
0.838101571 0.695314426 0.708013029 0.658030738
0.684947671 0.676120852 0.681653649 0.724987478
0.74030281 0.763610184
CATS2D_sens 0.604234896 0.527810006 0 0.802025701
0.813246498 0.586017085 0.657385092 0.644284574
0.748130893 0.637517198 0.647883523 0.762647571
0.508850369 0.498999261 0.496792499 0.567839584
0.628762922 0.660251865
ESshape3D 0.81633558 0.717152297 0.802025701 0
0.45126512 0.798631989 0.850255382 0.854053843
0.86119084 0.767022521 0.772664169 0.385778005
0.725827117 0.742129876 0.710755251 0.771803281
0.848821186 0.862117695
ESshape3D_HYD 0.825335532 0.71301454 0.813246498
0.45126512 0 0.803605862 0.848908492 0.884103682
0.870408442 0.740194649 0.739312919 0.510523939
0.791839743 0.793789164 0.765704661 0.798810694
0.834886817 0.850504202
GpiDAPH3 0.524528856 0.704920407 0.586017085 0.798631989
0.803605862 0 0.562163742 0.708450488 0.760633679
0.579464726 0.585005577 0.749366733 0.571611393
0.521768278 0.558088067 0.575014163 0.378608491
0.440989906
LINGO 0.545776535 0.753227192 0.657385092 0.850255382
0.848908492 0.562163742 0 0.756939017 0.76533775
0.592743103 0.593401818 0.792181501 0.636293415
0.598485771 0.622629691 0.664174062 0.591468277
0.610469183
LIQUID 0.716839538 0.770079192 0.644284574 0.854053843
0.884103682 0.708450488 0.756939017 0 0.852400719
0.8011805 0.813879654 0.828564188 0.639968054
0.628385508 0.673973703 0.644158009 0.71465588
0.7353891
PRPS 0.763979141 0.838101571 0.748130893 0.86119084
0.870408442 0.760633679 0.76533775 0.852400719
0 0.769186741 0.761877445 0.848115451 0.716245886
0.729228484 0.732664089 0.767157307 0.772588217
0.79839223
PhAST_2D 0.621370817 0.695314426 0.637517198 0.767022521
0.740194649 0.579464726 0.592743103 0.8011805
0.769186741 0 0.308005447 0.735167705 0.6421203830.608697167 0.616099789 0.663466906 0.635162206
0.651219016
PhAST_3D 0.626834628 0.708013029 0.647883523 0.772664169
0.739312919 0.585005577 0.593401818 0.813879654
0.761877445 0.308005447 0 0.745893869 0.640048008
0.614684901 0.61840541 0.669957062 0.646797904
0.661973613
SIMPLE_DESC 0.758220312 0.658030738 0.762647571
0.385778005 0.510523939 0.749366733 0.792181501
0.828564188 0.848115451 0.735167705 0.745893869
0 0.71258691 0.721853104 0.693940407 0.742437411
0.797894918 0.825367109
TAD 0.596611071 0.684947671 0.508850369 0.725827117
0.791839743 0.571611393 0.636293415 0.639968054
0.716245886 0.642120383 0.640048008 0.71258691
0 0.276732262 0.246919091 0.464929319 0.623813501
0.644651874
TAT 0.549738521 0.676120852 0.498999261 0.742129876
0.793789164 0.521768278 0.598485771 0.628385508
0.729228484 0.608697167 0.614684901 0.721853104
0.276732262 0 0.331133564 0.471311977 0.568275256
0.593722361
TGD 0.586082362 0.681653649 0.496792499 0.710755251
0.765704661 0.558088067 0.622629691 0.673973703
0.732664089 0.616099789 0.61840541 0.693940407
0.246919091 0.331133564 0 0.415864882 0.630170409
0.65368489
TGT 0.609575465 0.724987478 0.567839584 0.771803281
0.798810694 0.575014163 0.664174062 0.644158009
0.767157307 0.663466906 0.669957062 0.742437411
0.464929319 0.471311977 0.415864882 0 0.614969762
0.652180369
piDAPH3 0.566874258 0.74030281 0.628762922 0.848821186
0.834886817 0.378608491 0.591468277 0.71465588
0.772588217 0.635162206 0.646797904 0.797894918
0.623813501 0.568275256 0.630170409 0.614969762
0 0.338718486
piDAPH4 0.609301341 0.763610184 0.660251865 0.862117695
0.850504202 0.440989906 0.610469183 0.7353891
0.79839223 0.651219016 0.661973613 0.825367109
0.644651874 0.593722361 0.65368489 0.652180369
0.338718486 0Distance Matrix of Screening Methods based on Signiﬁcance (0.01)
MACCS 0 0.5838641 0.010640128 0.790030577 0.811569432
0.163569129 0.127220374 0.443175522 0.150660678
0.066407638 0.027893327 0.722048465 0.032994218
0.08631428 0.01950191 0.110819333 0.154356922
0.251801684
CATS2D_raw 0.5838641 0 0.617480655 0.521846705
0.529398508 0.653498078 0.721918757 0.029298078
0.191686759 0.610583805 0.612417706 0.140256315
0.629480539 0.686522234 0.675337269 0.518477949
0.381158711 0.372293701
CATS2D_sens 0.010640128 0.617480655 0 0.657625428
0.656375518 0.150387592 0.19588545 0.526971282
0.142119346 0.220661013 0.215237205 0.518072139
0.056287607 0.171161625 0.109878752 0.170175596
0.094799979 0.111727937
ESshape3D 0.790030577 0.521846705 0.657625428 0
0.138635168 0.785230728 0.841314612 0.533563414
0.589554053 0.883092222 0.878850764 0.631539072
0.743691863 0.802970466 0.75125772 0.718059727
0.717283001 0.616297035
ESshape3D_HYD 0.811569432 0.529398508 0.656375518
0.138635168 0 0.818500503 0.844444623 0.512442405
0.583905141 0.882895071 0.884042316 0.614352418
0.747835595 0.805892011 0.761991677 0.733352957
0.725446724 0.651993887
GpiDAPH3 0.163569129 0.653498078 0.150387592 0.785230728
0.818500503 0 0.074525561 0.512853713 0.276930409
8.66E-04 0.056036478 0.661594818 0.169238744 0.108601371
0.196269563 0.289832144 0.44853586 0.464429728
LINGO 0.127220374 0.721918757 0.19588545 0.841314612
0.844444623 0.074525561 0 0.665361409 0.269062341
0.100234157 0.073858189 0.746756514 0.272109157
0.117602705 0.226519556 0.391439674 0.18185819
0.314421884
LIQUID 0.443175522 0.029298078 0.526971282 0.533563414
0.512442405 0.512853713 0.665361409 0 0.158389413
0.57420793 0.539300877 0.225108875 0.567155145
0.690576822 0.603324937 0.498448003 0.285869984
0.245238165
PRPS 0.150660678 0.191686759 0.142119346 0.589554053
0.583905141 0.276930409 0.269062341 0.158389413
0 0.105925259 0.092664066 0.404327319 0.208341965
0.251938705 0.169450538 0.084676808 0.095371278
0.039781639
PhAST_2D 0.066407638 0.610583805 0.220661013 0.883092222
0.882895071 8.66E-04 0.100234157 0.57420793 0.105925259
0 0.13690565 0.754991296 0.132313222 0.055691443
0.147568579 0.316434124 0.151444885 0.254436578PhAST_3D 0.027893327 0.612417706 0.215237205 0.878850764
0.884042316 0.056036478 0.073858189 0.539300877
0.092664066 0.13690565 0 0.692774034 0.149946669
0.071998586 0.17469046 0.327335398 0.108870375
0.245285266
SIMPLE_DESC 0.722048465 0.140256315 0.518072139
0.631539072 0.614352418 0.661594818 0.746756514
0.225108875 0.404327319 0.754991296 0.692774034
0 0.619272767 0.664631312 0.598881402 0.531870547
0.521349357 0.459981098
TAD 0.032994218 0.629480539 0.056287607 0.743691863
0.747835595 0.169238744 0.272109157 0.567155145
0.208341965 0.132313222 0.149946669 0.619272767
0 0.28972976 0.036647118 0.219710379 0.084167012
0.162089831
TAT 0.08631428 0.686522234 0.171161625 0.802970466
0.805892011 0.108601371 0.117602705 0.690576822
0.251938705 0.055691443 0.071998586 0.664631312
0.28972976 0 0.262943161 0.352678713 0.212732023
0.264410096
TGD 0.01950191 0.675337269 0.109878752 0.75125772
0.761991677 0.196269563 0.226519556 0.603324937
0.169450538 0.147568579 0.17469046 0.598881402
0.036647118 0.262943161 0 0.290615754 0.058684846
0.189966805
TGT 0.110819333 0.518477949 0.170175596 0.718059727
0.733352957 0.289832144 0.391439674 0.498448003
0.084676808 0.316434124 0.327335398 0.531870547
0.219710379 0.352678713 0.290615754 0 0.014665438
0.035279019
piDAPH3 0.154356922 0.381158711 0.094799979 0.717283001
0.725446724 0.44853586 0.18185819 0.285869984
0.095371278 0.151444885 0.108870375 0.521349357
0.084167012 0.212732023 0.058684846 0.014665438
0 0.041746778
piDAPH4 0.251801684 0.372293701 0.111727937 0.616297035
0.651993887 0.464429728 0.314421884 0.245238165
0.039781639 0.254436578 0.245285266 0.459981098
0.162089831 0.264410096 0.189966805 0.035279019
0.041746778 0Distance Matrix of Screening Methods based on Signiﬁcance (0.05)
MACCS 0 0.58122645 0.034658251 0.791172755 0.809738037
0.1708456 0.109176271 0.445693149 0.146374522
0.048483634 0.020804981 0.720631868 0.027922818
0.093327197 0.025623974 0.120515872 0.154447319
0.255419391
CATS2D_raw 0.58122645 0 0.639036612 0.527416382
0.52982844 0.64879737 0.731433048 0.046705853
0.202057622 0.616744663 0.612708867 0.133947825
0.625414384 0.668634378 0.680928446 0.528387647
0.375176152 0.363295715
CATS2D_sens 0.034658251 0.639036612 0 0.680729989
0.659787395 0.130285253 0.189451626 0.532436083
0.162200186 0.226751997 0.205458564 0.539399969
0.071499172 0.177012329 0.104099696 0.168219112
0.098714478 0.138340815
ESshape3D 0.791172755 0.527416382 0.680729989 0
0.095913596 0.787681709 0.837646512 0.536578765
0.60649768 0.884970461 0.88477488 0.650745311
0.739214524 0.798220161 0.752977706 0.716954015
0.717025003 0.62430756
ESshape3D_HYD 0.809738037 0.52982844 0.659787395
0.095913596 0 0.821872131 0.851525885 0.534540988
0.585245821 0.88511462 0.886604704 0.607094388
0.751928316 0.803261278 0.760766187 0.735392753
0.715668083 0.638077763
GpiDAPH3 0.1708456 0.64879737 0.130285253 0.787681709
0.821872131 0 0.06085882 0.521340538 0.280358782
0.005497824 0.046232877 0.667786833 0.159663438
0.110424394 0.188261854 0.297306394 0.440678522
0.464001878
LINGO 0.109176271 0.731433048 0.189451626 0.837646512
0.851525885 0.06085882 0 0.667923798 0.267230947
0.105021725 0.075954731 0.74392116 0.254850787
0.127768459 0.197411349 0.396806749 0.205808137
0.326512489
LIQUID 0.445693149 0.046705853 0.532436083 0.536578765
0.534540988 0.521340538 0.667923798 0 0.179335685
0.574634082 0.542629441 0.238201112 0.56510222
0.695811722 0.605281422 0.501282071 0.289546454
0.250251534
PRPS 0.146374522 0.202057622 0.162200186 0.60649768
0.585245821 0.280358782 0.267230947 0.179335685
0 0.109107233 0.08172248 0.403253486 0.216998641
0.258094253 0.172507423 0.063859175 0.113380444
0.027391746
PhAST_2D 0.048483634 0.616744663 0.226751997 0.884970461
0.88511462 0.005497824 0.105021725 0.574634082
0.109107233 0 0.13188391 0.764139165 0.1266744670.061893835 0.124167058 0.31962978 0.14248208
0.242564764
PhAST_3D 0.020804981 0.612708867 0.205458564 0.88477488
0.886604704 0.046232877 0.075954731 0.542629441
0.08172248 0.13188391 0 0.687335799 0.139842007
0.087425562 0.175345228 0.336621241 0.088492255
0.233133401
SIMPLE 0.720631868 0.133947825 0.539399969 0.650745311
0.607094388 0.667786833 0.74392116 0.238201112
0.403253486 0.764139165 0.687335799 0 0.615481904
0.672920113 0.605203573 0.535570048 0.511031458
0.459238505
TAD 0.027922818 0.625414384 0.071499172 0.739214524
0.751928316 0.159663438 0.254850787 0.56510222
0.216998641 0.126674467 0.139842007 0.615481904
0 0.300333985 0.043709142 0.253342771 0.086677722
0.169737714
TAT 0.093327197 0.668634378 0.177012329 0.798220161
0.803261278 0.110424394 0.127768459 0.695811722
0.258094253 0.061893835 0.087425562 0.672920113
0.300333985 0 0.274446302 0.347312603 0.21438495
0.262665317
TGD 0.025623974 0.680928446 0.104099696 0.752977706
0.760766187 0.188261854 0.197411349 0.605281422
0.172507423 0.124167058 0.175345228 0.605203573
0.043709142 0.274446302 0 0.294093956 0.068430324
0.191973438
TGT 0.120515872 0.528387647 0.168219112 0.716954015
0.735392753 0.297306394 0.396806749 0.501282071
0.063859175 0.31962978 0.336621241 0.535570048
0.253342771 0.347312603 0.294093956 0 0.009482217
0.039568479
piDAPH3 0.154447319 0.375176152 0.098714478 0.717025003
0.715668083 0.440678522 0.205808137 0.289546454
0.113380444 0.14248208 0.088492255 0.511031458
0.086677722 0.21438495 0.068430324 0.009482217
0 0.030590502
piDAPH4 0.255419391 0.363295715 0.138340815 0.62430756
0.638077763 0.464001878 0.326512489 0.250251534
0.027391746 0.242564764 0.233133401 0.459238505
0.169737714 0.262665317 0.191973438 0.039568479
0.030590502 0 
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ABSTRACT 
 
The text-based similarity searching method PhAST is grounded on pairwise comparisons of 
potential pharmacophoric points between a query and screening compounds. The underlying 
scoring matrix is of critical importance for successful virtual screening and hit retrieval from 
large  compound  libraries.  Here,  we  compare  three  conceptually  different  computational 
methods for systematic deduction of scoring matrices: assignment-based, alignment-based, 
and stochastic optimization. All three methods resulted in optimized pharmacophore scoring 
matrices  with  significantly  superior  retrospective  performance  in  comparison  to  simplistic 
scoring schemes. Computer-generated similarity matrices of pharmacophoric features turned 
out to agree well with a manually constructed matrix. We introduce the concept of position-
specific scoring to text-based similarity searching so that knowledge about specific ligand-
receptor binding patterns can be included, and demonstrate its benefit for hit retrieval. The 
approach was also used for automated pharmacophore elucidation in agonists of peroxisome 
proliferator activated receptor (PPAR) gamma, successfully identifying key interactions for 
receptor activation. 
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INTRODUCTION 
 
The Pharmacophore Alignment Search Tool (PhAST) is a string-based approach to virtual 
screening  utilizing  topological  molecule  information.
1-3  It  reduces  each  molecule  to  an 
unambiguous linear representation by describing its potential pharmacophore in three steps: i) 
each non-hydrogen atom of the molecular graph is replaced by a potential pharmacophoric 
point (PPP) symbol, and hydrogen atoms are removed, ii) vertices of this ‘pharmacophore 
graph’  are  canonically  labeled,  and  iii)  vertex  symbols  are  concatenated  into  a  string  in 
increasing order according to their canonic labels. For virtual screening, both the screening 
compound  collection  (compound  ‘library’)  and  the  query  molecule(s)  are  converted  as 
described, and the resulting ‘PhAST-sequences’ are compared using pairwise global sequence 
alignment
4.  Molecular  similarity  is  calculated  as  the  ratio  of  the  alignment  score  and  the 
alignment length for the purpose of retrieving pharmacophorically similar molecules from 
compound libraries. 
Previously, we analyzed the impact of structure canonization algorithms, 
1-3 sequence 
alignment evaluation,
1,2 and the dimensionality of molecular representation
3 on the virtual 
screening performance of PhAST. Here, we investigate the effect of the PPP scoring system 
for  matches  and  mismatches  in  the  alignment  on  virtual  screening  performance.  For  this 
purpose we adapted methods that are related to the approach used for score calculations in the 
Point-Accepted-Mutation (PAM) matrix
5 and BLOcks SUbstitution Matrix (BLOSUM)
6 used 
for protein sequence alignments. Scores for matches and mismatches are determined from i) 
kernel-based  assignments  of  potential  pharmacophoric  points
7  as  well  as  from  ii)  global 
pairwise sequence alignments,
4 both created from bioactive reference ligands. As reference 
datasets we employed a dataset collected by Krier & Hutter
8 for the construction of a score 
matrix.  In  addition  to  systematic  determination  of  scores  from  reference  alignments  we 
performed stochastic optimization of match- and mismatch-scores. The overall aim was to 
quantify the influence of PPP scoring on similarity searching with PhAST.  
  A second aim was to assess the usefulness and effect of position-specific scoring. 
PhAST  employs  a  general  score  matrix  for  matches  and  mismatches  of  PPPs.  However, 
sequence alignment allows for using a position-specific scoring matrix
9 that scores the same 
matches  and  mismatches  differently  depending  on  PPP  symbol  positions.  For  protein 
sequences, it is common practice to use explicit position-specific scoring matrices with a 
specific set of match- and mismatch-scores for each residue position.
9,10 In analogy, we have 
implemented a weighting scheme based on an implicit definition of a position-specific score 
matrix: Here, positional specificity is achieved through a weighting factor associated with a 
particular position of the query sequence. This way it is possible to incorporate knowledge 
about the relative importance of pharmacophoric features into a PhAST similarity search. A 
weighting factor > 1 increases the influence of this position on alignment generation and the 
alignment  score  used  for  similarity  assessment,  potentially  resulting  in  better  contrasting 
between compounds with and without this particular feature.  
  We compared the different score matrices and the effects of positional weighting of 
PhAST-sequences  by  retrospective  virtual  screening  of  a  collection  of  drugs  and  lead 
compounds  (COBRA).
11  For  statistical  evaluation  we  used  the  Boltzmann-enhanced 
discrimination of receiver operating characteristic (BEDROC)
12 in combination with a paired 
permutation test for significance assessment.
13 
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METHODS 
 
Sequence Alignment 
 
Sequence  alignment  is  used  in  bioinformatics  to  estimate  the  phylogenetic  relationship 
between two sequences (DNA, RNA, amino acid sequences). To create the alignment of two 
sequences X = x1x2…xn and Y = y1y2…ym, their symbols are matched. Thereby the symbol 
order is retained and gaps may be inserted to improve the matching (insertion of paired gaps 
is forbidden). Three cases exist: (i) xi is aligned to yj and xi  = yj (match), (ii) xi is aligned to yj 
and xi ! yj (mismatch), (iii) xi is aligned to a gap in Y, or yj is aligned to a gap in X. In protein 
sequence  alignment,  matches  represent  ‘conserved’  residues.  Mismatches  may  arise  from 
mutations, and gaps from insertions or deletions in an assumed evolutionary process of the 
compared sequences. Consequently, matches are rewarded with a positive score, mismatches 
are -- depending on the specific case -- either rewarded with a positive score or penalized by a 
negative score contribution, and gaps are always penalized by a negative score. The optimal 
alignment is the one with the highest score (summed over the whole alignment). It can be 
computed  using  dynamic  programming
14.  Instead  of  the  original  Needleman-Wunsch 
algorithm
14 we employed a faster method described by Durbin et al..
4 It can be derived from a 
simple  finite  state  machine  and  therefore  will  be  referred  to  as  ‘FSM  algorithm’.  We 
previously demonstrated that it runs 60% faster than the Needleman-Wunsch algorithm and 
the calculated alignments are nearly identical.
2 
 
Alignment Evaluation 
Sequence  alignments  are  used  for  similarity  assessment  between  PhAST-sequences.  In  a 
previous study,
2 we identified the alignment score normalized to the alignment length to be 
the best performing alignment evaluation method for our purpose so far. In the present work 
we only considered this evaluation method for comparison of PhAST screening performance. 
 
 
Matrix Calculation 
 
The main focus of this study lies on the systematic construction and evaluation of scoring 
schemes for PPPs using a set of bioactive reference compounds. The pharmacophore model 
employed in PhAST is presented in Table 1 and Table 2, the current scoring scheme is given 
in Table 3. 
 
Dataset 
We used a dataset of reference compounds compiled by Krier & Hutter for score calculation.
8 
This  set  was  used  for  the  construction  of  a  score  matrix.  It  contains  molecules  of  33 
therapeutic  classes.  For  evaluation  of  new  scoring  schemes,  we  performed  retrospective 
screenings using the COBRA collection of drugs and lead compounds
11 (version 6.1, 8311 
bioactive compounds; see Table 4 for a list of the selected targets). We removed duplicates 
and eliminated overlap between the Krier dataset and our COBRA library, resulting in a total 
of 1268 compounds for the Krier dataset distributed among compound classes as shown in 
Table 5. Both datasets are fairly similar with respect to their PPP composition (Table 6). 
 
Methodology 
PAM
5  and  BLOSUM
6 matrices used in protein sequence  alignment had been constructed 
based on the idea that scores should reflect the frequency of point mutations in proteins: 
Frequent events should receive low scores, and rare events should contribute to the overall 
alignment  score  by  high  score  values.  For  this  purpose,  multiple  sequence  alignments  of 
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closely related protein sequences were constructed, and the numbers of symbol occurrences in 
gap-free regions used for the calculations of log-odds scores. We adopted this idea by using 
PhAST-sequences generated from compounds of the same activity class (instead of closely 
related protein sequences) and pairwise vertex assignments and symbol alignments (instead of 
a multiple sequence alignment). The usage of multiple sequence alignments for estimation of 
symbol alignment frequencies was not possible, as each PhAST-sequence would have to be 
aligned  in  its  original  and  inverted  orientation.  This  is  due  to  the  PhAST  canonization 
algorithm which employs minimum volume embedding, where small modifications to the 
molecular  graph  can  invert  the  one-dimensional  coordinate  system.  For  a  dataset  with  n 
molecules we would have to create 2
n multiple sequence alignments in each iteration, which 
is practically not feasible. Scores of matches and mismatches were calculated according to 
Eq. (1): 
 
s(pi,p j) ! round c*logb
h(pi ,p j )
hpi *hp j
"#
$#
%# %#
&#
'#
(# (#  ,          (1) 
 
where  c is constant,  b the logarithm base,  hpi the relative frequency of PPP type  i, 
hp j the relative frequency of PPP type  j  and  h(pi ,p j )the relative frequency of the event of 
alignment or assignment of PPPs of type i and type  j. We used c = 10 and b = 10, as these 
settings yield scores in a range that are comparable to our original score matrix. As default 
frequency for assignment / alignment types not observed we used a value of 10
-5 to avoid 
calculating log(0). 
Meaningful assignments or matches and mismatches in alignments between molecules 
from the same activity class are only obtained if reference compounds have the same binding 
mode at the same biological target. For both datasets used in this study the target binding 
modes  of  most  of  the  compounds  are  unknown.  In  studies  specifically  investigating 
bioisosteric replacement the related problem of identifying related compound pairs is tackled 
by computing a similarity measure between compounds in combination with a threshold  t:
16 
Compound pairs exhibiting a similarity >  t are treated as if they had the same binding mode 
and it is assumed that structural differences are caused by the exchange of bioisosters. We 
adopted this idea and used MACCS keys
17 and the Tanimoto coefficient
18 as similarity index: 
Only compound pairs with Tanimoto similarity < 0.98 were included in the process of score 
calculation to exclude identical molecules and trivial analogues. For  t as lower bound we 
used 0, 0.5, 0.75, and 0.90. For each compound class presented in Table 5, we included each 
unique pair of non-identical compounds exactly once. 
 
Assignment-based matrices 
The iterative similarity optimal assignment (ISOA) kernel
7 generates assignments between 
two labeled graphs  A and  B, assigning each vertex of the smaller structure to exactly one 
vertex of the larger one. In a first step, ISOAK computes a similarity value for each vertex 
pair  vi
A,v j
B ) *.  The  similarity  of  two  vertices  is  influenced  by  two  components.  The  first 
component compares the isolated vertices based on their labels. For this purpose ISOAK uses 
the Dirac kernel that returns ‘1’ if two vertices have identical labels and ‘0’ otherwise. The 
second component of vertex similarity considers the environment of each vertex for similarity 
assessment and returns high similarity values if these neighborhoods are similar. Recursive 
measurement incorporates vertex similarities of neighboring vertices as well as a comparison 
of the connecting edges. For edge comparison, a Dirac kernel based on the bond order labels 
is applied. The recursive nature of the given vertex similarity definition is expressed by an 
iterative computation, where vertex similarities of pairs of neighboring vertices incorporated 
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in the actual calculation of iteration i are taken from results of the previous iteration i +1. In 
iteration 0, only direct vertex comparisons are employed and the neighborhood is ignored. 
The final similarity of two vertices is expressed as a weighted sum of the two components, 
where the influence of each component is controlled by parameter  0 ,- ,1. Component 1 
(vertex label) is weighted by 1+-, whereas component 2 (neighborhood) is weighted by -. 
As a result, high  - increase the influence of the topological graph neighborhood on vertex 
comparison. 
We applied the ISOA kernel to graphs of PPPs created from reference compounds. We 
used the ISOA kernel with settings for  -: 0.25 (high influence of vertex label), 0.5 (equal 
influence),  and  0.75  (high  influence  of  vertex  neighborhood).  Background  frequencies  of 
PPPs necessary for the calculation of log-odds scores were determined from all PPPs involved 
in assignments, and unassigned vertices were ignored. Combining three settings for  - with 
four different thresholds for minimum similarity of molecules, we  calculated 12 different 
score matrices based on symbol and assignment frequencies following Eq. 1. 
Gap penalties were optimized using grid-search, as it is difficult to choose them by 
intuition.
19 For each score matrix based on ISOAK assignments each penalty combination 
starting from gap open penalty = -2 and gap extension penalty = -1 up to gap open penalty = -
28 and gap extension penalty = -27 with the gap extension penalty lower than the gap open 
penalty was evaluated in a series of retrospective screenings (cf. Screening Protocol 1). Gap 
penalties exceeding -28 seem unreasonable as no mismatch penalty exceeds this value. 
 
Alignment-based matrices 
BLOSUM matrices used for scoring matches and mismatches in protein sequence alignments 
are constructed in an iterative process:
6 First, scores are estimated from symbol- and symbol 
alignment-frequencies in gap-free blocks of multiple sequence alignments of closely related 
protein sequences. These scores are then used to recalculate the multiple sequence alignments, 
yielding altered frequencies and new scores. This process is iterated three times. We adopted 
this BLOSUM concept for the construction of score matrices for PPPS in PhAST: Based on 
all pairwise alignments within each compound class fulfilling the similarity constraints we 
determined background frequencies of symbols and alignment events, yielding a first matrix 
of log-odds scores calculated according to Eq. 1 (gapped regions were excluded). Using this 
score matrix, the same sequences were re-aligned, resulting in new frequencies and a new 
score  matrix.  We  iterated  this  process  until  convergence:  When  the  actual  matrix  was 
identical to any of the matrices generated in previous iterations, the process was terminated. 
We performed the iterative construction of score matrices with fixed gap open penalty 
=  5  and  gap  extension  penalty  =  1.  We  chose  this  combination  because  of  its  good 
performance with our original score matrix.
1,2 Using variable gap penalties as additional free 
parameters  is  unnecessary  because  in  this  approach  scores  are  adapted  to  the  penalty 
combination. For the initial start scoring scheme we used a primitive match = +2 mismatch = 
-1 system and our original score matrix (Table 3). Combining these two basic scoring systems 
with four different similarity thresholds for pair filtering resulted in a total of eight alignment-
based scoring matrices.  
 
Stochastic Optimization 
As  an  alternative  approach  to  deducing  alignment  scores  from  reference  alignments  we 
optimized  score  matrices  in  a  multi-start  stochastic  optimization:  50  score  matrices  were 
randomly  initialized  with  uniformly  distributed  scores  in  [+20,20].  All  matrices  were 
evaluated on the Krier dataset as training data, results were evaluated using the BEDROC 
metric.
12 The matrix with highest averaged performance served as template for the generation 
of 49 new score matrices. With probability 0.1 scores were modified by adding a uniformly 
distributed  number  from  in  the  interval  [+10,10].  A  fiftieth  score  matrix  was  again  built 
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randomly with uniformly distributed scores. The template matrix was not part of the next 
cycle. This procedure was repeated for 100 iterations. The best performing matrix of each 
generation was evaluated in a set of virtual screenings on the COBRA library as test data (see 
Screening Protocol 1). We performed three independent optimization runs. 
We chose targets with IDs 5, 6, 10, 13, 17, 23, 24, 29 and 31 from the Krier dataset 
(Table  5)  for  matrix  evaluation  by  retrospective  screening.  This  choice  was  guided  by 
recommendations by Truchon and Bayly,
12 who suggest ratios of actives to decoys that avoid 
saturation effects in retrospective evaluation. BEDROC is mainly influenced by the early part 
of  a  ranked  list.  If  the  ratio  between  active  and  inactive  compounds  exceeds  a  certain 
threshold, and actives ‘saturate’ the early ranks, and BEDROC values become meaningless. 
We chose targets so that the saturation effect remained below 20%, calculated as described by 
Truchon and Bayly.
12 Sequence alignments were computed with fixed gap open penalty of 5 
and gap extension penalty of 1, as these values yielded good results with the original score 
matrix (Table 3). 
 
 
Screening Protocol 1 
 
All score matrices were evaluated in a series of retrospective screenings. For each target 
(Table 4) each active was used once as query, resulting in 689 screenings. Each screening was 
evaluated with the (BEDROC) metric.
12 BEDROC scores were calculated with  . = 20, the 
suggested default value for evaluation.
12 We first evaluated screening performance for each 
target by averaging the corresponding BEDROC scores. Total retrospective performance was 
expressed as the mean of these averages. We used the mean of averages to give equal weight 
to each target although the COBRA library contains unequal numbers of actives for different 
targets.  Best  performing  matrices  from  all  three  approaches  presented  in  this  study  were 
compared to the basic +2 (match) -1 (mismatch) scoring scheme in combination with gap 
open penalty = 5 and gap extension penalty = 1 (baseline total averaged BEDROC = 0.28) 
 
 
Significance Assessment 
 
We compared the retrospective performance of PhAST with each new scoring matrix to the 
result obtained with the original matrix (Table 3). To assess whether differences in screening 
performance are statistically significant we used a paired permutation test
13 that was recently 
found to be the most powerful available significance test for this purpose.
20 It has the null 
hypothesis  that  virtual  screening  method  P  performs  significantly  better  than  method  Q. 
Assuming p and q are rank lists of actives resulting from the virtual screening methods, the 
null hypothesis requires that BEDROC(p) > BEDROC(q). As each active has two ranks, one 
in p and one in q, new rank lists p* and q* can be created by swapping ranks in p with 
corresponding ranks in q for each active with a probability of 50%. This was repeated 10,000 
times and the frequency of the event that (BEDROC(p) – BEDROC(q)) < (BEDROC(p*) – 
BEDROC(q*)) is the type I error rate for the null hypothesis, which was used as p-value for 
significance estimation. As significance levels we used 0.05 (5%) and 0.01 (1%). 
As  we  performed  the  paired  permutation  test  with  10
4  permutations,  the  lowest 
measurable  p-value  equals  10
-4  and  results  if  only  for  one  out  of  10
4  permutations 
(BEDROC(p) – BEDROC(q)) < (BEDROC(p*) – BEDROC(q*)).  
 
 
Weighted PhAST 
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The flexible scoring system of PhAST allows for incorporation of a priori knowledge about 
important  PPPs  into  the  alignment  process.  The  idea  is  similar  to  the  construction  of  a 
position-specific score matrix,
9,10 but with our approach it is constructed implicitly. Utilizing 
a  general  score  matrix,  the  alignment  of  symbol  xi  from  PhAST-sequence  X  (query 
compound) and symbol  y j from PhAST-sequence Y (library compound) is scored with score 
s(xi,y j). If a weighting factor  wi is applied to symbol  xi the score  wi *s(xi,y j) is computed 
instead. The unweighted version of PhAST is identical to the application of weight 1 to every 
position  of  .  We  applied  weighted  PhAST  to  four  peroxisome  proliferator  activated 
receptor gamma (PPAR-*#agonists (Figure 1). For these molecules it is known that a negative 
charge in the carboxyl group is critical for receptor activation.
21 We used weights 1, 2, 3, 4, 5, 
10, 15, and 20, where a weight value of 1 corresponds to ‘no weighting’, in combination with 
the original PhAST scoring matrix (Table 3).
1 
As an alternative, using explicit of match- and mismatch-scores for each position in a 
query sequence would be possible with a position-specific scoring matrix. We chose implicit 
weighting factors as our aim was the extension of PhAST to position-specificity in a simple 
way.  For  explicit  position-specific  scores,  each  match-  and  mismatch-score  has  to  be 
determined, which is a more complex problem and might be not as intuitive as our simplistic 
approach. 
 
 
Pharmacophore Elucidation 
 
Given sets of active and inactive compounds for a certain target, the idea of weighted PhAST 
can  be  used  for  automated  pharmacophore  elucidation  through  interaction  profiling  for  a 
particular query structure. For this purpose we applied weights from the interval [+20,20] to 
each position of a query PhAST-sequence and performed retrospective screening using the 
dataset of known actives and inactives. If retrospective performance increases with a specific 
weight at a particular position, then the increase in performance indicates relative greater 
importance  of  this  particular  pharmacophoric  feature.  Positive  weights  identify  important 
potential  pharmacophoric  points.  Negative  weights  indicate  variable  positions  in  PhAST-
sequences for which mismatches are tolerated. Applying the paired permutation test to ranked 
lists  received  from  weighted  and  unweighted  screenings  allows  for  the  identification  of 
features responsible for significant differences. As example we used actives and decoys for 
PPAR-  available  in  the  COBRA  dataset,  as  we  know  that  for  the  four  PPAR-  agonists 
depicted in Figure 1 the only negative charge present in these molecules should be identified 
as the most important feature. 
 
 
Screening Protocol 2 
 
Effects of weighted features on retrospective performance were evaluated by retrospective 
screenings using the COBRA library. As the PPAR- agonists used as queries with weighted 
features were taken from this dataset, the query molecule was removed from the screening 
library. We performed exactly one screening for each combination of a query and a weighting 
scheme. The  resulting ranked lists were evaluated using the BEDROC metric (.#= 20).
12 
Significance of improvements was assessed by computing p-values in a paired permutation 
test.
13 
 
 
Library Preparation 
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All  molecules  were  protonated  using  the  ‘wash’  function  of  MOE  (Molecular  Operating 
environment,  version  2010.06,  Chemical  Computing  Group  Inc.,  Montreal,  Canada).  For 
similarity assessment between molecules we calculated MACCS keys
17 and the Tanimoto 
coefficient
18 as implemented in MOE. 
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RESULTS AND DISCUSSION 
 
Score Matrices 
 
We  deduced  log-odds  scores  for  the  alignment  of  symbols  representing  potential 
pharmacophoric  points  (PPPs)  from  symbol  frequencies  observed  in  a  reference  set  of 
compounds. Observed exchange frequencies of PPPs were estimated from pairwise kernel-
based assignments of graphs of potential pharmacophoric points as well as pairwise global 
sequence alignments. 
 
Assignment-based scoring  
For  each  matrix  created  based  on  pairwise  assignments  of  vertices  between  graphs  of 
potential pharmacophoric points attained using the ISOA kernel we performed a grid-search 
for best performing gap penalties (Table 7). For all subsequent calculations, scoring matrices 
were only used in combination with the best performing set of gap penalties. 
For  all  three  values  of  -,  best  retrospective  performance  was  observed  with  a 
similarity threshold of 0.9 for the molecule pairs used as reference. Differences in averaged 
retrospective performance were marginal, but highest performance (BEDROC = 0.35) was 
observed with the matrix calculated from ISOA kernel assignments generated with - = 0.75 
and similarity threshold = 0.9, in combination with gap open penalty = 9 and gap extension 
penalty = 1. This score matrix is presented in Table 8. The superiority of the original PhAST 
score matrix with average retrospective performance of 0.40 is significant: We calculated the 
percentage  of  screenings  per  target  in  which  PhAST  with  the  original  score  matrix 
outperforms PhAST with the best performing ISOA kernel score matrix and vice versa (Table 
9).  On  all  targets  and  both  significance  levels  PhAST  with  the  original  score  matrix 
performed significantly and exclusively better to a higher percentage, with values above 50% 
for COX2, DHFR, FXA, and THR. Averaged over all targets this superiority manifests in a 
total  of  67%  (65%)  for  all  screenings  at  0.05  (0.01)  significance  level.  Notably,  the  best 
performing  ISOA  kernel  score  matrix  performs  significantly  better  than  simple  scoring 
(averaged BEDROC = 0.28) on both significance levels in more than 50% of all screenings 
with only three exceptions: COX2 at 0.05 and 0.01, and PPAR- at 0.01 (Table 9). 
Score  matrices  created  with  different  parameterizations  of  the  ISOA  kernel  and 
similarity thresholds are not only similar judged from their retrospective performance but 
from  the  actual  scores  as  well.  The  averaged  absolute  difference  per  score  between  the 
original PhAST score matrix and the best performing ISOA kernel score matrix was 9.02, 
which is even smaller than the highest averaged difference within the ISOA kernel matrices 
(9.69 between matrices calculated with   = 0.5 (0.75) and similarity threshold 0.9 (0)) (see 
also the complete dissimilarity matrix in supplemental Table S1). For each kernel matrix, the 
remaining matrices calculated with the same similarity threshold are most similar, indicating 
that changing this parameter has a greater overall effect than kernel parameterization. The 
good agreement of matches between the original PhAST score matrix and the best performing 
ISOA kernel score matrix is reflected in a mean difference of match scores of 4.78 and 10.08 
for mismatch scores. Taking relations of match scores into account both matrices agree as 
well:  In  both  matrices  the  most  frequent  symbols  (R,  L,  O)  have  the  lowest  scores  for 
matches. On the other hand, rarely occurring symbols (P, N, E, Q) correspond to high match 
scores. Divergences are bigger for mismatch scores, with the maximum difference of 24 for 
the mismatch (A,Q) and (L,Q). 
 
Alignment-based scoring  
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Figure 2 presents the development of retrospective performance for scoring matrices created 
through iterated alignment and determination of symbol- and symbol-alignment frequencies 
necessary for calculation of log-odds scores (see also supplemental Table S2 and Table S3). 
At  no  point  during  this  process  a  matrix  was  created  with  better  retrospective 
performance  than  the  original  PhAST  score  matrix.  Iteration  processes  starting  from  the 
original PhAST score matrix lost retrospective performance in each step. Although processes 
starting from the +2 (match) -1 (mismatch) scoring scheme yielded matrices with a slightly 
increased retrospective performance after the first step, after convergence the final matrices 
were  always  inferior.  Irrespective  of  the  starting  conditions, all  final  matrices  showed  an 
averaged  retrospective  performance  between  BEDROC  =  0.33  and  0.35  compared  to 
BEDROC = 0.40 of the original PhAST scoring matrix. The best performing (converged) 
matrix created in this approach (starting from +2/-1 scoring and a similarity threshold of 0.9) 
with averaged retrospective performance of BEDROC = 0.34 is presented in Table 10. The 
superiority of the original PhAST score matrix is significant (Table 11): On five out of six 
targets (with exception of ACE) and on both significance levels PhAST with the original 
score matrix performed significantly better to a higher percentage, with values above 50% for 
COX2, DHFR, FXA and THR, with the opposite being true only for ACE at 0.01 significance 
level. Averaged over all targets this superiority manifests in 69% (66%) of all screenings at 
0.05  (0.01)  significance  level.  Still,  the  best  performing  iterated  alignment  score  matrix 
performs significantly better than simple scoring (averaged BEDROC = 0.28): Except for 
COX2, simple scoring was significantly outperformed on each target in more than 50% of all 
screenings at the 0.05 significance level, and at 0.01 except for COX2 and PPAR-. 
The mean averaged absolute score difference between all matrices created through 
iterated alignment is 6.34, indicating that these matrices diverge more from each other than 
the  matrices  created  using  ISOAK  assignments  (see  the  full  dissimilariy  matrix  in 
supplemental Table S4). The averaged difference per score between the original PhAST score 
matrix and the best performing matrix created in our iterated approach was 13.8, i.e. greater 
than the largest distance between any pair of these matrices. As for the ISOAK matrices, 
agreement  between  both  matrices  is  best  for  match  scores  with  an  averaged  match  score 
difference of 4.4 compared to 16.2 for mismatch scores. The relation of match scores agrees 
also: Matches of L, R, and O get lowest scores, and matches between P, N, E, and Q receive 
high scores. Scores for mismatches concur less well, with the highest difference of 37 for the 
(A, L) mismatch. 
Summarizing, both of our systematic approaches to generating scoring matrices for 
PPPs from a set of reference compounds yielded matrices that perform significantly better 
than  simple  +2/-1  scoring.  Still,  none  of  the  resulting  matrices  exhibited  better  averaged 
retrospective  performance  than  the  original  PhAST  score  matrix  (Table  3).  The  best 
performing matrices from both approaches agree well with an averaged difference per score 
of 5.44.  In both approaches highest performance resulted from using only closely related 
molecule pairs from the collection of reference compounds, indicating that the quality of the 
reference set has an influence on matrix properties. As none of the used datasets was built 
explicitly to contain only examples of observed bioisosterisms, this might present a possibility 
to further increase the quality of systematically constructed scoring matrices for molecular 
similarity assessment. 
 
Stochastically optimized scoring 
We  performed  stochastic  optimization  of  match  and  mismatch  scores  using  the  averaged 
retrospective performance on nine targets from the Krier dataset as evaluation function. The 
best  performing  matrix  from  each  generation  was  evaluated  in  a  set  of  retrospective 
screenings on the COBRA library as test dataset. Results for three independent optimization 
runs are presented in Figure 3. For all three optimizations, retrospective performance steadily 
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increases  on  the  training  dataset.  Retrospective  performance  on  the  test  dataset  increases 
overall as well. For both datasets the increase flattens after 20 generations. At no time the 
performance on the test dataset decreases strongly, suggesting that the optimization does not 
greatly suffer from overfitting to the training data. The matrix with the highest retrospective 
performance was created in run no. two in generation 85 yielding an averaged BEDROC of 
0.38.  Still,  we  chose  the  final  matrix  based  on  retrospective  performance  on  the  training 
dataset for further experiments; for all optimization runs this was the best performing matrix 
from the last optimization cycle (averaged BEDROC: 0.37) (Table 12). 
Retrospective performance of the best stochastic scoring matrix was inferior to the 
original  PhAST  score  matrix  (averaged  BEDROC  =  0.40).  This  difference  is  significant 
(Table  13):  For  three  targets  (COX2,  DHFR,  THR)  the  best  stochastic  scoring  matrix  is 
outperformed in more than 50% of all screenings at both significance levels with the opposite 
being true only in one case (FXA). Averaged over all targets, this superiority manifests in 
53% (51%) of all screenings at 0.05 (0.01) significance level, whereas the best stochastic 
scoring matrix performs significantly better only in 35% (32%) of all screenings. On the other 
hand, the best performing stochastic scoring matrix outperforms simple +2/-1 scoring in 84% 
(81%)  of  all  screenings  at  the  0.05  (0.01)  significance  level.  Its  averaged  retrospective 
performance  (BEDROC  =  0.37)  is  statistically  significantly  better  compared  to  the  best 
ISOAK score matrix (BEDROC = 0. 35) and iterated alignment score matrix (BEDROC = 
0.34). 
Compared  to  the  matrices  created  using  the  ISOA  kernel  and  iterated  alignment, 
matrices resulting from stochastic optimization are more diverse: the top-performing matrix in 
the last cycle of run no. two has an averaged per-score difference to that of the first (third) run 
of 16.9 (10.4). The top-performing matrices from the last optimization cycle of the first and 
second run diverge by 15.2. The best-performing stochastic score matrix diverges from the 
original PhAST score matrix to an even higher degree, as the averaged per-score difference 
between those two matrices is 16.8. This value is mainly influenced by scores for matches, for 
which  alone  the  averaged  difference  is  30.8.  With  13.4  the  averaged  difference  for 
mismatches  is  comparatively  small.  But  even  with  the  high  divergence  of  match  scores 
relations between them agree fairly well: Matches for L, O, and R received the lowest score 
(only the score for an (A,A) match is lower); and P, N, E, and Q are scored higher. 
  Summarizing,  these  results  demonstrate  that  stochastic  optimization  yielded  score 
matrices that significantly outperform simple scoring and the score matrices attained using the 
presented systematic approaches for score calculation. But even the best matrix resulting from 
this approach is inferior to the original PhAST score matrix. 
Despite the fact that retrospective performance differs significantly between matrices, 
and scores for matches and mismatches differ highly in some cases, all matrices seem to 
describe  connatural  relationships  between  PPPs.  We  brought  scores  for  matches  and 
mismatches in sequential order for each of the four matrices (row-to-row concatenation in the 
order given in this publication) and calculated Pearson’s correlation coefficient (Table 14). 
Similarity of score relations is highest between the best performing ISOA kernel and iterated 
alignment matrices with a correlation of r = 0.9. The matrix with most dissimilar relations to 
all other matrices is the original PhAST score matrix. With an averaged correlation coefficient 
of r = 0.68 it still has scoring principles common to the other ones. The scores in the original 
PhAST  score  matrix  were  determined  based  on  chemical  intuition  and  PPP  frequencies. 
Apparently, there are certain properties and relations between molecular features that were 
recognized by chemists and computer-based methods alike. 
 
 
Weighted PhAST 
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We evaluated the influence of the application of weights to known key interaction features in 
virtual screenings with PhAST using the example of PPAR-#agonist retrieval. For four test 
cases of PPAR- agonists, a set of weights was applied to a negative charge known to be 
essential for activity and the resulting ranked lists were evaluated using the BEDROC metric 
(Table 15). In all cases hit retrieval was significantly improved. Each combination of query 
and  PPP  feature  weights  weights  outperformed  unweighted  virtual  screening.  Best  results 
were obtained with different weights for different queries. Highest retrospective performance 
averaged over all four PPAR agonists results from the application of a weight value of 10. For 
each  query,  the  paired  permutation  test  between  the  unweighted  and  the  best  performing 
weighted  screening  resulted  in  a  p-value  <  10
-4,  meaning  that  the  improvements  are 
statistically  significant.  The  outcome  of  this  preliminary  study  demonstrates  that  by 
incorporation  of  knowledge  about  relevant  PPPs  virtual  screening  by  PhAST  can  be 
improved. Which particular weighting scheme should be applied certainly depends on the 
target, the particular interaction type, and the dataset used for screening. 
 
 
Pharmacophore Elucidation 
 
Finally,  we  used  weighted  PhAST  in  a  series  of  retrospective  screenings  for  automated 
identification of important PPPs. Again, PPAR- agonists served as an example. For our four 
test compounds the weights for each position resulting in highest retrospective performance 
are given in Table 16. Notably, up-weighting the sole negative charge present in the query 
compounds resulted in highest retrospective performance compared to each other combination 
of weight and position in the PhAST-sequences. The increase in retrospective performance is 
significant (p < 10
-4). This result proves that our approach can be used to identify critical 
PPPs.  
Systematic  application  of  weights  revealed  additional  PPPs  whose  weighting 
significantly increased retrospective performance (p < 10
-4). For each query, we selected the 
four  PPPs  causing  highest  performance  when  emphasized  with  the  identified  best  weight 
(Figure 4) and used these for retrospective screening. For query structure A (B) [C] {D} 
screening performance was again significantly improved from BEDROC = 0.24 (0.29) [0.12] 
{0.15}  to  0.36  (0.54)  [0.42]  {0.39}  with  p-values  <  10
-4.  For  query  structure  A,  the 
improvement is smaller than with weighting of the negative charge alone (BEDROC = 0.40). 
Visual  inspection  of  the  molecule  revealed  that  the  acceptor  functionality  identified  as  a 
potentially important interaction is part of the same carboxyl group as the negative charge. So 
weighting this substructure twice might be redundant. When the weight of this acceptor was 
decreased  to  one  and  the  screening  was  repeated  with  only  the  remaining  three  weights 
retrospective performance increased to BEDROC = 0.44 (p < 10
-4). Surprisingly, weighting of 
the  acceptor  functionality  in  the  carboxyl  group  of  query  B  did  not  cause  a  decrease  in 
retrospective performance, and when omitted caused performance to decrease to BEDROC = 
0.5. In this case the acceptor functionality weighted with -1 resulted in best performance, 
inverting the scores of the original PhAST score matrix (Table 3). Apparently, exchanges at 
this position are rewarded, contrary to query structure A where this feature was weighted with 
weight = 5, preferring a conservation of this functionality at this position. Apparently favoring 
exchange  of  functionality  at  this  position  is  beneficial.  Some  additional  potential 
pharmacophoric  points  of  types  L  and  O  were  suggested  as  ‘important’  interaction.  This 
exposes  the  significance  of  increase  in  retrospective  performance  as  a  necessary  but 
insufficient indication for the relative importance of a PPP.  
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CONCLUSIONS 
 
In this study we investigated the influence of modified scoring schemes on our text-based 
virtual screening approach PhAST. The impact of this study is three-fold. 
First,  we  proposed  and  validated  three  approaches  for  the  generation  of  scoring 
systems for potential pharmacophoric points. These approaches can be applied to custom sets 
of  reference  compounds  and  yield  scoring  systems  that  are  significant  improvements  to 
simple scoring (matches +2, mismatches -1). The two systematic methods calculate scores 
within minutes. Runtime of stochastic optimization is subject to parameterization. Besides 
their general applicability, these methods can be used in the future for rapid evaluation of 
modifications to the pharmacophore model employed in our screening method PhAST. Matrix 
quality might be increased by a set of reference compounds containing proven examples of 
bioisosterism, as we could show that retrospective performance increases if only very similar 
molecules are used for score calculations. 
Second,  we  demonstrated  the  importance  of  knowledge  about  receptor-ligand 
interactions being incorporated into the virtual screening process. With our screening method 
PhAST as example we could show that such weighting of interactions significantly improves 
screening performance. Previously,
3 we demonstrated that the overall performance of PhAST 
is comparable to other ligand-based virtual screening techniques. This increase in screening 
performance  renders  PhAST  a  potentially  valuable  tool  for  hit  retrieval  from  very  large 
compound collections. 
Third,  we  demonstrated  the  pharmacophore  elucidation  capabilities  of  text-based 
virtual screening. Given a set of compounds with known pharmacological (in)activity, PhAST 
may be used to construct a set of optimal positional weights that indicate key interaction 
points common between active compounds. This set of weights can instantly be used for 
weighted prospective screenings. Expanding the protocol used for pharmacophore elucidation 
to the generation of a complete set of match- and mismatch-scores for a position instead of a 
weight applied to all scores might also provide reasonable suggestions for substitutions of 
functional groups in a molecule. This aspect will be subject to further investigations. 
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Legends to the Figures 
 
 
Figure  1.  Selected  PPAR--agonists.
11  These  four  compounds  were  used  as  queries  in 
weighted virtual screening and as test cases for automated pharmacophore elucidation with 
PhAST. The negative charge highlighted by circles is essential for PPAR- activation.
21 
 
Figure  2.  BEDROC  performance  of  scoring  matrices  based  on  iterated  alignment.  O  = 
original PhAST score matrix used for initial alignments, S = simple +2 (match) -1 (mismatch) 
scoring used for initial alignments, t = similarity threshold for aligned molecule pairs. 
 
Figure 3. Performance  of the stochastic score  matrix optimization. For each iteration the 
retrospective performance on test and training dataset is given as averaged BEDROC score. 
A)  first  optimization  run,  B)  second  optimization  run,  C)  third  optimization  run.  Final 
averaged BEDROC scores on the test dataset are: A) 0.34, B) 0.37, C) 0.36. 
 
Figure 4. Automated pharmacophore elucidation with PhAST. For each marked atom of the 
four PPAR- agonists the weight of the corresponding pharmacophoric feature is given. Larger 
values indicate potentially greater importance. 
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TEXT FOR GRAPHICAL ABSTRACT 
 
Various  scoring  schemes  assessing  the  similarity  of  potential  pharmacophoric  points  in 
bioactive compounds were generated by algorithmic optimization, and compared to a scheme 
based  on  chemical  intuition.  We  demonstrate  that  screening  performance  of  text-based 
similarity  searching  is  significantly  increased  by  position-specific  weighting  of  ligand-
receptor interaction sites, and suitable sets of weights can be generated fully automatically. 
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Table 1. Potential pharmacophoric points used in PhAST and their corresponding 
symbols. 
 
possible interactions  symbol 
hydrogen bond acceptor  A 
charge positive  P 
charge negative  N 
lipophilic  L 
aromatic  R 
hydrogen bond acceptor, hydrogen bond donor  E 
hydrogen bond acceptor, polar  Q 
hydrogen bond acceptor, hydrogen bond donor, polar  U 
no possible interactions  O 
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Table  2.  MQL  queries  defining  pharmacophoric  points  in  PhAST.  Symbols  are 
assigned to atoms used in queries from left to right. Queries are used in the given 
order from top to bottom. 
 
MQL query  PPP symbols 
c  R 
n  R 
*[charge<0]  N 
*[charge>0]  P 
C(=O)-O-H  O;N;E 
P(=O)-O-H  O;N;E 
S(=O)-O-H  O;N;E 
N[allHydrogens=0&totalConnections=3]  Q 
N[allHydrogens=1&totalConnections=3](-C')-C'  U 
N[allHydrogens=2&totalConnections=3]-C'  U 
N[allHydrogens=1&totalConnections=2]=C'  E 
N[allHydrogens=0&totalConnections=2](=C')-C'  A 
O-H  E 
C=O  O;A 
C[!bound(~N)&!bound(~O)]-*'[C|F|Cl|Br|I|S]  L 
Cl  L 
Br  L 
I  L 
S[!bound(~N)&!bound(~O)]~*'[C|H]  L 
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Table  3.  Original  PhAST  score  matrix  for  matches  and  mismatches  of  potential 
pharmacophoric points. 
 
 A   E   L   N   O   P  Q  R  U 
A  8  2  2  -1  -2  -4  4  -4  -2 
E    12  -4  -9  -4  -6  -4  -9  0 
L      2  -2  -2  -2  -4  1  -6 
N        10  -2  -6  -7  -4  -10 
O          2  -2  -4  -4  -6 
P            10  6  -5  4 
Q              14  -9  6 
R                3  -13 
U                  16 
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Table 4. Targets in the COBRA library version 6.1 used for retrospective virtual screenings. 
Shown are abbreviations used in this study as well as the number of active compounds. The 
total number of molecules in the COBRA library is 8311. 
 
Target  Abbreviation  No. Actives 
Angiotensine-
converting 
Enzyme 
ACE  34 
Cyclooxygenase 2  COX2  136 
Dihydrofolat-
reductase  DHFR  64 
Factor Xa  FXA  228 
Peroxisome-
proliferator activated 
receptor ! 
PPAR!  44 
Thrombin  THR  183 
Total    689 
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Table 5. 31 therapeutic classes of the Krier dataset used for score matrix calculation. For each 
class  the  number  of  compounds  and  the  number  of  unique  pairs  with  similarity  above 
similarity threshold t measured by MACCS keys and the Tanimoto coefficient is shown. As 
additional constraint pairwise similarity has to be below 0.98 to exclude trivial analogues 
from score matrix calculation. 
 
ID  Therapeutic class  No. 
Compounds 
No. Pairs 
(t = 0.0) 
No. Pairs 
(t = 0.5) 
No. Pairs 
(t = 0.75) 
No. Pairs 
(t = 0.90) 
1  ACE inhibitors  43  902  742  128  16 
2  anabolic steroids  51  1261  1092  592  144 
3  androgens  39  726  697  338  120 
4  angiotensin II-antagonists  25  300  272  23  1 
5  antiarrhythmics (class III)  17  135  41  7  0 
6  barbitals  23  252  250  103  13 
7  benzodiazepams  97  4653  2825  203  33 
8  beta-blockers  50  1224  1047  217  9 
9  calcium channel blockers  30  435  259  52  9 
10  carbonic anhydrase inhibitors  8  28  25  3  0 
11  antifungals (Conazoles)  54  1424  1002  119  28 
12  COX inhibitors  73  2628  520  77  24 
13  dazoles  17  136  56  9  2 
14  floxacines  39  740  677  270  51 
15  histamine H1-antagonists  28  378  208  12  2 
16  histamine H2-antagonists  26  325  132  15  3 
17  HIV protease inhibitors  18  153  113  21  6 
18  leukotriene antagonists  58  1653  221  7  0 
19  local anesthetics (Caines)  64  2011  1257  135  21 
20  nitrofuranes  29  405  374  40  2 
21  penicillines and derivatives  163  13196  11420  1329  78 
22  phosphodiesterase IV inhibitors  11  55  6  1  0 
23  pramines  22  231  181  41  7 
24  antiulcers (Prazoles)  18  153  87  27  2 
25  progestogens  59  1688  1678  739  107 
26  reverse transcriptase inhibitors  66  2145  1189  215  26 
27  serotonin antagonists  25  300  164  14  1 
28  sulfonamides  54  1427  1373  286  28 
29  tetracyclines  18  152  152  86  24 
30  anticoagulants  29  406  112  8  0 
31  tyrosine kinase inhibitors  14  91  49  4  0 
  Total  1268  39613  28221  5121  757 
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Table 6. Relative frequencies of potential pharmacophoric point symbols in datasets. Shown 
are the percentages of each symbol in PhAST-sequences created from all molecules of the 
respective compound collection. 
 
Symbol  COBRA  Krier 
A  4.95  6.44 
E  1.44  1.37 
L  19.65  24.38 
N  1.22  1.75 
O  24.63  26.35 
P  1.80  1.72 
Q  1.58  1.99 
R  41.61  33.49 
U  3.11  2.49 
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Table 7. Retrospective performance of score matrices for potential pharmacophoric points 
calculated based on ISOAK assignments. For all combinations of a in the ISOA kernel and 
the similarity threshold for molecule pairs used as reference the best performing combination 
of gap penalties and averaged retrospective performance are shown. t = similarity threshold 
for molecule pairs, GO = gap open penalty, GE = gap extension penalty. 
 
ISOAK !  t  GO  GE  Ø BEDROC 
0.00  9  2  0.3349 
0.50  7  1  0.3353 
0.75  9  1  0.3396 
0.25 
0.90  9  1  0.3505 
0.00  9  2  0.3343 
0.50  7  1  0.3345 
0.75  9  1  0.3399 
0.50 
0.90  9  1  0.3505 
0.00  8  1  0.3329 
0.50  7  1  0.3359 
0.75  8  1  0.3386 
0.75 
0.90  9  1  0.3506 
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Table 8. Best performing score matrix calculated based on ISOAK assignments. 
 
 A  E  L   N   O   P   Q   R   U  
A  12  1  -15  -4  -11  -11  -20  -23  -20 
E   1 7   -19  -4  -12  -6  -5  -26  -8 
L      3  -14  -11  -19  -28  -8  -15 
N      1 9   -14  -4  -13  -10  -13 
O        6   -11  -25  -13  -13 
P          2 0   -12  -12  -2 
Q            1 8   -24  -3 
R              7   -14 
U                1 8  
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Table 9. Comparison of the best performing ISOAK score matrix to the original PhAST score 
matrix and simple +2  (match) -1 (mismatch) scoring. Shown are percentages of retrospective 
screenings PhAST employing one score matrix outperforms PhAST in combination with the 
other one at 0.05 (0.01) significance level. 
 
 Ø   A C E   C O X 2   D H F R   F X A   PPAR!  THR 
ISOAK best  72 (69)  94 (91)  11 (9)  92 (91)  79 (78)  64 (59)  91 (88) 
Simple  20 (19)  0 (0)  85 (83)  3 (3)  14 (14)  16 (14)  4 (3) 
              
ISOAK best  19 (17)  26 (26)  13 (12)  6 (3)  28 (28)  32 (27)  8 (8) 
PhAST original  67 (65)  41 (41)  85 (85)  88 (86)  66 (65)  39 (34)  84 (80) 
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Table 10. Best performing score matrix based on iterated alignment. 
 
 A  E   L   N   O   P   Q   R   U  
A  11  1  -35  10  -14  -18  -20  -31  -20 
E   1 6   -30  -14  -13  -5  -15  -26  -16 
L    3   - 2 8   - 2 3   - 2 6   - 2 9   - 2 8   - 1 8  
N      1 7   - 2 4   - 1 1   - 1 3   - 2 4   - 1 3  
O         7   - 1 2   - 2 5   - 3 6   - 1 3  
P          2 0   - 1 2   - 2 2   - 1 2  
Q            1 8   - 2 5   - 1 4  
R               7   - 1 7  
U                1 8  
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Table  11.  Comparison  of  the  best  performing  score  matrix  calculated  based  on  iterated 
alignment to the original PhAST score matrix and simple +2  (match) -1 (mismatch) scoring. 
Shown  are  percentages  of  retrospective  screenings  PhAST  employing  one  score  matrix 
outperforms PhAST in combination with the other one at 0.05 (0.01) significance level. 
 
 Ø   A C E   C O X 2   D H F R   F X A   PPAR!  THR 
Iterated best  69 (67)  94 (91)  14 (13)  86 (84)  82 (80)  52 (45)  89 (86) 
Simple  20 (19)  0 (0)  79 (79)  6 (5)  13 (12)  18 (14)  4 (3) 
              
Iterated best  18 (16)  35 (29)  12 (12)  5 (3)  29 (27) 2 3   ( 1 8 )   6   ( 6 )  
PhAST original  69 (66)  35 (26)  86 (86)  95 (92)  66 (66)  43 (41)  85 (83) 
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 Table 12. Best performing score matrix resulting from stochastic optimization. 
 
! A  E  L  N  O  P  Q  R  U 
A  "! #$%! #$&! $! #%! #%'! #$(! #%%! (!
E  !) * ! # % & ! +! &! #+(! %(! &! #$"!
L  !!' $ ! # ' + ! #+! #'(! #$)! "! '!
N  !! !* ) ! # % $ ! #$,! #,! #'(! #%!
O  !! ! !' % ! ( ! # $ ' ! *! '!
P  !! ! ! ! * % ! $ + ! # " ! # $ ( !
Q  !! ! ! ! ! ' ) ! + ! " !
R  !! ! ! ! ! ! $ ) ! ' !
U  !! ! ! ! ! ! ! & ' !
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Table  13.  Comparison  of  the  best  performing  score  matrix  attained  from  stochastic 
optimization to the original PhAST score matrix, simple +2  (match) -1 (mismatch) scoring 
and the best performing score matrices calculated based on ISOAK assignments and iterated 
alignment. Shown are percentages of retrospective screenings PhAST employing one score 
matrix outperforms PhAST in combination with the other one at 0.05 (0.01) significance 
level. 
 
 M e a n   A C E   C O X 2   D H F R   F X A   PPAR!  THR 
Stochastic best  84 (81)  88 (88)  62 (57)  91 (91)  89 (88)  77 (68)  96 (96) 
Simple  10 (10)  3 (3)  33 (32)  5 (3)  7 (6)  11 (11)  3 (3) 
              
Stochastic best  35 (32)  32 (24)  28 (26)  0 (0)  68 (67)  48 (43)  35 (34) 
PhAST original  53 (51)  41 (32)  68 (65)  98 (97)  26 (25)  27 (27)  60 (58) 
              
Stochastic best  54 (50)  35 (21)  85 (85)  14 (14)  69 (68)  43 (41)  74 (74) 
ISOAK best  31 (30)  35 (32)  12 (10)  73 (73)  24 (23)  23 (20)  22 (20) 
              
Stochastic best  54 (52)  18 (15)  80 (79)  20 (19)  72 (69)  57 (52)  75 (75) 
Iterated best  32 (29)  56 (47)  13 (11)  64 (61)  22 (20)  18 (14)  20 (20) 
              
Iterated best  30 (26)  47 (35)  35 (31)  5 (5)  41 (36)  16 (14)  35 (33) 
ISOAK best  47 (42)  18 (15)  41 (35)  78 (69)  48 (46)  52 (43)  45 (42) 
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Table 14. Comparison of score matrices by Pearson correlation coefficient. 
 
 O r i g i n a l   I S O A K   I t e r a t e d   S t o c h a s t i c  
Original  1  0.76  0.67  0.62 
ISOAK    1  0.90  0.72 
Iterated      1  0.71 
Stochastic        1 
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Table  15.  Retrospective  performance  of  weighted  PhAST.  Shown  are  BEDROC  scores 
calculated for screenings of PPAR! -agonists with upweighted key interaction, the difference 
between  unweighted  and  the  maximum  of  weighted  performance  as  well  as  the  p-values 
calculated for the improvement from unweighted to the best performing weighted screening.  
 
 C o m p o u n d    
weight  A  C  B  D  Ø BEDROC 
1  0.24  0.12  0.29  0.15  0.20 
2  0.32  0.15  0.40  0.19  0.26 
3  0.37  0.18  0.44  0.23  0.30 
4  0.39  0.22  0.45  0.26  0.33 
5  0.40  0.25  0.45  0.29  0.35 
10  0.40  0.30  0.44  0.32  0.37 
15  0.40  0.32  0.42  0.33  0.37 
20  0.40  0.32  0.40  0.34  0.37 
          
BEDROC (unweighted)  0.24  0.12  0.29  0.15   
BEDROC (max weighted)  0.40  0.32  0.45  0.34   
p-Value  < 10
-4  < 10
-4  < 10
-4  < 10
-4   
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Table 16. Results of the pharmacophore elucidation for four PPAR!-agonists. Shown are 
PhAST-sequences,  weights  resulting  in  highest  retrospective  performance,  corresponding 
BEDROC score and significance estimation for performance increase as well as the BEDROC 
scores  of  the  corresponding  unweighted  screenings  (shown  in  parentheses).  S  =  symbol 
corresponding  to  a  potential  pharmacophoric  point,  W  =  weight  resulting  in  highest 
retrospective  performance  for  this  position,  B  =  BEDROC  score  obtained  with  the  given 
weight, P = p-value indicating the significance of increase in retrospective performance of the 
weighted screening performed with the given weight at this position; if no p-value is given, no 
weight could increase retrospective performance compared to the unweighted screening; “-“ 
indicates  p-values  below  10
-4.  Bold  positions  were  used  in  a  combined  retrospective 
screening. 
 
Structure A    Structure B    Structure C    Structure D 
(BEDROC 0.24)    (BEDROC 0.29)    (BEDROC 0.12)    (BEDROC 0.15) 
S  W  B  P    S  W  B  P    S  W  B  P    S  W  B  P 
O  -1  0.26  -   R   1  0.29     L   2 0   0.14  0.00   R   14  0.17  0.00 
O  -1  0.25  0.03   R   1  0.29     R   7  0.12  0.02   R   20  0.16  0.01 
O  -1  0.25  0.07   R   0  0.30  0.01   R   11  0.12  0.42   R   20  0.16  0.00 
L  0  0.25  -   R   1  0.29     R   0  0.12  0.09   R   13  0.16  0.00 
O  3  0.25  0.14   R   0  0.30  0.24   R   0  0.12  0.06   R   -1  0.16  0.06 
N  12  0.40  -   R   1  0.29     R   -1  0.12  0.13    O  20  0.19  0.00 
A  5  0.29  -   R   0  0.30  0.08   R   4  0.12  0.00   R   12  0.17  0.00 
O  -1  0.26  0.01   O   -2  0.32  0.00   L   - 1   0.13  0.07   Q   2  0.15  0.36 
O  -1  0.28  -   O   -1  0.32  0.00    O  16  0.16  0.00   O   19  0.17  0.00 
O  0  0.25  0.08   R   10  0.32  0.00    O  14  0.15  0.00   O   19  0.17  0.00 
L  20  0.30  -   Q   0  0.32  0.00   R   5  0.12  0.39   O   19  0.17  0.00 
R  2  0.24  0.37   O   0  0.30  0.01   R   4  0.12  0.02   R   10  0.16  0.01 
R  3  0.25  0.02   O   17  0.32  0.00   R   4  0.12  0.03   R   12  0.16  0.00 
R  3  0.24  0.09   O   17  0.32  0.01   R   5  0.12  0.03   R   12  0.16  0.00 
R  0  0.25  0.21   R   9  0.30  0.23   R   6  0.12  0.06   R   12  0.16  0.00 
R  0  0.24  0.39   R   6  0.30  0.03   R   6  0.12  0.02   R   12  0.16  0.00 
R  0  0.24  0.51   R   6  0.30  0.13    L  20  0.15  0.00   R   12  0.17  0.00 
R  0  0.26  0.01   R   6  0.30  0.03   O   5  0.12  0.08    L  20  0.18  0.00 
O  11  0.28  -   R   5  0.30  0.06   O   4  0.12  0.03   O   19  0.16  0.08 
R  -1  0.27  -   R   8  0.30  0.14   U   0  0.16  0.00   O   20  0.17  0.00 
L  10  0.26  0.01    L  20  0.34  0.00   R   20  0.12  0.03    U  0  0.20  0.00 
R  2  0.24  0.46   O   0  0.29  0.46   A   -10  0.13  0.10   R   1  0.15   
R  2  0.24  0.46   O   0  0.32  0.00    N  20  0.32  0.00   A   8   0.16  0.06 
R  3  0.24  0.16   O   -1  0.32  0.00   R   0  0.12  0.34    N  20  0.34  0.00 
O  9  0.26  0.07    A  -1  0.35  0.00   R   1  0.12     R   0  0.16  0.17 
R  0  0.24  0.31    N  5  0.45  0.00   O   0  0.12  0.21   R   0  0.16  0.00 
L  15  0.28  -   O   4  0.33  0.00   R   1  0.12     O   6  0.16  0.14 
R  0  0.25  0.01    L  -1  0.32  0.00   R   0  0.12  0.39   R   0  0.16  0.00 
R  0  0.24  0.03   O   -1  0.33  0.00   R   0  0.12  0.15   R   0  0.16  0.02 
R  0  0.25  -   O   -1  0.32  0.00   A   20  0.14  0.00   R   0  0.16  0.00 
R  0  0.25  0.13   O   -1  0.33  0.00   R   0  0.12  0.07   A  2 0   0.17  0.03 
R  1  0.24             R   0  0.12  0.29   R   -1  0.17  0.01 
R  2  0.24  0.37           R   0  0.12  0.36   R   -1  0.18  0.01 
                R   2  0.12  0.31   R   -1  0.18  0.00 
                R   2  0.12  0.47   R   -1  0.16  0.14 
                R   1  0.12     R   -1  0.17  0.05 
                         R   0  0.16  0.04 
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60Table S1. Matrix of averaged differences between score matrices calculated based on ISOAK 
assignments. ! = parameter of the ISOA kernel, t = similarity threshold for aligned molecules 
pairs. 
!
  !=0.25 
t=0.00 
!=0.25 
t=0.50 
!=0.25 
t=0.75 
!=0.25 
t=0.90 
!=0.50 
t=0.00 
!=0.50 
t=0.50 
!=0.50 
t=0.75 
!=0.50 
t=0.90 
!=0.75 
t=0.00 
!=0.75 
t=0.50 
!=0.75 
t=0.75 
!=0.75 
t=0.90 
!=0.25 
t=0.00 
0.00  0.89  3.87  9.40  0.07  0.89  3.87  9.42  0.49  1.02  3.67  8.93 
!=0.25 
t=0.50 
  0.00  3.07  8.60  0.91  0.09  3.07  8.62  1.07  0.58  2.78  8.13 
!=0.25 
t=0.75 
    0.00  5.62  3.89  3.11  0.22  5.64  4.13  3.38  0.56  5.16 
!=0.25 
t=0.90 
      0.00  9.47  8.64  5.62  0.07  9.67  8.87  6.00  1.00 
!=0.50 
t=0.00 
        0.00  0.91  3.89  9.49  0.42  1.00  3.69  9.00 
!=0.50 
t=0.50 
          0.00  3.11  8.67  1.02  0.53  2.78  8.18 
!=0.50 
t=0.75 
            0.00  5.64  4.13  3.38  0.60  5.16 
!=0.50 
t=0.90 
              0.00  9.69  8.89  6.02  1.02 
!=0.75 
t=0.00 
                0.00  0.93  3.80  9.20 
!=0.75 
t=0.50 
                  0.00  3.04  8.40 
!=0.75 
t=0.75 
                    0.00  5.53 
!=0.75 
t=0.90 
                      0.00 
 Table S2. Development of retrospective performance during iterated alignment. Shown is the 
averaged retrospective performance on the COBRA dataset, iterated alignment was performed 
on the Krier dataset. t = similarity threshold for aligned molecule pairs. The original PhAST 
score matrix was used as scoring scheme for the first alignment step, gap penalties were fixed 
at gap open penalty 5 and gap extension penalty 1. 
 
Iteration  t = 0.00  t = 0.50  t = 0.75  t = 0.90 
1  0.4001  0.4001  0.4001  0.4001 
2  0.3790  0.3691  0.3536  0.3518 
3  0.3617  0.3590  0.3396  0.3464 
4  0.3539  0.3367  0.3379  0.3449 
5  0.3450  0.3330  0.3373  0.3436 
6  0.3365  0.3303  0.3370  0.3425 
7  0.3341  0.3295  0.3367  0.3424 
8  0.3297  0.3269  0.3368   
9  0.3305  0.3263  0.3368   
10  0.3282  0.3263  0.3368   
11  0.3280  0.3261  0.3370   
12  0.3280  0.3261  0.3369   
13  0.3280  0.3261  0.3369   
14  0.3280  0.3260  0.3368   
15  0.3280  0.3260  0.3368   
16    0.3260     
17    0.3260     
18    0.3260     
19    0.3260     
20    0.3260     
 
 Table S3. Development of retrospective performance during iterated alignment. Shown is the 
averaged retrospective performance on the COBRA dataset, iterated alignment was performed 
on the Krier dataset. t = similarity threshold for aligned molecule pairs. Simple +2 (match) -1 
(mismatch) scoring was used as scoring scheme for the first alignment step, gap penalties 
were fixed at gap open penalty 5 and gap extension penalty 1. 
 
Iteration  t = 0.00  t = 0.50  t = 0.75  t = 0.90 
1  0.2801  0.2801  0.2801  0.2801 
2  0.3367  0.3382  0.3443  0.3456 
3  0.3406  0.3363  0.3397  0.3482 
4  0.3305  0.3298  0.3396  0.3452 
5  0.3325  0.3298  0.3389  0.3440 
6  0.3321  0.3296  0.3382  0.3435 
7  0.3322  0.3284  0.3377  0.3433 
8  0.3310  0.3283  0.3374  0.3433 
9  0.3296  0.3278  0.3374  0.3433 
10  0.3297  0.3272  0.3374   
11  0.3296  0.3264  0.3374   
12  0.3297  0.3262  0.3374   
13  0.3298  0.3259     
14  0.3298  0.3260     
15  0.3299  0.3260     
16  0.3296  0.3260     
17  0.3296  0.3260     
18    0.3260     
19    0.3260     
20    0.3260     
21    0.3260     
22    0.3260     
23    0.3260     
24    0.3260     
25    0.3260     
26    0.3260     
27    0.3260     
28    0.3260     
29    0.3260     
30    0.3260     
 
 Table S4. Matrix of averaged differences between score matrices calculated based on iterated 
alignment. O = alignment iteration beginning with the original PhAST score matrix, S = 
alignment  iteration  beginning  with  simple  +2  (match)  -1  (mismatch)  scoring  scheme,  t  = 
similarity threshold for aligned molecules pairs. 
!
  O 
t=0.00 
O 
t=0.50 
O 
t=0.75 
O 
t=0.90 
S 
t=0.00 
S 
t=0.50 
S 
t=0.75 
S 
t=0.90 
O 
t=0.00  0.00  3.13  7.07  10.20  3.91  5.07  7.71  10.89 
O 
t=0.05    0.00  5.58  8.80  3.80  4.24  6.36  9.49 
O 
t=0.75      0.00  4.87  6.98  7.33  2.51  5.87 
O 
t=0.90        0.00  9.18  9.27  4.89  1.44 
S 
t=0.00          0.00  3.20  6.02  9.29 
S 
t=0.50            0.00  6.16  9.07 
S 
t=0.75              0.00  5.09 
S 
t=0.90                0.00 
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Introduction
Staphylococcus aureus (S. aureus) causes multiple diseases
ranging in severity from minor skin infections to life-threat-
ening conditions, such as endocarditis, pneumonia, and
sepsis.
[1] Methicillin-resistant S. aureus (MRSA) has been
widespread and has become a serious pathogenic bacterium,
leading to high morbidity and mortality.
[2,3] MRSA is not
only resistant to treatment with ß-lactams, but often also to
other antibiotics such as aminoglycosides, macrolides, linco-
samides, and fluoroquinolones, because many MRSA strains
possess a multidrug resistant genotype. Moreover, the ap-
pearance of vancomycin and linezolid resistance limited op-
tions for therapy against MRSA.
[4,5] This evolution points to
an urgent need for new anti-MRSA compounds and for the
optimization of established ones with high antimicrobial ac-
tivity.
Folic acid antagonists, such as trimethoprim/sulfamethoxa-
zole (SXT), possess a wide antimicrobial spectrum and show
good antimicrobial activity against S. aureus including
MRSA.
[6,7] These bioactive agents inhibit different enzymat-
ic steps of the folic acid pathway leading to cessation of the
bacterial synthesis of deoxythymidine monophosphate
(dTMP) by thymidylate synthase. However, several bacterial
species including S. aureus possess an alternative pathway
for synthesis of intracellular dTMP by uptake of extracellu-
lar thymidine and subsequent intracellular phosphorylation
to dTMP. Thus, the effect of folic acid antagonists can be an-
tagonized by a high extracellular thymidine concentration as
detected in tissues with necrotic cells such as pus and
sputum from cystic fibrosis patients.
[8–10] Indeed, there are
several reports of unsuccessful treatment with folic acid an-
tagonists, supposedly due to elevated thymidine concentra-
tions in human tissues containing necrotic cells.
[9,11,12]
We recently showed that, in the presence of thymidine, si-
multaneous inhibition of the folic acid pathway by SXT and
the bacterial thymidine kinase (TK; EC 2.7.1.21) by nucleo-
side analogues, especially halogenated 2’-deoxyuridine de-
rivatives, results in synergistic antimicrobial activity against
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[10] Halogenated 2’-deoxyuridine derivatives such as
5-chloro-2’-deoxyuridine (5-CldU) and 5-iodo-2’-deoxyuri-
dine (5-IdU) have been shown to inhibit bacterial TK.
[13,14]
However, nucleoside analogues can be associated with cyto-
toxicity when phosphorylated to triphosphates and incorpo-
rated into DNA, thereby leading to single-strand
breaks.
[15,16] Screening for non-nucleoside analogues as po-
tential thymidine kinase inhibi-
tors is therefore of particular
interest for the development of
novel antibiotics.
This study was aimed at
1) screening for non-nucleoside
analogue inhibitors of S. aureus
thymidine kinase by multistep
virtual screening, and 2) deter-
mining the in vitro activity of
these thymidine kinase inhibi-
tors against S. aureus in combi-
nation with SXT in the pres-
ence of thymidine.
Results and Discussion
Substances that interact with
viral and human thymidine kin-
ases have been studied for
many decades and several com-
pounds have been found that
exhibit high antiviral or anticancer activity.
[17,18] In contrast,
inhibitors of bacterial thymidine kinases have not attracted
much attention in antibacterial research.
[10,15,19,20] In most
bacteria intracellular dTMP can be synthesized by two dif-
ferent pathways, which suggests combinations of bioactive
agents inhibiting both pathways simultaneously.
[10] Thymi-
dine kinase inhibitors impair the salvage pathway for dTMP,
which is initiated by thymidine kinase catalyzing the transfer
of a gamma-phosphate group from adenosine-5’-triphos-
phate (ATP) to thymidine.
[21] Folic acid antagonists inhibit
different enzymatic steps of the bacterial synthesis of meth-
ylenetetrahydrofolate, an essential cofactor of thymidylate
synthase for generation of dTMP from deoxyuridine mono-
phosphate (dUMP). Simultaneous inhibition of both path-
ways therefore results in an intracellular lack of dTMP
[22]
and synergistic antimicrobial activity in the presence of thy-
midine.
[10]
Comparative protein model: Here we used a virtual screen-
ing protocol to find potential thymidine kinase inhibitors
with non-nucleoside structures. A crucial step of our screen-
ing protocol comprised automated docking of selected com-
pounds into a homology model of S. aureus thymidine
kinase (SaTK). Several bacterial thymidine kinases can be
crystallized, such as thymidine kinases from S. aureus
(SaTK, PDB identifier: 3e2i), Ureaplasma urealyticum, Ba-
cillus cereus, and Bacillus anthracis.
[13,20,23] As a crystal struc-
ture of SaTK in the presence of a natural ligand (thymidine)
is not known, we used the structure of Bacillus anthracis
thymidine kinase (BaTK, PDB identifier: 2j9r, resolution:
2.7  )
[20] as template for this purpose as the best available
model. A sequence alignment between BaTK and SaTK ex-
hibits sequence identity of 63% overall and 100% in the
thymidine binding-site residues (Figure 1). Consequently,
the resulting homology model (SaTK) shows excellent struc-
tural agreement with the template (BaTK), especially in the
thymidine binding site (Figure 2). A continuous sequence
stretch from BaTK comprising 17 residues is missing in the
template structure. This part is predicted to form a helix in
the homology model of SaTK. TKs of ATCC 29213 and
ATCC 700699 have perfect sequence identity. This justifies
employing one homology model for both proteins.
We explicitly did not perform docking studies on an exist-
ing crystal structure of SaTK (PDB identifier: 3e2i).
[23] The
need for a homology model regardless of an existing struc-
ture of the target protein is rationalized by the fact that the
structure of SaTK has been crystallized in its apo form (i.e.,
no bound thymidine). It was shown that TKs of several mi-
croorganisms undergo substantial structural changes in a
loop region forming the upper part of the binding pocket
upon thymidine binding.
[24] This renders the existing X-ray
structure of the SaTK in its apo form unsuitable for docking
efforts. It is therefore not surprising that a comparison be-
tween the homology model of SaTK and the respective crys-
tal structure of the apo form exhibits a relatively high root-
mean-square deviation (RMSD) of 3.9  . This finding origi-
nates from 1) a deviation in the position of the loop region
of SaTK that depends on the missing ligand binding and
2) the fact that a part of the sequence corresponding to the
one missing in the template structure of BaTK is also absent
in the structure of the SaTK apo form (Figure 3).
Figure 1. Sequence alignment of thymidine kinases. The first two sequences represent the alignment that was
used for the homology model (63% sequence identity). PDB entry 2j9r of B. anthracis thymidine kinase
misses some parts of the complete sequence (highlighted by black boxes and white letters) in the complete
protein sequence, third line. A continuous gap was inserted at the corresponding position. Complete sequence
identity of binding pocket residues (gray boxes) can be observed.
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we used 5-chloro-2’-deoxyuridine (5-CldU, 3) with a minimal
inhibitory concentration (MIC) of 0.0625 mgL
 1 against
both S. aureus strains when combined with SXT in the pres-
ence of thymidine (1). The same MICs were determined for
5-iodo-2’-deoxyuridine (5-IdU, 2), another ligand of bacteri-
al thymidine kinase.
[14] SXT alone in the presence of thymi-
dine showed MIC values of >128 mgL
 1 against both S.
aureus strains (not shown). 5-CldU and 5-IdU were chosen
as reference ligands because halogenated 2’-deoxyuridine
derivatives have recently been reported as thymidine kinase
inhibitors showing significantly improved antimicrobial ac-
tivity against S. aureus when combined with SXT in the
presence of elevated thymidine concentrations.
[10] Moreover,
Kosinska and co-workers showed that thymidine kinase
from Ureaplasma urealyticum exhibits pronounced phos-
phorylation activity with 5-CldU as substrate.
[13] In a first
study, we re-docked the natural ligand thymidine and the
screening reference 5-CldU to obtain a reference value for
the assessment of docking scores and to evaluate the perfor-
mance of our docking protocol. Notably, automated ligand
docking was able to reproduce the binding pose of thymi-
dine. Thymidine and 5-CldU achieved favorable comparable
docking scores of 37 and 38, respectively (higher docking
scores suggest better ligand binding; Table 1).
Virtual screening protocol: We followed a stepwise virtual
screening protocol (Figure 4). A diverse screening library
containing approximately 557000 readily available com-
pounds from two different suppliers was prepared. The first
virtual screening step consisted of a rigorous reduction of
the screening library (“negative design”) by similarity analy-
sis of pool compounds with the reference ligand 5-CldU
(Table 1). For this purpose an in-house implementation of a
self-organizing map (SOM)
[25] was employed to map the
screening pool (represented in a high-dimensional space
spanned by uncorrelated molecular descriptors) to a two-di-
mensional (2D) regular grid, as described.
[26] The SOM al-
lowed for the identification of a cluster of 912 compounds
Figure 2. Binding-site model of SaTK. Left: Comparison of a homology
model of S. aureus thymidine kinase and the template structure of B. an-
thracis thymidine kinase (PDB entry: 2j9r, chain A), together with bound
native ligand thymidine. The missing part of the template (cf. Figure 1) is
predicted to form a helix (arrow) flanked by two loop regions. Right:
Perfect alignment between amino acid side chains of the model (transpar-
ent) and the template (solid). Identifiers of selected pocket residues of
the model and a short stretch of the backbone (sketched) are shown for
orientation.
Figure 3. Comparative “homology” model of SaTK. Comparison of the
homology model of S. aureus thymidine kinase (light gray) and an exist-
ing X-ray apo structure of the same protein (dark gray, PDB entry: 3e2i).
Structural difference can be found mainly in the position of the loop de-
fining the upper part of the binding cavity upon ligand binding (arrow).
Bound glycerol (not shown) does not populate the thymidine binding
pocket in structure 3e2i. As within the structure of thymidine kinase of
B. anthracis that was used as template for homology modeling, an equiva-
lent part of structure 3e2i is missing (dashed circle).
Table 1. Reference compounds and values. Minimal inhibitory concentra-
tion (MIC) values measured for both S. aureus strains, and docking
scores.
Structure MIC [mgL
 1] Docking
ATCC
700699
ATCC
29213
score
(ASP)
1
– – 37
thymidine
2
0.0625 0.0625 38
5-iodo-2’-deoxyuridine (5-
IdU)
3
0.0625 0.0625 38
5-chloro-2’-deoxyuridine
(5-CldU)
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(“positive design”).
These candidate ligands were considered for the next
screening steps. Three ligand-based screening techniques—
each one focusing on a different aspect of ligand similari-
ty—were applied on this small pre-filtered compound collec-
tion with respect to the same
reference ligand (5-CldU):
1) The pharmacophore align-
ment search tool
(PhAST)
[27] compares mole-
cules by aligning strings of
pharmacophoric feature
types devised from their 2D
representation.
2) Pseudoreceptor point simi-
larity (PRPS)
[28] computes
pseudoreceptor representa-
tions of molecules based on
three-dimensional (3D) con-
formations.
3) ShaEP
[29] calculates a simi-
larity score by comparing
3D conformers with respect
to spatial overlap of shape
and electrostatic potentials.
PhAST was applied in two
different modes of structure
canonization (for more infor-
mation, see the Experimental
Section) resulting in a total of
four individual screening runs.
Each method provided us with
a sorted list of the remaining
912 screening compounds,
ranked according to the scoring
schemes of the methods. Molecules ranked among the top
50 of each individual list were subsequently docked into a
homology model of S. aureus thymidine kinase. Compounds
from the top scoring ranks with plausible docking poses
yielding high docking scores and hydrogen bridges similar to
the reference ligands were considered for further investiga-
tion. We selected and ordered 14 compounds, which were
tested in vitro for their biological activity on S. aureus thy-
midine kinase. A bacterial whole-cell assay was chosen to
see whether virtual screening can cope with antibacterial ac-
tivity without explicitly predicting this property. Out of the
14 tested compounds, seven compounds (4–10) exhibit anti-
microbial activity against S. aureus strain ATCC 700699 and
S. aureus ATCC 29213 when combined with SXT in the
presence of thymidine (Table 2). None of these compounds
had any intrinsic antimicrobial activity (data not shown).
The fact that 50% of the 14 compounds chosen for in vitro
screening showed antimicrobial activity when combined
with folic acid antagonists argues for an effective first
screening round. Based on the findings of the first screening
two parallel strategies were applied to select compounds in
a second screening round:
1) A second pseudoreceptor model using our software
PRPS was employed to screen the complete compound
Figure 4. Virtual screening protocol. The second test round was per-
formed on the complete screening compound library with the best hits
from the first screening round.
Table 2. Results of the first round of virtual screening and in vitro tests. MIC values represent the median of
three experiments.
Structure MIC [mgL
 1] Docking Virtual screening rank
ATCC 700699 ATCC 29213 score (ASP) P1
[a] P2
[b] PRPS ShaEP
4 128 128 36 3 2 – –
5 128 128 38 11 41 – –
6 128 128 39 17 18 – –
7 128 >128 31 – – 2 –
8 128 128 26 – – 6 –
9 32 64 42 – 8 5 –
10 32 64 41 – – – 18
[a] PhASTwith Isomap canonization. [b] PhASTwith Prabhakar canonization (cf. Experimental Section).
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Multistep Virtual Screeninglibrary ( 557000 molecules) again. The model was built
from all seven active compounds found in the first
screening round. Reference compounds were aligned ac-
cording to their docking poses.
2) Compound 10 contains a catechol moiety that is buried
deep inside the thymidine binding site according to the
docking hypothesis. This “head group” is of particular in-
terest as it is structurally distinct from nucleosides.
Therefore, we performed a substructure search for com-
pounds featuring this head group.
The top-scoring 100 molecules of the PRPS screening
with the second pseudoreceptor model were docked into the
homology model, and seven compounds were selected for
testing, from which six compounds (11–16) exhibit antimi-
crobial activity in combination with SXT. Compound 16 has
higher activity than the best compounds 9 and 10 found in
the first screening round (Table 3). In addition, we retrieved
50 compounds containing the head group identified as
promising in round one and docked them into the homology
model. Compounds 17–24 were selected for testing accord-
ing to plausibility of generated poses, high docking scores,
and structural variations of the “tail group”. All eight sub-
stances exhibit the desired effect (hit rate 100%) with six
compounds showing improved MIC values with respect to
compounds of test round one. The most potent compound,
24, exhibits a MIC value of 0.25 mgL
 1 on both S. aureus
strains when combined with SXT in the presence of thymi-
dine, which is only fourfold less potent than 5-CldU and 5-
IdU (Table 4). Again, docking of 24 suggests that the head
group is buried in the binding pocket while the methylqui-
noline tail group interacts with the protein surface outside
the cavity (not shown).
Compound 24 has a rather poor ligand efficiency
[30] [LE=
 lnACHTUNGTRENNUNG(MIC)/(no. of non-hydrogen atoms)] of 0.06. For both
reference compounds, 5-IdU and 5-CldU, we obtained an
LE value of 0.16. Although the primary aim of this work
was to identify non-nucleoside inhibitors of SaTK, the moti-
vating findings suggest that there is room for further optimi-
zation with respect to both binding affinity and molecular
mass.
Five compounds (19, 20, 21, 23, 24) exhibit intrinsic anti-
microbial activity. MICs of these compounds in the presence
of thymidine against S. aureus strains ATCC 29213 and
ATCC 700699 are given in Table 5. MICs are substantially
higher than those obtained in combination with SXT. The
fact that the substances tested in this study showed no or
only weak intrinsic antimicrobial activity is consistent with
mainly thymidine kinase inhibition. It is known that some
thymidine kinase inhibitors such as 5-fluoro-2’-deoxyuridine
also inhibit thymidylate synthase and as a consequence have
intrinsic antimicrobial activity.
[15] Future studies aiming at
hit-to-lead structure optimization should use direct bacterial
thymidine kinase inhibition assays to verify thymidine
kinase being the target of these non-nucleoside antibiotics.
Conclusion
Our study demonstrates that multistep virtual screening can
help identify bioactive substances from a large screening
compound pool with limited experimental effort. Rapid fo-
cusing on promising candidate structures was possible, so
that inhibitors of bacterial thymidine kinase with non-nu-
cleoside scaffolds were identified. These inhibitory com-
pounds exhibit moderate to high antimicrobial activity when
combined with folic acid antagonists in the presence of thy-
midine, and provide rich opportunity for further optimiza-
tion. Notably, at least two subsequent screening rounds were
Table 3. Screening results of the second PRPS model based on the active
compounds of the first round. MIC values represent the median of three
experiments.
Structure MIC [mgL
 1] Docking
ATCC
700699
ATCC
29213
score
(ASP)
11 128 128 45
12 128 128 41
13 128 128 41
14 64 128 42
15 32 128 43
16 16 16 45
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tion gained about the structuring of the chemical space
spanned by the screening compound pool for “adaptive” op-
timization based on iterative learning.
[31] We suggest explo-
ration of the full potential of
adaptive multistep and multi-
method virtual screening in
early drug discovery projects,
[32]
which might speed up the tran-
sition from biological target val-
idation to chemical hit and lead
structure optimization.
Experimental Section
Strains and genetic sequence determi-
nation of bacterial thymidine kinase:
S. aureus strain ATCC 700699 is resist-
ant to methicillin (MRSA) and exhib-
its reduced susceptibility to vancomy-
cin.
[33] The genetic sequence of its thy-
midine kinase-encoding tdk gene was
published in 2001 as part of the whole
genome sequence.
[34] Methicillin-sus-
ceptible S. aureus strain ATCC 29213
serves as a quality-control strain for
antibiotic susceptibility testing.
[35] The
chromosomal tdk gene of S. aureus
strain ATCC 29213 was amplified by
polymerase chain reaction (PCR) with
forward primer P1 (5’-GCGAT-
TATGTTTTGAAAAAGGTGG-3’)
and reverse primer P2 (5’-
GTTCGTATCTTTCTTCTACAA-
TATC-3’). The nucleotide sequence of
the tdk gene of S. aureus ATCC 29213
was determined by cycle sequencing
using an ABI PRISM DNA sequencer
(Applied Biosystems, Foster City,
USA).
Compound library: Virtual screening
was performed with a structurally di-
verse set of compounds from supplier
catalogues of Specs (v01/2009, Specs,
Delft, The Netherlands) and Asinex
Gold and Platinum collections (v11/
2008, Asinex, Moscow, Russia). Proto-
nation states of all compounds were
standardized (“washed”) using the
“wash” function of MOE (v2008.10,
Chemical Computing Group, Montreal, QC, Canada). Single three-di-
mensional conformations for each screening compound were computed
with the software CORINA (v3.2, Molecular Networks, Erlangen, Ger-
many).
Self-organizing map: The reference compound 5-CldU was added to the
screening library before the calculation of all 184 2D descriptors of MOE
for each molecule. Principal component analysis
[36] revealed that 95% of
the variance in the dataset could be explained using the 40 first principal
components, so these uncorrelated descriptors were used for representing
the screening compound library. We used an implementation of the self-
organizing map (SOM)
[25] algorithm to further reduce the dimensionality
of the dataset.
[26] The SOM performed a nonlinear mapping from the
original descriptor space (here: 40-dimensional) on a two-dimensional
map. Each molecule is assigned to one of the receptive fields (clusters) of
the SOM. We used a SOM with a topology of 20 30 neurons (600 recep-
tive fields) organized as a torus. The SOM was trained in 5 10
6 cycles.
The parameter defining the decay of weight update during training was
initialized with 1. The initial width of the Gaussian neighborhood func-
tion was 5. Distances were calculated as the Euclidean distance. From
Table 4. Results of substructure screening. The dihydroxyphenyl head group is preserved in all active mole-
cules. MIC values represent the median of three experiments.
Structure MIC [mgL
 1] Docking
ATCC 700699 ATCC 29213 score (ASP)
17 128 >128 37
18 128 128 39
19 16 8 43
20 8 8 46
21 4 2 41
22 4 2 45
23 1 1 38
24 0.25 0.25 39
Table 5. Intrinsic antimicrobial effect of non-nucleoside analogues. MIC
values were measured in the presence of thymidine (200 mgL
 1) and ab-
sence of SXT against both S. aureus strains. Values are medians of three
experiments.
MIC [mgL
 1]
ATCC 700699 ATCC 29213
19 128 128
20 64 128
21 64 64
23 16 32
24 32 32
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containing the reference compound for the virtual screening process.
PhAST: The pharmacophore alignment search tool (PhAST) is a string-
based approach to virtual screening.
[27] It reduces each molecule to an un-
ambiguous linear representation describing its pharmacophoric fea-
tures—called  PhAST-sequence —in three steps: 1) each non-hydrogen
atom in the structure graph is replaced by a potential pharmacophoric
point symbol; hydrogen atoms are removed; 2) vertices of this pharmaco-
phoric feature graph are canonically labeled, and 3) vertex symbols are
concatenated into a string in increasing order of their canonical labels.
For virtual screening, both the screening compound collection ( library )
and the query molecules were converted and the resulting PhAST se-
quences were compared using pairwise global sequence alignment.
[37] As
a result, molecular similarity values are computed from the pairwise
alignments, which were used for the retrieval of molecules with similar
pharmacophoric features from a compound database. PhAST distin-
guishes between nine different potential pharmacophore points: positive
charge; negative charge; aromatic; lipophilic; hydrogen-bond donor; hy-
drogen-bond donor and acceptor; hydrogen-bond acceptor and positive
charge; hydrogen-bond donor and acceptor and positive charge; no inter-
action. The original version of PhAST uses the algorithm of Weininger
et al.
[38] for canonization. In this work we employed the algorithm by
Prabhakar and Balasubramanian
[39] (referred to as  PhAST Prabhakar’)
and the Isomap algorithm
[40] (referred to as  PhAST Isomap’). PhAST
Prabhakar was used with gap open penalty=5 and gap extension penal-
ty=1; PhAST Isomap with gap open penalty=8 and gap extension pen-
alty=1. With all versions of PhAST the published standard score matrix
was used.
[27] In contrast to the original version of PhAST, we calculated
the alignment score normalized to the alignment length as a similarity
measure between aligned sequences instead of sequence identity. These
modifications were shown to be superior to the original approach.
[41]
PRPS: Pseudoreceptor point similarity (PRPS) is a virtual screening tool
bridging receptor- and ligand-based screening techniques.
[28] Starting
from a 3D conformation of a ligand, PRPS projects potential interaction
points into the surrounding space mimicking a surrounding “idealized”
receptor pocket. Location of interaction points depends on known pre-
ferred distances and angles of the respective hypothetical interaction, as-
sumed to be possible at this position of the ligand. The type of an interac-
tion point (hydrogen-bond donor, hydrogen-bond acceptor, p stacking
(“aromatic”)) is complementary to the respective potential pharmaco-
phoric point of the ligand. The spatial arrangement of generated interac-
tion points is then transformed into an alignment-invariant representa-
tion as a cross-correlation descriptor. PRPS compares two molecules by
calculating the Euclidian distance between their descriptor representa-
tions. A PRPS model can be computed for a single ligand or for a set of
multiple ligands. In the latter case the model is built based on an align-
ment of all compounds, and projected interaction points are weighted by
the number of molecules that projected them to the same location.
ShaEP: ShaEP is a tool for 3D ligand-based virtual screening that evalu-
ates the similarity between two molecules by means of spatial overlap in
volume and calculated electrostatic potential fields.
[29] Rigid body align-
ment of the molecules is performed to optimize overlaps. Ligand flexibili-
ty can be addressed implicitly by not only comparing a single conforma-
tion of both molecules but instead by performing an exhaustive pairwise
comparison of conformation ensembles. For ShaEP screenings, up to 10
conformations of both the reference ligand and each screening compound
were generated using the stochastic conformer generation routine of
MOE. Partial charges for every conformation were calculated according
to the MMFF94 parameter set available in MOE. Only the highest score
of all pairwise comparisons was considered for the final ranking of
screening compounds.
Homology model: A comparative protein model (“homology model”) of
SaTK was built using the web service of Swiss Model
[42,43] in automated
mode. The crystal structure of Bacillus anthracis thymidine kinase (PDB
identifier: 2j9r, chain A) served as template. The query sequence was de-
rived from S. aureus ATCC 700699 thymidine kinase (access number:
NP_372643).
Automated ligand docking: Docking experiments were performed using
the software GOLD
[44] with the ASP scoring function. Residues F92,
L116, D119, F120, F125, T155, R157, I170, I171, L172, V173, G174, and
Y179 defined the binding site. Initial 3D conformations of docked com-
pounds were calculated by CORINA prior to docking.
Microdilution assay: Minimal inhibitory concentrations (MICs) of the po-
tential different thymidine kinase inhibitors alone and in combination
with SXT against S. aureus strain ATCC 700699 and S. aureus ATCC
29213 in the presence of thymidine were determined according to Clini-
cal and Laboratory Standards Institute (CLSI) guidelines with some
modifications.
[34] Therefore, a bacterial suspension (95 mL, exponential
growth phase) of S. aureus strains (ca. 5 10
5 cellsmL
 1) in cation-adjust-
ed Mueller–Hinton broth (Becton, Dickinson and Company, Sparks,
USA) supplemented with thymidine (200 mgL
 1; Sigma–Aldrich, Munich,
Germany) and with or without trimethoprim/sulfamethoxazole (40 mg)
in a ratio of 1:19 (both Sigma–Aldrich) was added to each well of a 96-
well microtiter plate (Greiner, Monroe, USA). A solution (5 mL) of dif-
ferent potential thymidine kinase inhibitors in various dilutions was
added to each well (range of final concentrations: 0.03125 to 128 mgL
 1).
After 20 h of incubation at 378C, MICs were determined. Experiments
were performed in triplicate.
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